Remdesivir Is the First FDA-Approved Treatment for COVID-19

On Oct. 22, the Food and Drug Administration (FDA) approved the first drug for treating COVID-19. Remdesivir, an antiviral medication given intravenously, is now approved for anyone hospitalized with COVID-19. It works by blocking the virus’s ability to make more copies of itself. Earlier this year, the drug had received emergency use authorization (EUA), which falls short of approval but is granted during a public health crisis if there is encouraging data supporting its potential benefits. Approval means the drug’s maker, Gilead, provided more information to the FDA on the medication’s effectiveness and safety than was used to issue the EUA.

“This decision by the FDA is a milestone in the treatment of hospitalized patients with COVID-19,” says Dr. Andre Kalil, professor of internal medicine at University of Nebraska Medical Center who was among the first to treat patients from the Diamond Princess Cruise ship with remdesivir and runs one of the drug’s clinical trials. “Remdesivir shortens the recovery time by 5-7 days, provides 50% faster clinical improvement, prevents patients’ progression to mechanical ventilation, and is associated with a 45% mortality reduction in the first two weeks of disease. These are real and meaningful benefits to our patients.”

The FDA decision is based on three randomized controlled trials that found that people receiving remdesivir shortened their recovery time. While the data did not find a statistically significant benefit in reducing mortality, doctors involved in one of the studies, published in the New England Journal of Medicine (NEJM), reported a trend toward reduced mortality after about a month, especially among people who received the drug early in their infection, as Kalil notes. Patients receiving the drug also needed less additional oxygen and were less likely to progress to severe disease compared to those receiving placebo. The NEJM study was placebo-controlled and supported by the U.S. National Institute of Allergy and Infectious Diseases.

The other two studies, sponsored by Gilead, did not include placebo controls, but compared patients receiving the drug and standard of care to those getting standard of care alone. The drug was effective, and those receiving five days of remdesivir treatment improved as much as those receiving a 10-day course.

The National Institutes of Health now includes remdesivir as part of its recommended treatment strategy for hospitalized COVID-19 patients, and doctors treating patients have said that the drug is one of the reasons that death rates from the disease may have started to drop since the beginning of the pandemic. Other medications and treatment strategies, such as anti-inflammatories and keeping patients on their stomachs to prevent worsening respiratory symptoms, are other likely contributors to the decline in death rates.

The FDA approval comes days after a study from the World Health Organization found no benefit of the drug in reducing early death or in preventing progression to serious disease among nearly 3000 COVID-19 patients. That study, however, did not include a placebo control and compared outcomes to standard of care. It’s also not clear how sick the patients in that study were and therefore how meaningful the results are.

The NEJM study included hints that people who receive the drug earlier in their disease may benefit more, and doctors are already studying whether people with mild symptoms but who don’t need to be hospitalized can be treated with remdesivir on an outpatient basis.

Cyber Attack on Vaccines

Indian drugmaker Dr Reddy’s, which is to run clinical trials of Russia’s Sputnik V Covid-19 vaccine, said it has isolated all its data centres in the wake of a cyber-attack. “We are anticipating all services to be up within 24 hours and we do not foresee any major impact on our operations due to this incident,” the company said in a statement.

Business news channel ET Now, citing sources, said the company has shut all key plants across the globe due to the data breach. The plants in the UK, US, Brazil, India and Russia have been impacted due to the breach.

It is not yet known if the attack was related to Dr Reddy’s work on Covid-19. Beside the trial of the Russian vaccine, the drugmaker also has tie-ups with global firms to sell coronavirus treatments remdesivir and favipiravir in India.

Cyber-attacks to steal proprietary information is not rare. Early in July, security agencies of the United States, United Kingdom and Canada said a Russia-linked hacking group is targeting universities involved in the Covid-19 vaccine research. The same month, the Indian Computer Emergency Response Team (CERT-In), India’s nodal cybersecurity agency, said Indian healthcare services and educational institutions have faced increased cyber-attacks from China and Pakistan since the nationwide lockdown in mid-march.

COVID Vaccination Best for the Older Adults

The Covid-19 vaccine candidate developed by the Oxford University and AstraZeneca has prompted a robust immune response in elderly people, the Financial Times reported, citing people familiar with the findings. The observations are from the so-called immunogenicity blood tests done on a subset of older participants of the trial. Oxford has not officially commented on the report.

A safe and effective vaccine for the elderly is crucial to beat the pandemic as they are among the most at-risk population. But the fact that the immune system weakens with age, raises fears that the very group that most needs the protection may generate the least effective response against a vaccine.

“If what they have is data which shows that the vaccine generates good immunity, as measured in the laboratory, in the overage group — plus 55-year-old — and that also includes good responses in people who are even older than that, I think that’s a promising sign,” Jonathan Ball, professor of virology at the University of Nottingham, said.

Another candidate to have shown promise among the elderly is the mRNA vaccine developed by Moderna, though that too is a preliminary finding. Russia’s Gamaleya Institute has also claimed that its Sputnik V is effective on the elderly but the claim has not been independently reviewed.

The FT report comes shortly after Oxford-AstraZeneca received clearance from the US FDA to restart its trial in the country after pausing it due to potential safety concern — a volunteer in the UK trial had fallen ill.

“The restart of clinical trials across the world is great news as it allows us to continue our efforts to develop this vaccine to help defeat this terrible pandemic,” Pascal Soriot, AstraZeneca’s CEO, said in a statement. The US trial of the vaccine candidate developed by Johnson & Johnson, too, is set to resume after a brief pause.

You can come to India for family or business, but not for pleasure The Ministry of Home Affairs (MHA) on Thursday came out with a notification permitting “all OCI and PIO card holders and all other foreign nationals intending to visit India for any purpose, except on a tourist visa“.

Announcing the “graded relaxation”, the MHA will “restore with immediate effect all existing visas (except electronic visa, Tourist Visa and Medical Visa)” — for visas that may have expired, fresh visas will be issued while for medical visa, foreign nationals need to apply afresh.

The Centre had on March 11 suspended all visas, with relaxation being granted in June for “foreign businessmen coming to India on a Business visa” and those coming for purposes of work.

It may be recalled that hotels were allowed to reopen only in August while tourist sites like the Taj Mahal were reopened last month. Though foreign tourists constitute just 0.5% of all tourists — India received 10.89 million foreign tourists in 2019 — the country earned almost Rs 2.11 lakh crore as forex from them last year.

AAPI Expresses Grief Over the Passing Away of Dr. Mukul Chandra

(Chicago, IL: October 24th, 2020) (Chicago, IL: October 24th, 2020) “We are deeply saddened and disheartened at the passing away of Dr. Mukul Chandra, a cardiologist and network wellbeing advocate, died on Sunday, October 18th, because of harms brought about by COVID.” Dr. Sudhakar Jonnalagadda, President of American Association of Physicians of Indian Origin (AAPI) said here today. Dr.Chandra passed away peacefully at the Cleveland Clinic in the presence of his family on Sunday, October 18, 2020. Dr. Chandra graduated from MS University in Baroda, India, and completed further trainings at SGPGI Lucknow, India; Hadassah University Hospital Ein Kerem – Jerusalem, Israel; and Emory University, Atlanta. He completed his cardiology fellowship at the University of Texas Medical Branch. Dr. Chandra served as Medical Director of Cardiac Preventive Care and Research at And was the Vice Chair of the Cardiovascular Service Line at Miami Valley Hospital. He also was an Assistant Clinical Professor at Wright State University. He was the recipient of the 2008 AHA Distinguished Achievement Award and the Health Care Hero and Innovator of the Year Award from the Dayton Business Journal. Dr. Dr.Mukul S Chandra is yet another physician of Indian Origin who has succumbed to the deadly virus, after a long battle against COVID-19 and related complications. Dr. Chandra is survived by his wife Arti, son Shubham, and daughter Aayushi. “Thank you all from the bottom of our hearts for your tremendous support through last 7 months. Your support through calls, prayers and positive thoughts have provided great comfort to the family and friends through this difficult journey,” the family acknowledged in a report. The family reported that Dr. Chandra died on Sunday from lasting damages following a COVID-19 diagnosis earlier this year. “He was always thinking of the people of Dayton. Their love supported him and carried him, and all of us, through our hardest months,” Shubham said. “Indian American Physicians are bearing the brunt of this pandemic in the US,” said Dr. Sajani Shah, Chair of AAPI BOT. “Not a day goes by without hearing about many of them getting infected with Coronavirus, and several of them fighting for their life, because of their disproportionate share of the population in the Healthcare field. This pandemic is hitting close to home for me and my colleagues,” Dr. Shah added.Dr. Anupama Gotimukula, President-Elect of AAPI, pointed to the fact that “The deadly Corona virus has claimed over a million deaths around the world with the US leading the chart with nearly 212,000 deaths. The pandemic has placed the entire healthcare sector, and in particular the Indian American medical fraternity at the frontlines of the fight against the pandemic.” Dr. Priya Khanna, 43, an Indian American nephrologist died in a New Jersey Hospital. Her father Satyendra Khanna (78), a general surgeon was another Indian American who has sacrificed his life while saving the lives of others. Dr. Ajay Lodha, past president of AAPI is battling for his life with complications from the virus. “We have a proud moment, it is (also) a scary moment; it is a mixed feeling, but this virus is a deadly virus” Dr. Ravi Kolli, Vice President of AAPI, describing the situation under which the physicians of Indian Origin serving people infected with the virus. “They tend to work disproportionately in areas that are medically underserved like rural and inner city areas taking on a heavier workload with patients who are more ill. We are definitely in the frontline fighting this deadly battle,” against the coronavirus, Reddy said. “Our Indian American Physicians are down in the trenches in the frontline bravely taking care of the sick,” Dr. Amit Chakrabarty, Secretary of AAPI pointed out.  “Unfortunately, we have had multiple heart-bearing incidents about our physicians that have contracted the disease while performing their duties, several who are on ventilator and in critical condition and some who have succumbed to the disease.   However, undaunted, they continue to perform their duties in this time of national crisis.” Expressing hope, Dr. Satheesh Kathula, Treasurer of AAPI says, “AAPI members continue to donate money for AAPI to provide essential personal protective equipment to areas that are in short supply. Finally, AAPI has provided through various channels, spiritual and motivational guidance to our members and their families.  We are in this together.” There are about 80,000 practicing Indian American physicians who are at the forefront of fighting COVID-19 pandemic in the United States. In addition, there are around 40,000 medical students, residents, and fellows of Indian origin in this country who are supporting many of the hospitals affected by the pandemic. As the family and friends continue to grieve the death of Dr. Mukul Chandra, we are hearing from one of his friends. In a statement, Premier Health said in part, “He was a prolific educator in our Dayton community, and served as a leading spokesperson for the local American Heart Association, always looking for ways to share information about heart health. We realize every day that COVID is so unpredictable, there isn’t an age demographic, there isn’t a race, there isn’t a social-economic status it affects. The Chandra Family had released a statement earlier: “The Chandra family has been overwhelmed by the wonderful outreach from both those in the local community and those around the world who have rallied in their time of great need. They are extremely humbled and thankful for the tireless work of so many. We respectfully ask you refrain from contacting the family or caregivers directly. This will allow us to focus on providing our energy to support the recovery of Dr. Chandra. Thank you for your support, cooperation and understanding.” The family says they are not accepting donations at this time, but they will be asking people to donate to a local organization in lieu of flowers. The wake and funeral services will be  held on 10/24/2020, Saturday at 10:30am ET. Please find the zoom link below to join. Date and time: 10/24/2020, 10:30am – 12pm. Zoom link: https://relx.zoom.us/j/95199885485 If unable to login the above Zoom meeting, please watch the service below: https://www.youtube.com/channel/UCX1rDhDYhGcYgblrvh3I8Gg Donations in lieu of flowers may be sent to Community Health Centers of Dayton, https://www.communityhealthdayton.org 

 

AAPI-AHA Jointly Organize World Restart A Heart Day

 Sudden cardiac arrest is a serious public health crisis costing about 360,000 human lives here alone in the United States. Studies have shown that immigrants from India, Pakistan, Bangladesh, Sri Lanka and Nepal are experiencing a dramatic rise in heart disease. South Asians make up 25 per cent of the world’s population but they contribute 50 percent to global cardiovascular deaths.

Unfortunately 9/10 persons with sudden cardiac arrests do not survive but if rescued by timely CPR before the emergency help arrives, then we can double or triple the chances of recovery. Majority of cardiac arrest patients have underlying coronary disease but for some especially, South Asians,  who have this problem could recognize the manifestation of this illness very late.

With an ever increasing need  in reducing morbidity and mortality due to heart attacks and strokes, especially among Indians and  Indian Americans, the American Association of Physicians of Indian Origin (AAPI) and the American Heart Association (AHA) joined hands together for the first time for a Global Initiative, World Restart A Heart Day with the objective of raising awareness about “Sudden Cardiac Arrest“ and how “Hands Only CPR“ is done  at home, thus rescuing and saving the lives of our loved ones on Sunday, October 18, 2020.

Francesca Martinez, representing AHA addressed the event. Panelists at the live virtual session included, Dr. Kapil Pareek, a SCD survivor; Anupama Gotimukula, President-Elect of AAPI; Dr. Brahma Sharma, Cardiologist; and Dr. Sudhakar Jonnalgadda, President of American Association of Physicians of Indian Origin (AAPI).

Dr. Sudhakar Jonnalgadda said this is first time in AAPI history in Association with AHA observe the world restart Heart Day. It’s a total commitment to the joint efforts by AAPI and AHA. “I am very impressed with the energy and strength of the leaders who have taken upon themselves this noble task on creating awareness and educating the physicians and the public on this very serious disease, especially among South Asians in the US. We have the talents, skills, strength and the commitment. Let’s put them to work and help our brethren.”

The World Federation Societies of Anesthesiologists (WFSA), in collaboration with the International Liaison Committee on Resuscitation (ILCOR) runs the “World Restart a Heart Day,” a global campaign on the occasion of World Anesthesia Day. This is a global initiative, started in 2018 to increase the awareness of Bystander-CPR, in addition to increasing the overall Bystander CPR rates.

Dr. Brahma Sharma, a prominent cardiologist, serving as the Chair of the AAPI And AHA Liason Committee on South Asians CVD, said, “For too long, we South Asians have silently suffered from senseless premature death of our loved ones from cardiac arrests in our homes but no more , we have to be proactive so Under this historic AAPI – AHA alliance , we plan to  take this initiative of Hands only CPR” to every household so we can feel comfortable to pitch in and rescue these  previous lives in first few minutes before help arrives “

During the event, AAPI stressed the importance of Hands Only CPR for bystanders and immediately rescue lives and reduce “Out of Hospital Cardiac Arrests. A Hands on only CPR demonstration was led by Dr. Anupama Gotimukula, President-Elect of AAPI. “Every family member needs to know how to do “Hands Only CPR” to save a life from sudden Cardiac Arrest!” It’s a day to commemorate the importance of Anesthesia specialty in the medical field with which we are able to make wonders in the medical field, especially the surgical specialties and able to do all complex surgeries successfully today!!

The AAPI-AHA Liaison Committee Advisor Dr. Vemuri S. Murthy, an advocate of Community and Physician Resuscitation Education and Training for more than three decades in USA and India, in a recent interview, shared his thoughts and concerns regarding current status of the out- of- hospital cardiac arrests and diminishing bystander resuscitation help during COVID-19 pandemic. Cardiopulmonary Resuscitation (CPR), if performed immediately, can double or triple a cardiac arrest victim’s chances of survival. In majority of cases, immediate Hands-only CPR may have similar survival outcomes comparable to the conventional CPR performed with both chest compressions and breaths.

Global evidence-based information has proven that Bystander CPR is life-saving in sudden cardiac arrest. The latter is recognized by sudden collapse of the person without any breathing, pulse or consciousness. It’s important to call 911 first before performing Hands-only CPR. The bystander performing CPR needs to cover the mouth and nose fully with a face mask or cloth. The victim’s mouth and nose must be covered too with a face mask or cloth. Performing Hands-Only CPR involves pushing hard and fast in the center of the chest at a rate of 100 to 120 compressions per minute. Automated External Defibrillator (AED) needs to be utilized as soon as it’s available. This high-quality CPR should be continued by the bystander until the  arrival of paramedics. It’s important to follow the Good Samaritan Laws of a particular US State while performing Bystander CPR.

While serving as an umbrella organization for more than 200 member associations nationwide, AAPI was formed to coordinate the efforts of the physicians of Indian origin, currently working in the United States. Headquartered in Chicago, AAPI has come to be recognized as a strong voice in the healthcare legislation and policy arena. For more information on AAPI, please visit: www.aapiusa.org

UN Survives a World Turned Upside Down

As the United Nations plans to commemorate its annual UN Day, come October 24, Secretary-General Antonio Guterres is presiding over a world body which has remained locked down since last March because of the spreading coronavirus pandemic.

“In a world turned upside down, this General Assembly Hall is among the strangest sights of all,” said Guterres last month, describing the venue of the UN’s highest policy-making body.

At its 75th anniversary last month, the UN resembled a ghost town, with not a single world leader in sight. But an overwhelming majority did address the UN—remotely via video conferencing, for the first time in the history of the 193-member Organization.

Still, the United States was notoriously missing in action (MIA).

“It was like staging Hamlet without the Prince of Denmark,” remarked one delegate, using a Shakespearean metaphor.

The US, which is traditionally given pride of place as host country to the UN, was not represented either by the President, the Secretary of State or the Permanent Representative to the UN (in that pecking order).

The designated speaker for the commemorative meeting was a deputy US Permanent Representative—way done the political hierarchy.

Vijay Prashad, Director of Tricontinental: Institute for Social Research, told IPS the United States stands almost alone in its disdain for the UN and for the goals of the UN Charter of 1945.

Disrespect to the UN at the 75th anniversary meeting comes alongside US withdrawal or pledges to withdraw from UNESCO, UNICEF, UNRWA, and the WHO.

Keep in mind, he said, that the US government has sanctioned senior members of the International Criminal Court (ICC), while US unilateral sanctions against countries such as Cuba, Iran, and Venezuela are a violation of international law.

There is no surprise that no senior official came for the anniversary meeting; in fact, it is to be expected, he added.

The United Nations remains one of the most important institutions committed to international peace and development, declared Prashad, author of thirty books, including Washington Bullets, Red Star Over the Third World, The Darker Nations: A People’s History of the Third World and The Poorer Nations: A Possible History of the Global South.

Meanwhile, as the lock down continued, the overwhelming majority of over 3,000 staffers at the UN, and its affiliated agencies in New York, are working from home.

Speaking of the 75th anniversary meeting, Barbara Adams, chair of the board of Global Policy Forum and former Chief of Strategic Partnerships and Communications for the UN Development Fund for Women (UNIFEM), told IPS: “Yet again people around the world were witnesses to the enormous gap between the well- articulated diagnosis of where we are and what needs to be done not only in the face of COVID-19 but also of pre-existing inequalities, vulnerabilities and multi-dimensional violence.

Could it be, she asked, that the UN has been “captured” as the President of Equatorial Guinea lamented: “We cannot accept [either] that after so many years, the Charter of the UN continues to preserve the primacy of the major powers who trample on the legitimate aspirations of the weak so that they can enjoy the advantages of the UN system.””

Joseph Chamie, a former director of the UN Population Division, and currently an independent consulting demographer, told IPS: “In my opinion I did not hear any significant or noteworthy contributions from world leaders who addressed the meeting.

Their statements were not informative, insightful or inspiring. In brief, their remarks were disappointing and unmemorable, he pointed out.

Chamie said the lofty goals, ideals and accomplishments of the United Nations should have been highlighted and stressed.

During the past 75 years, he argued, the United Nations has accomplished much and contributed greatly to many critical areas, including peace, security, human rights, health, education, women’s equality and development.

“In the next 75 years, the United Nations must promote and expand its essential work for a world population now approaching nearly 8 billion, four times its size when the United Nations was established”.

While many challenges remain, including the current pandemic, this is an opportune time for world leaders to support and strengthen the United Nations and work together on effectively addressing the critical issues of today and tomorrow, said Chamie.

“The spirit, leadership and vision of 1945 can be rekindled and the United Nations revitalized for its indispensable role in the 21st century”, he declared.

The final declaration, which was adopted by the 193 member nations, singled out the UN as the only global organization with the power to bring countries together and give “hope to so many people for a better world and … deliver the future we want.”

https://www.un.org/en/un75

“No other global organization gives hope to so many people for a better world and can deliver the future we want. The urgency for all countries to come together, to fulfil the promise of the nations united, has rarely been greater,” the declaration said.

(By Thalif Deen at IPS)

Mouthwashes, Oral Rinses May Inactivate Human Coronaviruses

Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study. The results indicate that some of these products might be useful for reducing the viral load, or amount of virus, in the mouth after infection and may help to reduce the spread of SARS-CoV-2, the coronavirus that causes COVID-19.

Craig Meyers, distinguished professor of microbiology and immunology and obstetrics and gynecology, led a group of physicians and scientists who tested several oral and nasopharyngeal rinses in a laboratory setting for their ability to inactivate human coronaviruses, which are similar in structure to SARS-CoV-2. The products evaluated include a 1% solution of baby shampoo, a neti pot, peroxide sore-mouth cleansers and mouthwashes.

The researchers found that several of the nasal and oral rinses had a strong ability to neutralize human coronavirus, which suggests that these products may have the potential to reduce the amount of virus spread by people who are COVID-19 positive.

“While we wait for a vaccine to be developed, methods to reduce transmission are needed,” Meyers said. “The products we tested are readily available and often already part of people’s daily routines.”

Meyers and colleagues used a test to replicate the interaction of the virus in the nasal and oral cavities with the rinses and mouthwashes. Nasal and oral cavities are major points of entry and transmission for human coronaviruses. They treated solutions containing a strain of human coronavirus, which served as a readily available and genetically similar alternative for SARS-CoV-2, with the baby shampoo solutions, various peroxide antiseptic rinses and various brands of mouthwash. They allowed the solutions to interact with the virus for 30 seconds, one minute and two minutes, before diluting the solutions to prevent further virus inactivation. According to Meyers, the outer envelopes of the human coronavirus tested and SARS-CoV-2 are genetically similar so the research team hypothesizes that a similar amount of SARS-CoV-2 may be inactivated upon exposure to the solution.

To measure how much virus was inactivated, the researchers placed the diluted solutions in contact with cultured human cells. They counted how many cells remained alive after a few days of exposure to the viral solution and used that number to calculate the amount of human coronavirus that was inactivated as a result of exposure to the mouthwash or oral rinse that was tested. The results were published in the Journal of Medical Virology.

The 1% baby shampoo solution, which is often used by head and neck doctors to rinse the sinuses, inactivated greater than 99.9% of human coronavirus after a two-minute contact time. Several of the mouthwash and gargle products also were effective at inactivating the infectious virus. Many inactivated greater than 99.9% of virus after only 30 seconds of contact time and some inactivated 99.99% of the virus after 30 seconds.   

According to Meyers, the results with mouthwashes are promising and add to the findings of a study showing that certain types of oral rinses could inactivate SARS-CoV-2 in similar experimental conditions. In addition to evaluating the solutions at longer contact times, they studied over-the-counter products and nasal rinses that were not evaluated in the other study. Meyers said the next step to expand upon these results is to design and conduct clinical trials that evaluate whether products like mouthwashes can effectively reduce viral load in COVID-19 positive patients.

“People who test positive for COVID-19 and return home to quarantine may possibly transmit the virus to those they live with,” said Meyers, a researcher at Penn State Cancer Institute. “Certain professions including dentists and other health care workers are at a constant risk of exposure. Clinical trials are needed to determine if these products can reduce the amount of virus COVID-positive patients or those with high-risk occupations may spread while talking, coughing or sneezing. Even if the use of these solutions could reduce transmission by 50%, it would have a major impact.”

Future studies may include a continued investigation of products that inactive human coronaviruses and what specific ingredients in the solutions tested inactivate the virus.

Janice Milici, Samina Alam, David Quillen, David Goldenberg and Rena Kass of Penn State College of Medicine and Richard Robison of Brigham Young University also contributed to this research.

The research was supported by funds from Penn State Huck Institutes for the Life Sciences. The researchers declare no conflict of interest.

About Penn State College of Medicine Located on the campus of Penn State Health Milton S. Hershey Medical Center in Hershey, Pa., Penn State College of Medicine boasts a portfolio of nearly $100 million in funded research. Projects range from development of artificial organs and advanced diagnostics to groundbreaking cancer treatments and understanding the fundamental causes of disease. Enrolling its first students in 1967, the College of Medicine has more than 1,700 students and trainees in medicine, nursing, the health professions and biomedical research on its two campuses.

Are climate scientists being too cautious when linking extreme weather to climate change?

In this year of extreme weather events — from devastating West Coast wildfires to tropical Atlantic storms that have exhausted the alphabet — scientists and members of the public are asking when these extreme events can be scientifically linked to climate change.

Dale Durran, a professor of atmospheric sciences at the University of Washington, argues that climate science need to approach this question in a way similar to how weather forecasters issue warnings for hazardous weather.

In a new paper, published in the October issue of the Bulletin of the American Meteorological Society, he draws on the weather forecasting community’s experience in predicting extreme weather events such as tornadoes, flash floods, high winds and winter storms. If forecasters send out a mistaken alert too often, people will start to ignore them. If they don’t alert for severe events, people will get hurt. How can the atmospheric sciences community find the right balance?

Most current approaches to attributing extreme weather events to global warming, he says, such as the conditions leading to the ongoing Western wildfires, focus on the likelihood of raising a false alarm. Scientists do this by using statistics to estimate the increase in the probability of that event that is attributable to climate change.  Those statistical measures are closely related to the “false alarm ratio,” an important metric used to assess the quality of hazardous weather warnings.

But there is a second key metric used to assess the performance of weather forecasters, he argues: The probably that the forecast will correctly warn of events that actually occur, known as  the “probability of detection.” The ideal probability of detection score is 100%, while the ideal false-alarm rate would be zero.

Probability of detection has mostly been ignored when it comes to linking extreme events to climate change, he says. Yet both weather forecasting and climate change attribution face a tradeoff between the two. In both weather forecasting and climate-change attribution, calculations in the paper show that raising the thresholds to reduce false alarms produces a much greater drop in the probability of detection.

Drawing on a hypothetical example of a tornado forecaster whose false alarm ratio is zero, but is accompanied by a low probability of detection, he writes that such an “overly cautious tornado forecasting strategy might be argued by some to be smart politics in the context of attributing extreme events to global warming, but it is inconsistent with the way meteorologists warn for a wide range of hazardous weather, and arguably with the way society expects to be warned about threats to property and human life.”

Why does this matter? The paper concludes by noting: “If a forecaster fails to warn for a tornado there may be serious consequences and loss of life, but missing the forecast does not make next year’s tornadoes more severe. On the other hand, every failure to alert the public about those extreme events actually influenced by global warming facilitates the illusion that mankind has time to delay the actions required to address the source of that warming. Because the residence time of CO2 in the atmosphere is many hundreds to thousands of years the cumulative consequences of such errors can have a very long lifetime.”

Dr. Sudhakar Jonnalagadda Given Excellence in Leadership Award During IAPC’s 7th Annual International Media Conference

Dr. Sudhakar Jonnalagadda, President of the American Association of Physicians of Indian Origin (AAPI), was conferred the Excellence in Leadership Award during the 7th annual International Media Conference (IMC 2020) organized by the Indo-American Press Club (IAPC) on 18th 2020. Dr. Jonnalagadda was chosen for the prestigious award by IAPC for his great leadership of AAPI, the largest ethnic medical organization in the US, especially during the Pandemic. In his acceptance speech, Dr. Jonnalagadda, said, “Wanted to express my sincere gratitude and appreciation to Indo American Press Club for selecting to receive the Excellence in Leadership Award. As you are aware Wanted to congratulate IAPC for your contributions, especially during the Covid pandemic for being the heroic warriors who work hard and go beyond to report accurately of the challenges humanity faces. Thank you all for reporting and sharing the news about the challenges  and accomplishments of Indian Americans  and in particular those in the Healthcare industry. Congratulations to all of my coawardees.

Dr. Sudhakar Jonnalagadda assumed office as the  37th President of American Association of Physicians of Indian Origin (AAPI) on Saturday, July 11, 2020, and committed himself to “make AAPI stronger, more vibrant, united, transparent, politically engaged, ensuring active participation of young physicians, increasing membership, and enabling that AAPI’s voice is heard in the corridors of power,” . AAPI is the largest Medical Organization in the United States, representing the interests of the over 100,000 physicians and Fellows of Indian origin in the United States, serving the interests of the Indian American physicians in the US and in many ways contributing to the shaping of the healthcare delivery in the US for the past 39 years. “AAPI must be responsive to its members, supportive of the leadership and a true advocate for our mission,” he said. Dr. Jonnalagadda was born in a family of Physicians. His dad was a Professor at a Medical College in India and his mother was a Teacher. He and his siblings aspired to be physicians and dedicate their lives for the greater good of humanity. “I am committed to serving the community and help the needy. That gives me the greatest satisfaction in life,” he said modesty.  Ambitious and wanting to achieve greater things in life, Dr. Jonnalagadda has numerous achievements in life. He currently serves as the President of the Medical Staff at the Hospital. And now, “being elected as the President of AAPI is greatest achievement of my life,” As the President of AAPI, the dynamic physician from the state of Andhra Pradesh, wants to “develop a committee to work with children of AAPI members who are interested in medical school, to educate on choosing a school and gaining acceptance; Develop a committee to work with medical residents who are potential AAPI members, to educate on contract negotiation, patient communication, and practice management; Develop a committee to work with AAPI medical students, and to provide proctorship to improve their selection of medical residencies.” Dr. Jonnalagadda wants to emphasize the importance of Legislative Agenda both here in the US and overseas, benefitting the physicians and the people AAPI is committed to serve. According to him, “The growing clout of the physicians of Indian origin in the United States is seen everywhere as several physicians of Indian origin hold critical positions in the healthcare, academic, research and administration across the nation.” He is actively involved with the Indian community and member at large of the Asian Indian Alliance, which actively participates in a bipartisan way to support and fund electoral candidates. His vision for AAPI is to increase the awareness of APPI globally and help its voice heard in the corridors of power.  “I would like to see us lobby the US Congress and create an AAPI PAC and advocate for an increase in the number of available Residency Positions and Green Cards to Indian American Physicians so as to help alleviate the shortage of Doctors in the US.” .   A Board-Certified Gastroenterologist/Transplant Hepatologist, working in Douglas, GA, Dr. Jonnalagadda is a former Assistant Professor at the Medical College of Georgia. He was the President of Coffee Regional Medical Staff 2018, and had served as the Director of Medical Association of Georgia Board from 2016 onwards. He had served as the President of Georgia Association of Physicians of Indian Heritage 2007-2008, and was the past Chair of Board of Trustees, GAPI. He was the Chairman of the Medical Association of Georgia, IMG Section, and was a Graduate, Georgia Physicians Leadership Academy (advocacy training).   “AAPI and the Charitable Foundation has several programs in India. Under my leadership, we will be able to initiate several more program benefitting our motherland, India,” Dr. Jonnalagadda said. The solemn Award Ceremony by IAPC was led by Padma Shri Dr. Sudhir Parikh, Chairman of Parikh Media and an active leader of AAPI. The virtual ceremony was organized, among others, by Dr. Joseph Chalil, IAPC Chairman; Korason Varghese, Award Committee Chair; & Dr. P.V. Baiju, IAPC Board Member. Dr. Vinod K. Shah, Managing Director of MedStar Shah Medical Group, CEO of Health Prime, and former President of AAPI, was conferred with the prestigious Karma Shrestha Award. WHEELS Global Foundation, a charitable initiative by the Indian Institute of Technology alumni, was conferred The Sathkarma Award. Ranjani Saigal, Executive Director of Ekal Vidyalaya, and Dean Nitin Nohria, Dean of Harvard Business School, were given The SathKarma Award. Ambassador Pradeep Kapur, the author of the book Beyond Covid-19 Pandemic and former Ambassador of India to Chile and Cambodia, received the Excellence in Literature Award. Chancellor of the University of California San Diego, Pradeep Khosla, was awarded the Excellence in Technology & Education Award. The Humanitarian Award was given to Dr. Sunil D. Kumar, Broward Health Medical Center, and former President of AKMG. Satish Korpe, the past President of the Indian American Forum for Political Education, and Madhavan B. Nair, former President of FOKANA, received the Community Service Award. Lalit K. Jha, Chief US Correspondent for Press Trust of India (PTI), was given the IAPC Media Excellence Award. The Indo-American Press Club (IAPC), a 501 (c) 3 Non-Profit Organization headquartered in New York, was formed in 2013 with the ideals of providing a  common platform to journalists of  Indian-origin living in the United States and Canada committed to professionalism and well-being of the larger society.  IAPC is also committed to recognize and honor the outstanding entities and individuals in the community that creates a social impact and excel in their field of profession, culture, service, and business.

IAPC Confers Lifetime Achievement Award On Karma Shreshta, Dr. Vinod K. Shah By Ajay Ghosh

Dr. Vinod K Shah, an Eminent Cardiologist, Managing Director of MedStar Shah Medical Group, CEO of Health Prime, and former President of AAPI, was presented with the prestigious Life Time Achievement Award or the “Karma Shreshta Award” during a solemn virtual awards ceremony organized by Indo-American Club (IAPC) during the 7th annual International Media Conference on October 18th, 2020.

Dr. Vinod Shah has spent the past half a century, serving the larger US population, contributing to the Indo-US relations, towards education, transforming healthcare delivery and investing in the growth of the community. His hard work and commitment to noble causes led to the United States House Majority Leader and twenty-term Congressman Steny Hoyer calling Dr. Shah “one of the most decent, honorable and honest men that I have ever met.” 

Apart from being a well-known Cardiologist in Southern Maryland and Washington, D.C., Dr. Shah has worked very closely with many community organizations serving as a member of the Rotary Club of Charlotte Hall and board member of St. Mary’s College. As the President of AAPI, he has worked closely and relentlessly with the members of the US Congress to develop and promote Indo-US relations and fight for the rights of foreign medical graduates. An advocate for physicians, his ultimate passion has been to provide the best healthcare for patients with an emphasis on the early detection and prevention of diseases.

A true visionary and reputed for his excellence in healthcare, education, leadership and social services, Dr. Shah received his medical degree from Bombay University, completed his cardiology training at Georgetown University Hospital. Dr. Shah moved to rural Southern Maryland 45 years ago with his wife, Dr. Ila Shah, a Pediatrician and his brother, Dr. U.K. Shah, a Gastroenterologist, and together they founded Shah Associates, the largest private multi-specialty practice in Maryland.

Born in 1941 in Ranpur in Gujarat, India, as the eldest of nine siblings in a middle class family, Dr. Shah obtained his medical degree from Bombay University and moved to the United States in 1967. He completed prestigious fellowships in cardiology at the Georgetown University Program at the VA Hospital. He then chose to settle in a small community that was woefully underserved by the healthcare system: as one indicator, the local residents had access to a cardiologist for just four hours a month.  

When Dr. Shah arrived to his current home in 1974, the local hospital in rural Southern Maryland did not have one full-time specialist physician dedicated to the residents who lived there. Today, top quality physicians are available to serve the once-underserved population of the County. At 78, Dr. Shah continues to work tirelessly to improve the health and quality of life of the nearly 70% of St. Mary’s County 110,000 residents whose lives he has touched. He sees patients and administers multiple private and public healthcare-related organizations to improve healthcare access to all of Southern Maryland. 

Dr. Shah has demonstrated a lifelong commitment to both his adopted country and his country of birth. Since 1981, he has been involved with the American Association of Physicians of Indian Origin (AAPI), a professional group with more than 80,000 physicians and 200 chapters which supports practitioners and highlights the distinctive contributions of Indian culture to American medicine. Dr. Shah served as the Legislative Chair, advocating for policies beneficial to both the state of healthcare in the US and to physicians trained in India. 

Dr. Shah has consistently used his personal connections with US Lawmakers to advocate for an increase in the number of medical schools and residencies, with the dual goal of improving access to care nationwide and allowing more qualified and deserving graduates, such as those from India, to practice in the US. As the President of AAPI, Dr. Shah facilitated trips to India with both Maryland Governor Martin O’Malley and a number of Members of Congress, including the current House Majority Leader, Steny Hoyer. In addition to general cultural exchange, Dr. Shah helped bring about the creation of a sister state relationship between Maryland and Maharashtra, with the purpose of encouraging research and investment in life-saving medical technology.  

Dr. Shah has been highly involved in both domestic and international aid work, working to establish thirty clinics in the US and seventeen clinics in India to provide primary care for those who cannot afford it. He and his wife, Ila, are active members of Rotary International, through which they have run a dozen outreach missions, providing artificial limbs and surgery for victims of polio. Dr. Shah coordinated a Women’s Wellness project in Kutch from 2012 to 2014, which provided thousands of screenings and hundreds of surgeries. He also organized a Global Health Care Summit in New Delhi in 2009, where representatives of numerous nations shared perspectives on a variety of healthcare initiatives, working together, for example, to support the Indian Ministry of Health in its systematic efforts to combat tuberculosis. 

Educated decades ago, Dr. Shah is well-versed in the use of modern technology.  “Access to healthcare is a significant problem in the US,” Dr. Sha says, “Utilizing technology, and creating a center of excellence that focuses on data driven processes and procedures has helped to save many lives. I have provided exceptional healthcare to an underserved population. I have created thousands of jobs, and improved the quality of life of hundreds of thousands of people. “I have created an outsourced service line that impacts both people in the US as well as in India,” Dr. Sha says.

Towards Indo-US Relations, Dr. Shah says, “I have been instrumental in working with US Lawmakers to bridge relations with India. Having lived in Washington, DC. Region for the last 50 years, I am well acquainted with the need to educate and lobby US lawmakers regarding India. I serve as a liaison to bring an extraordinary relationship between Indian and the United States.”

Philanthropic Giving to both US and Indian educational and medical facilities has been a passion for Dr. Sha and his family.  “Through a private foundation my wife and I supported qualified medical students from underserved areas in India,” Dr. Shah says. “Today 60+ students have graduated and are practicing in their medical fields. To help accommodate students, our company’s charitable arm supports the construction of dormitories to house students near Vidyanagar. In addition, through the work of Rotary International, we have raised over a million dollars for multiple matching grant projects in India including polio corrective surgery, cataract surgery, women’s health, and clean water.” 

 With the help of the physicians among his extended family, Dr. Shah has profoundly enhanced access to medical care for the people of the State of Maryland across the socio-economic spectrum. Dr. Shah used his resources to create a number of state of the art multi-specialty facilities which provide integrated care to thousands of patients. He runs an annual Health and Wellness Fair providing free comprehensive care to indigent patients. Dr. Shah also founded Health Prime International, a company which provides back-office and recordkeeping services to physicians. Not only does the company ease the administrative burden on its physician clients, but it also has created more than 600 jobs in India, and its advanced data analytics allow doctors to better understand their patients’ needs and provide better preventative care. 

As the AAPI President, Dr. Shah traveled throughout the country to raise awareness about serving the needs of the US population especially in underserved areas. “My work has led to the creation of jobs, the creation of government policies and procedures to support healthcare, and has assisted Indian medical graduates to obtain medical residency in the US. I have helped to create a competent workforce in medicine that will continue to benefit our patients is thankfully my legacy.” 

As the Legislative Chair and AAPI President, “I often visited both Capitol Hill and The Indian Embassy, to promote Indo-US relationship as a goodwill ambassador. I have traveled with US Lawmakers across the US and beyond to introduce them to Indian society, and the strength of Indian Culture. I am confident that my contributions to further the relations between these two nations will lead to a greater understanding of each other and a more united front in the world.”

His literary skills came to be recognized around the world, when he penned the publication of “Antarnaad – Introspection,” created with images of India’s past, present and future with the purpose of educating younger generations in both India and the US as well as US lawmakers as to the strength of democracy. The accompanying documentary film he had produced describes the compelling story of The Golden Era, Islamic Invasion and British India, and was followed by Freedom Movement, Partition, and the Post-Independence India with emphasis on human weakness, corruption, license Raj, and the revolt by the people leading to the Promised Land.
  Awards and recognitions came his way as people around the nation recognized his commitment to the lager good of the nation. Hon. Martin O’Malley, Governor of Maryland, appointed Dr. Shah as a member of the Maryland Quality and Safety Commission in Healthcare in 2008.  He was award the Outstanding Physician of the Year 2010 by The Council of Rural Maryland for developing health care infrastructure in a physician deprived area. He received the Lifetime Achievement Aware 2015 for Excellence in Healthcare St Mary’s Hospital. 

Dr. Shah was recognized by Hon. Steny Hoyer, US House Majority Leader, for outstanding contributions to community in 2007.  He was accorded the prestigious Presidential Award, American Association of Physician of Indian Origin in 2019. In 2008, Dr. Shah was given the Paul Harris Fellow Award by the Rotary International, and the Service above Self Award by the Rotary International in 2000. Dr. Shah was given the Presidential Award for Outstanding Humanitarian Service by AAPI at the Global Health Summit, Mumbai, India 2019.   

In short, Dr. Vinod K. Shah has shown a boundless dedication to professional, diplomatic, and charitable service both in the United States and in India. He has improved the lives of thousands of physicians and patients, and facilitated momentous policy decisions on the local, national, and international levels. His contributions to the larger society are immense and are an inspiration for generations to be inspired and to emulate.

Antiviral Drug Remdesivir Proves Ineffective In Treating Covid-19, WHO Study Finds

The antiviral drug remdesivir had little or no effect in treating patients hospitalized with Covid-19, according to a study that has not yet been peer reviewed, but was coordinated by the World Health Organization and released on Thursday, casting doubt on one of the few promising treatments for the coronavirus.

Key Facts

Deeming it “the world’s largest randomized control trial on Covid-19 therapeutics,” the six-month long study of four drugs—remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon—proved “unpromising.”

“The main outcomes of mortality, initiation of ventilation and hospitalization duration were not clearly reduced by any study drug,” the study reads.

Over 11,000 adults across 30 countries and 405 hospitals were studied to come to these results.

Regimens involving the anti-malarial drug hydroxychloroquine have already been proven ineffective, but remdesivir appeared to be one of the few therapies to prove effective in combating Covid-19 symptoms.

The WHO’s results come just a week after a study published in the New England Journal of Medicine that found remdesivir shortened the time of recovery for adults hospitalized with Covid-19.

President Trump, who contracted Covid-19 and spent time at Walter Reed hospital upon suffering from symptoms, was administered remdesivir as part of his treatment.

Key Background

Remdesivir is the only specific drug with an emergency use authorization from the Food and Drug Administration. A vaccine for Covid-19 isn’t expected for approval until the end of the year, and even then, it will take months before there’s enough widespread distribution. Several countries like France are experiencing record daily case numbers in October. The United States continues to be the hardest hit. Despite having 4% of the world’s population, the country owns nearly 21% of all cases with almost 8 million and 20% of global deaths with around 218,000.

World Restart A Heart Day Organized

Dr. Vemuri S. Murthy, an advocate of Community and Physician resuscitation education and training for more than three decades in USA and India, is a past President of the Chicago Medical Society and current adjunct Faculty in the Department of Emergency Medicine at the University of Illinois @ Chicago College of Medicine, Chicago, Illinois. He is the Founder of Chicago Medical Society’s Community CPR Project SMILE (Saving More Illinois Lives through Education).

 In a recent interview, Dr. Vemuri Murthy shared his thoughts and concerns regarding current status of the out- of- hospital cardiac arrests and diminishing bystander resuscitation help during COVID-19 pandemic. According to the American Heart Association, there are more than 356,000 out-of-hospital cardiac arrests annually in the U.S. (2018 update).Nearly 90% of them are fatal. Cardiopulmonary Resuscitation (CPR), if performed immediately, can double or triple a cardiac arrest victim’s chances of survival. In majority of cases, immediate Hands-only CPR may have similar survival outcomes comparable to the conventional CPR performed with both chest compressions and breaths.

Global evidence-based information has proven that Bystander CPR is life-saving in sudden cardiac arrest. The latter is recognized by sudden collapse of the person without any breathing, pulse or consciousness. It’s important to call 911 first before performing Hands-only CPR. The bystander performing CPR needs to cover the mouth and nose fully with a face mask or cloth. The victim’s mouth and nose must be covered too with a face mask or cloth. Performing Hands-Only CPR involves pushing hard and fast in the center of the chest at a rate of 100 to 120 compressions per minute. Automated External Defibrillator (AED) needs to be utilized as soon as it’s available. This high-quality CPR should be continued by the bystander until the  arrival of paramedics. It’s important to follow the Good Samaritan Laws of a particular US State while performing Bystander CPR.

Personal protection from any potential droplet infection is of paramount importance while managing any person in cardiac arrest, as the COVID-19 status of the victim may be unknown. The bystander needs to thoroughly wash the hands with soap and water after providing CPR.

Dr. Vemuri S. Murthy (Chicago Medical Society’s COVID-19 Task Force) appeals for practicing three basic preventive measures during the COVID-19 Pandemic: Wearing a Mask covering the mouth and nose, Washing Hands with soap and water for 20 seconds, and watching social distancing of at least 6 feet.

Covid-19 deaths in India may have exceeded 2.5 million: What expert panel says about lockdown, festivals

The government-appointed panel which studied the mathematical progression of Covid-19 numbers in the country said only 30 per cent of the population has developed immunity so far. The Centre had appointed a 10-member committee, headed by NITI Aayog member VK Paul, to study the mathematical progression of Covid-19 virus in India. The committee submitted its report on a day Union health minister Harsh Vardhan admitted community transmission of Covid-19 in certain pockets of a limited number of states in the country.

The study sheds light on where India stands in its fight against Covid-19 and what lies ahead.

  1. India may see an exponential increase of 26 lakh cases in a month because of the festival season if precautions are not followed.
  2. Kerala, Karnataka, Rajasthan, Chhattisgarh and West Bengal are still seeing a rise in the number of cases, while elsewhere the pandemic has stabilised.
  3. A second wave of coronavirus can’t be ruled out in winter.
  4. Local lockdown are not effective now, but had there been no lockdown in March-April, India’s total deaths could have exceeded 25 lakh in August. The death toll now stands at 1.14 lakh.
  5. Only 30 per cent of the population has developed immunity so far.
  6. India reached the peak of Covid-19 in September and is now on the downward slope.
  7. The crisis is likely to be over by February 2021. By that time, there could be 10.5 million cases.
  8. Migrants didn’t make much difference to the number of overall infections.
  9. We have to be careful in the coming months also because of pollution on north India.
  10. The curve is flattened and early lockdown bolstered by better-equipped health care system helped in flattening the curve.

WHEELS, AAPI, PanIIT & IAPC Support the Launch of Book “Beyond Covid-19 Pandemic Envisioning a Better World by Transforming the Future of Healthcare” by Ambassador Pradeep Kapur & Dr. Joseph Chalil, Saturday October 17th, 10 AM US EST and 7.30 PM IST

(Washington, DC: October 12th, 2020) The much anticipated and timely book, Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare, authored by Ambassador Pradeep Kapur, a practitioner of Public Policy and Dr. Joseph Chalil, an expert in healthcare policy, offering rare insights into the current state of affairs on global health policy and healthcare, is planned to be released in Washington, DC on Saturday, October 17th, 2020.

The WHEELS Global Foundation in association with Indo-American Press Club, PanIIT USA and American Association of Physicians of Indian Origin is jointly hosting the launch event in the national capital. The event will be graced by the former Chief Technology Officer in the United States in President Obama’s Administration, Mr. Aneesh Chopra. The event will also be live cast by the media in the United States and India.

The authors will donate the proceeds from the sale of their book to WHEELS! Please support this first such event focused on common sense solutions to transform healthcare in the post-pandemic world and the policy changes required. It will also help to raise money for a worthy cause.

Speakers at the launch event include Mr. Sundaram “Sundy” Srinivasan, Chief Operating Officer of Zentech Inc. President of the PanIIT USA representing all the IIT Alumni in the USA; Dr. Sudhakar Jonnalagadda, MD. President, American Association of Physicians of Indian Origin; Mr. Aneesh Chopra, President of Care Journey, Former U.S. Chief Technology Officer under President Obama; Mr. Suresh Shenoy, President, WHEELS Global Foundation, Distinguished Alumnus of IIT Bombay Class of 1972; and Mr. Yogesh Andlay, Board Member, WHEELS Charitable Foundation and Advisor to FICCI.

Ambassador Pradeep Kapur is an acknowledged “luminary diplomat,” with a distinguished career working with leaders and policymakers in different continents of the world: Asia, Africa, Europe, North America, and South America. Author and editor of many books, he was Ambassador of India to Chile and to Cambodia, and Secretary at the Indian Ministry of External Affairs, before joining as an academic in reputed universities in USA and India. A graduate of the globally acclaimed Indian Institute of Technology, Delhi (IIT-D), he is Executive Director of Smart Village Development Fund (SVDF); International Economic Strategic Advisor, Intellect Design Arena; and Chairman, Advisory Council, DiplomacyIndia.com. His contributions in healthcare include setting up of BP Koirala Institute of Health Sciences in Eastern Nepal which is acclaimed as an exemplary bilateral India Nepal initiative.

Dr. Joseph Chalil, an author of several scientific and research papers in international publications, is the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida and a member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council. A veteran of the U.S. Navy Medical Corps, he is board certified in healthcare management. He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Dr. Chalil is the Chairman of the Indo American Press Club (IAPC), the largest ethnic fraternity of Indian American and Indian Canadian media with a mandate to help shape a world through media that is fair, just, and equitable for all, and future generations. He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care. With years of experience working in the U.S. healthcare system, he discusses the challenges of healthcare delivery, including providing quality, affordable patient care to all, and alternate templates for health insurance.

Around the world, providing quality and affordable healthcare remains a challenge. As the COVID-19 pandemic began, it quickly became apparent that public policy and current healthcare systems were ill-prepared to deal with the challenges. Ambassador Kapur and Dr. Chalil discuss the lessons learned and the way ahead in the book, Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare.

The authors offer sustainable and revolutionary solutions to change healthcare delivery in the United States and a model for other countries. With a combination of a public SafetyNet and free-market competition, they offer their “Grand Plan.” The advances and adoption of current and new technology will revolutionize the field of healthcare. They offer critical strategies that countries can adopt during natural disasters, wars, or a pandemic.

The authors focus on breaking the chain of employer-based health insurance, where your health insurance is not tied to your employment. Too often, the benefits of providing healthcare for all is lost in discussions about health insurance. Yet, this book does not allow these issues to control the analysis of healthcare delivery.

This book offers practical solutions, addressing the needs of citizens now and into the future while empowering them to be more responsible for their health. The emerging global scenarios, as envisioned by the authors, address healthcare needs, education, and sustainable lifestyle choices, reducing the need for more intensive and costly interventions to improve the overall quality of life. There is a roadmap for UN and WHO, which are not living up to their initial promise, that goes beyond just reform. They challenge the world to have the political consensus to create meaningful change for all, both in the United States, the United Nations, and around the globe.

Please register to join the launch event online on Saturday, October 17th, from 10 am to 11:30 am (US EST), 7:30 pm to 9 pm (IST) at https://tinyurl.com/beyondcovid-wheels

For more information on the book and authors, please visit: https://beyondcovidbook.com

Covid-19 Deaths, 1 Million and Surging

Covid-19 deaths worldwide have surpassed 1 million. With new cases of coronavirus infections rapidly mounting again, the numbers of Covid-19 deaths are feared to surge in the coming months. 

It took approximately 40 weeks to reach the first million Covid-19 recorded deaths. Some have projected the second million Covid-19 deaths to take about 10 weeks, arriving in late December, and the third million to take an additional 4 weeks, arriving in late January.

Approximately 60 percent of the 1 million Covid-19 deaths to date have taken place in 6 countries (Figure 1). The United States continues to maintain its dominant lead in Covid-19 deaths as well as in coronavirus cases. With only 4 percent of the world’s population, the U.S. accounts for 21 percent of all Covid-19 deaths worldwide, or approximately 210,000 deaths that have jettison Covid-19 to the third leading cause of death in the U.S. after heart disease and cancer. 

 The country in second place is Brazil, which with less than 3 percent of the world’s population accounts for 14 percent of all Covid-19 deaths. Brazil is followed by India at 10 percent, Mexico at 8 percent, and the United Kingdom and Italy both at 4 percent.

In several months India is projected to overtake the U.S. as the country with the largest number of  Covid-19 deaths. India’s daily virus-related deaths are currently around 1,100 versus 760 for the U.S. In addition, India’s daily virus infections have surpassed 90,000 compared to about 42,000 for the U.S.

Due to differences in the population size of countries, Covid-19 death rates provide a meaningful comparative perspective on the performances of countries in confronting the coronavirus pandemic. While the Covid-19 death rate for the world is about 130 deaths per million population, the rates of the dozen deadliest countries, which except for the U.S. are located in Latin America and Europe, are about 600 or more Covid-19 deaths per million population (Figure 2).

The top two countries are Peru and Belgium, with rates of 980 and 860 Covid-19 deaths per million population, respectively. The countries with the next highest death rates of approximately 670 Covid-19 deaths per million population are Spain, Bolivia, Brazil and Chile. 

The high Covid-19 death rate of Peru is believed due in part to the country’s poor health system, which failed to conduct effective testing and contact tracing, and the fact that 70 percent of Peruvian workers are in the informal sector with most not able to afford to isolate as they are dependent on daily earnings. 

In the case of Belgium, government officials say their high Covid-19 death rate is likely due to a number of factors including their exceptional way of counting unconfirmed Covid-19 deaths, the high level of elderly placed in care homes and poor initial preparations at home care centers permitting the virus to spread rapidly and have devastating effects. 

In striking contrast to the rates of the deadliest dozen countries are the substantially lower Covid-19 death rates of many other countries around the world. Denmark and Germany, for example, report Covid-19 death rates of 112 and 114 per million population, respectively. Even lower rates are observed in Norway, Australia and Japan, of 50, 35 and 12 Covid-19 deaths per million population, respectively.

It took approximately 40 weeks to reach the first million Covid-19 recorded deaths. Some have projected the second million Covid-19 deaths to take about 10 weeks, arriving in late December, and the third million to take an additional 4 weeks, arriving in late January

Unfortunately, in many countries a combination of denial, deception and defiance stands in stark contrast to the overwhelming public health evidence concerning the dissemination of the coronavirus and lethality of Covid-19.

The interaction of the pandemic’s fallout with the growth of populism and extremism around the world hindered effective responses. In too many instances, the recommended mitigation measures became politized and openly ignored, denigrated and resisted by some groups.

Some contend that the various public health measures to limit the spread of the coronavirus, including masking wearing, social distancing and sheltering-in-place, are infringements on their liberties and freedoms and constituted unconstitutional violations of their basic rights.

However, it is widely recognized that measures and regulations intended to promote the health and safety of the general public are well within a state’s authority.

Many of the deaths in the high Covid-19 mortality countries likely would have been prevented by the early intervention and widespread use of face masks, social distancing, hand hygiene, sheltering-in-place, testing, contact tracing and related other measures.

Downplaying the threat of the pandemic, making misleading pronouncements, sending confused messages, offering unfounded reassurances, maligning health officials, delaying/resisting public health measures and deflecting blame to others contributed to the disastrous spread of the disease and subsequent rapid rise of Covid-19 deaths in many countries. 

For example, if the United States response to the pandemic had been more successful and had been able to achieve the relatively low Covid-19 death rate of Germany (114 versus 638 per million population), the U.S. Covid-19 death toll would have been approximately 38,000 rather than 210,000.

Even the relatively higher Covid-19 death rate of neighboring Canada (246 deaths per million population) would have more than halved the US death toll, avoiding approximately 130,000 U.S. Covid-19 deaths (Figure 3).

Similarly, the different approaches of Sweden and Denmark resulted in significantly higher Covid-19 death rates for Sweden, 583 versus 112 deaths per million population. While Sweden adopted libertarian policies of minimal regulations perhaps with the aim to achieve herd immunity, Denmark imposed social distancing, mask wearing and related public health measures.

If Sweden had been able to achieve the Covid-19 death rate of nearby Denmark, the Swedish death toll from Covid-19 would have been substantially less, about 1,100 rather than 5,900. 

While in mid-April the world’s daily Covid-19 deaths peaked at around 8,500, the average daily number of deaths near the end of September was approximately 5,300. In recent weeks, however, growing numbers of countries in various regions are reporting surges in daily coronavirus cases.

In the third week of September, nearly 2 million new Covid-19 cases were reported worldwide, the highest number of reported cases in a week since the start of the pandemic. 

In Europe weekly cases are now exceeding those reported when the pandemic first peaked in March. Those growing numbers of coronavirus cases point to the beginning of a second surge of Covid-19 deaths, especially for many of the countries in the northern hemisphere where approaching cold weather will drive more people indoors.  

vaccine for the coronavirus, which now has approximately three dozen candidates in human trials, is unlikely to be widely available before the expected second wave of the pandemic. If the second wave follows the path that some now fear, the current number of one million Covid-19 deaths could triple in a matter of months.

Moreover, if the world’s Covid-19 death rate were to begin to approach the current level of the United States or the United Kingdom, the million Covid-19 deaths could more than triple in the coming year.

It is widely recognized that a vaccine for the coronavirus will not be 100 percent effective. Some of the world’s largest pharmaceutical companies place the effectiveness of a hoped for vaccine at around 60 percent.  In the United States the Food and Drug Administration has indicated that any coronavirus vaccine must be at least 50 percent effective to secure approval from regulators. 

Some scenarios envision the coronavirus pandemic continuing for the long haul, perhaps for at least several more years. Some fear that an approved vaccine may offer only limited seasonal protection, similar to other coronaviruses in circulation. 

Also, significant numbers may decide to avoid getting inoculated while many others may simply delay their decisions fearing vaccine safety may have been seriously compromised due to political influence. In addition, the global distribution of an approved vaccine may remain limited for some time due to insufficient supplies, relatively high costs for those in low income countries and international political disputes.

Consequently, in order to check the spread of the second and subsequent waves of coronavirus infections and limit the numbers of Covid-19 deaths, public health mitigation measures, including mask wearing, social distancing, hand hygiene, sanitizing, sheltering-in-place, quarantining, testing, contact tracing and staying at home when sick, will remain the primary tools in the medical arsenal to confront the pandemic for the foreseeable future.

(By Joseph Chamieat IPS. He is an independent consulting demographer and a former director of the United Nations Population Division.)

AAPI Urges US Senate To Pass South Asian Heart Health Awareness and Research Act of 2020

(Washington, DC: October5th, 2020) “We want to express our sincere gratitude and appreciatio9n to US Congress for unanimously passing the legislation, South Asian Heart Health Awareness and Research Act of 2020 on September 29th, 2020,” Dr. Sudhakar Jonnalgadda, President of American Association of Physicians of Indian Origin (AAPI) said here today. “We urge the US Senate to take up the Bill without further delay, helping South Asians living in the United States to become aware of the risks they face daily due cardiac issues.”

Initiated by Indian-American Congresswoman Pramila Jayapal, H.R.3131 – South Asian Heart Health Awareness and Research Act of 2020 was voted overwhelmingly by the full House of Representatives. The Act stipulates raising awareness on the alarming rate of heart disease in South Asian communities in the United States while investing in strategies to reverse the deadly trend. The Bill was received in the US Senate on September 30th and has been referred to the Senate Committee on Health, Education, Labor, and Pensions.  

“As the first South Asian-American woman ever elected to the House of Representatives, I am fully committed to not only raising awareness and educating the South Asian community about the risk factors for heart disease but also ensuring that those living with heart disease receive the care, treatment, resources and support they need,” Congresswoman Jayapal, who represents Washington’s 7th Congressional district.  “I am proud that this urgently necessary legislation passed (the) committee today and I won’t stop fighting until it becomes law,” she added.

The legislation directs the Department of Health and Human Services (HHS) Secretary to create grants, such as South Asian Heart Health Promotion Grants at the Centers for Disease Control and Prevention (CDC) to provide funding for community groups involved in South Asian heart health promotion and to develop culturally appropriate materials to promote heart health in the South Asian community.

The Bill also asks the HHS Secretary to fund grants through the National Institutes of Health (NIH) to conduct research on cardiovascular disease and other heart ailments among communities disproportionately affected by heart disease, such as South Asian populations living in the United States, and develop a clearinghouse and web portal of information on heart health research, such as South Asian heart health.

Dr. Brahma Sharma, a prominent cardiologist affiliated with VA University of Pittsburgh, and serving as the Chair of AAPI-AHA Liaison committee on South Asian Heart Disease, said, “This is a historic day for south Asian community and we all appreciate the bipartisan efforts by Rep. Pramila Jaypal and Rep Joe Wilson (R- SC). It is gratifying to see this hidden threat for South Asians community finally being recognized. We have to continue this advocacy, so it passes through US Senate as well and provides the necessary support for education, research for early detection , prevention and even reversal of this epidemic of cardio-metabolic disease among South Asians who are at the highest risk.”

Indeed, cardiovascular disease is the leading cause of death in the U.S. and the U.S. spends over $500 billion on cardiovascular disease each year. Studies have shown that immigrants from India, Pakistan, Bangladesh, Sri Lanka and Nepal are experiencing a dramatic rise in heart disease. South Asians make up 25 per cent of the world”s population but they contribute 50 per cent to global cardiovascular deaths.

Prevalence of Diabetes for the South Asian subgroup in the United States has been found to be an alarming 23.3%, an important research relevant to South Asian cardiometabolic disease, by Cheng YJ, Kanaya AM et al entitled, “Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016,” published in JAMA in December, 2019 stated. These valuable data demonstrate the incredibly high, vastly under-appreciated burden of diabetes among South Asians. Particularly distressing is how many South Asians have diabetes without even knowing it. This phenomenon is surely fueling the cardiovascular epidemic among South Asians.

Dr. Anupama Gotimukula, President-Elect of AAPI, said, “The vital findings of the JAMA paper and the need for creating awareness about the prevalence of Diabetes, the symptoms, efforts to prevent and effective treatment are very critical today. The passing of the crucial Bill by the US Congress recognizes the need for additional resources to be made available for creating awareness, offering preventive measures and treatment to our community, and continuing with the research on this vital healthcare area.” 

 

 

 

Dr. Sudhakar Jonnalgadda offered total commitment to these efforts. “I am very impressed with the energy and strength of the leaders who have taken upon themselves this noble task on creating awareness and educating the physicians and the public on this very serious disease among South Asians in the US. We have the talents, skills, strength and the commitment. Let’s put them to work and help our brethren.” For more information on AAPI, please visit: www.aapiusa.org

 

 

 

Shri Venkiah Naidu Urges AAPI To Build Collaborations In Research And Development To Address Various Health Issues In India

“It’s very great joy that I welcome you all who have come to be part of the MINI Convention and the Fall Governing Body Meeting of American Association of Physicians of Indian Origin here in Chicago, IL. I appreciate your presence here in spite of the fears of the Covid Pandemic,” Dr. Sudhakar Jonnalagadda, President, AAPI, told the AAPI delegates who had come from around the nation on Saturday, September 26th, 2020 at the Renaissance Schaumburg Convention Center Hotel, in the Windy City.

 “Basically organized as the “Volunteers Recognition Ceremony” to honor all those hundreds of volunteers of AAPI, who have worked hard during the year 2019-20, especially during the COVID Pandemic, the Convention has been unique in so many ways,” Dr. Suresh Reddy, Immediate Past President of AAPI and the Chief Organizer of the Convention, said. “A special feature of the Convention has been honoring the hundreds of Volunteers who have dedicated their time, energy and efforts in the past one year for the success the many initiatives under my leadership. All the volunteers have raised the bar of AAPI and we salute your generosity and admire your sacrifices.”

 Chief Guest at the Convention, Shri M. Venkaiah Naidu, Honorable Vice President, in his address, virtually, said: “I congratulate the leadership of AAPI and the members for your great contributions to India, your motherland and the United States, your adopted land.” Referring to the Convention, the leader of India said, “This is not just an event but a showcase of a critical health mission that will empower us greatly to tide over the crippling effects of this pandemic.”

 “I applaud AAPI for being a dynamic body, spearheading legislative agendas and influencing the advancement of medical care not only in the US but across the globe,” Shri Naidu said. “I am also glad to know that AAPI’s mission for India is to play an important role in making quality healthcare accessible and affordable to all people of India. It is indeed a laudable objective as both accessibility and affordability are the need of the hour, especially in a vast developing country like India with a huge population of middle class and lower middle class,” Shri Naidu said.

India is now facing a huge challenge in the form of rising Antibiotic Resistance. The Vice President of India “urged the AAPI fraternity to share with their Indian counterparts and Indian Medical Association, the invaluable experiences gained by our doctors working abroad, which will help in devising an effective strategy to combat Antibiotic resistance. “I would also urge Indian doctors working abroad to build collaborations in Research and Development to address various health issues, including combating  tropical diseases like Tuberculosis and Malaria. Such collaborations will provide a boost to India’s quest to effectively and quickly eradicate these diseases,” India’s Vice President told AAPI leaders.

A dedicated pool of Physicians led by Dr. Meher Medavaram, Convention, Cahir, has been working hard to make the convention a memorable experience for all. “With Corona Virus impacting every aspect of life around the world, posing several challenges in carrying out with numerous plans and programs for AAPI in 2020, Dr. Suresh Reddy, the 36th President of AAPI, has been right on task and has devoted the past one year leading AAPI to stability and greater heights. The deadly pandemic, COVID-19 that has been instrumental in the lockdown of almost all major programs and activities around the world, could not lockdown the creative minds of AAPI leaders,” she said.  

A Coffee Table Book, chronicling the history of AAPI was released. “This coffee table book is dedicated to all the “First Ladies” who have sacrificed innumerable hours of their family time for the sake of AAPI,” Dr. Suresh Reddy said. “My sincere gratitude and appreciation to all of the leaders of AAPI, and in particular to Dr. Ranga Reddy for being the “Shrusti-Kartha” of this book. He chronicled the history of AAPI. Spending thousands of hours in the past 25 years, making sure this book saw the light of the day. He wrote the biographic sketches of each past President with inputs from most of them.”

In her farewell message, Dr. Seema Arora, Immediate Past COT Chair, said, “I am honored and humbled to have served our dignified organization working harmoniously together with the Executive Committee throughout this term. We overachieved all missions and goals of our organization in spite of the unprecedented pandemic, which actually brought us together with fresh ideas and creativity, helping to enhance the image of AAPI around the world.”

“Taking the lockdown and the social distancing as a challenge, the organizing committee of the AAPI Mini Convention has put together a unique Convention with Physical Distancing; Universal Masking; and Total Outdoor Setting,” said Dr. Sajani Shah, Chairwoman of AAPI Board of Trustees. Strict Covid precautions as per CDC, state and federal regulations was observed throughout the convention, ensuring the safety and well-being of every participating delegate, she added.  

Other main Guests at the Mini Convention included, Congressman Raja Krishnamoorthi, Consulate General of India in Chicago, Honorable Amit Kumar and Dr. Srinath Reddy, President of Public Health Foundation of India.

Describing Indian American Physicians as the “Best of America,” Raja Krishnamoorthi praised them for their dedication and skills. “We are proud of your achievements,” he told AAPI members. Given that a physician of Indian origin sees every 7th patient in this country and every 5th patient in rural and inner cities across the nation, the reach and influence of AAPI members’ contributions go well beyond the Convention, he said, while urging everyone to participate actively during the General Election on November 3rd.

Ambassador Amit Kumar acknowledged with gratitude the contributions of Indian American Physicians, especially during the pandemic. He referred to AAPI members writing over 1,000 prescriptions to the stranded visitors and students from India during the Covid pandemic. Ambassador Kumar thanked AAPI for its numerous initiatives to benefit people in India thorugh AAPI’s collaborative efforts with Apollo Hospital and Tata Trust in India.

Under the leadership of Dr. Vemuri S. Murthy, Chair of AAPI Webinar CME Committee, during the CMEs, eminent and world renowned experts in their respective areas of expertise shared their knowledge and wisdom, enlightening the delegates with new advances in their field of practice.

Physician Wellness: Stress and Burnout was the topic addressed by Dr. Lucky Jain, Professor and Chair at Emory University School of Medicine, Department of Pediatrics& Chief Academic Officer, Children’s Healthcare of Atlanta; and, Dr. Rohit Kumar Vasa, an Attending Neonatologist at Ann and Robert H. Lurie Children’s Hospital, Chicago, Chair of Pediatrics and Neonatology Site Leader, Mercy Hospital and Medical Center, Chicago.

CME on “A Global Health Topic: Learnings for India’s Health System” featured Dr. K. Srinath Reddy, President, Public Health Foundation of India and was moderated by Dr. Navin C. Nanda, Distinguished Professor of Medicine & Cardiovascular Disease at the University of Alabama at Birmingham, Birmingham, AL; and, Dr. T.S. Ravi Kumar, President, AIIMS, Mangalagiri, AP, India and a Member of WHO Global Patient Safety Experts Curriculum Committee.

 The session on Surgical Management of Intracerebral Hemorrhage was led by Dr. Joseph C. Serrone, Assistant Professor, Neurosurgery and Radiology at Loyola University Medical Center & Neurosurgeon, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois; and, Dr. Suresh Reddy, Associate Professor of Radiology at Loyola University Medical Center & Chief of Radiology, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois.

“The American Association of Physicians of Indian Origin Mini Convention offered an exciting venue to interact with leading physicians, health professionals, academicians, and scientists of Indian origin,” Dr. Anupama Gotimukula, President-Elect of AAPI, said. “The General Body Meeting and the Convention had participants discuss and plan activities and program priorities for the current year and beyond,” she added.

“The Mini Convention provided a forum for AAPI members to network, share knowledge and thoughts, and thus, enrich one another, and rededicate ourselves for the health and wellbeing of the people in the US and back home in India,” Dr. Ravi Kolli, Vice President of AAPI, said,

Dr. Amit Chakrabarty, Secretary of AAPI said. “The Mehfil/AAPI Talent Show provided a perfect setting for the AAPI delegates to display their talents. The Convention also featured and honored the “Best Mask; Best Obesity; and, Best Monument Picture.”

 “The convention offered a variety of ways to reach physicians and their families. It provided access to AAPI members who attended in person and virtually, regarding new products and services,” Dr. Satish Kathula, Treasurer of AAPI, said.

Physicians of Indian Origin in the United States are reputed to be leading health care providers, holding crucial positions in various hospitals and health care facilities around the nation and the world. Known to be a leading ethnic medical organization that represents nearly 100,000 physicians and fellows of Indian Origin in the US, and being their voice and providing a forum to its members to collectively work together to meet their diverse needs, AAPI members are proud to contribute to the wellbeing of their motherland India, and their adopted land, the United States.

 In his Message, calling for Unity, Dr. Sudhakar Jonnalagadda said: “When we come together for AAPI events we meet as friends. We interact with one another with respect, acknowledging the unique qualities and background, each one comes from. We respect their languages, religions, regional backgrounds and work together for what AAPI stands for. We may have differences of opinions; differences of approaches to various issues; our political and cultural affinities are unique. We acknowledge and accord that each of us will work together for the common good of the people we are called to serve and to realize the vision and mission of AAPI,” the President of AAPI added. For more details, and sponsorship opportunities, please visit: www.aapiusa.org

COVID-19 Infects Majority Of Bad Dreams: Study

Scientists used artificial intelligence to help analyses the dream content of close to a thousand people and found that the novel coronavirus had infected more than half of the distressed dreams reported.

The study was published in the journal Frontiers in Psychology. The researchers crowdsourced sleep and stress data from more than 4,000 people during the sixth week of the COVID-19 lockdown in Finland. About 800 respondents also contributed information about their dreams during that time – many of which revealed shared anxiety about the pandemic.

“We were thrilled to observe repeating dream content associations across individuals that reflected the apocalyptic ambience of COVID-19 lockdown,” said lead author Dr. Anu-Katriina Pesonen, head of the Sleep & Mind Research Group at the University of Helsinki.

“The results allowed us to speculate that dreaming in extreme circumstances reveals shared visual imagery and memory traces, and in this way, dreams can indicate some form of shared mindscape across individuals,” added Pesonen.

“The idea of a shared imagery reflected in dreams is intriguing,” she added. Pesonen and her team transcribed the content of the dreams from Finnish into English word lists and fed the data into an AI algorithm, which scanned for frequently appearing word associations.
The computer built what the researchers called dream clusters from the “smaller dream particles” rather than entire dreams.

Eventually, 33 dream clusters or themes emerged. Twenty of the dream clusters were classified as bad dreams, and 55 per cent of those had pandemic-specific content.

Themes such as failures in social distancing, coronavirus contagion, personal protective equipment, dystopia, and apocalypse were rated as pandemic specific.

For example, word pairs in a dream cluster labelled “Disregard of Distancing” included mistake-hug, hug-handshake, handshake-restriction, handshake-distancing, distancing-disregard, distancing-crowd, crowd-restriction and crowd-party.

“The computational linguistics-based, AI-assisted analytics that we used is really a novel approach in dream research. We hope to see more AI-assisted dream research in future. We hope that our study opened the development towards that direction,” Pesonen said.

The study also offered some insights into the sleep patterns and stress levels of people during the pandemic lockdown. For instance, more than half of respondents reported sleeping more than before the period of self-quarantine, though 10 per cent had a harder time falling asleep and more than a quarter reported more frequent nightmares.

Not surprisingly, more than half of the study participants reported increases in stress levels, which were more closely linked to patterns like fitful sleep and bad dreams. Those most stressed-out also had more pandemic-specific dreams.

The research could provide valuable insights for medical experts who are already assessing the toll the coronavirus is having on mental health. Sleep is a central factor in all mental health issues, according to Pesonen.

“Repeated, intense nightmares may refer to post-traumatic stress. The content of dreams is not entirely random, but can be an important key to understanding what is the essence in the experience of stress, trauma, and anxiety,” she said. (ANI)

Americans Favor A Single Government Program To Provide Health Care Coverage

A majority of Americans continue to say the federal government has a responsibility to make sure all Americans have health care coverage. And since last year, there has been an increase – especially among Democrats – in the share saying health insurance should be provided by a single national program run by the government.

How we did this

Among the public overall, 63% of U.S. adults say the government has the responsibility to provide health care coverage for all, up slightly from 59% last year. Roughly a third (37%) say this is not the responsibility of the federal government, according to a Pew Research Center survey conducted July 27 to Aug. 2 among 11,001 adults.

When asked how the government should provide health insurance coverage, 36% of Americans say it should be provided through a single national government program, while 26% say it should continue to be provided through a mix of private insurance companies and government programs. This is a change from about a year ago, when nearly equal shares supported a “single payer” health insurance program (30%) and a mix of government programs and private insurers (28%).

Most of the increase has come among Democrats and Democratic-leaning independents. A 54% majority of Democrats and Democratic leaners now favor a single national government program to provide health insurance, up from 44% last year. Support for single payer health coverage has increased among most groups of Democrats, including those who describe their political views as very liberal (up from 66% to 77%), liberal (50% to 61%) and conservative or moderate (35% to 43%).

Among Republicans and Republican leaners, a 66% majority says the government does not have the responsibility to make sure all Americans have health care coverage. Among the one-third of Republicans who say the government does have this responsibility, opinion is divided over whether or not it should be provided through a single government program or a mix of private and government programs.

Although most Republicans say it is not the government’s responsibility to ensure health coverage for all, a 54% majority says the government “should continue to provide programs like Medicare and Medicaid for seniors and the very poor.” Only 11% of Republicans say the government should not be involved at all in providing health insurance.

While divisions remain within the Democratic Party about the best way to provide health insurance, increasing shares across most demographic and ideological groups support a single national government program.

Very liberal Democrats, who in 2019 constituted 15% of Democratic registered voters, are far more likely than liberal Democrats (32% of Democrats) and moderates and conservatives (51%) to say that health insurance should be provided by a single government program.

White Democrats remain more likely than those of other races and ethnicities to support a single national program, but White, Black and Hispanic Democrats have each increased their support for a single national program by about 10 percentage points since last year.

A similar pattern emerges with age: Younger Democrats are still more supportive than older Democrats, but Democrats of all ages have increased their support over the past year.

(Source: Pew Research Center. By Bradley Jones)

Best Indian Diet Plan for Weight Loss

Are you looking for the best Indian diet plan to lose weight? The rules are simple. All you need to do is start eating right. But in India, this can feel like an insurmountable challenge, given our food culture and dietary habits. For instance, a typical Indian meal is high in carbohydrates and sugar – we eat a lot of potatoes, rice and sweets. We also love our snacks and can’t imagine a day without our fix of namkeens and bhujias. We pressurize our friends and family into eating too much, as a sign of hospitality and affection, and consider refusing an extra helping a rebuff. To top it all, we’ve never embraced physical exercise as essential. It’s no wonder that India is battling a growing obesity problem.

But the answer doesn’t lie in shunning Indian food in favour of foreign ingredients or fad diets. You’ll find that the best Indian diet plan consists of foods you’ve already got in your kitchen and that you can lose weight by making a few changes to your diet.

Understand the Science Behind Weight Loss

Weight loss and gain, revolve around caloric consumption and expenditure. You lose weight when you consume fewer calories than you expend. Conversely, you gain weight when you consume more calories than you expend. To drop those excess kilos, all you need to do is eat within your calorie budget and burn the required number of calories. A combination of the two works best suggest experts. Get your daily requirement of calorie consumption and burn based on your lifestyle and dietary preferences, by signing up on HealthifyMe.

However, simply determining how many calories your body needs isn’t enough. After all, four samosas (600 calories), two slices of pizza (500 calories) and two gulab jamuns (385 calories) may be within your daily requirement of 1500 calories, but these unhealthy food choices will eventually lead to other health problems like high cholesterol and blood sugar. To lose weight the healthy way, you also need to ensure your diet is balanced i.e. it covers all food groups and provides all the nutrients you need necessary for good health.

The Best Indian Diet Plan for Weight Loss

No single food provides all the calories and nutrients the body needs to stay healthy. That’s why a balanced diet comprising of macronutrients like carbohydrates, protein and fat along with micronutrients such as vitamins and minerals, is recommended.

The best Indian diet for weight loss is a combination of the five major food groups – fruits and vegetables, cereals and pulses, meat and dairy products, and fats and oils. Knowing how to divvy up the food groups, allocate portion sizes, and the best/ideal time to eat is also important.

1200 Calorie Diet Plan

A lot can be spoken about what goes into an ideal diet chart. However, one’s nutritional requirement varies based on various factors. It could change depending on gender, for example, male dietary requirements vary from that of a female. Geography can play a role as well, with North Indian diets being largely different from South Indian ones. Meal preferences come into play since the consumption of food by a vegetarian or a vegan differing largely from that by a non-vegetarian.

However, we have put together a diet plan for weight loss with Indian food. This 7 day diet plan, 1200 calorie diet plan is a sample, and should not be followed by any individual without consulting with a nutritionist.

Day 1:

  • After starting your day with cucumber water, have oats porridge and mixed nuts for breakfast.
  • Have a roti with dal and gajar matar sabzi for lunch.
  • Follow that up with dal and lauki sabzi to go with a roti for dinner.

Day 1

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Oats Porridge in Skimmed Milk(1 bowl)

Mixed Nuts(25 grams)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Dal(1 katori)Gajar Matar Sabzi(1 katori)

Roti (1 roti/chapati)

4:00 PM

Cut Fruits(1 cup)Buttermilk(1 glass)

5:30 PM

Tea with Less Sugar and Milk(1 teacup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Dal(1 katori)Lauki Sabzi(1 katori)

Roti (1 roti/chapati)

Day 2:

  • On the second day, eat a mixed vegetable stuffed roti with curd for breakfast.
  • For lunch, have half a katori of methi rice along with lentil curry.
  • End your day with sauteed vegetables and green chutney.

Day 2

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Curd(1.5 katori)Mixed Vegetable Stuffed Roti(2 piece)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Lentil Curry(0.75 bowl)Methi Rice(0.5 katori)

4:00 PM

Apple(0.5 small (2-3/4″ dia))Buttermilk(1 glass)

5:30 PM

Coffee with Milk and Less Sugar(0.5 tea cup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Sauteed Vegetables with Paneer(1 katori)Roti (1 roti/chapati)

Green Chutney(2 tablespoon)

Day 3:

  • Breakfast on day 3 would include Multigrain Toast and Skim Milk Yogurt.
  • In the afternoon, have sauteed vegetables with paneer and some green chutney.
  • Half a katori of methi rice and some lentil curry to make sure you end the day on a healthy note.

Day 3

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Skim Milk Yoghurt(1 cup (8 fl oz))Multigrain Toast(2 toast)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Sauteed Vegetables with Paneer(1 katori)Roti (1 roti/chapati)

Green Chutney(2 tablespoon)

4:00 PM

Banana(0.5 small (6″ to 6-7/8″ long))Buttermilk(1 glass)

5:30 PM

Tea with Less Sugar and Milk(1 teacup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Lentil Curry(0.75 bowl)Methi Rice(0.5 katori)

Day 4:

  • Start Day 4 with a Fruit and Nuts Yogurt Smoothie and Egg Omelette
  • Follow that up with Moong Dal, Bhindi Sabzi, and roti.
  • Complete the day’s food intake with steamed rice and palak chole.

Day 4

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Fruit and Nuts Yogurt Smoothie(0.75 glass)

Egg Omelette(1 serve(one egg))

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Green Gram Whole Dal Cooked(1 katori)Bhindi sabzi(1 katori)

Roti (1 roti/chapati)

4:00 PM

Orange(1 fruit (2-5/8″ dia))Buttermilk(1 glass)

5:30 PM

Coffee with Milk and Less Sugar(0.5 tea cup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Palak Chole(1 bowl)Steamed Rice(0.5 katori)

Day 5:

  • Have a glass of skimmed milk and peas poha for breakfast on the fifth day.
  • Eat a missi roti with low fat paneer curry in the afternoon.
  • End the day with roti, curd and aloo baingan tamatar ki sabzi.

Day 5

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Skimmed Milk(1 glass)Peas Poha(1.5 katori)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Low Fat Paneer Curry(1.5 katori)Missi Roti(1 roti)

4:00 PM

Papaya(1 cup 1″ pieces)Buttermilk(1 glass)

5:30 PM

Tea with Less Sugar and Milk(1 teacup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Curd(1.5 katori)Aloo Baingan Tamatar Ki Sabzi(1 katori)

Roti (1 roti/chapati)

Day 6:

  • On Day 6, have idli with sambar for breakfast
  • For lunch, roti with curd and aloo baingan tamatar ki sabzi
  • To end Day 6, eat green gram with roti and bhindi sabzi

Day 6

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Mixed Sambar(1 bowl)Idli(2 idli)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Curd(1.5 katori)Aloo Baingan Tamatar Ki Sabzi(1 katori)

Roti (1 roti/chapati)

4:00 PM

Cut Fruits(1 cup)Buttermilk(1 glass)

5:30 PM

Coffee with Milk and Less Sugar(0.5 tea cup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Green Gram Whole Dal Cooked(1 katori)Bhindi sabzi(1 katori)

Roti (1 roti/chapati)

Day 7:

  • On the seventh day, start with besan chilla and green garlic chutney.
  • Have steamed rice and palak chole for lunch.
  • End the week on a healthy note with low fat paneer curry and missi roti.

Day 7

Diet Chart

6:30 AM

Cucumber Detox Water(1 glass)

8:00 AM

Besan Chilla(2 cheela)Green Garlic Chutney(3 tablespoon)

12:00 PM

Skimmed Milk Paneer(100 grams)

2:00 PM

Mixed Vegetable Salad(1 katori)

2:10 PM

Palak Chole(1 bowl)Steamed Rice(0.5 katori)

4:00 PM

Apple(0.5 small (2-3/4″ dia))Buttermilk(1 glass)

5:30 PM

Tea with Less Sugar and Milk(1 teacup)

8:50 PM

Mixed Vegetable Salad(1 katori)

9:00 PM

Low Fat Paneer Curry(1 katori)Missi Roti(1 roti)

Balanced Diet Chart

While creating a diet chart, it is important to make sure it is balanced, in order to ensure that you receive all the required nutrients. Include the following nutrients in your diet plan:

1. Carbohydrates

Carbs are the body’s main source of energy and should make up half of your daily calorie requirement. However, it’s important to choose the right type of carbs. Simple carbs, such as bread, biscuit, white rice and wheat flour, contain too much sugar and are bad for you. Instead, opt for complex carbs that are high in fiber and packed with nutrients as compared to simple carbs. Fiber-rich complex carbs are slow to digest, leave you feeling full for longer, and are therefore the best option for weight control. Brown rice, millets such as ragi and oats are all good complex carb choices.

 

2. Proteins

Most Indians fail to meet their daily protein requirement. This is troublesome, as proteins are essential to help paper writer the body build and repair tissue, muscles, cartilage and skin, as well as pump blood. A high protein diet can also help you lose weight, as it helps build muscle – which burns more calories than fat.

About 30% of your diet should consist of protein in the form of whole dals, paneer, chana, milk, leafy greens, eggs, white meat or sprouts. Having one helping of protein with every meal is essential.

3. Fats

A food group that has acquired a bad reputation, fats are essential for the body as they synthesize hormones, store vitamins and provide energy. Experts suggest one-fifth or 20% of your diet comprise of healthy fats – polyunsaturated, monounsaturated and Omega-3 fatty acids. Using a combination of oils for different meals – including olive oil, rice bran oil, mustard oil, soya bean, sesame, sunflower and groundnut oil – along with restricted quantities of butter and ghee is the most optimal way to consume fats. Avoid trans fats – that are found in fried snacks, completely.

4. Vitamins and minerals

Vitamin A, E, B12, D, calcium and iron are essential for the body as they support metabolism, nerve and muscle function, bone maintenance, and cell production. Primarily derived from plants, meat and fish, minerals can be found in nuts, oilseeds, fruits and green leafy vegetables. Experts recommend consuming 100 grams of greens and 100 grams of fruits everyday.

5. Meal Swaps

One of the easiest ways to eat healthy is to swap out the unhealthy foods in your diet with healthier alternatives. For example, fulfil your cravings for a snack to munch on with air popped popcorn instead of relying on potato chips. Check out a few healthy meal swaps that you could try going forward:

Along with a balanced diet plan, these habits will help you stay healthy

  • Opt for 5-6 meals a day: Instead of three large meals, try having three modest meals and a few snack breaks through the day in controlled portions. Spacing your meals across regular intervals prevents acidity and bloating, and also keeps hunger pangs at bay. Quit your junk food habit by making healthier snack choices.
  • Have an early dinner: Indians eat dinner later than the other societies across the world. Metabolism slows down at night, so a late dinner can lead to weight gain. Experts recommend you eat your last meal of the day by 8 pm.
  • Drink a lot of water: How does drinking more water help you lose weight? For starters, it’s zero calories. Also, drinking a glass of water can help curb hunger pangs. Have six to eight glasses of water daily to lose weight. You can also find a list of drinks that will help you lose weight here.
  • Eat a lot of fiber: A person needs at least 15 gm of fiber every day, as it aids digestion and heart health. Oats, lentils, flax seeds, apples and broccoli are some great sources of fiber.

You don’t have to ditch your regular food habits or make massive changes to your diet, you just need the best balanced Indian diet plan to get fit!

(source: https://www.healthifyme.com/blog/best-indian-diet-plan-weight-loss/?fbclid=IwAR2Yy8i6yP7ancgpkgIiW1u3kj6Tw_P42lsAanPoxgHhsjueChH9t_o5vgQ)

 

AAPI’s Mini Convention Held In Chicago Shri Venkiah Naidu, Vice President Of India, Urges AAPI To Build Collaborations In Research And Development To Address Various Health Issues In India

(Chicago, IL: September 28th, 2020): “It’s very great joy that I welcome you all who have come to be part of the MINI Convention and the Fall Governing Body Meeting of American Association of Physicians of Indian Origin here in Chicago, IL. I appreciate your presence here in spite of the fears of the Covid Pandemic,” Dr. Sudhakar Jonnalagadda, President, AAPI, told the AAPI delegates who had come from around the nation on Saturday, September 26th, 2020 at the Renaissance Schaumburg Convention Center Hotel, in the Windy City.

“Basically organized as the “Volunteers Recognition Ceremony” to honor all those hundreds of volunteers of AAPI, who have worked hard during the year 2019-20, especially during the COVID Pandemic, the Convention has been unique in so many ways,” Dr. Suresh Reddy, Immediate Past President of AAPI and the Chief Organizer of the Convention, said. “A special feature of the Convention has been honoring the hundreds of Volunteers who have dedicated their time, energy and efforts in the past one year for the success the many initiatives under my leadership. All the volunteers have raised the bar of AAPI and we salute your generosity and admire your sacrifices.”

Chief Guest at the Convention, Shri M. Venkaiah Naidu, Honorable Vice President, in his address, virtually, said: “I congratulate the leadership of AAPI and the members for your great contributions to India, your motherland and the United States, your adopted land.” Referring to the Convention, the leader of India said, “This is not just an event but a showcase of a critical health mission that will empower us greatly to tide over the crippling effects of this pandemic.”

“I applaud AAPI for being a dynamic body, spearheading legislative agendas and influencing the advancement of medical care not only in the US but across the globe,” Shri Naidu said. “I am also glad to know that AAPI’s mission for India is to play an important role in making quality healthcare accessible and affordable to all people of India. It is indeed a laudable objective as both accessibility and affordability are the need of the hour, especially in a vast developing country like India with a huge population of middle class and lower middle class,” Shri Naidu said.

India is now facing a huge challenge in the form of rising Antibiotic Resistance. The Vice President of India “urged the AAPI fraternity to share with their Indian counterparts and Indian Medical Association, the invaluable experiences gained by our doctors working abroad, which will help in devising an effective strategy to combat Antibiotic resistance. “I would also urge Indian doctors working abroad to build collaborations in Research and Development to address various health issues, including combating  tropical diseases like Tuberculosis and Malaria. Such collaborations will provide a boost to India’s quest to effectively and quickly eradicate these diseases,” India’s Vice President told AAPI leaders.

A dedicated pool of Physicians led by Dr. Meher Medavaram, Convention, Cahir, has been working hard to make the convention a memorable experience for all. “With Corona Virus impacting every aspect of life around the world, posing several challenges in carrying out with numerous plans and programs for AAPI in 2020, Dr. Suresh Reddy, the 36th President of AAPI, has been right on task and has devoted the past one year leading AAPI to stability and greater heights. The deadly pandemic, COVID-19 that has been instrumental in the lockdown of almost all major programs and activities around the world, could not lockdown the creative minds of AAPI leaders,” she said.  

A Coffee Table Book, chronicling the history of AAPI was released. “This coffee table book is dedicated to all the “First Ladies” who have sacrificed innumerable hours of their family time for the sake of AAPI,” Dr. Suresh Reddy said. “My sincere gratitude and appreciation to all of the leaders of AAPI, and in particular to Dr. Ranga Reddy for being the “Shrusti-Kartha” of this book. He chronicled the history of AAPI. Spending thousands of hours in the past 25 years, making sure this book saw the light of the day. He wrote the biographic sketches of each past President with inputs from most of them.”

In her farewell message, Dr. Seema Arora, Immediate Past COT Chair, said, “I am honored and humbled to have served our dignified organization working harmoniously together with the Executive Committee throughout this term. We overachieved all missions and goals of our organization in spite of the unprecedented pandemic, which actually brought us together with fresh ideas and creativity, helping to enhance the image of AAPI around the world.”

“Taking the lockdown and the social distancing as a challenge, the organizing committee of the AAPI Mini Convention has put together a unique Convention with Physical Distancing; Universal Masking; and Total Outdoor Setting,” said Dr. Sajani Shah, Chairwoman of AAPI Board of Trustees. Strict Covid precautions as per CDC, state and federal regulations was observed throughout the convention, ensuring the safety and wellbeing of every participating delegate, she added.  

Other main Guests at the Mini Convention included, Congressman Raja Krishnamoorthi, Consulate General of India in Chicago, Honorable Amit Kumar and Dr. Srinath Reddy, President of Public Health Foundation of India.

Describing Indian American Physicians as the “Best of America,” Raja Krishnamoorthi praised them for their dedication and skills. “We are proud of your achievements,” he told AAPI members. Given that a physician of Indian origin sees every 7th patient in this country and every 5th patient in rural and inner cities across the nation, the reach and influence of AAPI members’ contributions go well beyond the Convention, he said, while urging everyone to participate actively during the General Election on November 3rd.

Ambassador Amit Kumar acknowledged with gratitude the contributions of Indian American Physicians, especially during the pandemic. He referred to AAPI members writing over 1,000 prescriptions to the stranded visitors and students from India during the Covid pandemic. Ambassador Kumar thanked AAPI for its numerous initiatives to benefit people in India thorugh AAPI’s collaborative efforts with Apollo Hospital and Tata Trust in India.

Under the leadership of Dr. Vemuri S. Murthy, Chair of AAPI Webinar CME Committee, during the CMEs, eminent and world renowned experts in their respective areas of expertise shared their knowledge and wisdom, enlightening the delegates with new advances in their field of practice.

Physician Wellness: Stress and Burnout was the topic addressed by Dr. Lucky Jain, Professor and Chair at Emory University School of Medicine, Department of Pediatrics& Chief Academic Officer, Children’s Healthcare of Atlanta; and, Dr. Rohit Kumar Vasa, an Attending Neonatologist at Ann and Robert H. Lurie Children’s Hospital, Chicago, Chair of Pediatrics and Neonatology Site Leader, Mercy Hospital and Medical Center, Chicago.

A CME on “A Global Health Topic: Learnings for India’s Health System” featured Dr. K. Srinath Reddy, President, Public Health Foundation of India and was moderated by Dr. Navin C. Nanda, Distinguished Professor of Medicine & Cardiovascular Disease at the University of Alabama at Birmingham, Birmingham, AL; and, Dr. T.S. Ravi Kumar, President, AIIMS, Mangalagiri, AP, India and a Member of WHO Global Patient Safety Experts Curriculum Committee.

The session on Surgical Management of Intracerebral Hemorrhage was led by Dr. Joseph C. Serrone, Assistant Professor, Neurosurgery and Radiology at Loyola University Medical Center & Neurosurgeon, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois; and, Dr. Suresh Reddy, Associate Professor of Radiology at Loyola University Medical Center & Chief of Radiology, Edward Hines Jr. Veterans Administration Hospital in Maywood, Illinois.

“The American Association of Physicians of Indian Origin Mini Convention offered an exciting venue to interact with leading physicians, health professionals, academicians, and scientists of Indian origin,” Dr. Anupama Gotimukula, President-Elect of AAPI, said. “The General Body Meeting and the Convention had participants discuss and plan activities and program priorities for the current year and beyond,” she added.

“The Mini Convention provided a forum for AAPI members to network, share knowledge and thoughts, and thus, enrich one another, and rededicate ourselves for the health and wellbeing of the people in the US and back home in India,” Dr. Ravi Kolli, Vice President of AAPI, said,

Dr. Amit Chakrabarty, Secretary of AAPI said. “The Mehfil/AAPI Talent Show provided a perfect setting for the AAPI delegates to display their talents. The Convention also featured and honored the “Best Mask; Best Obesity; and, Best Monument Picture.”

“The convention offered a variety of ways to reach physicians and their families. It provided access to AAPI members who attended in person and virtually, regarding new products and services,” Dr. Satish Kathula, Treasurer of AAPI, said.

Physicians of Indian Origin in the United States are reputed to be leading health care providers, holding crucial positions in various hospitals and health care facilities around the nation and the world. Known to be a leading ethnic medical organization that represents nearly 100,000 physicians and fellows of Indian Origin in the US, and being their voice and providing a forum to its members to collectively work together to meet their diverse needs, AAPI members are proud to contribute to the wellbeing of their motherland India, and their adopted land, the United States.

In his Message, calling for Unity, Dr. Sudhakar Jonnalagadda said: “When we come together for AAPI events we meet as friends. We interact with one another with respect, acknowledging the unique qualities and background, each one comes from. We respect their languages, religions, regional backgrounds and work together for what AAPI stands for. We may have differences of opinions; differences of approaches to various issues; our political and cultural affinities are unique. We acknowledge and accord that each of us will work together for the common good of the people we are called to serve and to realize the vision and mission of AAPI,” the President of AAPI added. For more details, and sponsorship opportunities, please visit: www.aapiusa.org

Two Million Deaths ‘Very Likely’ Even With Vaccine, WHO Warns

The global coronavirus death toll could hit two million before an effective vaccine is widely used, the World Health Organization (WHO) has warned. Dr. Mike Ryan, the WHO’s emergencies head, said the figure could be higher without concerted international action. Almost one million people have died with Covid-19 worldwide since the disease first emerged in China late last year. Virus infections continue to rise, with 32 million cases confirmed globally. The start of a second surge of coronavirus infections has been seen in many countries in the northern hemisphere as winter approaches. So far, the US, India and Brazil have confirmed the most cases, recording more than 15 million between them. But in recent days, there has been a resurgence of infections across Europe, prompting warnings of national lockdowns similar to those imposed at the height of the first wave of the pandemic. “Overall within that very large region, we are seeing worrying increases of the disease,” Dr Ryan said of the marked spike in cases in Europe. He urged Europeans to ask themselves whether they had done enough to avoid the need for lockdowns – and whether alternatives, such as testing and tracing, quarantines and social distancing, had been implemented. “Lockdowns are almost a last resort – and to think that we’re back in last-resort territory in September, that’s a pretty sobering thought,” Dr Ryan told reporters at the WHO’s headquarters in Geneva. 

What did he say about the death toll?

Asked whether two million fatalities worldwide was possible before a vaccine became available, Dr. Ryan said: “It’s not impossible.” He added that fatality rates were dropping as treatments for the disease improve. But better treatments and even effective vaccines might not be enough on their own to prevent deaths surpassing two million, he said. “Are we prepared to do what it takes to avoid that number?” Dr Ryan asked, calling on governments to do everything to control Covid-19. “Unless we do it all, the number you speak about is not only imaginable, but unfortunately and sadly, very likely.” 

What are the latest developments globally?

Around the world, stricter social-distancing guidelines and restrictions on businesses are being brought into effect to curb a second spike. In Spain, the government has recommended reimposing a partial lockdown on all of Madrid area, where cases have risen sharply. Instead, local authorities stepped up restrictions on some districts of the city, affecting a million people. Meanwhile in France, staff from bars and restaurants in the southern city Marseille protested against the closure of their workplaces on Saturday. On Friday, more restrictions were announced in several regions of the UK, as new daily infections continue to rise. The pandemic officially started when the WHO declared it in March 2020 but how will it end? In contrast, curbs on businesses are being lifted in some US states, despite the increasing number of cases nationwide. Dr. Anthony Fauci, the country’s top infectious diseases expert, said the first wave of the pandemic had not ended yet in the US, because infections have not decreased sufficiently since the initial outbreak. “Rather than say, ‘a second wave,’ why don’t we say, ‘are we prepared for the challenge of the fall and the winter?’,” Dr Fauci told CNN. Elsewhere, Israel tightened restrictions on businesses and travel, one week after the country became the first in the world to begin a second nationwide lockdown. 

What is Aiding India’s Low Covid Mortality Rate

A study conducted by top genetic experts has revealed that Indians should be thankful to their genes for tiding over the Covid pandemic with a relatively lesser mortality rate as compared to the U.S. and European nations.

A team comprising distinguished genetic experts from six institutions, led by Prof. Gyaneshwer Chaubey of the Banaras Hindu University, analyzed complete DNA data of the Angiotensin-converting enzyme 2 (ACE2) gene of X chromosome from various continental populations and found that it is the Indian genes that have protected the population and helped battle the deadly virus.

This explains why the mortality rate of Covid-19 has been much higher in European countries and in the U.S., as compared to India and Southeast Asian countries.

The results of the team’s analysis have been published in the internationally renowned journal PLOS ONE, released Sept. 17.

The scientists have provided a possible molecular genetic explanation for why Iranians, Europeans and Americans of European ancestry are at more mortality risk to the novel Coronavirus than people in India and East Asia, as reflected in the current global distribution of reported Covid-19 cases per 1,00,000 inhabitants.

The international team analyzed complete DNA data of the ACE2 gene from various continental populations and found that certain mutations in this gene are helping South Asian and East Asian populations in successfully battling the virus and reducing mortality rate in comparison to the U.S. and Europe.

“The ACE2 gene is the gateway point of the Coronavirus and certain genetic mutations of this gene are related to the disease severity,” said Chaubey.

There have been a few initial studies on the ACE2 gene by other research groups, but all of them looked for the presence or absence of various mutations, whereas this team used more powerful haplotype-based analysis (the method in which experts break the whole length of DNA into several pieces and make comparisons).

“The genetic ancestry of most South Asians can be traced to West Eurasian populations rather than with East Eurasians, whereas for this gene, the result is other way round,” said Prof. George van Driem of University of Bern, Switzerland, one of the experts on the team in the paper.

In this type of analysis, several DNA fragments are compared rather than few mutations as populations that share more DNA chunks are considered to be closer, said Chaubey.

“The match of DNA fragments of South Asians with East Asians suggests that the entry gate of Corona virus among South Asians will be more similar to that of East Asians rather than that of Europeans or Americans. This also explains the low mortality rate in South Asia,” he explained.

The second important finding is about two major mutations which are responsible for strengthening the entry point of the Coronavirus among South Asians. “Thus, this paper adds important potential implications to understanding the transmission patterns of Coronavirus in various populations across the world,” said Anshika Srivastava, one of the authors of the paper.

Rudra Pandey and Prajwal Singh from BHU, Avinash Rasalkar, Pankaj Srivastava from Sagar Central University, Rakesh Tamang from Calcutta University and Pramod Kumar from National Centre for Disease Control were also involved in this research.

Why distributing a SARS-CoV-2 vaccine will be global challenge

There’s nearly universal agreement that a safe and effective SARS-CoV-2 vaccine should be available and affordable to all countries—rich or poor—both as a moral imperative and because the globe’s health and economy will depend on it. But the rollout of a vaccine will be hugely expensive and time consuming, potentially leaving poorer countries and disadvantaged communities last in line and also forcing tough decisions about which members of society ought to get it first.

During a recent “Ethics Talk” videocast from the AMA Journal of Ethics® (@JournalofEthics), Ruth Faden, PhD, MPH, professor of biomedical ethics at the Johns Hopkins Berman Institute of Bioethics, summarized efforts underway to head off inequity in distributing vaccines and outlined the top-level ethical arguments around who should get the vaccine first when supply is limited.

A global public health good

The need for countries to balance their commitments to securing vaccines for their populations without simultaneously depriving low- and middle-income countries of access to doses is a “global ethics sweet spot,” Faden said.

The COVID-19 Vaccines Global Access (COVAX) facility, headed by the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, was organized to help with this. By pooling demand, it provides countries that have entered into bilateral agreements with manufacturers an insurance policy in the form of a larger portfolio of vaccine candidates. At the same time, it gives governments lacking bilateral agreements—typically low- and middle-incomes countries—a reliable supply of vaccines, with financial support coming from various donor sources.

As of early September, more than 170 countries had signed on to the effort. The U.S. wasn’t one of them, though, ostensibly because of its objection to the WHO’s involvement. But there are “prudential, self-interested reasons” for getting behind it, Faden noted.

In public health, she said, it’s axiomatic that, “if there are outbreaks anywhere, there are outbreaks everywhere.”

Front-line health care workers should be prioritized for vaccination because of their societal value during a pandemic, Faden said. But determining who else is essential is more challenging.

For starters, decision-makers need to avoid the elitist bias that “essential” necessarily means highly skilled, well-trained or professional. Within health care, for example, essential workers ought to include custodial staff and food preparers, she said.

Outside of health care, they might include people who are critical to the country’s food supply, transportation system and power grid, but this is normatively charged territory, Faden added. Primary, middle and high school teachers illustrate the point.

“Are they essential workers or not?” Faden asked, noting that many essential workers are, in fact, highly skilled and cannot be replaced easily. “I would make a big plug for K–12 workers being essential workers. Someone else might want to throw in university professors into that category as well.”

Making such a determination is also a matter of assessing whether additional risk of infection comes with the occupation, whether risk can be mitigated by PPE, whether there is adequate availability and quality of PPE and potential for physical distancing at the work site.

But while limited vaccine supply might prevent some essential workers from getting doses as soon as they are available, Faden added, U.S. health care workers should enjoy priority for another reason: The country owes it to them.

“We also need to incentivize people to continue to do those jobs,” she said, “to make them feel not only acknowledged and that expression of national gratitude, but also, ‘OK, I can keep doing this because I’m going to be protected.’”

The AMA and the Centers for Disease Control and Prevention are closely monitoring the COVID-19 pandemic. Learn more at the AMA COVID-19 resource center. Also check out pandemic resources available from the AMA Code of Medical EthicsJAMA Network™ and AMA Journal of Ethics, and consult the AMA’s physician guide to COVID-19.

U.S. Won’t Get Back To Normal Until Late 2021

The nation’s leading infectious disease expert also voiced concerns about states starting to resume certain indoor activities like dining. Even as movie theaters, gyms and salons are opening and some states are allowing limited indoor dining, daily life in the U.S. won’t get back to normal until late 2021 when a vaccine for COVID-19 could be widely distributed, the nation’s leading infectious disease expert, Dr. Anthony Fauci, said Friday.

In an interview on MSNBC’s “Andrea Mitchell Reports,” Fauci, who is the director of the National Institute for Allergy and Infectious Diseases, said he remains confident there will be a vaccine available by the end of this year or early 2021.

“But by the time you mobilize the distribution of the vaccine and get a majority or more of the population vaccinated and protected, that’s likely not going to happen until the end of 2021,” he said. “If you’re talking about getting back to a degree of normality prior to COVID, it’s going to be well into 2021, towards the end of 2021.”

As the U.S. is plateauing at a high level of around 40,000 new cases and 1,000 deaths a day, Fauci also voiced concerns about states starting to resume certain indoor activities like dining.

“Being indoors absolutely increases the risk” of transmission, Fauci said. “I am concerned when I see things starting indoors, and that becomes more compelling when you move into fall and winter season.”

This week, New York Gov. Andrew Cuomo said restaurants will reopen on Sept. 30, at 25 percent capacity and allow 50 percent capacity in November. Miami-Dade restaurants were allowed to reopen at 50 percent capacity at the end of August.

A report published Thursday by the Centers for Disease Control and Prevention found that adults who tested positive for COVID-19 were twice as likely to report having eaten at a restaurant in the past two weeks.

Fauci stressed that the safest way to resume indoor activities is to bring down community transmission to the lowest possible level. He also noted that being outdoors doesn’t offer blanket protection, either. “Just because you’re outdoors does not that mean you’re protected, particularly if you’re in a crowd and you’re not wearing masks,” he said, referring to political rallies.

Fauci didn’t offer more details about the University of Oxford vaccine trial, which was paused by ther drug maker AstraZeneca this week after a participant developed a spinal issue, but did say the safety board was investigating.

Married And Lived Together For 50 Years, A Couple Die Minutes Apart, While Holding Hands

A couple married for 48 years, and together for over 50, died of coronavirus only minutes apart holding hands.  Johnny Lee Peoples, 67, and his wife Cathy “Darlene” Peoples, 65 started feeling symptoms at the beginning of August, but would not make it to see more than two days of September.

“Mom and Dad lived hand to hand for 50 years, they died hand to hand, now they’re walking in heaven hand to hand,” their son, Shane Peoples, told CNN.  “The message our family would like to convey is that Covid is real. It’s not a hoax or a joke. Our parents took the proper precautions but tragically still contracted the virus.”

Johnny served in the US Army for over 17 years and retired from the North Carolina Department of Correction a few years ago. Darlene worked at Rowan Family Physicians where she was employed by LabCorp and was supposed to retire on September 1, the day before she and her husband died.

 

Darlene had a fever on August 1 and had a coronavirus test that week. Shane said that on August 10 she tested negative, which the family believes was a false negative because she later tested positive at the hospital.

 

Johnny started having symptoms on August 5 and tested positive on August 7. Then on August 11, both were admitted to the Covid-19 unit at their local hospital, Novant Health Rowan Regional Medical Center, because of difficulty breathing due to previous illness.

Darlene had high blood pressure, fibromyalgia, and Type 2 diabetes, while Johnny had pneumonia two years ago that caused some damage to his lungs, Shane said.

 

“(On September 1), we were told they had no chance of surviving. Dad could continue to live on the ventilator but would never come off of it. Mom’s organs were failing,” Shane said.

The next day, they were placed in the same room next to each other. They were taken off the ventilator and died a few minutes apart.

“They both had pre-existing conditions. Just keep in mind, these didn’t kill my parents, Covid-19 did,” Shane said. “This was the first time for that ICU staff to deal with two family members passing. The hospital staff was amazing through the whole thing.”

The couple is survived by their three children and nine grandchildren.  In their memory, the family is asking for donations to Dr. Vandana Shashi’s Genetic Sequencing Research in the Department of Pediatrics, Duke University School of Medicine since two of their grandchildren have rare unnamed genetic disorders.

“We were cheated,” Shane said in a Facebook post after they died.  “My parents weren’t just a blessing for me, my brother, my sister, our spouses, and our children. They were a blessing to every person that met them… I just wish everyone could see them through my eyes. You would see the two most loving and caring couple, ever. Without them, this world just got a bit more gloomy.” (Source: CNN.COM)

Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer

 In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other organizations report in a new study.

The findings, based on data from a large observational study nested in a clinical trial, are in line with earlier studies showing a connection between regular coffee consumption and improved outcomes in patients with non-metastatic colorectal cancer. The study is being published today by JAMA Oncology.

The investigators found that in 1,171 patients treated for metastatic colorectal cancer, those who reported drinking two to three cups of coffee a day were likely to live longer overall, and had a longer time before their disease worsened, than those who didn’t drink coffee. Participants who drank larger amounts of coffee – more than four cups a day – had an even greater benefit in these measures. The benefits held for both caffeinated and decaffeinated coffee.

The findings enabled investigators to establish an association, but not a cause-and-effect relationship, between coffee drinking and reduced risk of cancer progression and death among study participants. As a result, the study doesn’t provide sufficient grounds for recommending, at this point, that people with advanced or metastatic colorectal cancer start drinking coffee on a daily basis or increase their consumption of the drink, researchers say.

“It’s known that several compounds in coffee have antioxidant, anti-inflammatory, and other properties that may be active against cancer,” says Dana-Farber’s Chen Yuan, ScD, the co-first author of the study with Christopher Mackintosh, MLA, of the Mayo Clinic School of Medicine. “Epidemiological studies have found that higher coffee intake was associated with improved survival in patients with stage 3 colon cancer, but the relationship between coffee consumption and survival in patients with metastatic forms of the disease hasn’t been known.”

The new study drew on data from the Alliance/SWOG 80405 study, a phase III clinical trial comparing the addition of the drugs cetuximab and/or bevacizumab to standard chemotherapy in patients with previously untreated, locally advanced or metastatic colorectal cancer. As part of the trial, participants reported their dietary intake, including coffee consumption, on a questionnaire at the time of enrollment. Researchers correlated this data with information on the course of the cancer after treatment.

They found that participants who drank two to three cups of coffee per day had a reduced hazard for death and for cancer progression compared to those who didn’t drink coffee. (Hazard is a measure of risk.) Those who consumed more than four cups per day had an even greater benefit.

“Although it is premature to recommend a high intake of coffee as a potential treatment for colorectal cancer, our study suggests that drinking coffee is not harmful and may potentially be beneficial,” says Dana-Farber’s Kimmie Ng, MD, MPH, senior author of the study.

“This study adds to the large body of literature supporting the importance of diet and other modifiable factors in the treatment of patients with colorectal cancer,” Ng adds. “Further research is needed to determine if there is indeed a causal connection between coffee consumption and improved outcomes in patients with colorectal cancer, and precisely which compounds within coffee are responsible for this benefit.”

Co-authors of the study are Sui Zhang, MS, Robert J. Mayer, MD, and Jeffrey A. Meyerhardt, MD, MPH, of Dana-Farber; Fang-Shu Ou, PhD, and Brian C. Mullen, MS, of the Mayo Clinic; Donna Niedzwiecki, PhD, of Duke University School of Medicine; I-Wen Chang, MD, of Southeast Clinical Oncology Research Consortium, Winston-Salem, N.C.; Bert H. O’Neil, MD, of Indiana University School of Medicine; Heinz-Josef Lenz, MD, of Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Charles D. Blanke, MD, of Knight Cancer Institute, Oregon Health and Science University; Alan P. Venook, MD, of University of California San Francisco School of Medicine; Charles S. Fuchs, MD, of Yale Cancer Center and Smilow Cancer Hospital; Federico Innocenti, M.D., PhD, of Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Andrew B. Nixon, PhD, of Duke Cancer Institute, Duke University Medical Center; Richard M. Goldberg, MD, of West Virginia University Cancer Institute; and Eileen M. O’Reilly, MD, of Weill Cornell Medical College, Cornell University and Memorial Sloan Kettering Cancer Center.

Funding for the study was provided by the National Cancer Institute (grants U10CA180821, U10CA180882, U10CA180795, U10CA180838, U10CA180867, U24CA196171, UG1CA189858, P50CA127003, R01CA118553, R01CA205406, U10CA180826, U10CA180830, and U10CA180888), the Project P Fund, Genentech, Sanofi, and Pfizer.

Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. We provide the latest treatments in cancer for adults through Dana-Farber/Brigham and Women’s Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 10 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.

As a global leader in oncology, Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world, offering more than 1,100 clinical trials. 

COVID-19 Has Killed Nearly 200,000 Americans: When & How Will This Pandemic End?

Among the world’s wealthy nations, only the U.S. has an outbreak that continues to spin out of control. Of the 10 worst-hit countries, the U.S. has the seventh-highest number of deaths per 100,000 population; the other nine countries in the top 10 have an average per capita GDP of $10,195, compared to $65,281 for the U.S. Some countries, like New Zealand, have even come close to eradicating COVID-19 entirely. Vietnam, where officials implemented particularly intense lockdown measures, didn’t record a single virus-related death until July 31.

Forty-five days before the announcement of the first suspected case of what would become known as COVID-19, the Global Health Security Index was published. The project—led by the Nuclear Threat Initiative and the Johns Hopkins Center for Health Security—assessed 195 countries on their perceived ability to handle a major disease outbreak. The U.S. ranked first.

It’s clear the report was wildly overconfident in the U.S., failing to account for social ills that had accumulated in the country over the past few years, rendering it unprepared for what was about to hit. At some point in mid-September—perhaps by the time you are reading this—the number of confirmed coronavirus-related deaths in the U.S. has passed 200,000, more than in any other country by far.

If early in the spring, the U.S. had mobilized its ample resources and expertise in a coherent national effort to prepare for the virus, things might have turned out differently. If, in midsummer, the country had doubled down on the measures (masks, social-distancing rules, restricted indoor activities and public gatherings) that seemed to be working, instead of prematurely declaring victory, things might have turned out differently. The tragedy is that if science and common sense solutions were united in a national, coordinated response, the U.S. could have avoided many thousands of more deaths this summer.

Indeed, many other countries in similar situations were able to face this challenge where the U.S. apparently could not. Italy, for example, had a similar per capita case rate as the U.S. in April. By emerging slowly from lockdowns, limiting domestic and foreign travel, and allowing its government response to be largely guided by scientists, Italy has kept COVID-19 almost entirely at bay. In that same time period, U.S. daily cases doubled, before they started to fall in late summer.

Seven months after the coronavirus was found on American soil, we’re still suffering hundreds, sometimes more than a thousand deaths every day. An American Nurses Association survey from late July and early August found that of 21,000 U.S. nurses polled, 42% reported either widespread or intermittent shortages in personal protective equipment (PPE) like masks, gloves and medical gowns. Schools and colleges are attempting to open for in-person learning only to suffer major outbreaks and send students home; some of them will likely spread the virus in their communities. More than 13 million Americans remain unemployed as of August, according to Bureau of Labor Statistics data published Sept. 4.

There is nothing auspicious about watching the summer turn to autumn; all the new season brings are more hard choices. At every level—from elected officials responsible for the lives of millions to parents responsible for the lives of one or two children—Americans will continue to have to make nearly impossible decisions, despite the fact that after months of watching their country fail, many are now profoundly distrustful, uneasy and confused.

  • India recorded 8,069 Covid-19 deaths in the past week, a sharp rise of 14.5% over the previous week (7,050 deaths, a 1.7% rise), with fatalities averaging more than 1,100 per day. For the first time, the national death toll remained above 1,000 on all days of the past week.
  • Fresh cases reported during the week also rose by 11%, as more than 640,000 infections were detected.
  • Both the case count and death toll in India during the week (September 7-13) were the highest in the world. While India has been reporting the highest number of Covid cases globally since August, the country’s rising death toll has overtaken other countries in September so far.
  • Maharashtra crossed a grim mark of over 1 million Covid-19 case count after nearly 25,000 new infections (24,886) were confirmed on Friday. The state accounts for nearly 22% of India’s total cases. If it were a country, Maharashtra would be the fifth worst-hit globally, with 10,15,681 cases, and may soon cross Russia’s count of 1.05 million cases.
  • Friday: 97,937 new cases (a record) and 1,249 fatalities
  • Total: 4,653,193 cases and 77,384 fatalities
  • Six other states — Uttar Pradesh (7,103 new cases), Odisha (3,996), Punjab (2,526), Madhya Pradesh (2,240), Rajasthan (1,660) and Gujarat (1,344) — also reported their highest daily count yet.

Pfizer ready to distribute vaccine in US before year-end

  • US pharmaceutical giant Pfizer, which has been working alongside Germany’s BioNTech on an mRNA-based Covid-19 vaccine, said it will be ready to distribute the vaccine to Americans before the end of the year if found to be safe and effective. The company is prepared to distribute “hundreds of thousands of doses” if the FDA approval is in place, Pfizer CEO Albert Bourla said.
  • Pfizer’s is one of the three highly-anticipated vaccine candidates in the world, alongside those developed by Moderna and Oxford University. It is currently undergoing Phase III trials. On Saturday Pfizer said it will expand those trials to 44,000 participants to collect more safety and efficacy data and to increase the diversity of the study’s participants by enrolling, among others, adolescents as young as 16 years of age.
  • Bourla’s statement comes weeks after the US Centers for Disease Control and Prevention (CDC) notified state and city officials in the country to prepare to distribute a coronavirus vaccine to priority groups as early as November. The CDC’s technical specifications for two candidates described as Vaccine A and Vaccine B seem to match the products developed by Pfizer and Moderna, The New York Times had reported.
  • Health minister Harsh Vardhan said the government is considering emergency authorisation of Covid vaccine so that it can be made available at the earliest for those in high-risk groups, including senior citizens and healthcare workers.
  • Also, patients who recover from Covid may continue to report a wide variety of signs and symptoms, including fatigue, body ache, cough, sore throat and difficulty in breathing, according to a fresh protocol issued by the health ministry for managing such patients. More here.
  • NEET: Attendance for the NEET-UG exam on Sunday was between 85% and 90%, the National Testing Agency said, based on random sampling. Those who missed the exams after testing positive will get another chance to take the test.
  • Serum Institute of India paused the trials of Covishield, Oxford University-AstraZeneca’s Covid-19 vaccine candidate, following Wednesday’s showcause notice issued by the central drug regulator. “We are reviewing the situation and pausing India trials till AstraZeneca restarts them. We are following the Drug Controller General of India’s instructions and will not be able to comment further on the same,” the Pune-based company said.

Seven in 10 Americans willing to get COVID-19 vaccine, survey finds

COLUMBUS, Ohio — Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine when one becomes available, according to a new study. But researchers say there are concerning gaps in interest, particularly among Black Americans, who suffer disproportionately from the virus. 

Researchers from The Ohio State University surveyed more than 2,000 Americans in May, asking them about their willingness to be vaccinated and 11 factors that could influence that decision. They found that 1,374 out of 2006 people in the survey, 69%, said they would “definitely” or “probably” get a vaccine. The survey found that 17% were “not sure” and 14% were “probably or “definitely” not willing. 

The study, one of the first estimates of COVID-19 vaccine acceptance in the U.S., appears online in the journal Vaccine

Lead researcher Paul Reiter, an associate professor of health behavior and health promotion, said he suspected there would be higher-than-normal interest in this vaccine, considering the nature of the pandemic and the severity of illness many people have experienced. 

“The interest here is higher than what we typically see for flu vaccine and other vaccines where there is a strong public health need for widespread protection,” he said. 

The strongest predictors of whether someone said they’d accept a vaccine were how well the vaccine works and whether their health care provider would recommend it. Individuals’ perceived personal health threat from COVID-19 also played strongly into their willingness to be vaccinated, the researchers found. “That aligns with what we see in public health in a variety of areas — if someone perceives themselves to be at a higher risk of a health issue, that’s going to make them more likely to engage in the health behavior, in this case vaccination,” Reiter said. 

One of the more unexpected findings in this study – and something that isn’t typical of public health research – is the correlation between political affiliation and willingness to adopt a public health intervention, Reiter said. Respondents who identified as liberal or moderate were significantly more likely to accept a vaccine. 

“COVID-19 has turned into a political issue in many cases, and I think that some people just pick their side based on that, without much research,” he said. “We’ve seen that with mask wearing. It’s a promising public health intervention, but it’s turned into a political powder keg.” 

The most worrisome finding was among Black survey respondents, as only 55% said they were willing to get a vaccine.  “Given the disproportionate burden of COVID-19 infection and death among Black Americans, it’s concerning to see that Black survey participants had less interest in a vaccine,” Reiter said. “I think there are likely several factors at play, including access to care and trust in health care and potential socioeconomic barriers.”  Reducing such barriers is important since only 35% of participants in the study would pay $50 or more out-of-pocket for a COVID-19 vaccine, Reiter said. 

As of the first week of September, 10 states had indicated plans to offer free vaccines when they become available, according to KFF (formerly known as the Kaiser Family Foundation.) Reiter said public health leaders and policymakers can look to this study as they shape efforts to communicate the benefits (and any risks) of a COVID-19 vaccine, once one is approved for general use. 

“You hear a lot of talk of vaccination and the benefits of herd immunity, the idea that when enough people have resistance to a virus it reduces the threat to the entire population. At 70%, we may or may not get there,” Reiter said. 

That makes it especially important to work toward educational efforts, the elimination of obstacles and other strategies to increase the chances of vaccination among those who face increased risks of severe illness or death. If the vaccine against COVID-19 requires more than one dose, it will present even more challenges, he said — a reality that has been made clear in recent years with efforts to fully vaccinate young people against HPV to help prevent cancer. The HPV vaccine requires at least two doses, and three when given later in the teen years. 

Though the survey was conducted four months ago, Reiter said he doesn’t expect much has changed in terms of public perception.  “As we get closer to a vaccine becoming available, factors that could further affect the public’s interest will include cost and the number of doses required,” he said. Other Ohio State researchers who worked on the study are Mira Katz and Michael Pennell. The National Center for Advancing Translational Sciences provided funding for the research. 

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells

The UNC School of Medicine laboratory of Camille Ehre, PhD, assistant professor of pediatrics, produced striking images in respiratory tract cultures of the infectious form of the SARS-CoV-2 virus produced by infected respiratory epithelial cells. The New England Journal of Medicine featured this work in its “Images in Medicine” section.

Ehre, a member of the UNC Marsico Lung Institute and the UNC Children’s Research Institute, captured these images to illustrate how intense the SARS-CoV-2 infection of the airways can be in very graphic and easily understood images. Her lab conducted this research in collaboration with the labs of Ralph Baric, PhD, the William R. Kenan Distinguished Professor of Epidemiology at the UNC Gillings School of Public Health, who holds a joint faculty appointment at the UNC Department of Microbiology and Immunology, and Richard Boucher, MD, the James C. Moeser Eminent Distinguished Professor of Medicine and Director of the Marsico Lung Institute at the UNC School of Medicine.

In a laboratory setting, the researchers inoculated the SARS-Co-V-2 virus into human bronchial epithelial cells, which were then examined 96 hours later using scanning electron microscopy.

The images, two of which are re-colorized here by UNC medical student Cameron Morrison, show infected ciliated cells with strands of mucus (yellow) attached to cilia tips (blue). Cilia are the hair-like structures on the surface of airway epithelial cells that transport mucus (and trapped viruses) from the lung. A higher power magnification image shows the structure and density of SARS-CoV-2 virions (red) produced by human airway epithelia. Virions are the complete, infectious form of the virus released onto respiratory surfaces by infected host cells.

This imaging research helps illustrate the incredibly high number of virions produced and released per cell inside the human respiratory system. The large viral burden is a source for spread of infection to multiple organs of an infected individual and likely mediates the high frequency of COVID-19 transmission to others.  These images make a strong case for the use of masks by infected and uninfected individuals to limit SARS-CoV-2 transmission. The National Institutes of Health and the Cystic Fibrosis Foundation funded this research. 

Dr. Ashish Jha Leaves Harvard to Head Brown School of Public Health

Ashish K. Jha, who served as director of the Harvard Global Health Institute and Global Health Professor and was frequent commentator in the media on COVID-19, has left Harvard to serve as the Dean of the School of Public Health at Brown University, according to a report by the Harvard Crimson newspaper.Dr. Jha is the 3rd Dean of the School of Public Health at Brown. Jha began as an assistant professor at the Harvard School of Public Health in 2004. He has also worked as a practicing general internist at the V.A. Boston Healthcare System, the Crimson said.

Jha was approached by former University President Drew G. Faust to head the Harvard Global Health Institute, where he began as director in 2014. The institute brought together a multidisciplinary team of researchers and affiliated faculty members from across Harvard’s schools, including the Law School, Business School, Medical School, and School of Public Health, according the Crimson.

“This is an unprecedented time to be joining you. In the midst of the largest public health crisis in a century, this is a moment to recast and reinvigorate public health. And we at the Brown School of Public Health are uniquely able to do so. In this moment of challenge, we have the ability to bring bold thinking and fearless research to this pandemic, to issues central to our school, and, importantly, to make clear the significance of public health in our community, our country, and around the globe. I am so excited about the opportunities ahead and look forward to working with all of you to meet them,” Dr. Jha said on the Brown University website.

As dean, Jha will oversee the School of Public Health’s academic departments, research centers, doctoral and master’s programs, and undergraduate concentrations, Brown University said in a press release. Key responsibilities include developing and executing strategies to expand sponsored research funding and elevate the school’s profile and impact locally and globally. Integral to his role will be cultivating a diverse and inclusive academic community, providing administrative oversight and ensuring the school’s fiscal strength.

In addition to his role leading the Harvard Global Health Institute, Jha is a professor of global health at the Harvard T.H. Chan School of Public Health and has served as the school’s dean for global strategy since 2018. He is also a practicing general internist at the V.A. Boston Healthcare System and a professor of medicine at Harvard Medical School.

His background as a practitioner providing care for individual patients, a scholar focused on national and global public health systems, and a global health advocate engaged on major issues such as the impact of climate change on public health, makes him an ideal leader to advance academic excellence and provide strategic direction for the school.

Jha said that the potential to build on the School of Public Health’s strengths and work with students, faculty and staff to position it as a leading public health school born in and built for the health challenges of the 21st century is exciting, especially in the context of Brown’s collaborative academic culture. And Brown’s track record of partnership with health care leaders and agencies in Rhode Island — through the School of Public Health, the Warren Alpert Medical School and other academic departments — is another essential factor in ensuring the role of public health educators and researchers in fulfilling the University’s mission, Jha added.

“The most significant public health problems of our time demand a multi-disciplinary approach, and faculty and students at Brown live that in addressing major challenges,” Jha said. “Brown is also deeply embedded in Rhode Island’s communities. The fact is, as Brown demonstrates, academic institutions function best when they partner with public health agencies and individuals to test ideas. It’s not a standard model for every university but it is for Brown, and that’s part of what makes me so enthusiastic about this new and important opportunity to be part of a community making a difference, locally and globally.”

With sponsored funding from sources such as the National Institutes of Health, the Gates Foundation, the Climate Change Solutions Fund and the Commonwealth Fund, Jha’s research focuses on improving the quality of health care systems with a specialized focus on how national policies impact care. He has led some of the seminal work comparing the performance of the U.S. health system to those of other high-income countries to better understand why the U.S. spends more but often achieves less in population health.

Jha co-chaired an international commission that examined the global response to the Ebola outbreak in West Africa in 2014 and what could be done to strengthen the approach to pandemic preparedness and response. He has written extensively on the importance of international agencies like the World Health Organization and how they can be made more effective in infectious disease outbreaks like Ebola, Zika and now Coronavirus.

He has published more than 200 empirical papers and writes regularly about ways to improve health care systems, both in the U.S. and globally. In addition to his academic appointments at Harvard, he served in a number of roles at the federal level, including as special assistant to the secretary in the Department of Veterans Affairs from 2009 to 2013. Jha was elected as a member of the National Academy of Medicine in 2013.

Jha will lead Brown’s School of Public Health as it continues to build national influence in impacting urgent health challenges and improving equity in health care through its research and teaching. Initially a department of Brown’s medical school, the school launched in 2013 and became fully accredited by the Council on Education for Public Health in 2016. With more than 250 faculty and 400 undergraduate and graduate students, the school is home to 13 nationally renowned research centers and receives more than $60 million in external research funding annually.

Jha earned a bachelor’s degree in economics from Columbia University in 1992 and an M.D. from Harvard Medical School in 1997, before training in internal medicine at the University of California in San Francisco. He completed his general medicine fellowship at Brigham & Women’s Hospital at Harvard Medical School and received his master of public health in 2004 from the Harvard T.H. Chan School of Public Health. As dean, Jha will report directly to Locke and serve as a member of the Provost’s Senior Academic Deans committee and of the President’s Cabinet. 

India Overtakes Brazil As Country With Second-Highest Number Of Covid-19 Cases

India has surpassed Brazil as the country with the second-highest number of confirmed Covid-19 cases after reporting a fresh daily high of 90,802 new infections on Monday.

India’s total number of cases now stands at 4,204,613, according to the Indian Ministry of Health and Family Welfare. In comparison, Brazil has confirmed 4,137,521 cases, according to Johns Hopkins University. 

India is the world’s second most populous nation, home to more than 1.3 billion people — more than six times the population of Brazil.

The United States remains the country with the highest number of recorded cases. As of Sunday night, the US had reported 6,275,643 cases, according to JHU.

Low death rate: As of Monday, India had recorded 71,642 virus-related deaths, far below the US at nearly 189,000 deaths and Brazil’s more than 126,000 fatalities.

India’s death rate of five virus-related fatalities per 100,000 people is lower than more than 80 countries and territories, according to JHU data.

For comparison, the US death rate is 58 per 100,000 people, while Brazil’s is 60 per 100,000 people, according to JHU.

Reopening: The rapid rise in infections in India comes after the government announced a new phase of reopening last week. Subway trains will be allowed to run for the first time in months from September 7 while gatherings of up to 100 people will be permitted at sports, entertainment, cultural and religious events outside of hotspot areas from September 21.

Schools and colleges will remain closed until the end of September.

India is now adding more daily cases than the US and Brazil combined; on cumulative cases, India is second only to the US. This has coincided with the faster spread of infections in rural India. The case count in the worst-hit states have continued to rise, save for Bihar, where the number has fallen to less than 2,000 from the peak of over 4,000 last month. In Tamil Nadu, the tally has curiously hovered around 5,500, neither rising nor declining by any considerable margin. In fact, Tamil Nadu’s standard deviation of cases, at around 4%, has been the lowest among all major states. Delhi appears to be experiencing a second wave.

The rise in active cases is also outpacing recoveries. Some states such as Andhra Pradesh and Tamil Nadu, though, have been recording more recoveries in recent weeks.

The rural surge is a particular concern. According to a recent report by the State Bank of India (SBI), 26 of the 50 worst affected districts for new cases in August were rural. The worst-hit rural areas are in Andhra Pradesh, Maharashtra, Uttar Pradesh, Telangana and Rajasthan.

 

Also: The number of districts with less than 1,000 cases has fallen, while those reporting between 5,000 to 10,000 cases have risen from July.

The Centre has now opted to coordinate directly with chief medical officers and administrative officials of the worst-hit districts to identify the loopholes in the strategy, as against addressing the health secretaries of the states, reports The Indian Express. 

UNICEF To Lead Global Supply Of Covid-19 Vaccine

In what could possibly be the world’s largest and fastest ever procurement and supply of vaccines, the United Nations Children’s Fund (Unicef) has said that it will lead efforts for Covid-19 vaccine supply for 92 low and lower middle-income countries.

These efforts will be part of the Covid-19 Vaccine Global Access Facility (Covax Facility) plans led by Gavi, the Vaccine Alliance.

Vaccine purchases for these countries will be supported by the mechanism through the Gavi Advance Market Commitment for Covid-19 Vaccines (Gavi Covax AMC) as well as a buffer stockpile for humanitarian emergencies, Unicef said.

In addition, the UN agency will also serve as the procurement coordinator to support procurement by 80 higher-income economies, which have expressed their intent to participate in the Covax Facility and would finance the vaccines from their own public finance budgets.

Unicef will undertake these efforts in close collaboration with the WHO, Gavi, Coalition for Epidemic Preparedness Innovations (CEPI), Pan American Health Organization (PAHO), World Bank, the Bill and Melinda Gates Foundation and other partners.

The Covax Facility is open to all countries to ensure that no country is left without access to a future Covid-19 vaccine.

“This is an all-hands on deck partnership between governments, manufacturers and multilateral partners to continue the high stakes fight against the Covid-19 pandemic,” Henrietta Fore, Unicef Executive Director, said in a statement.

“In our collective pursuit of a vaccine, Unicef is leveraging its unique strengths in vaccine supply to make sure that all countries have safe, fast and equitable access to the initial doses when they are available,” the statement read.

Unicef is the largest single vaccine buyer in the world, procuring more than two billion doses of vaccines annually for routine immunisation and outbreak response on behalf of nearly 100 countries.In response to an expression of interest that Unicef issued in June on behalf of the Covax Facility, 28 manufacturers with production facilities in 10 countries shared their annual production plans for Covid-19 vaccines through 2023.

According to the timelines indicated by the manufacturers, the span from development to production could be one of the fastest scientific and manufacturing leaps in history, the organisation said.

A Unicef market assessment, developed by compiling information submitted by the vaccine manufacturers along with publicly available data, revealed that manufacturers are willing to collectively produce unprecedented quantities of vaccines over the coming one to two years. However, manufacturers signalled that investments to support such large-scale production of doses would be highly dependent on, among other things, whether clinical trials are successful, advance purchase agreements are put in place, funding is confirmed, and regulatory and registration pathways are streamlined. 

An Early Effect of COVID-19 Disruption: Drinking to Cope with Distress

Using alcohol to cope with distress was associated with increased drinking during the early stages of the COVID-19 pandemic, according to a new study. Adults experiencing greater depression or lower social connectedness, and those with children under age 18, were among those at risk for drinking to cope. The COVID-19 pandemic brought extensive disruptions to daily life, involving elevated stress among the general public. This increased the likelihood of people using alcohol to cope, a motive linked to solitary drinking, heavier drinking, and alcohol-related problems. At the same time, social distancing and closures meant that access to healthier supports, such as counseling and recreation, was reduced. The study in Alcoholism: Clinical and Experimental Research explored adult drinkers’ use of alcohol to cope with distress during the early pandemic, with the goal of informing interventions to address long-term alcohol-related harms.

Motivational theories of alcohol use emphasize individuals’ varying reasons for drinking, including internal distress. Researchers applied this lens to data supplied by 320 Canadian adult drinkers recruited online. The participants took surveys assessing their drinking frequency and quantity over a 30-day period beginning soon after public health measures were implemented, and the preceding 30 days. They also reported on demographic factors, and influences known to be associated with drinking as a coping mechanism or considered likely to increase that risk. These including changes in work hours and income, having children at home, anxiety about health, depression, social connectedness, drinking alone, and alcohol-related problems. Researchers used statistical modeling to explore associations between these influences.

Overall, participants’ reported total alcohol consumption was fairly steady compared to the previous month, although some people reported increased drinking while others reported decreased drinking. Using alcohol to cope with distress was associated with increased drinking and greater alcohol problems during the early stage of COVID-19. The risk was most notable among participants with greater depression or lower social connectedness. It also affected those with a child under 18 living at home, in line with previous evidence of parenting stress linked to both drinking to cope and the pandemic. Although people who lost income reported increased alcohol use early in the pandemic, this was not explained by drinking to cope.

Solitary alcohol use, a behavior linked with alcohol problems, also increased (drinking in virtual social contexts was not considered solitary). However, increased solitary drinking was linked to situational factors (such as living alone) rather than drinking to cope. Men and people belonging to racial or ethnic minority groups were also more likely to report increased solitary drinking.

The study highlights the importance of addressing coping-motivated drinking among depressed or socially isolated people and parents of children under age 18. The researchers cautioned that the study findings are not necessarily generalizable and are limited by focusing on one point in time. They recommend further investigation involving larger and more diverse samples, and longitudinal research to clarify cause and effect.

Drinking to cope during COVID-19 pandemic: The role of external and internal factors in coping motive pathways to alcohol use, solitary drinking, and alcohol problems. J. Wardell, T. Kempe, K. Rapinda, A. Single, E. Bilevicius, J. Frohlich, C. Hendershot, M. Keough.

Foreign Secretary Shri Harsh Vardhan Shringla on 4 September 2020 delivered a major foreign policy lecture on “The Broad Canvas of Indian Diplomacy during the Pandemic,” during a virtual event organised by Indian Council of World Affairs, one of India’s premier and oldest foreign policy think tanks.

The scale and spread of the event covered the length and breadth of India, with participants from 28 states and 4 union territories. With 2000 registered participants, the lecture was attended by a diverse array of distinguished think-tankers and eminent academics, including deans and vice chancellors of prestigious universities and research centers. 

September 10th is World Suicide Prevention Day Light a candle near your window at 8:00 PM

There is hardly anyone whose life has not been touched by suicide in one way or another. September 10th is World Suicide Prevention Day. Let us take this opportunity to remember those whose lives have been affected by suicide, raise awareness, and take steps to prevent suicide.

Did you know that asking a depressed person about suicide thoughts does not amount to suggesting suicide or increasing the likelihood of suicide? By asking, you are not going to put a thought in their heads. In fact, asking often opens up a dialogue and a feeling of relief.

People often believe that suicide is not preventable. This is not true. There are 20 million people who attempt suicide. Most of them go on to live and not die by suicide. There are many factors that contribute to suicide. One of the most important factors is untreated mental illness, e.g., severe depression among many other conditions. Ninety percent of those who die by suicide had untreated mental illness.

Some of the reasons for not seeking treatment for mental illness include stigma and shame associated with mental illness, not understanding mental illness, myths associated with mental illness and available treatments, difficulty finding culturally competent care, financial reasons, and so on. Often, people have a tendency to deny and refuse to accept the idea of mental illness. I have often heard, “such things don’t happen in our family; we are educated and successful . . . mental illness affects weak people. We are strong.” Mental illness is not a disease of the “weak.” It affects people from every socioeconomic, ethnic, racial, cultural, and national background.

Some people choose to seek traditional interventions like yoga, meditation, Ayurveda, and so on instead of conventional treatments like medications and psychotherapy. Traditional interventions can be valuable when used in conjunction with conventional treatments. Often, people are not aware that there are many safe and effective treatments available for mental illness.  Their fears of treatments are often based on misperceptions of treatments. When treatments are delayed, it is harder and takes longer for the illness to respond to treatment. Sometimes, untreated mental illness results in a tragedy.

Preventing suicide is everyone’s business. The goal of suicide prevention is reducing the factors that increase the risk and increasing the factors that promote resilience (i.e., protective factors).  Learn more about the risk and protective factors. It is also important to become familiar with the warning signs of suicide.

Those who have lost someone to suicide are left with many unanswered questions and are plagued with guilt, shame, and a host of other confusing emotions. They suffer in silence. If you or someone you know has lost someone to suicide, consider attending a Suicide Loss Survivor Support group. You can find a Suicide Loss Survivor Support group near you. In Central New Jersey SAMHIN offers a free weekly support group, Janani for anyone who has lost someone to suicide. Talking about the loss can ease your burden.

Download Light at the End of the Tunnel to learn more about depression, myths about suicide, and tips on suicide prevention. Also see additional suicide prevention and suicide survivor resources.If you or someone you know is faced with a crisis, call National Suicide Prevention Lifeline at 1-800-273-8255 (TALK). 

Former Surgeon General Vivek Murthy Says, Joe Biden Will Help Heal The Nation

UN Secretary-General Antonio Guterres on Friday asked India to end its reliance on polluting, financially volatile and costly fossil fuels and invest in clean, economically resilient solar power. Addressing TERI’s Darbari Seth Memorial Lecture virtually from New York due to Covid-19 restrictions, the UN chief asked all G20 countries, including India, to invest in a clean, green transition. “Today, as we endure the twin crises of Covid-19 and climate change, this effort has never been more important. “Worldwide, the pandemic has exposed systemic fragilities and inequalities that threaten the basis of sustainable development. A rapidly heating world threatens even more disruption and exposes even further our world’s deep and damaging imbalances. “Today’s young climate activists understand this. They understand climate justice. They know that the countries most affected by climate change have done the least to contribute to it,” he said in his lecture titled ‘The rise of renewables: Shining a light on a sustainable future’. “As we look to recover from the Covid-19 pandemic, we must commit to doing better. That means transforming our economic, energy and health systems — to save lives, create stable, inclusive economies and stave off the existential threat of climate change. I want to talk to you today about how to bring that vision to life — and about India’s role in that vital effort,” said the UN Secretary-General.He said that India has all the ingredients for exerting the leadership at home and abroad envisioned by Darbari Seth, who co-founded TERI. “The drivers are poverty alleviation and universal energy access — two of India’s top priorities. Scaling up clean energy, particularly solar, is the recipe for solving both, he said.Investments in renewable energy, clean transport and energy efficiency during the recovery from the pandemic could extend electricity access to 270 million people worldwide — fully a third of the people that currently lack it. These same investments could help create nine million jobs annually over the next three years. Investments in renewable energy generate three times more jobs than investments in polluting fossil fuels. With the Covid-19 pandemic threatening to push many people back into poverty, such job creation is an opportunity that can’t be missed. Praising India, he said it is already pushing ahead in this direction.Since 2015, the number of people working in renewable energy in India has increased five-fold.Last year, the country’s spending on solar energy surpassed spending on coal-fired power generation for the first time. India has also made significant progress towards universal access to electricity. Yet despite an access rate of 95 per cent, 64 million Indians are still without access today. There is still work to do, and opportunities to be grasped. Clean energy and closing the energy access gap are good business. They are the ticket to growth and prosperity, he said. Yet, in India, subsidies for fossil fuels are still some seven times more than subsidies for clean energy. Continued support for fossil fuels in so many places around the world is deeply troubling. “I have asked all G20 countries, including India, to invest in a clean, green transition as they recover from the Covid-19 pandemic. This means ending fossil fuel subsidies, placing a price on carbon pollution and committing to no new coal after 2020,” said Guterres. “In their domestic stimulus and investment plans in response to Covid-19, countries such as the South Korea, the UK, and Germany, as well as the European Union, are speeding up the decarbonisation of their economies. “They are shifting from unsustainable fossil fuels to clean and efficient renewables, and investing in energy storage solutions, such as green hydrogen. And it is not just developed economies stepping up,” the UN Secretary-General said. “Many in the developing world are leading by example — countries such as Nigeria, which has recently reformed its fossil fuel subsidy framework. While I am encouraged by these positive signals, I am also increasingly concerned about several negative trends,” he said. Recent research on G20 recovery packages shows that twice as much recovery money has been spent on fossil fuels as clean energy. “In some cases, we are seeing countries doubling down on domestic coal and opening up coal auctions. This strategy will only lead to further economic contraction and damaging health consequences,” Guterres warned. “We have never had more evidence that pollution from fossil fuels and coal emissions severely damages human health and leads to much higher healthcare system costs. Outdoor air pollution, largely driven by high-emitting energy and transport sources, leads to damaging pulmonary diseases — asthma, pneumonia and lung cancer,” he said. Quoting scientific studies, he said this year researchers in the US concluded that people living in regions with high levels of air pollution are more likely to die from Covid-19. If fossil fuel emissions were eliminated, overall life expectancy could rise by more than 20 months, avoiding 5.5 million deaths per year worldwide. Investing in fossil fuels means more deaths and illness and rising healthcare costs. It is, simply put, a human disaster and bad economics, he said. “Not least, because the cost of renewables has fallen so much that it is already cheaper to build new renewable energy capacity than to continue operating 39 per cent of the world’s existing coal capacity. This share of uncompetitive coal plants will rapidly increase to 60 per cent in 2022. In India, 50 per cent of coal will be uncompetitive in 2022, reaching 85 per cent by 2025,” Guterres said. This is why the world’s largest investors are increasingly abandoning coal, he added. Urging all countries, especially the G20 countries, to commit to carbon neutrality before 2050 and to submit — well before COP26 — more ambitious nationally determined contributions, Guterres asked India to be at the helm of the ambitious leadership. Applauding India’s decision to take forward the International Solar Alliance in the form of One Sun, One World, One Grid, he said he was inspired by the Indian government’s decision to raise its target of renewable energy capacity from the initial 2015 goal of 175 gigawatts to 500 gigawatts by 2030.

Nurses Over Drivers? Elderly Over Youth?… Who Gets Vaccinated First?

In this age of coronavirus, with vaccine experimentation moving at historic pace to the clinical trials phase, the ideal inoculation policy would emphasize age more than work-exposure risk, according to a study involving Washington University in St. Louis economists. There are numerous facets and factors to their modeling, including stay-at-home orders — with or without designating certain occupations as essential — that try to limit the possible spread of workplace infection.For the most part, though, they found the key that unlocks the mystery to potentially optimal vaccine distribution is age: While all employed people age 60-plus would receive the vaccine, in many occupations people would receive the vaccine starting from age 50. In fact, the largest volume of vaccines would be allocated to populations ages 50-59, due to its group size, followed by 60-69. As the researchers focused across the occupation spectrum and not merely age or exposure risks, they found that a 50-year-old food-processing worker would be equally prioritized as a 60-year-old financial advisor. “We expected that age would be a driving factor in allocating vaccines,” said Ana Babus, assistant professor of economics in Arts & Sciences and co-author of “The Optimal Allocation of Covid-19 Vaccines.” “But we have also learned that it may be better to vaccinate, say, a 50-year-old bus driver instead of even a 30-year-old health-care worker, when vaccine doses are limited.” Babus and SangMok Lee, assistant professor of economics at Washington University, joined Sanmay Das of George Mason University in estimating age-based and work-based infection risks, using age-based fatality rates estimated elsewhere. That’s how they emerged at the conclusion that age meant more than occupation. Furthermore, they discovered that designating some occupations as essential doesn’t affect optimal vaccine allocation unless a stay-at-home order also is in effect. COVID-19 won’t die with the first emergence of a vaccine, they learned. Even if a limited vaccine were allocated optimally, their model showed that 1.37% of the employed workforce still would be expected to get infected until a vaccine becomes widely available. That means if, say, the United States used 60 million vaccines on only current members of the workforce, some 2.5 million workers ultimately would get infected. And these numbers are based on a vaccine that’s 50% effective. A vaccine that’s 70% effective could cut that number of 2.5 million infected-workers only by 8%, to 2.3 million, they found. “We easily agree to prioritize high-risk populations,” Lee said. “However, risk level isn’t one-dimensional — it’s exposure and mortality — and putting one person ahead of another by risk isn’t so obvious. The goal of our study is to find which risk dimension to emphasize more. The goal of our study is to find which risk dimension to emphasize more.” While a recent history of vaccinating U.S. schoolchildren greatly decreased the transmission of flu, COVID-19 is a different animal. It kills older adults in far greater numbers, as well as the underrepresented. In this case, the study attempts to provide a best-practice scenario to supplement a vaccine distribution strategy with a targeted stay-at-home order preventing certain age-occupation groups from returning to their workplaces and spreading infection. They tracked eight age-groups — 16-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79 and 80-plus — over 454 occupations, using data from the 2017 American Community Service and a sample thus representative of 60% of the U.S. population (now roughly 330 million). They factored a worker’s contribution to output as measured by GDP, infection fatality rate and age. Using the United Kingdom’s Office for National Statistics data between March and May, they were able to infer the infection deaths for each occupation group. They related that to U.S. occupations, particularly considering physical proximity — lack of social distance at work — means higher infection risk. They conducted three exercises plugging the data into their model. In essence:The stay-at-home orders in their experimentation lasted two months. The results: In exercises Nos. 1 and 2, the 50-59 and then 60-69 age groups presented the largest volumes of vaccine allocation. In exercise No. 3, the largest age group was 30-39. In the latter sample, teachers taught online from home and more, younger health-care workers were able to get vaccinated.Remove any stay-at-home order, the researchers determined, and all employed people age 60-plus could receive the vaccine. If more occupations work from home, and workers 70-plus were mandated to stay at home, that would allow vaccines to be distributed to, say, nurses and food-preparation workers as young as 20-plus, the researchers found. They realize that their model takes into account solely the possibility of infection exposure at work. If people face the same infection risk in their social and home life, their analysis tilts “even more toward the elderly,” they wrote.

37 Routine Activities Ranked by Risk of COVID-19 Infection

COVID-19 has redefined risky behavior. So how do we know what’s more risky: getting a haircut, eating inside a restaurant, traveling by plane or shaking someone’s hand? Trick question. They’re equally risky to our health, according to a new risk-assessment chart produced by the Texas Medical Association COVID-19 Task Force and Committee on Infectious Diseases. The chart ranks activities by risk level, from opening the mail (low) to going to the beach (moderate) to attending a large music concert (high). The first four activities mentioned above are each rated moderate-high risk, a 7 on a scale of 10. Physician members of the task force and committee established the levels, with the assumption that people are taking as many necessary safety precautions as possible, no matter the activity.Here’s the complete list, from lowest to highest risk: Low Risk: 1
Opening the mail Low Risk: 2
Getting restaurant takeout
Pumping gasoline
Playing tennis
Going camping Low-Moderate Risk: 3
Grocery shopping
Going for a walk, run, or bike ride with others
Playing golf Low-Moderate Risk: 4
Staying at a hotel for two nights
Sitting in a doctor’s waiting room
Going to a library or museum
Eating in a restaurant (outside)
Walking in a busy downtown
Spending an hour at a playground Moderate Risk: 5
Having dinner at someone else’s house
Attending a backyard barbecue
Going to a beach
Shopping at a mall Moderate Risk: 6
Sending kids to school, camp, or day care
Working a week in an office building
Swimming in a public pool
Visiting an elderly relative or friend in their home Moderate-High Risk: 7
Going to a hair salon or barbershop
Eating in a restaurant (inside)
Attending a wedding or funeral
Traveling by plane
Playing basketball
Playing football
Hugging or shaking hands when greeting a friend High Risk: 8
Eating at a buffet
Working out at a gym
Going to an amusement park
Going to a movie theater 

High Risk: 9

Attending a large music concert

Going to a sports stadium

Attending a religious service with 500-plus worshipers

Going to a bar

A COVID-19 Back-to-School Guide . . . for Parents

This is the time of year when parents and kids usually start thinking about going back to school and making shopping lists for new clothes, backpacks and supplies. But this isn’t a usual school year, as school districts and parents struggle to decide what school will look like during COVID-19. To help parents with some advice on how to return to in-person school, we turned to Dr. Virginia M. Bieluch, Director of the Division of Infectious Diseases for Hartford HealthCare’s Hospital of Central Connecticut and Associate Professor of Medicine at the University of Connecticut School of Medicine. “I think it is important for parents to talk to their children about how school is going to look different this year with physical distancing, children and teachers wearing masks, and any plans their school has for changes from previous years,” Dr. Bieluch said. Bieluch said an important resource for parents is the Centers for Disease Control and Prevention‘s back-to-school planning checklists for parents. The state of Connecticut has also issued guidelines for the safe operation of schools. Parents should also check their local school district’s website for local information and guidelines. And, Dr. Bieluch said, make sure your child is up-to-date with all vaccinations to minimize the risk of your child getting sick with other infections. Unless contraindicated, make sure your child gets a flu shot next year to decrease chances of influenza, another respiratory illness with fever and cough. What should kids bring to and from school?Children should bring items such as water bottles (if allowed by the school), writing utensils, coloring utensils, and they should not share with other children. They should be able to open and close any containers they have without assistance. How do you deal with the children’s school clothing/shoes?These items should be washed frequently but no special treatment is necessary. What are any extras students might need?Find out if water and hand sanitizer will be provided to children. If not, the children will need to bring their own to school daily. An extra mask would be helpful, should the child’s mask get wet or soiled during school. A container, such as a small plastic bag, would be useful for mask storage when masks are removed such as when the child eats. Make sure children know proper hand washing and hand sanitizing methods.Hands should be washed often but especially before eating, after using the restroom or after blowing nose/sneezing/coughing. Hand washing is preferred but use hand sanitizer when washing is not possible. It’s smart to practice these activities well in advance of returning to school, especially with younger children. Hand-washing (5 steps)

  1. Wet hands.
  2. Lather hands on both sides, include fingers and nails.
  3. Scrub 20 seconds (sing happy birthday twice).
  4. Rinse with water.
  5. Dry, using a clean towel or allow to air dry.

Hand sanitizer

  1. Apply gel to the palm of one hand.
  2. Rub hands together.
  3. Rub over all surfaces of hands and fingers until sanitizer is dry, about 20 seconds.

Wearing masksTalk to your children about the importance of wearing a mask (to keep others healthy). Make mask wearing “no big deal” by putting a mask on a favorite stuffed animal, for example.

  • Practice how to put on and take off a mask without touching the front of the mask.
  • Find a mask that is comfortable for your child.
  • Personalize the mask if possible (favorite sports team, TV character, color).
  • Label mask with your child’s name to identify which mask belongs to your child.
  • Masks should be worn on the way to and from school when children ride the bus, car pool or walk in groups in which physical distancing is not possible.

Dr. Sudhakar Jonnalagadda, President of AAPI, Proposes US-Israel-India Health Dialogue

The COVID-19 Pandemic continues to impact the world as never before with millions around the world being affected. India and the United States lead the world chart with some of the highest number of cases being impacted and several hundreds losing their lives.

Collaboration and sharing of knowledge and expertise among the nations of the world is key to combating the virus and finding solutions to contain the spread and heal those who are affected. In this context, a Virtual Panel Discussion on “Can 30 Seconds Save the World? Israeli-Indian Cooperation to develop a rapid test for COVID-19” was held on August 26th.

 Dr. Sudhir Parikh, Chairman, Parikh Media Worldwide moderated a panel discussion, which was cosponsored by the Indian and Israeli Consulates in New York, American Jewish Committee, American Association of Physicians of Indian Origin, Parikh Media Worldwide, ITV Gold and the Hindu-Jewish Coalition. New York based Consul Generals Israel Nitzan (Israel) and Randhir Jaiswal (India) gave opening remarks as the cohosts of the program along with Rabbi David Levy of AJC New Jersey. Dr. Parikh gave the audience of over 150 guests which included Panama’s Health Minister.

In his remarks, Dr. Sudhakar Jonnalagadda, President of American Association of Physicians of Indian Origin (AAPI) called for a joint US-Israel-India Health dialogue with Israeli physicians from reputed hospitals to study and identify as to how with significantly limited resources, Israel is able to provide quality healthcare to all of its citizens. Dr. Jonnalagadda provided a brief on AAPI’s role and several initiatives it has undertaken in fighting COVID-19 in the US and India. “AAPI members are putting their best efforts to help our patients, especially those impacted by COVID,” he said. “Several of our physicians have been affected in this pandemic. We are continuing our efforts to make AAPI a more dynamic and  vibrant organization playing a meaningful and relevant part in advocating health policies and practices that best serve the interests of all patients  and  promoting the  physician’s role   as  the  leaders of the  team based health care delivery.”

He recalled of the AAPI’s mission to Israel and Jordan in 2019, and hoped “to work with our close friend Nissim B Reuben to ensure that we take such a mission annually to Israel in cooperation with AJC where we will call on the Israeli PM, Foreign Minister as well as Indian & US Ambassadors in Israel, enabling series of dialogue and discussions between India, Israel and the United States.

Dr. Jagdish Gupta, AAPI Mid-Atlantic Director and a member of AAPI’s BOT, in his remarks highlighted that his alma mater the All India Institute of Medical Sciences (AIIMS) which hosted the large mission of Israeli COVID-19 experts on its premises earlier this month led by Ambassador Ron Malka, who has been playing a significant role in fighting COVID-19 in India. Dr. Gupta hopes to see Israel-India Medical Cooperation between healthcare institutions such as AIIMS as well as other leading private sector hospitals such as Apollo, Medanta, Zydus etc. He Dr. Gupta, in his capacity as the President of the AIIMS Alumni in the US, oferred whole hearted support from the Alumni Group in future Israel-India medical cooperation initiatives.Dr. Jonnalagadda and Dr. Gupta were referring to an Israeli team, led by a “high ranking” research and development (R&D) defense officials, were in Delhi recently with a multi-pronged mission, codenamed “Operation Breathing Space” to work with Indian authorities on the coronavirus (COVID-19) response.

Amongst the plans for the team, which were coordinated by Israel’s Ministry of Foreign Affairs (MFA), and Indian Ministry of Defense (MOD) and the Ministry of Health, were four different kinds of rapid tests, which are jointly developed after trials on Indian COVID-19 patients, as well as high-tech equipment to minimize exposure of medical staff to the virus, advanced respirators and special sanitizers developed in Israel.“What they all have in common is the ability to detect the presence of the virus in the body quickly — usually within minutes. Developing diagnostic capabilities is a goal for the State of Israel and of many additional countries around the world. It is the most effective way to cut off ‘chains of infection’, prevent prolonged quarantine and enable the reopening of the global economy,” a media report on the Israeli mission to India said.

“If even one of the tests proves to be effective in testing for coronavirus in 30-40 seconds, this could be a game changer for the whole world and how we behave, at least until we have a vaccine,” Israeli Ambassador Ron Malka, who flew to Delhi by the special flight from Tel Aviv with the team and medical equipment aid, had said. “Imagine how much easier it will be to operate flights, schedule conferences and meetings, if we can test so easily and quickly,” he explained.

In his remarks, Ambassador Dr. Ron Malka gave an impressive overview of India-Israel relations. Besides the recent mega COVID-19 mission, he mentioned that Israel recently signed a mega water management agreement with Uttar Pradesh, India’s largest state.

Dr. Sudhir Parikh provided an overview of the growth of Indo-Israeli relationship going back to 1950 when India recognized Israel. With tireless efforts from Indian American community, including Dr. Sudhir Parikh, Dr. Bharat Barai and several other Indian-American leaders nationwide, India formally established diplomatic relationship in 1991.

Dr. Parikh thanked his close friend Nissim B Reuben for inviting him and his colleagues Dr. Sudhakar Jonnalagadda and Dr. Jagdish Gupta to be part of the panel. Both the Parikh and Reuben families are personally known to Prime Minister Narendra Modi who fondly calls Nissim India’s Rashtradoot – Goodwill Ambassador to the Jewish World. Since 2002, Nissim has had a significant role to play through his work at AJC building robust Jewish & Indian diaspora relations jointly advocating for close ties between the US, India & Israel in the strategic, economic, tech & cultural areas including organizing Hanukkah receptions in his Indian-Jewish tradition at the Indian Embassy in Washington, DC and Consulates in New York, Atlanta, Chicago and Houston.

Dr. Parikh offered Ambassador Ron Malka assistance in the process of enabling a similar regular exchange of experts in the health sector between India & Israel. He commended both PMs Narendra Modi and Benjamin Netanyahu, their scientific advisors & Ambassadors Ron Malka and Sanjeev Singla for their role in spearheading the robust India-Israel ties mentioning that the large Israeli delegation setting up a two weeks COVID testing camp in Delhi under Ambassador Malka’s leadership as an example.

As Secretary of the Global Association of Physicians of Indian Origin (GAPIO) both Dr. Sudhir Parikh and American Association of Physicians of Indian Origin (AAPI) President Dr. Sudhakar Jonnalagadda enthusiastically offered to advocate with the US administration and congress the importance of forging closer cooperation in the health and disaster management sector between the US, India and Israel.

Israel has set up 29 Centers of Excellence across India to help Indian farmers learn the best Israeli expertise in Agriculture to benefit Indian farmers. This is a huge help as 60% of the Indian economy is still dependent on Agriculture. Dr. Parikh suggested to Ambassador Ron Malka, that “with assistance from the Indian & Jewish diaspora communities, we would like Israel to be able to set up similar Centers of Health Cooperation across India.” He offered whole hearted support from GAPIO & AAPI for this endeavor bringing in our own USAID into the loop from the US.

Andrew Gross, Director, New-Jersey—Israel Commission from the New Jersey Governor’s office gave closing remarks offering Governor Phil Murphy’s robust support to partnership initiatives between New Jersey, Israel and India in all areas especially in the health, biomedical and biotech sectors.Nissim B. Reuben, Assistant Director, Asia Pacific Institute (API) and American Jewish Committee (AJC)  said, “I am honored to represent AJC every year and address on the US-India-Israel partnership at the AAPI Legislative Day on Capitol Hill. “We are looking forward to working with Nissim & AJC on taking an AAPI Leadership Mission to Israel and helping in the process of establishing Israeli Medical Centers of Excellence in India,” Dr. Jonnalagadda added. For more details on AAPI and its many programs and events, please visit: www.aapiusa.org 

Let Your Brain Rest: Boredom Can Be Good For Your Health

The human brain is a powerful tool. Always on, the brain is thinking and dealing with decisions and stressors and subconscious activities. But as much as the human brain function has a large capacity, it also has limits. Alicia Walf, a neuroscientist and a senior lecturer in the Department of Cognitive Science at Rensselaer Polytechnic Institute, says it is critical for brain health to let yourself be bored from time to time.
Being bored can help improve social connections. When we are not busy with other thoughts and activities, we focus inward as well as looking to reconnect with friends and family. 
Being bored can help foster creativity. The eureka moment when solving a complex problem when one stops thinking about it is called insight.
Additionally, being bored can improve overall brain health.  During exciting times, the brain releases a chemical called dopamine which is associated with feeling good.  When the brain has fallen into a predictable, monotonous pattern, many people feel bored, even depressed. This might be because we have lower levels of dopamine.  One approach is to retrain the brain to actually enjoy these less exciting, and perhaps boring, times.
Walf’s research has long focused on neuroplasticity as it relates to behavior/cognition and health of body and brain. She studies the brain mechanisms of stress and reproductive hormones as they relate to behavior and cognition, brain plasticity, and brain health over the lifespan.  Specific areas of Walf’s expertise are memory, emotions, and social interactions and how these functions not only arise from the brain but change the brain itself.

Coronavirus Pandemic Could Be Over Within Two Years – WHO Head

Speaking in Geneva, Tedros Adhanom Ghebreyesus said the Spanish flu of 1918 had taken two years to overcome. But he added that current advances in technology could enable the world to halt the virus “in a shorter time”.

“Of course with more connectiveness, the virus has a better chance of spreading,” he said.

“But at the same time, we have also the technology to stop it, and the knowledge to stop it,” he noted, stressing the importance of “national unity, global solidarity”. The flu of 1918 killed at least 50 million people.

Coronavirus has so far killed 800,000 people. Nearly 23 million infections have been recorded but the number of people who have actually had the virus is thought to be much higher due to inadequate testing and asymptomatic cases.

Prof Sir Mark Walport, a member of the UK’s Scientific Advisory Group for Emergencies (Sage) – on Saturday said that Covid-19 was “going to be with us forever in some form or another. So, a bit like flu, people will need re-vaccination at regular intervals,” he told the media.

In Geneva, Dr Tedros said corruption related to supplies of personal protective equipment (PPE) during the pandemic was “unacceptable”, describing it as “murder”.  “If health workers work without PPE, we’re risking their lives. And that also risks the lives of the people they serve,” he added, in response to a question.

The U.S.-India Health-Care Partnership Will Be Crucial In The Battle Against The Coronavirus

As both India and the United States combat a pandemic of unprecedented scale, we have drawn upon the strength of our long-standing health-care ties to help us better understand the novel coronavirus and find workable solutions.

In India, the government and the private sector have worked together to ensure the integrity of medical supply chains, and essential medicines from India have continued to reach the United States and some 150 partner countries. But more urgently, the India-U.S. cooperation is proving crucial to confront health challenges posed by the pandemic, including future vaccine development and distribution.

From therapeutics to diagnostics, the medical supply industry in India has ramped up production to meet domestic needs and also respond, where feasible, to global needs. Prime Minister Narendra Modi took the initiative of bringing together leaders of the South Asian Association for Regional Cooperation (SAARC) to deliberate on collaborative efforts to combat the disease, including establishing a SAARC Emergency Response Fund.

And as we move toward an effective vaccine for the novel coronavirus, India’s research laboratories and manufacturing facilities — which produce more than 60 percent of the world’s vaccines in a normal year — are integral to the effort. There are at least four ongoing vaccine development programs between Indian and U.S. firms and research institutions.

Over the years, scientific cooperation has become a critical element of India’s expanding strategic ties with the United States. Last year India and the United States signed an agreement to promote scientific exchanges, cooperative research projects and the establishment of innovative public-private partnerships. U.S.-India scientific collaborations have expanded in fields ranging from health and energy to earth and ocean sciences, and from space to agriculture. Such collaborations have fostered innovation, empowered industry and economic growth.

Further, under the bilateral Health Dialogue that commenced in 2015, supported by private-sector engagements, India’s partnership with the United States in the health sector has yielded significant results on a global scale. The collaboration under the Vaccine Action Program resulted in the development of the ROTAVAC vaccine against the rotavirus, which causes severe diarrhea in children. The rollout of an affordable vaccine by an Indian company has enabled its use in several developing countries. This success stands as a true testament to the benefits of the India-U.S. partnership for the greater good of humanity. Today there are more than 200 active collaborations between the U.S. National Institutes of Health network of labs and leading research agencies in India, all focused on delivering affordable health-care solutions.

The India-U.S. partnership in medical research has been complemented by the strength of our cooperation in pharmaceuticals. India’s capabilities in R&D and in manufacturing have made its pharmaceutical sector the world’s third-largest by volume. These strengths have been bolstered by government incentives to encourage investments in the manufacture of active pharmaceutical ingredients. Indian generic drugs have found a ready market across the globe, with Indian firms supplying about 40 percent of generic formulations marketed in the United States. This has allowed American health-care consumers to save billions and enjoy enhanced access to quality medicines. The pharmaceutical sector has also been a significant job creator in the United States, with Indian firms investing billions to establish manufacturing facilities in different states in this country.

When the coronavirus outbreak began, the network of existing collaborations between our countries sprang into action. Using the platform of the India-U.S. Science and Technology Forum, an initiative led by both governments, calls were put out to support joint research and incubate start-up engagements. The initiative was directed at developing technologies for the containment and management of the novel coronavirus, including diagnostics and therapeutics.

As a country we are committed to increasing health-care spending to 2.5 percent of gross domestic product by 2025. Regulatory reforms, policy actions and investment incentives are imparting fresh dynamism to health care in India. Ayushman Bharat, the National Health Protection Mission, is the world’s largest such public-funded program. The pandemic has also not stopped India from undertaking bold initiatives. The recently launched National Digital Health Mission will facilitate the creation of a virtuous health ecosystem, expanding access for hitherto underserved populations. All this opens up immense opportunities for expanding the India-U.S. health-care partnership.

Meanwhile, we continue to combat the virus at home. While the number of coronavirus cases in India has surpassed 3 million, we are encouraged that the recovery rate is also significantly high, at more than 70 percent, and the case fatality rate is below 2 percent. India’s health-care providers, comprising 1 million mostly female workers, have also risen to the challenge and have been active at the clinical, treatment and grass-roots levels, playing an essential role in pandemic control. The current pandemic has made it clear that ensuring affordable and timely access to health care is a priority for all. It has emphasized the need to diversify health supply chains and foster new international partnerships for global health safety. India is well positioned to offer a reliable alternative, with its strengths in manufacturing and innovation, and with its skilled workforce. As societies that respect innovation, India and the United States can do much to provide solutions to the novel coronavirus pandemic and to build a healthier, safer world beyond.

Under Pressure From Trump, FDA Announces Emergency Authorization For Convalescent Plasma To Treat Covid-19

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the “known and potential benefits of the product outweigh the known and potential risks of the product.”

The FDA said more than 70,000 patients had been treated with convalescent plasma,which is made using the blood of people who have recovered from coronavirus infections.

“Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives,” President Trump said at a White House briefing, referring to the coronavirus that causes Covid-19. “Today’s action will dramatically increase access to this treatment.”

Last week, Trump accused some health officials of playing politics regarding an EUA for convalescent plasma. When asked about the FDA not having granted an EUA, Trump said the reason was political.

On Sunday, a source who is close to the White House Coronavirus Task Force told CNN the FDA had reviewed additional data to inform its EUA decision. This official has not personally reviewed the data. They added the FDA is under no obligation to consult anyone outside the agency about its decision.

Convalescent plasma is taken from the blood of people who have recovered from Covid-19. At the end of March, the FDA set up a pathway for scientists to try convalescent plasma with patients and study its impact. It has already been used to treat more than 60,000 Covid-19 patients.

However, like blood, convalescent plasma is in limited supply and must come from donors. And while there are promising signals from some studies, there is not yet randomized clinical trial data on convalescent plasma to treat Covid-19. Some of those trials are underway.

Experts say more data is needed

US Health and Human Services Secretary Alex Azar said studies involving 70,000 volunteers justified the EUA.

“The data we gathered suggests that patients who were treated early in their disease course, within three days of being diagnosed, with plasma containing high levels of antibodies, benefited the most from treatment. We saw about a 35% better survival in the patients who benefited most from the treatment,” Azar told the White House briefing.

“We dream in drug development of something like a 35% mortality reduction. This is a major advance in the treatment of patients. A major advance.”

Azar appeared to be referring to a national study of 35,000 patients treated with convalescent plasma. The study, released August 12 in a pre-print, meaning it had not yet been peer-reviewed, showed that 8.7% of patients who were treated within three days of diagnosis died, compared to about 12% of patients who were treated four days or more after their diagnosis. That’s about a difference of about 37%.

Those treated with plasma containing the highest levels of antibodies had a 35% lower risk of dying within a week compared to those treated with less-rich plasma.

But this is not how doctors usually measure the benefit of a treatment. The gold standard is a randomized, placebo-controlled clinical trial that means that doctors randomly choose who gets the treatment and who doesn’t, so they can truly tell whether it’s the treatment affecting survival and not something else. And the comparison is usually treated patients compared to untreated patients — not patients treated earlier compared to those treated later.

“The problem is, we don’t really have enough data to really understand how effective convalescent plasma is,” Dr. Jonathan Reiner, a professor of medicine at George Washington University and a CNN medical analyst, said Sunday.

“While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment,” Dr. Thomas File, president of the Infectious Diseases Society of America, said in a statement.

Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said he thought it likely the White House pressured the FDA into pushing through the EUA.

“I think what’s happening here is you’re seeing bullying, at least at the highest level of the FDA, and I’m sure that there are people at the FDA right now who are the workers there that are as upset about this as I am,” Offit told CNN’s Wolf Blitzer.

According to a knowledgeable source, Dr. Francis Collins, head of the National Institutes of Health; Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and Dr. H. Clifford Lane, who works under Fauci at NIAID, were among government health officials who had previously been skeptical there was enough data to justify emergency authorization of plasma for Covid-19.

‘Great demand from patients and doctors’

President Trump said there might have been a holdup on the EUA, “but we broke the logjam over the last week to be honest,” Trump said at the briefing. He said he believed there were officials at the FDA and in the Department of Health and Human Services “that can see things being held up and wouldn’t mind so much.”

“It’s my opinion, very strong opinion, and that’s for political reasons,” Trump said. Hahn denied the decision was made for any other than legitimate medical reasons.

“I took an oath as a doctor 35 years ago to do no harm. I abide by that every day,” Hahn said in a statement to CNN’s Jim Acosta.

“I’ve never been asked to make any decision at the FDA based on politics. The decisions the scientists at the FDA are making are done on data only.”

Hahn said during the briefing the agency decided the treatment was safe, and looked potentially effective enough to justify the EUA, which is not the same as full approval.

“So we have ongoing clinical trials that are randomized between a placebo, or an inactive substance, and the convalescent plasma. While that was going on we knew there was great demand from patients and doctors,” Hahn said.

While an EUA can open the treatment to more patients, it could also have the effect of limiting enrollment in clinical trials that determine whether it’s effective.

On Thursday, Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said that doctors have treated so many Covid-19 patients with convalescent plasma, it has been difficult to figure out if the treatment works.

“The problem with convalescent plasma is the great enthusiasm about it,” Woodcock said in an online conversation about the latest science behind monoclonal antibody treatments and convalescent plasma. “It exceeded anyone’s expectation as far as the demand.”

Bioethics expert Art Caplan said he’s worried about whether there’s a large enough supply of convalescent plasma. With an EUA, doctors will be more likely to give convalescent plasma without tracking data, so it will then be difficult to determine which donors have the most effective plasma, and which patients are the best candidates to receive it.

“We’re going to get a gold rush towards plasma, with patients demanding it and doctors demanding it for their patients,” said Caplan, the founding head of the Division of Medical Ethics at NYU School of Medicine.

Managing Children’s Back-to-School Anxiety

Kelly Moore, a Rutgers mental health expert discusses how to prepare children to return to school, signs of emotional distress and benefits of virtual learning.

Students preparing to return to school — in-person, remotely or both — are facing stresses unique to the type of learning they will engage in this fall. Knowing signs of emotional distress and preparing children to bond with peers and teachers before school begins is important to a successful transition, says Kelly Moore, a licensed clinical psychologist and program manager for the Children’s Center for Resilience and Trauma Recovery at Rutgers University Behavioral Healthcare, who discusses how parents and teachers can help children navigate the return to school:

How can students form a bond with teachers and classmates while remote learning?

Students should be as engaged as possible. They should be required to use their video option, so they can be seen and should ask questions or offer comments during class instruction. Teachers should engage students by calling on those who do not often speak up. It is critical that schools ensure that virtual classroom features facilitate this process and that students and teachers know how to use the technology.

Some children have really thrived in this virtual school environment while others have struggled. This difference can be true even with siblings. This type of school situation calls for parents, teachers and school staff to really work together to help students stay connected educationally and socially. Once schools get acclimated to remote learning this fall, having virtual clubs for students would be an excellent idea for student engagement.

Adults likely will need to be more hands-on than ever before to ensure that children connect with peers. Many students use online gaming and social media platforms to stay connected. Parents can arrange for virtual activities – virtual escape rooms and mystery games, for example – that are increasingly available. They also can do activities that strengthen family bonds: puzzles, movie nights or creating a family book club where you read a book and then watch the movie.

What are signs of emotional distress in children?

Parents should watch for changes in their children’s normal mood patterns: Are they withdrawing, irritable, having trouble sleeping or being overly clingy and fearful? Elementary school-age children will often show their emotions through their behaviors. Signs of emotional distress can include regression in behaviors that were once mastered, increased separation anxiety or asking a lot of questions repeatedly.

Teachers may notice students who used to be participatory are being less vocal, turning in assignments late or not at all. If teachers notice shifts in class engagement, work performance or attendance that is a red flag.

In addition to the Covid pandemic, many young people may also be feeling the emotional stress and frustration regarding recent events like the murders of unarmed Black men and women and the increased talk about racism in America. I would encourage all parents to talk to their children about these issues in an age-appropriate manner. We cannot take it for granted that they know how to talk about how it’s affecting them and having to now return to school may just intensify those emotions. And if you don’t know how, read books or articles that give you ideas on how to talk to kids about race.

Therapists are offering free or reduced cost support groups for youth and teens. Introduce children and teens to apps that teach them about meditation, guided imagery and yoga. Learning new stress management skills may become a lifelong practice.

How can adults ease the distress children feel about returning to school or continuing virtual learning?

In an unpredictable world, having accurate information in doses we can tolerate and establishing routines can ease distress. Schools and families with students learning at home should establish a clear structure and routine. Children returning physically to school should understand what to expect and the safety guidelines in place. Children might feel more in control if they can pick out or decorate their own masks to wear each day in the classroom.

If at-home learning is feasible, parents can empower children by including them in discussions about whether to pursue in-person, hybrid or virtual learning, and ask them to list their pros and cons about each option.

What are the emotional pros and cons of virtual learning?

While hybrid or virtual leaning can impact some of the traditional aspects of social and emotional skill building like making friends, speaking in groups or navigating a new building, virtual learning may promote new skills. On these platforms, the student has to stay more engaged, pay attention to facial cues during conversations and improve their technological skills, so they can take advantage of chat and reaction features. As students and teachers become more comfortable with these platforms, students also may speak up more to be recognized and communicate more clearly and concisely. Their typing skills also may improve.

What unique challenges do children in underserved communities face?

Children in these communities are now at a greater risk for food insecurity and falling behind academically. It is critical that they have at least one supportive adult to help ensure they have their basic needs — food, safety, shelter and technology— met so they can keep up with their peers. Schools should enlist their counselors, social workers, nurses and child study team staff in innovative ways to reach these students.

(Kelly Moore is a licensed clinical psychologist and program manager for the Children’s Center for Resilience and Trauma Recovery at Rutgers University Behavioral Healthcare)

Dr. Sajani Shah, A Second Generation Physician Of Indian Origin Becomes Chair Of BOT, AAPI

(Chicago, IL – August 22, 2020) “We are extremely happy that Dr. Sajani Shah, a second generation physician of Indian Origin, and the first ever from the Young Physicians Section, has become the Chair of BOT, AAPI for the year 2020-21,” Dr. Dr. Sudhakar Jonnalagadda, President of AAPI announced here. “I am so proud that this historic milestone by AAPI has occurred during my Presidency.”

Dr. Sajani Shah assumed charge as the Chair of Board of Trustees, AAPI during the first ever Virtual Summit on July 12th. Also, Dr. Ami Baxi was sworn as the President of YPS and Dr. Kinjal Solanki as the AAPI MSRF President. In her farewell message, Dr. Seema Arora, outgoing BOT Chair, said, “I congratulate and wish the very best to three incoming Trustees – Dr. Jagdish Gupta, Dr. Raghu Lolabhattu and Dr. V. Ranga, the incoming President, Dr. Sudhakar Jonnalagadda and the incoming BOT Chair, Dr. Sajani Shah and entire AAPI leadership & membership to take AAPI to further heights in the future.”

Dr. Shah is a general surgeon from Boston, MA who specializes in minimally invasive Bariatric Surgery. She earned her executive MBA from Massachusetts Institute of Technology. Currently, she is serving as the Chief of Minimally Invasive Bariatric/Surgery and is the Medical Director of Weight and Wellness, Obesity Treatment Program in New England. Dr. Shah is an Associate Professor of Surgery at Tufts University School of Medicine. As the Board Chair, Dr. Shah “will focus on what is best for the AAPI organization by facilitating board leadership and governance by setting the direction and priorities of the board for the upcoming year.”

“An organization can only survive to its fullest potential when it is financially independent,” says Dr. Shah, who lives in Boston with her family and enjoys traveling and visiting her family in New York. “The trustee account from which we have been drawing each past year will deplete someday, therefore, it’s vital that we work on strategies to help strengthen the financial well-being of AAPI.” Dr. Shah promises to focus on academic excellence, without compromising AAPI’s financial well-being or the fact that AAPI is an organization of friends and families.” Dr. Shah wants to “work with her board to help engage the younger generation of physicians to the organization and overall increase in AAPI membership.”

Dr. Sajani Shah, a past president of IMANE, a subchapter of AAPI, has been serving as a member of BOT, AAPI since 2018 and involved in AAPI since the 2007 in several capacities including regional director, co-chair of the academic committee and chair of the women’s forum, “hopes to continue molding the organization’s culture, mission and work ethics.” Working in coordination with She is excited for a wonderful slate of board members and looks forward to actively engaging the board members, building upon each member’s individual strengths to accomplish great things this year.” Dr. Shah is confident that “working collaboratively under the guidance of the AAPI president and his executive team, AAPI will be lifted to new heights. As a second generation Indian and youngest to serve as the Chair of the Board of Trustees, I am truly humbled, honored and excited to start my tenure as the new BOT Chair.”

Dr. Ami Baxi, AAPI YPS President, is a board certified psychiatrist, based in New York City. During Residency, she had served as Chief Resident in her final year, Dr. Baxi has advanced up the chain of hospital administration at Lenox Hill Hospital, a prestigious Upper East Side hospital, part of the Northwell health system.  After serving as Director of Inpatient Psychiatry for five years, Dr. Baxi is now Director of Ambulatory Services within the Department of Psychiatry. Dr. Baxi’s keen interest in the training and education of future doctors resulted in an appointment as the Director of Medical Student Education, overseeing medical students and residents from Downstate Medical College, Westchester Medical Center, New York Medical College, and Staten Island University Hospital. Dr. Baxi’s work has not gone unnoticed by her trainees as they have often appointed her Faculty of the Year. Finally, Dr. Baxi also most recently graduated from Northwell’s esteemed Physician Leadership Development Program.

Dr. Baxi has been familiar with AAPI, growing up in a family of physicians and as her own career developed, she naturally took a leadership role as an active member of the Young Physicians Section.  In her first year on the YPS Executive Committee, she served as the convention chair of their Marquee event, the Winter Medical Conference in Las Vegas,  In subsequent years, she served as Treasurer, then President-Elect prior to now being President of YPS.

In her new role, Dr. Baxi wants to “work towards increasing AAPI membership to sustain the future of the national organization while continuing to enhance value to the YPS constituents, and growing the mentorship program so that members may benefit from each other’s experiences and accomplishments.” While recognizing the challenges of unprecedented times, Dr. Baxi is aware that “flexibility is of utmost importance to successfully implement the goals of our organization.  We plan to leverage our networks and work with national AAPI to organize webinars with well-credentialed industry experts to assure the community and physicians from all over the country benefit from the wealth of information that AAPI has to offer.”  In this way, Dr. Baxi hopes to increase YPS’s visibility and value throughout the nation.

“Working in close coordination with AAPI leadership, YPS will remain actively engaged with our contemporaries in India via the Global Health Summit to ensure AAPI’s presence on a global stage while also giving back to our motherland,” says the young physician endowed with a vision to serve India.  “We will continue to be a voice for young physicians at next year’s annual convention in Orlando, Florida.  And, of course, our highly acclaimed 8th Annual Winter Medical Conference will be second to none as we bring our members the best and most current content from the country’s most renowned medical professionals.  We are confident these will all be events not to be missed.”

Dr. Kinjal Solanki, AAPI MSRF President is an Infectious Disease Fellow in New Jersey. “I am honored to take over the role as the president for the AAPI medical students, residents, and fellows. As a first-generation Indian-American and an international medical graduate, I truly believe my multicultural experiences have humbled me, cultivated my cultural awareness, and enabled me to relate to others on both personal and professional levels.”  Giving credit to her Indian heritage in shaping who she is today, Dr. Solanki says, “I am grateful for the opportunity to give back to our Indian-American community through my involvement in AAPI these past four years. This upcoming year, I am excited to help develop AAPI as an organization, further advance its mission, and continue to learn from and work alongside all of the AAPI members.”

In her new role as the MSRF President for the year 2020-2021, Dr. Solanki is looking forward “to working with the YPS team and the AAPI Executive Committee on various projects that will interest and benefit medical students, residents, and my co-fellows. This year presents with both academic as well as professional and personal challenges as the world continues to tackle the COVID-19 global pandemic. We plan to hold a series of virtual seminars to educate, discuss, and navigate these challenges. My main goal for this year is to increase awareness and interest in AAPI via the easily accessible virtual platform. I look forward to a great and productive year ahead.”

“We are so excited that all the three leaders Indian American women leaders, who are passionate about AAPI and its noble mission to be the voice of the over 100,000 Physicians of Indian Origin in the United States,” said Dr. Anupama Gotimukula, another woman leader of AAPI, who will become the president of AAPI in 2021.  For more information about AAPI and the many initiatives of AAPI, please visit www.appiusa.org

Scientists Identify The Order Of COVID-19 Symptoms

University of Southern California researchers have found what appears to be the likely order in which COVID-19 symptoms first appear: fever, cough and muscle pain, then nausea and/or vomiting, then diarrhea. Knowing the order of COVID-19’s symptoms may help patients seek care promptly or decide promptly to self-isolate, the scientists say. It also could help doctors rule out other illnesses or plan how to treat patients, according to the study led by doctoral candidate Joseph Larsen and his colleagues with faculty advisers Peter Kuhn and James Hicks at the USC Michelson Center for Convergent Bioscience’s Convergent Science Institute in Cancer. The scientific findings were published in the journal Frontiers in Public Health. “This order is especially important to know when we have overlapping cycles of illnesses like the flu that coincide with infections of COVID-19,” said Kuhn, professor of medicine, biomedical engineering, and aerospace and mechanical engineering at the USC Dornsife College of Letters, Arts and Sciences, in a statement. “Doctors can determine what steps to take to care for the patient, and they may prevent the patient’s condition from worsening.” “Given that there are now better approaches to treatments for COVID-19, identifying patients earlier could reduce hospitalization time,” said Larsen, the study’s lead author and a USC Dornsife professor. Determining COVID-19 symptoms can help doctors plan treatments accordingly Fever and cough are frequently associated with a variety of respiratory illnesses, including Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). But the timing and symptoms in the upper and lower gastrointestinal tract set COVID-19 apart. “The upper GI tract (i.e., nausea/vomiting) seems to be affected before the lower GI tract (i.e., diarrhea) in COVID-19, which is the opposite from MERS and SARS,” the scientists wrote. The authors predicted the order of symptoms this spring from the rates of symptom incidence of more than 55,000 confirmed coronavirus cases in China, all of which were collected from Feb. 16-24 by the World Health Organization. They also studied a dataset of nearly 1,100 cases collected from Dec. 11-Jan. 29 by the China Medical Treatment Expert Group via the National Health Commission of China. To compare the order of COVID-19 symptoms to influenza, the researchers examined data from 2,470 cases in North America, Europe and the Southern Hemisphere that were reported to health authorities from 1994 to 1998. “The order of the symptoms matter. Knowing that each illness progresses differently means that doctors can identify sooner whether someone likely has COVID-19, or another illness, which can help them make better treatment decisions,” Larsen said. 

Modi Addresses Indian American Physicians At India Independence Day Celebrations and Medical Symposium

(Tampa, FL; August 17th, 2020) “India’s not for money but for humanity. We are known to be connected with humanity,”  Prime Minister Narendra Modi told members of American Association of Physicians of Indian Origin (AAPI) and Florida Association of Physicians of Indian origin (FAPI) during a virtual India’s 74th Independence Day Celebrations and day long Medical Symposium on August 15th, 2020.

In his keynote address, India’s Prime Minister, Narendra Modi said. “During this critical times when humanity has been impacted by Corona pandemic, India has been leading the efforts to alleviate people’s sufferings by exporting necessary medicine and medical equipment to 150 countries including to the US. In addition, India is working with 16 nations around the world, helping developing human resources, training them and equipping them to meet the challenges posed by the Covid virus.”

There is a high demand for hydroxychloroquine in the international market including U.S. Responding to this need, India has exported hydroxychloroquine to several nations, including the US, Prime Minister Modi told the Physicians of Indian Origin.  “In addition, with other nations, we are working collaboratively towards developing vaccine,” he said.

Highlighting the importance of the ancient Medical Systems that originated in India, Modi said, “India has been leading in research on health and well-being from early civilization onwards. Changes in life style are occurring around world, and people have come to appreciate the benefits of Ayurveda. People are looking upto India for leadership in Medicine and holistic living. Ayurveda has become popular around the world in preventing and cure people of illnesses,” he said. In his address, he pointed “immune promoters and natural healers,” stating that import of Turmeric by the US and Europe has significantly increased in nrecent years.

Prime Minister Modi urged “more collaboration by Physicians of Indian Origin in India’s progress, manufacturing medicine and medical device. We want you to participate more actively in the mission of India in research, manufacture, pharma sector and telehealth, reaching health and well-being to rural India.” Describing that Physicians of Indian Origin are “part of the growth and progress of India,: he acknowledged the sacrifices of Indian Origin physicians, Modi said, “I want to express my sincere gratitude for being the warriors who are committed to save the lives of so many during the pandemic. Stay safe and continue to work hard and contribute to the humanity and make India shine.”

Ambassador Taranjit Singh Sandhu greeted AAPI and FAPI members as “we are commemorating the 74th year of India’s Independence.” Pointing to how the pandemic has changed our lives, he said, “Covid has taken a toll on human lives. I congratulate AAPI and FAPI for organizing this special Medical Symposium.”

Calling the Indian American Physicians as the “real heroes” Ambassador Sandhu said “You are the real heroes who have risked your lives and have been out to assist others. “What is unique about AAPI is that you bring a global perspective to defeat the virus and serve the people. We are proud of the achievements of the 4 million Indians in the United States.” There is a widespread recognition of their contributions in the US, he added. “Indian American Physicians members have greatly contributed risking their own lives.” Expressing his deepest condolences to AAPI and the families of those Physicians, who had lost their lives, the Indian Envoy thanked AAPI for “your support to the Indian Embassy helping Indian students and others stranded here due to the pandemic. Your online Health Desk has helped many Indians in the US affected by the pandemic.”

Praising AAPI for the several charitable works in India, Ambassador Sandhu, said, “India and the US are strategic partners” and pointed to collaboration between the two nations on cutting edge medical research in healthcare sector and science. India is geared up to face the challenges and we have enhanced our capacity to test, trace and treat those affected by the virus,” the Indian Envoy said. “Although the cases in India have been on the rise, the death rate is significantly lower. And recovery rate is high. Drawing on the inherent strengths of the Indian system, we are working to develop vaccines to prevent and eradicate the pandemic,” he said.

With inexpensive medical supplies to 150 countries, India has become “a reliable partner in global supply chain of all healthcare needs.”

Dr. Amit Chakrabarty, Secretary of AAPI introduced Ambassador Taranjit Singh Sandhu as “one of the most experienced Indian diplomats on US affairs, having served in the Indian Mission in Washington DC in various capacities and at the Permanent Mission of India to United Nations, New York.” 

COVID-19 has now killed at least 775,489 people worldwide, and the U.S. ranks 10th in the world for deaths per 100,000 people (51.5), Johns Hopkins University says. As of Monday, the U.S. has the world’s highest number of confirmed COVID-19 cases (5,403,361) and deaths (170,052). Worldwide, confirmed cases are now at 21,684,349.

“We’ve got to get those numbers down,” stressed Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease (NIAID). “If we don’t get them down, we’re going to have a really bad situation in the fall … as you get indoors and you get the complications of influenza season.” Dr. Fauxi in his address on Covid -9 and Research to combat the pandemic, provided a brief historical overview of the different viruses, their origin the recent past, including Covid that originated in China.

“Covid is the worst the world has seen since 1918 with 20 million infected and 70000 deaths in nthe US alone,” Dr. Fauci said. Drawing the attention of the physicians to the fact that the US has been the worst hit nation by the pandemnic, in comparison with Europe, Dr. Fauci referred to the pattern of responses has been different in each nation and within the US in different regions. Dr. Fauci also referred to India, faced with serious challenges. Impact varies from person to person moderate to severe including death, he said.

In his eloquent presentation, Dr. Fauci educated the physicians on Covid Virus: Physio genetic Trees; Virology of Cocid-19; Clinical Presentation/Symptoms; Manifestations of Severe Covid Disease, which are fare more than what was initially thought to be; Racial/Ethnic Inequalities among those affected by the Virus; Types of Tests administered to diagnose the virus; Treatment Modalities and the currently available drugs to treat the virus, including Remdesivir, which has proven to  have 32% faster response rate; Vaccines that are in the making, with the hope that by November/December possible results will be known for the effectiveness of the Vaccines.

Stating that 40 to 45 percent of those who are carrying the virus are are symptomatic, Dr. Fauci reminded of the Five Effective Ways: Wear a mask consistently and correctly; Avoid crowds; Stay six feet apart; Opt for the outdoors; and , Wash your hands.

Dr. Sudhakar Jonnalagadda, President of AAPI, said, “This year India celebrates its 74th Independence Day remembering the sacrifices made by the freedom fighters, political leaders and citizens in order to free the motherland from colonial rule.  This year, COVID-19 has eliminated the ability for spectators and celebrations.  The virtual world allows celebrations to proceed in a different manner, but this is also an opportunity to be re-inspired by the legacy of the Father of Nation.  After all, isn’t service of mankind the best way to celebrate India’s Independence?”

Dr. Rakesh K. Sharma, President, Florida Association of Physicians of Indian Origin (FAPI) welcomed the participants and speakers at the event. He seamlessly coordinated the day long event with speakers and singers from around the world. “The day long Medical Symposium was packed with 8.5 hours of CMEs, with the objectives of educating the physicians on the current standards, laws & rules on prescribing controlled substances; Identify multiple strategies for preventing medical errors; and, Describe the best strategies for managing COVID-19 patients.” Dr. Sharma said. 

Dr. Sajani Shah, Chair of AAPI’s BOT, said, “AAPI members are putting their best efforts to help our patients, especially those impacted by COVID. Several of our physicians have been affected in this pandemic. The day long workshop was a way to educate them on the current pandemic and best practice.”

Dr. Anupama Yeluru Gotimukula, President-Elect, AAPI, who will be the President of AAPI in the year 2021-22, says, “We are going through a deadly pandemic now. Our healthcare heroes are putting their lives on frontline  and working in every possible way to eradicate COVID-19, through preventive efforts, clinical, therapeutic and research trials, doing philanthropic services and many more other activities to help the community.” 

Dr. Ravi Kolli, Vice President,reminded AAPI members that thorugh organizing such events, “We are continuing to make AAPI a more dynamic and  vibrant organization playing a meaningful and relevant part in advocating health policies and practices that best serve the interests of all patients  and  promoting the  physician’s role   as  the  leaders of the  team based health care delivery.”

Dr. Satheesh Kathula, Treasurer of AAPI, “This is another example of our ongoing efforts to make AAPI a mainstream organization and work on issues affecting physicians including physician shortage, burnout, and credentialing, while leveraging the strength of 100,000 Indian American physcians.”

The participants were treated to an entrainment segment by Bollywood singers, including Anoop Sankar who entertained the audience with renditions in multiple Indian languages dedicating his music to the Doctors who work to save lives, especially during this pandemic. For more details, please visit: http://www.aapiusa.org

FROM VARIOLATION TO VACCINATION

The world anxiously awaits the discovery of a vaccine against the novel corona virus which is the only foreseeable hope of restoring the old order and thereby our dreams of a future which has been so brutally and abruptly interrupted by this pandemic.

Vaccines are an integral part of medicine today. Each vaccine contains a small amount of the disease germ or germ particle along with ingredients that provide stability, prevent contamination of multi- dose vials by bacteria or fungi and sometimes substances to boost the immune response. Vaccines are essentially prophylactic in that they prevent or ameliorate the effects of a future infection but can be therapeutic as well, to fight a disease that has already occurred, such as cancer. Upon receiving a vaccine the immune system in the body recognizes that specific disease causing germ in the vaccine as being foreign, responds by making antibodies to that germ for the future for a finite length of time, and remembers the germ so that the immune system is able to rapidly destroy it before sickness sets in.

Naturally acquired immunity that comes from the disease itself can be at the cost of serious and at times lethal complications. Vaccines imitate that infection in a less severe form and cause the immune system to produce T- lymphocytes and antibodies. As the minor side effects such as fever, malaise, aches go away the body is left with “memory” T- lymphocytes and B- lymphocytes that will remember how to fight the disease in the future. This process takes a few weeks and one may develop the disease before protection has occurred.

There are five main types of vaccine:

  1. Live attenuated such as measles mumps rubella and chickenpox /TB vaccine.
  2. Inactivated vaccines such as polio vaccine.
  3. Toxoid vaccine to prevent diseases caused by bacteria producing toxins such as diphtheria and tetanus.
  4. Subunit vaccine that includes only the essential antigenic part of the germ such as the pertussis component.
  5. Conjugate vaccines to fight bacteria that have an outer coating of polysaccharides such as those against meningitis.

Vaccines may need multiple doses or a booster dose after so many years. Some viruses like the flu virus change every season so an annual dose is required. Severe allergy to any component of vaccine is a contraindication. Pregnancy and immunosuppression are contraindications to live vaccines. There are certain precautions for each individual vaccine as well, which must be taken into consideration prior to administration. The bogey of autism secondary to childhood vaccines or their preservatives has been raised in the past, but multiple studies have shown no link and original work that raised this concern was found to be flawed.

The evolution of vaccination is fascinating. There was a concept of immunity as early as 430 B.C when the Greek historian Thucydides noted in his account of the plague that killed a third of the population of Athens, that those who recovered were resistant to future attacks of the same disease. The history of vaccination is intricately connected to smallpox epidemics. The first efforts to vaccinate were in fact variolation which was the practice of using secretions from the pustules of someone with smallpox or variola to infect a healthy individual and create a mild form of the disease. The origin of inoculation is possibly from India where itinerant Brahmins inoculated by dipping a sharp iron needle into a smallpox pustule then puncturing the skin repeatedly in a small circle or perhaps in China where variolation was practiced by nasal insufflation of powdered smallpox scabs. In Africa mothers would tie a cloth around a child’s smallpox covered arm and then transfer the cloth to a healthy child.

In the 18th and 19th centuries the practice made its way to England thanks to Lady Montagu the wife of the British ambassador to Turkey who had observed variolation. New England and other American colonies saw smallpox arrive with cargo ships to Boston with devastating effects. Cotton Mather, an influential minister in Boston was told of the practice of variolation by his slave Onesimus who had experienced variolation in Africa and he took the bold step of introducing this concept despite much resistance.

Variolation did not prevent the disease, it just made it milder, and in some cases, people still developed severe symptoms and died. In late 1700, Edward Jenner noted that milkmaids got cow pox on their hands, but not smallpox. He took fluid from the cowpox and scratched it into his gardener’s son’s arm, a practice now called vaccination from vacca or cow. Two months later he inoculated the boy again, now with smallpox matter and no disease developed and the vaccine was a success. Louis Pasteur’s 1885 rabies vaccine came next followed by development of antitoxins and vaccines against diphtheria, tetanus, anthrax, cholera, plague typhoid, tuberculosis, yellow fever, herpes simplex. Middle of 20th century was an active time for the development of vaccines.  Noteworthy is the development of the injectable killed virus Salk polio vaccine and the live attenuated oral Sabin polio vaccine amidst the intense rivalry between the two teams. Recombinant DNA technology and new delivery techniques addressed noninfectious conditions such as addiction and allergies. Among the fastest vaccines ever produced was the current mumps vaccine isolated by a scientist Dr. Hilleman who was working for Merck, obtained from the throat washings of his daughter JerylLynn in 1963 with the eponymous vaccine being licensed in 1967. In recent years, the Ebola vaccine though long in development was granted Breakthrough Therapy designation and FDA worked closely with the company and completed its evaluation for safety and effectiveness in six months.

Researchers around the world are developing more than 165 vaccines, and 28 vaccines are in human trial for the novel corona virus. Work began in January 2020 with deciphering the Sars-Co V-2 genome. Phase 1- about 18 vaccines testing safety and dosage, Phase II -12 vaccines in expanded safety trials, Phase III – 6 vaccines in large scale efficacy tests and 1 vaccine has been approved for limited use. Vaccines typically take years of research and testing before reaching the clinics, but scientists all over the world are racing to provide a safe and effective vaccine by next year. Many governments including the US have bank rolled these efforts. Moderna along with NIH have launched a Phase III trial on July 27th, 2020 on a Messenger RNA based vaccine. The final trial will enroll 30,000 healthy people at about 89 sites around US- Moderna has $1 billion in support from the US government. Operation Warp Speed is supporting a portfolio of similar vaccines so that they can meet FDA’s gold standards and reach the public without delay. University of Oxford and Jenner institute is also a front runner with U.K investing $6.5 million along with layers of private and international investors; India’s Bharat Biotech and Zydus Cadila have started Phase 1 and 2 clinical trials.  Germany, Russia and China are heavily funding their own trials. Serum Institute of India, Pune, under the chairmanship of Dr. Cyrus S. Poonawala is poised to be a big player in the manufacturing and distribution of the vaccine. It will also be a part of Phase 3 Novavax trials in India. One out of every two children in the world is vaccinated by a vaccine from the Serum Institute.

The successful companies will be runaway winners from both humanitarian and financial standpoints. Many ethical challenges regarding cost, prioritization of delivery, transparency of risk- benefit data remain. One thing is clear, there will be no resolution of the Covid-19 Crisis without the utmost harmonious and strategic cooperation of all global participants.

Russia just announced the development of a vaccine – has not been thoroughly tested 

(Udita Jahagirdar M.D., F.A. C. O. G. is a Gynecolgist in active practice in Yhe Orlando, FL area)

Low Sodium and Low Blood Sugar: Reverse causation By Surender Reddy Neravetla, MD, FACS, Director Cardiac Surgery , Springfield Regional Medical Center, Springfield, OH

Don’t salt your own food because you hear someone has low sodium. That could be a catastrophic mistake. You wouldn’t start eating plain sugar because you hear someone suffered hypoglycemia, would you?

Hypoglycemia (low blood sugar) usually occurs in someone who is already diabetic. You have to treat with sugar immediately, otherwise it could be fatal. That, however, is not a good reason for everybody else to consume plain sugar to prevent hypoglycemia. Hypoglycemia is a problem usually in people who already have diabetes.

In the same way, average healthy individuals hardly ever have low sodium. Low sodium, with rare exceptions, is a problem in people who already are on multiple medications, are in renal failure, heart failure, taking chemotherapy or otherwise not in good general health and not able to consume a regular variety of food for any reason.  Eating plain sugar and salt will drive you into getting these very problems which in turn can lead to low sodium or low sugar. This phenomenon has been described by multiple authors as “reverse causation”

We should be stepping up efforts to cut salt in our food. You don’t want to risk far too many health problems linked to salt to yourself or your loved ones in the name of “taste”.  In case you missed it, high blood pressure, which is only one of the many problems linked to salt, is a bigger health problem when compared to tobacco; declared WHO almost a decade ago.  On top of all the health problems we already know that are linked to table salt, we are learning in the last few years, that we are also reducing our defense against infections and increasing self-destructing auto-immune responses

Even Medical professionals need to more aggressively engaged in prevention of salt related health problems. Based on thousands of scientific papers, every medical organization in the world is recommending salt reduction. Yet medical professionals largely on the sidelines specially when it comes to following themselves and leading by example. Please see attached one of many review articles titled “Understanding the science that supports population‐wide salt reduction programs”.

 The misunderstanding of low sodium has been in part the reason for this lack of engagement. I urge my colleagues to look little deeper and look at the extensive criticism of these papers focused on the issue of low sodium. Please attached examples references to the criticism of these papers coming from prestigious institutions across the globe written by prominent scientists who have most of their lifetime on this subject. These references come not just from one country, but from America, Canada, Europe and England.

For Example:   Prof Francesco Cappuccio: “President and Trustee of the British and Irish Hypertension Society, Head of the WHO Collaborating Centre for Nutrition, member of CASH, WASH, True Consortium – all unpaid”; summarized one of major sources of this confusion as follows:

The PURE study, due to the numerous flaws highlighted in the last few years in international journals, is not fit to address any of the issues regarding salt consumption and cardiovascular outcomes.

Additional quotes from some of these papers are attached below.

Hypoglycemia and symptomatic low sodium have to be treated immediately. But to keep on simply eating salt and sugar may not be the best solution. There are better things you can do about low sodium.

First, rule out medication induced low sodium. Try to aggressively wean off all the non-essential pills. Then reduce the doses of the essential ones to the lowest level or stop entirely for a duration of time under the guidance of a medical professional. Add medications one at a time at the lowest doses as needed.

Low sodium could be an indication of renal, gastrointestinal or endocrine problems. Salt-wasting enteropathies and nephropathies have been described. To look into it, it will require a diligent physician who may order tests that are not the usual run-of-the-mill type, such as urine electrolytes.

High Potassium needs immediate attention just like hypoglycemia. However low sodium can be watched to a certain level if there are no symptoms. High potassium in combination with low sodium could be a sign of a deep-rooted kidney problem.  A kidney specialist (Nephrologist) should be consulted at this stage. 

Some of the most commonly used diuretics (water pills) by design will make the kidney lose potassium as well as sodium.  Individualized selection of the right combination of medications may address this problem.

In summary, persistent low sodium needs a deeper look. Given the long list of health problems associated with salt, simply eating salt should be reserved for symptomatic low sodium situations, the same way as hypoglycemia.

 

  1. https://www.sciencedirect.com/science/article/pii/S0939475318303521

             Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement          from the European Salt Action Network

               https://www.nmcd-journal.com/article/S0939-4753(18)30352-1/fulltext

 

  1. https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.12437

Is Reducing Dietary Sodium Controversial? Is It the Conduct of Studies

With Flawed Research Methods That Is Controversial? A Perspective

From the World Hypertension League Executive Committee. Norm R.C. Campbell, MD;1 Daniel T. Lackland, DrPH;2 Mark L. Niebylski, PhD, MBA, MS;3 Peter M. Nilsson, MD, PhD4

 The Journal of Clinical Hypertension Vol 17 | No 2 | February 2015

        3         https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.12994

 Understanding the science that supports population‐wide salt reduction programs

Jacqui Webster PhD Temo Waqanivalu MBBS, MPH JoAnne Arcand PhD, RD  Kathy Trieu MPH  Francesco P. Cappuccio MD, DSc  Lawrence J. Appel MD, MPH … See all authors

 

 

  1. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.113.006032

      Lower Levels of Sodium Intake and Reduced Cardiovascular Risk

No evidence for an increased CVD risk with very low sodium intake

Cook NR, Appel LJ, Whelton PK

Circulation. January 10, 2014 doi: 10.1161/​CIRCULATIONAHA.113.006032

 

 

  1. http://www.worldactiononsalt.com/news/salt-in-the-news/2016/news-stories/wash-response-to-lancet-publication.html

WASH response to Lancet publication

 

Selected Quotations:

 

The PURE study, due to the numerous flaws highlighted in the last few years in international journals, is not fit to address any of the issues regarding salt consumption and cardiovascular outcomes.       Prof Francesco Cappuccio: “President and Trustee of the President of the British and Irish Hypertension Society, Head of the WHO Collaborating Centre for Nutrition, member of CASH, WASH, TRUE Consortium – all unpaid.”

 

 

 In our view, papers of poor scientific quality should not be considered as part of the evidence base.” …. Prof Graham MacGregor: “Graham is Chair of Blood Pressure UK (BPUK), Action on Salt and World Action on Salt and Health.  BPUK, Action on Salt and WASH are non-profit charitable organizations and Graham does not receive any financial support from any of these organizations.”

 

salt consumption to prevent cardiovascular disease is strong and such new controversial studies – in particular the PURE Study – are inappropriate to address the complex associations between salt intake and CVD outcomes and should not overturn the concerted public health action to reduce salt intake globally….

A scientific statement from the European Salt Action Network

How Countries Are Reopening Schools During the Pandemic

Newswise — By late March 2020, as the coronavirus pandemic unfolded, primary and secondary schools closed in nearly every country, affecting more than 1.5 billion learners, according to UNESCO. In many places, educators quickly shifted to remote teaching with the hope of salvaging the academic year.

Since then, some countries have cautiously reopened schools with mixed results. Others don’t plan to resume in-person classes until 2021. But lack of access to technology and concerns about widening achievement gaps have forced a seemingly impossible decision onto school leaders: reopen their doors and risk new outbreaks of the virus, or continue virtual alternatives that could leave students further behind and suffering from social isolation.

What are the challenges to reopening schools?

Schools have struggled with what to do if a student or teacher tests positive. Most of the dozens of countries that reopened schools earlier in the year reported relatively low numbers of cases of the new coronavirus disease, COVID-19, and conducted widespread contact tracing. It remains to be seen, however, if schools can safely reopen in places suffering widespread outbreaks and community transmission, such as in many U.S. communities.

“It is possible to safely reopen schools, but one of the first criteria that needs to be met is that we not have an epidemic that’s spiraling out of control,” says Jennifer Nuzzo, an epidemiologist at Johns Hopkins University.

The worst-case scenario for many school administrators and public health officials is if schools suffer an outbreak after reopening that sickens dozens of students or teachers, spreads to the community, and causes deaths. When Israel reopened schools in May, the government did not require schools to follow social-distancing guidelines for long, and many classrooms returned to full size with around forty students. Since then, more than two thousand people have tested positive throughout the country’s education system and at least one teacher has died. In Israel and other countries, some parents and guardians have refused to send their children to school out of concern for both their child’s safety and their own.

After its disaster in the spring, Israel is now requiring schools with reported coronavirus cases to close for two weeks and all students and staff to quarantine. Schools in Germany, where infection rates are low, have taken a different approach, keeping classes running and forcing only close contacts of the infected person to quarantine.

Reopening schools is also expensive. Health experts have called on schools to guarantee they have enough personal protective equipment (PPE), such as masks and face shields, for students and teachers; cleaning supplies; and other safety materials, including plastic barriers, the costs of which can add up. Some schools have hired more teachers because of smaller class sizes, and others have paid to improve their ventilation systems and build handwashing stations. While primary and secondary schools in the United States have so far received $13.5 billion in federal relief, education policy researchers say it’s not enough for schools that were already struggling with funding. One report estimates that implementing precautions will cost $1.8 million for a U.S. school district with around 3,200 students. For example, reopening all of Maine’s public schools will cost an estimated $328 million.

Pandemic safeguards have also put special burdens on educators. Restrictions have made it difficult to promote collaborative and engaging learning, especially for younger students. In addition to fearing for their own health, teachers in schools that follow a hybrid model of in-person and online learning face the added stress of preparing lesson plans for both approaches. 

What health and safety steps have countries taken when reopening schools?

To mitigate the challenges of reopening, schools have implemented many precautions, including the following:

Requiring masks. Researchers have shown that wearing masks can significantly decrease the chances of infection. Many schools have required students and faculty to wear masks while in the classroom. Taiwan’s government, which never closed most schools, provides new masks to all adults and children every two weeks. 

Checking temperatures. Many schools require students to prove on a daily basis that they don’t have a fever, including by checking their temperature and filling out a form at home, entering their temperature into a mobile app, or using a contactless thermometer at the school’s entrance. 

Social distancing. Schools have tried to keep students and faculty at least six feet apart by increasing the distance between desks, using plastic barriers in classrooms, and closing group spaces. Most public schools in Hong Kong closed their cafeterias, requiring students to bring lunch. In Denmark, schools are not required to enforce social distancing. Instead students are allowed to play with others in their class “bubbles,” small groups that arrive at school at the same time, use the same classroom and playground area, and are taught by the same teacher to try to prevent a widespread outbreak.  

Decreasing capacity. Experts have suggested limiting class sizes to only a dozen students to reduce social contact, creating challenges for schools that usually have more than thirty students in a class. To address this, some schools have tried staggered schedules in which some students come to school on Mondays and Thursdays and others come on Tuesdays and Fridays. In Tokyo, high school grades were divided into two groups, with half attending in morning and half in afternoon. 

Prioritizing vulnerable students. Denmark first opened schools and day-care centers for children younger than twelve, reasoning that they are at lower risk from the virus and benefit more from interactive in-person learning than older students. Uruguay allowed students in rural areas and those who had trouble accessing online materials back to school first. 

Holding classes outdoors. Some schools have tried occasionally holding classes outdoors, which reduces the risk of transmission. If weather conditions prevent outdoor learning, experts say schools should open windows and filter indoor air. Frequently touched surfaces should be cleaned often. 

Virus testing. Routine testing at schools has been rare. However, one school in Germany offers free tests to students and teachers twice a week that they can administer themselves at home. And Luxembourg tested about six thousand high school students and two thousand teachers before classes resumed in May.

What have been alternatives to in-person instruction?

Many countries rapidly transitioned to remote learning as outbreaks took hold in early 2020, and some have chosen to continue this form of instruction—including learning online, through radio and television programming, and via text messaging—until the virus is sufficiently contained or there is a cure. 

In India, many states have relied on government-developed e-learning portals since the summer break ended in June, a massive challenge in a country where just 11 percent of households had a computer and 24 percent had internet [PDF] in 2018, though at least one of these portals can be used offline. States are still undecided about when to bring students back into classrooms, particularly as the country recorded its highest single-day increase in coronavirus cases in late July. The Philippines has ordered that in-person instruction not resume until there is an effective vaccine. Education authorities plan to roll out distance learning nationwide when the summer holiday ends in August, but teachers have raised concerns that many of the country’s twenty-seven million school-age children do not have computers or internet at home. 

 Other countries have suspended instruction altogether. Kenya’s education ministry announced in July that schools will remain closed through the end of 2020, with students expected to repeat the school year. While the government said it is working to make online learning more accessible for Kenyan students and has been broadcasting some school programs on the radio and television, it acknowledged that many households do not have the technological resources to fully switch to remote learning.

What are the risks of keeping students at home?

Education experts warn of severe consequences for students missing out on critical in-person instruction. Researchers project significant learning losses across countries that have closed schools, with even worse consequences expected for children in countries with already low learning outcomes and less resilience to shocks. In a June statement, the American Academy of Pediatrics urged school leadership to strive to have U.S. students “physically present in school” in the coming academic year, noting that school spaces are fundamental not only for academic instruction but also for children’s nutrition, social and emotional skills, and mental and physical health. The organization later qualified its guidance by saying that “science should drive decision-making” on whether to reopen.

Many educators express particular concern about underserved children, including those in racial minority groups and lower-income communities, where households may not be able to provide meals normally offered at school nor have the technology required for online learning. Teachers have also pointed out challenges for the five million students learning English in U.S. primary and secondary schools. “It was a challenge to get all of our students engaged on a weekly basis,” says Ramya Subramanian, assistant principal of a California charter school, of the switch to remote instruction. “Our students who are English learners had the hardest time being able to access our resources, which are primarily in English; they needed a lot of support.”

At the same time, social workers and child advocates have raised alarm that school closures could lead to a surge in child abuse. While there is no evidence of such a spike, they say teachers and nurses are not able to monitor children for possible cases.

Some critics of long-term distance learning also argue that as parents and guardians return to work, they will not be able to stay at home with their children. Experts have said this conundrum could lead to more accidents and injury among children left home alone, or deeper economic woes for parents who quit their jobs or cut back on their working hours to stay at home. One study in Germany estimated that 8 percent of the country’s economic activity [PDF] would be lost if schools and day-care centers remained closed.

Are children less likely to get and transmit COVID-19?

According to the U.S. Centers for Disease Control and Prevention (CDC), children are less likely than adults to contract COVID-19. Across several hard-hit countries, the proportion of cases among people under the age of eighteen ranged between roughly 1 and 2 percent of total confirmed cases. Some children infected with COVID-19 appeared to show no symptoms, but scientists say the prevalence of asymptomatic child cases and whether those cases are infectious is still unknown.

Young children also appear to be less likely to spread the virus to others. However, older children—between the ages of ten and nineteen—appear to transmit the new coronavirus as much as adults, according to one study of more than sixty-five thousand people in South Korea.

Despite the lower infection rate, many parents are fearful of returning their children to classrooms, seeing any risk of them becoming severely ill as too high. Alongside these concerns are worries that millions of older family members living with school-age children as well as a large portion of teachers and school staff—an estimated one in four in the United States—are at high risk of serious infection.

When will U.S. schools reopen?

When and how schools will reopen varies across states and localities. Some school districts, such as those in Chicago and New York City, plan to hold a mix of online and in-person classes. Others, including the Los Angeles and San Diego school districts, will hold all classes online.

Although the federal government and the CDC provided guidelines for schools on how to safely operate, ultimately the decision of what schooling will look like is up to local officials. Most state governors have announced rules school districts must follow to reopen. California’s rules state that schools cannot reopen until the surrounding areas have seen fourteen consecutive days of declining coronavirus cases. It requires students in fourth grade and above to wear masks and forces schools to close if they report a case. In Florida, where cases are surging, the education commissioner signed an executive order that would force public schools to hold classes in person in August. However, some districts are letting parents and guardians decide whether their student will learn in person, strictly online, or through a blended model.

 

Private schools, which serve an estimated 10 percent of children nationwide, often have more resources to implement state guidelines and can therefore reopen sooner than public schools. They tend to have smaller student bodies, making it easier to limit class sizes, and funds to hire more teachers. Private schools also don’t have the same curriculum requirements and facilities restrictions as public schools, allowing them to be more creative in their reopening plans. In some U.S. cities, parents are hiring teachers to conduct private lessons with small groups of children in their homes, dubbed “microschooling” and “pandemic pods.”

Indian Americans Lead In COVID-19 Responses

These are difficult and extremely challenging times. The life across the world has changed for ever. The COVI-a9 pandemic has affected the lives of everyone as no other single factor has touched did, including wars, natural calamities and famine since the beginning of the human civilization.

People from every walk of walk of life have risen to the occasion: from children to adults, professionals and lay people, leaders of the world to ordinary citizens have done their part to combat and minimize the sufferings of the people impacted by the deadly pandemic.  

According to the U.S. Census Bureau, Indian-Americans in this country are one of the fastest-growing ethnic groups with one of the highest household incomes of any community. The numerous initiatives by several groups from the Indian Diaspora show they are committed to providing sustained long-term relief during the pandemic and serve as a model and inspiration for individuals and communities across the globe.

They rallied through cultural, religious, and social service organizations, not just to support their own members, but to gather resources including masks, funds for buying protective equipment, food distribution to frontline workers and the needy, as well as help organizations in India during the pandemic. These include small and large groups in local communities and towns and cities, mandirs, gurdwaras, mosques, professional organizations like the American Association of Physicians of Indian Origin, AAPI, and numerous others. The relief efforts were undertaken across age-groups, involving the young and the old.

A 2020 Indian Diaspora in Action: Tracking the Indian American Response to COVID-19, a report detailing the philanthropic impact of the diaspora on COVID-19 relief., has chronicled the great contributions of Indian Americans in the past few months, since the pandemic has impacted almost every aspect of people’s lives. The report released July 30, 2020, tracks 58 out of the hundreds of organizations and actions taken in the Indian-American community to support COVID-19 relief efforts.

Prepared by Indiaspora, a nonprofit organization of global Indian diaspora leaders from various backgrounds and professions, the report has highlighted the tremendous outpouring of support for both the U.S. and India, which has been witnessed across the board from helping to provide meals to migrant workers in India, personal protective equipment to frontline healthcare workers, education through e-learning and healthcare, the organization said in a statement.

The report details the actions of 58 non-profit organizations re-purposing their efforts in response to the pandemic and illustrates the power of the Indian Diaspora community. “Never before have we witnessed such a united all-out community relief effort amongst the diaspora. One of the most unique aspects we witnessed was the efforts by the next generation of philanthropists through their incredible volunteer efforts,” said Gabrielle Trippe, Indiaspora Philanthropy Initiatives Manager.

Under the leadership of Dr. Suresh Reddy, past President of AAPI, AAPI became the first major organization to call for ‘universal masking’. AAPI provided free masks to thousands of health care workers. In addition to offering education through its multiple zoom sessions on various aspects of Covid and on ways to combat the pandemic, AAPI members honored more than 10,000 nurses in over 100 hospitals across more than 40 states by sponsoring lunches for them during the Nurses Week. AAPI has also stood against racial discrimination. “We are proud to say that for all our Doctors ‘all lives matter,’” Dr. Sudhakar Jonnalgadda, current President of AAPI said.

Another notable group that has been at the forefront of the response since the onset of the pandemic is the India Philanthropy Alliance (IPA). IPA is a coalition of twelve development and humanitarian organizations working together to mobilize resources and build alliances to benefit India. Charmain of India Philanthropy Alliance Deepak Raj stated, “It is an honor to  lead such a remarkable group of organizations coming together in a historic response to support those most in need during these incredibly challenging times.”

 “We feel it is our dharma, or duty, to help others during this time,” said Arun Kankani, President at Sewa International, USA, whose nonprofit has been providing on-the-ground relief, and also began a COVID-19 plasma registry to help physicians treat patients with respiratory failure from COVID-19. “When we saw so many affected, we didn’t feel like we had a choice in the matter.”

Indiaspora is proud to note that several of these organizations were founded by Indiaspora members. These organizations include: 360Plus, Arogya World, Achieving Women Equity Foundation, Freedom Employability Academy, Indian American Council’s Hunger Mitao, and WISH Foundation.

Rehan Mehmood, director of health services at the South Asian Council for Social Services, delivering a bag of food to a client in Queens, observing COVID-19 social distancing rules. A California-based non-profit organization says the philanthropic impact of the Indian diaspora on COVID-19 disaster relief displays of the power of this community.

“We feel it is our dharma, or duty, to help others during this time,” Arun Kankani, president at Sewa International, USA, is quoted saying in the Indiaspora press release. Sewa International USA,  not only provides on-the-ground relief, it also began a COVID-19 plasma registry to help physicians treat patients with respiratory failure from COVID-19. “When we saw so many affected, we didn’t feel like we had a choice in the matter.”

One of the groups that has been at the forefront of the response since the onset of the pandemic, Indiaspora said, is the India Philanthropy Alliance. The IPA is a coalition of twelve development and humanitarian organizations working together to mobilize resources and build alliances to benefit India.

“The tremendous outpouring of support for both the U.S. and India has been witnessed across the board from helping to provide meals to migrant workers in India, personal protective equipment to frontline healthcare workers, education through e-learning and healthcare,” says the press release, tracking the work done by 58 non-profit organizations which redirected their effort to pandemic relief and rehabilitation.

“Never before have we witnessed such a united all-out community relief effort amongst the diaspora. One of the most unique aspects we witnessed was the efforts by the next generation of philanthropists through their incredible volunteer efforts,” Indiaspora Philanthropy Initiatives Manager. Gabrielle Trippe, is quoted saying in the press release.

Indiaspora said several of the IPA participating organizations were  founded by Indiaspora members, among them, 360Plus, Arogya World, Achieving Women Equity Foundation, Freedom Employability Academy, Indian American Council’s Hunger Mitao, and WISH Foundation. Indiaspora said it also recently completed a giving campaign to fight hunger, ChaloGive for COVID-19, targeted at food insecurity issues, and its fundraising campaign raised more than $1.18 million and provided more than 8 million meals through partner organizations Feeding America in the U.S. and Goonj in India.

AAPI Condemns Life Threatening Attack On Dr. Dinesh Verma At Alpha Hospital, Latur COVID Center AAPI urges Modi Administration to prevent violence against physicians and bring to justice those behind the attack

Chicago, IL: July 30, 2020:  “AAPI is shocked about the brutal and life threatening attack on Dr. Dinesh Verma at the COVID Center, Alpha Hospital, Latur in the state of Maharashrta, India on Wednesday, July 29th.  We want to express our prayers and best wishes for speedy recovery to Dr. Verma, who has dedicated his life in the service of the patients affected by the deadly pandemic, COVI-19,” Dr. Sudhakar Jonnalagadda, President of American Association of Physicians of India Origin (AAPI) said here today. In a statement issued here Dr. Jonnalagadda condemned the brutal attack on Dr. Verma. He urged the Government of India and the State Government of Maharashtra to bring to justice those behind the cruel attack on the physician who has dedicated all his life for serving the sick, especially during the critical times, risking his own life and that of his dear ones. “We at AAPI, the largest ethnic medical organization in the nation, urge the Government of India and every state in India to make all the efforts possible to prevent violence against medical professionals and enable them to continue to serve the country with dignity, pride and security,” Dr. Verma was allegedly attacked with a sharp weapon by the son of a Covid-19 patient, who died at a hospital in Latur on Wednesday. Dr. Verma was stabbed with sharp objects over chest and neck multiple times by the relative of a Covid patient who died yesterday while being treated for COVID related symptoms. As per reports, the pt was having other co morbidities like diabetes and hypertension. She was referred to Latur from Udgir as her oxygen saturation was not maintaining well and it was around 70-80%. The Attending Doctor was confronted by the relatives and one of them suddenly attacked him and stabbed Dr. Verma multiple times. Dr. Verma received multiple sutures for the wounds over his chest, neck and hand. Police later registered a case and arrested the 35-year-old man on charges of assault against Dr. Dinesh Verma, attached to Alfa Hospital. Police said Dr. Verma suffered a deep cut to his chest and was rescued by the hospital’s security guards, after which he was rushed to another hospital. The Indian Medical Association (IMA) staged a protest with local doctors shutting down their clinics after the attack. Expressing shock that despite these noble intentions, many doctors and nurses put their own lives on the line in the course of their jobs, facing attacks from the very people they are trying to help, Dr. Jonnalagadda added. Recalling that from ancient times, physicians across the world have been revered for dedicating their lives for the noble mission of preventing people from getting and saving millions of lives of people from illnesses, Dr. Anupama Gotimukula, President-Elect of AAPI, said,  said. “We as a community of physicians and individual members of this fraternity have decided to go into the medical profession with the best of intentions. We as physicians want to help people, ease suffering and save lives. Physicians of Indian origin are well known around the world for their compassion, passion for patient care, medical skills, research, and leadership.” The members of the American Association of Physicians of Indian Origin (AAPI), an umbrella organization which has nearly 110 local chapters, specialty societies and alumni organizations, with over 35 years of history of dedicated services to their motherland and the adopted land, are appalled at the growing violence against our fellow physicians, Dr. Jonnalagadda said. “We strongly condemn this ongoing violence. And we want immediate action against the culprits, who have been carrying on these criminal acts. We are shocked by the lack of coherent action against such violence and protect members of this noble fraternity.” For more information on AAPI, please visit: http://www.aapiusa.org/

Indian Billionaires Take Lead In Coronavirus Vaccine Investments

The world’s largest vaccine producer, the Serum Institute, announced a plan to make hundreds of millions of doses of an unproven inoculation. It’s a gamble with a huge upside. And huge risks.In early May, an extremely well-sealed steel box arrived at the cold room of the Serum Institute of India, the world’s largest vaccine maker.

Inside, packed in dry ice, sat a tiny 1-milliliter vial from Oxford, England, containing the cellular material for one of the world’s most promising coronavirus vaccines. Scientists in white lab coats brought the vial to Building 14, carefully poured the contents into a flask, added a medium of vitamins and sugar and began growing billions of cells. Thus began one of the biggest gambles yet in the quest to find the vaccine that will bring the world’s Covid-19 nightmare to an end.

The Serum Institute, which is exclusively controlled by a small and fabulously rich Indian family and started out years ago as a horse farm, is doing what a few other companies in the race for a vaccine are doing: mass-producing hundreds of millions of doses of a vaccine candidate that is still in trials and might not even work.

But if it does, Adar Poonawalla, Serum’s chief executive and the only child of the company’s founder, will become one of the most tugged-at men in the world. He will have on hand what everyone wants, possibly in greater quantities before anyone else.

His company, which has teamed up with the Oxford scientists developing the vaccine, was one of the first to boldly announce, in April, that it was going to mass-produce a vaccine before clinical trials even ended. Now, Mr. Poonawalla’s fastest vaccine assembly lines are being readied to crank out 500 doses each minute, and his phone rings endlessly.

National health ministers, prime ministers and other heads of state (he wouldn’t say who) and friends he hasn’t heard from in years have been calling him, he said, begging for the first batches. “I’ve had to explain to them that, ‘Look I can’t just give it to you like this,’” he said.

Adar Poonawalla, Serum’s chief executive, says that he will split the hundreds of millions of vaccine doses he produces 50-50 between India and the rest of the world.Credit…Atul Loke for The New York Times

With the coronavirus pandemic turning the world upside down and all hopes pinned on a vaccine, the Serum Institute finds itself in the middle of an extremely competitive and murky endeavor. To get the vaccine out as soon as possible, vaccine developers say they need Serum’s mammoth assembly lines — each year, it churns out 1.5 billion doses of other vaccines, mostly for poor countries, more than any other company. Half of the world’s children have been vaccinated with Serum’s products. Scale is its specialty. Just the other day, Mr. Poonawalla received a shipment of 600 million glass vials.

But right now it’s not entirely clear how much of the coronavirus vaccine that Serum will mass-produce will be kept by India or who will fund its production, leaving the Poonawallas to navigate a torrent of cross-pressures, political, financial, external and domestic.

India has been walloped by the coronavirus, and with 1.3 billion people, it needs vaccine doses as much as anywhere. It’s also led by a highly nationalistic prime minister, Narendra Modi, whose government has already blocked exports of drugs that were believed to help treat Covid-19, the disease caused by the coronavirus.

Adar Poonawalla, 39, says that he will split the hundreds of millions of vaccine doses he produces 50-50 between India and the rest of the world, with a focus on poorer countries, and that Mr. Modi’s government has not objected to this. But he added, “Look, they may still invoke some kind of emergency if they deem fit or if they want to.”

The Oxford-designed vaccine is just one of several promising contenders that will soon be mass-produced, in different factories around the world, before they are proven to work. Vaccines take time not just to perfect but to manufacture. Live cultures need weeks to grow inside bioreactors, for instance, and each vial needs to be carefully cleaned, filled, stoppered, sealed and packaged.

The idea is to conduct these two processes simultaneously and start production now, while the vaccines are still in trials, so that as soon as the trials are finished — at best within the next six months, though no one really knows — vaccine doses will be on hand, ready for a world desperate to protect itself.

American and European governments have committed billions of dollars to this effort, cutting deals with pharmaceutical giants such as Johnson & Johnson, Pfizer, Sanofi and AstraZeneca to speed up the development and production of select vaccine candidates in exchange for hundreds of millions of doses.

AstraZeneca is the lead partner with the Oxford scientists, and it has signed government contracts worth more than $1 billion to manufacture the vaccine for Europe, the United States and other markets. But it has allowed the Serum Institute to produce it as well. The difference, Mr. Poonawalla said, is that his company is shouldering the cost of production on its own.

But Serum is distinct from all other major vaccine producers in an important way. Like many highly successful Indian businesses, it is family-run. It can make decisions quickly and take big risks, like the one it’s about to, which could cost the family hundreds of millions of dollars.
Adar Poonawalla turned a vintage plane that no longer flies into an office suite on Serum’s campus in Pune. Mr. Poonawalla said he was “70 to 80 percent” sure the Oxford vaccine would work. But, he added, “I hope we don’t go in too deep.”

Unbeholden to shareholders, the Serum Institute is steered by only two men: Mr. Poonawalla and his father, Cyrus, a horse breeder turned billionaire. More than 50 years ago, the Serum Institute began as a shed on the family’s thoroughbred horse farm. The elder Poonawalla realized that instead of donating horses to a vaccine laboratory that needed horse serum — one way of producing vaccines is to inject horses with small amounts of toxins and then extract their antibody-rich blood serum — he could process the serum and make the vaccines himself.

He started with tetanus in 1967. Then snake bite antidotes. Then shots for tuberculosis, hepatitis, polio and the flu. From his stud farm in the fertile and pleasantly humid town of Pune, Mr. Poonawalla built a vaccine empire, and a staggering fortune.

Capitalizing on India’s combination of cheap labor and advanced technology, the Serum Institute won contracts from Unicef, the Pan American Health Organization and scores of countries, many of them poor, to supply low-cost vaccines. The Poonawallas have now entered the pantheon of India’s richest families, worth more than $5 billion.

Horses are still everywhere. Live ones trot around emerald paddocks, topiary ones guard the front gates, and fancy glass ornaments frozen in mid-strut stand on the tabletop of Serum’s baronial boardroom overlooking its industrial park, where 5,000 people work.

Inside the facility producing the coronavirus vaccine candidate, white-hooded scientists monitor the vital signs of the bioreactors, huge stainless steel vats where the vaccine’s cellular material is reproduced. Visitors are not allowed inside but can peer through double-paned glass.
“These cells are very delicate,” said Santosh Narwade, a Serum scientist. “We have to take care with oxygen levels and mixing speed or the cells get ruptured.”

Do some people have protection against the coronavirus? By Dr. Sanjay Gupta and Andrea Kane, CNN

We’re now more than seven months into the coronavirus pandemic that has upended the lives of most of Earth’s inhabitants. And while it is true that the scientific community has learned many things about the SARS-CoV-2 virus and the disease it causes, Covid-19, there are also many gaps in our understanding.

One big mystery: Why do some people get very sick and even die from their illness, while other similar people show no symptoms and may not realize they’ve been infected at all?

We know some of the big factors that put people at higher risk of having a severe, even fatal, course of disease: being over 60; being overweight or obese; having one or more chronic diseases such as diabetes, cardiovascular disease, kidney or lung disease, and cancer; and being a person of color — Black African American, Latino Latinx or Native American.

But might the opposite also be true: Could certain people actually have some type of protection? Looking to purchase your first bed-in-a-box mattress? Here’s exactly what to know before buying and a list of our top five mattress online delivery brands to try out now.

A recently published summary article in the journal Nature Reviews Immunology put forth a tantalizing possibility: A large percentage of the population appears to have immune cells that are able to recognize parts of the SARS-CoV-2 virus, and that may possibly be giving them a head start in fighting off an infection. In other words, some people may have some unknown degree of protection.

“What we found is that people that had never been exposed to SARS Cov2 … about half of the people had some T-cell reactivity,” co-author of the paper Alessandro Sette from the Center for Infectious Disease and Vaccine Research at La Jolla Institute for Immunology, told CNN.

Immunology 101

To understand why that’s important, here’s a little crash course in immunology. The human immune system, which is tasked with keeping you healthy in the face of bacterial, viral, fungal, parasitic and other invaders, has two main components: the innate immune system and the adaptive immune system.

The innate immune system is the very first line of defense. Parts of it include physical barriers like your skin and mucosal membranes, which physically stop invaders from getting in. It also includes certain cells, proteins and chemicals that do things like create inflammation and destroy invading cells.

Where the innate immune system is immediate and nonspecific (it tries to stop anything from entering the body), the adaptive immune system is targeted against a specific and previously recognized invader. This takes a bit longer to kick into gear.

The adaptive immune system includes a type of white blood cell, called a B cell, which patrols the body looking for bad guys. B cells each have a unique antibody that sits on its surface and can bind to a unique antigen (the technical name for the foreign invader) and stop it from entering a host cell. When it finds and binds to a bad guy, the B cell gets activated: it copies itself and churns out antibodies, eventually creating a mega-army of neutralizers for that particular invader.

That’s where antibodies created by the immune systems of people who’ve had Covid-19 come from. Unfortunately, a few recent studies have found that antibodies to this particular coronavirus can fade away pretty quickly especially in people who have had mild cases of Covid-19. This has worried many researchers: because the antibody response appears to fade quickly, the scientific community is not sure how long a person who has been infected with this virus will stay protected from a new infection. This is also worrisome since we are relying on vaccines to trigger an antibody response to help protect us, and we want that protection to last a long time.

Fortunately, antibodies aren’t the only weapon our adaptive immune system uses to stave off an infection. Enter the T cell. T cells, which come in three varieties, are created by the body after an infection to help with future infections from the same invader. One of those T cells helps the body remember that invader in case it comes knocking again, another hunts down and destroys infected host cells and a third helps out in other ways.

Accidental discovery

It’s T cells like those, which reacted to the SARS-CoV-2 virus, that Sette and his co-author Shane Crotty discovered — quite by accident — in the blood of people collected several years before this pandemic began.

They were running an experiment with Covid-19 convalescent blood. Because they needed a “negative control” to compare against the convalescent blood, they picked blood samples from healthy people collected in San Diego between 2015 and 2018.

Why some people who haven’t had Covid-19 might already have some immunity

“There was no way these people had been exposed to SARS-CoV2. And when we ran those … it turns out the negative control was not so negative: about half of the people had reactivity,” Sette explained.

“Shane and I pored over the data; we were looking at it from the right, from the left, from the top, from the bottom — and it was really ‘real’; this reactivity was real. So, this showed that people that have never seen this virus have some T-cell reactivity against the virus.”

“That has been now confirmed in different continents, different labs, with different techniques, which is one of the hallmarks of when you start to actually really believe that something is scientifically well-established because it’s found independently by different studies and different labs,” said Sette.

They speculate that this T cell recognition of parts of the SARS-CoV-2 virus may come in part from past exposure to one of the four known circulating coronaviruses that cause the common cold in millions of people every year.

“The assumption is that’s actually coming from common cold coronaviruses that people have seen before, and Alex’s side was working really hard to actually figure that out, because that’s still scientifically a major debate,” said Crotty.

Friend or foe?

But many questions remain — including whether this recognition to parts of SARS-CoV-2 by T cells helps or hurts.

“Would these memory T cells be helpful for protecting you against Covid-19 disease, that’s the huge question,” said Crotty. “We don’t know if [the T cells] are helpful or not, but we think it’s reasonable to speculate that they may be helpful. It’s not that we think they would completely protect against any infection at all, but if you already have some cells around, they can fight the virus faster and so it’s plausible that instead of ending up in the ICU, you don’t. And instead of ending up in the hospital, you just end up with a bad cold.”

Other researchers are also intrigued by the possibilities put forth by this discovery. Dr. Arturo Casadevall told CNN his first thought was “Not surprising, important, good to know.” Casadevall chairs the department of molecular microbiology and immunology at the Johns Hopkins School of Public Health.

“Because these coronaviruses are all related, given that every year we run into one of them, it’s not surprising that we have T cells that are reactive with them,” he said. But, like Sette and Crotty, he questions whether this reactivity is a good thing or a bad thing.

A few months ago, Casadevall explored the idea of why some people get sick and some don’t in an opinion piece he co-wrote for Bloomberg.com. “One of the variables is what we call the immunological history. All the things that you have run into in your life, all the vaccines, the colds, all the GI upsets, have created a background knowledge that can help you or hurt you,” explained Casadevall.

“One of the things we know about this disease is that what kills you is an over exuberant immune response, in the lung… So, when you say, ‘They have T-cell reactivity,’ well that could help in some people, it could hurt in others,” he said.

Casadevall speculates that some of the asymptomatic people may be able to rapidly clear the virus thanks to this T-cell reactivity. “At the same time, some of the very sick people have that immunological history that instead of helping them, makes the immune system throw everything at it, and the net result is that you get this over-exuberant response,” he said, referring to the cytokine storm that some of the sickest of the sick with Covid-19 experience.
Sette and Crotty are looking into that possibility. But they say the overreaction of the innate immune system, not overreacting T cells, appears to set off the cytokine storm. “The data are still somewhat preliminary, but I think it’s in that direction. Certainly, we have not seen an immune response related to T cells in overdrive in the very severe cases,” said Sette.

Big implications for vaccines

So, assuming that a large portion of the population has some kind of T-cell reactivity to the SARS-CoV-2 virus, what does that mean for vaccine efforts?

There are several implications.

For Dr. Bruce Walker, an infectious disease physician-scientist who spends most of his time doing research in human immunology, it opens the door to a different type of vaccine, similar to the ones that are being used against certain cancers, like melanoma.

“What we know is that most vaccines that have been generated thus far have been based on generating antibodies. Now, antibodies should theoretically be able to prevent any cells from becoming infected — if you have enough antibodies around and any virus coming in, before it gets a chance to infect a cell, can be theoretically neutralized by the right kind of antibody,” explained Walker, who is the founding director of the Ragon Institute of Massachusetts General Hospital, MIT and Harvard.

“On the other hand, if some viruses sneak through and infect a cell; then the body is dependent upon T cells to eliminate the virus,” he said. “And therein lies the opportunity for us to rethink what we’re doing in terms of vaccination — because those T cells, at least theoretically, could be highly potent and could attenuate the disease. In other words, they wouldn’t protect against infection, but they might make infections so asymptomatic that you would not notice it yourself and, in fact, you would never have enough virus in your body to transmit it to somebody else. That’s the hypothesis.”

Another implication is that the results of a small, Phase 1 vaccine trial could be misinterpreted in one way or another if the T-cell reactivity status of participants isn’t taken into account. “For example, if subjects with pre-existing reactivity were sorted unevenly in different vaccine dose groups, this might lead to erroneous conclusions,” Sette and Crotty wrote in their paper.

Furthermore, Sette said upcoming vaccine trials could help uncover the effect of this T-cell cross-reactivity a lot more cheaply and easily than running other experiments. “It is a conceivable that if you have 10 people that have reactivity and 10 people that don’t have the pre-existing reactivity and you vaccinate them with a SARS CoV-2 vaccine, the ones that have the pre-existing immunity will respond faster or better to a vaccine. The beauty of that is that that is a relatively fast study with a smaller number [of people] … So, we have been suggesting to anybody that is running vaccine trials to also measure T-cell response,” said Sette.

The herd (immunity) grows stronger

There are also implications for when we might achieve “herd immunity” — meaning that enough of the population is immune to SARS-CoV-2, thanks either to infection or vaccination, and the virus can no longer be as easily transmitted.

“For herd immunity, if indeed we have a very large proportion of the population already being immune in one way or another, through these cellular responses, they can count towards the pool that you need to establish herd immunity. If you have 50% already in a way immune, because of these existing immune responses, then you don’t need 60 to 80%, you need 10 to 30% — you have covered the 50% already. The implications of having some pre-existing immunity suggests that maybe you need a small proportion of the population to be impacted before the epidemic wave dies out,” said Dr. John Ioannidis, a professor of medicine and epidemiology and population health at Stanford University.

Killer T-cells can save us

In other words, if there is a level of herd immunity, that changes how fast the virus ripples through different communities and populations.

In fact, Sette and Crotty wrote in their paper, “It should be noted that if some degree of pre-existing immunity against SARS-CoV-2 exists in the general population, this could also influence epidemiological modelling …”

Crotty points to a SARS-CoV-2 epidemiology paper that appeared in the journal Science at the end of May that tried to model transmission of the virus going forward. “We thought it was really striking that a number of the major differences in their models really came down to immunity, one way or another,” he said.

For example, Crotty said when the authors added a hypothetical 30% immunity to their epidemiological model of how many cases there would be in the world over the next couple of years, the virus faded away in the near future before returning in three or four years.

More questions than answers for now

And that brings us to another question raised by Sette and Crotty’s paper: because the common circulating coronaviruses (CCC) appear in different places, at different times, could some countries, cities or localities be disproportionately affected (or spared) because the population had less exposure to those CCCs, thus creating less opportunity to develop cross-reactivity?

“If the pre-existing T-cell immunity is related to CCC exposure, it will become important to better understand the patterns of CCC exposure in space and time. It is well established that the four main CCCs are cyclical in their prevalence, following multiyear cycles, which can differ across geographical locations. This leads to the speculative hypothesis that differences in CCC geo-distribution might correlate with burden of COVID-19 disease severity,” Sette and Crotty wrote..

So, ultimately can it be said that some people have at least partial natural protection from SARS-CoV-2, the novel coronavirus, if they have T-cell cross-reactivity?
“The biggest problem is that everybody wants a simple answer,” said Johns Hopkins’ Casadevall. “What nobody wants to hear is that it’s unpredictable, because many variables play together in ways that you can’t put together: your history, your nutrition, how you got infected, how much [virus] you got — even the time of the day you got infected. And all these variables combine in ways that are unpredictable.”

2nd Wave of Covid 19 Witnessed Around the World

While India continues to reel under Covid-19, a number of places that were once seen as the gold standard for pandemic responses are now also seeing surges in cases, as the coronavirus continues to spread around the world unabated.

Australia’s hard-hit Victoria state on Monday posted a new daily record of 532 new Covid cases, and Victoria Premier Daniel Andrews warned that a lockdown in the city of Melbourne will continue if infected people continue to go to work instead of staying home. Melbourne is almost half way through a six-week lockdown aimed at curbing community spread of the coronavirus. Mask wearing in Australia’s second-largest city became compulsory last week.Meanwhile, Hong Kong is locking down yet again amid its third wave. Hong Kong banned gatherings of more than two people, closed down restaurant dining and introduced mandatory face masks in public places, including outdoors.

And Japan, which has not imposed lockdowns, just recorded its highest daily infection rate yet, just before the weekend. Also, Vietnam is evacuating 80,000 people, mostly local tourists, from Danang after three residents tested positive at the weekend. Until Saturday, the country had reported no community infections since April.

In Europe, parts of Spain, which brought a virulent outbreak to heel this spring with strict measures, are closing down again as infections soar. In fact, a surge in infections in Spain prompted Britain to order all travellers from there to quarantine for two weeks, wrecking the travel plans of hundreds of thousands of people.

And the Czech Republic, which held a ‘farewell party’ to the pandemic just weeks ago, is experiencing a new jump in cases linked to a Prague nightclub. The Czech government, on Monday, announced an overhaul of its much-criticised ‘smart quarantine’ system of tracking and isolating contacts of people with Covid as it battles the spike in new infections.

Finally, China had managed to squelch local transmission through firm lockdowns after the virus first emerged in the central city of Wuhan late last year. But a new surge has been driven by infections in the far western region of Xinjiang. In the northeast, Liaoning province reported a fifth straight day of new infections and Jilin province reported two new cases, its first since late May.

So even with the most well-intentioned, widespread restrictions, it seems the virus is not going away anytime soon. And until there is a vaccine, governments may be forced to rely on the strategy of “suppress and lift” — coined by Hong Kong authorities — whereby rules are relaxed and then swiftly reinforced at the first sign of new spikes. The Covid map of India has transformed this month, with the virus having reached almost all the districts and cases growing fast. While the pressure seems to be easing in early hotspots like Delhi, Mumbai and Ahmedabad, roughly half the country’s districts now have more than 500 cases each. Of them, about 200 have more than 1,000 cases each, and there has been at least one Covid death in almost 80% of the districts. Many of these emerging hotspots have scanty health infrastructure and managing an explosion of cases could prove beyond their capabilities. Already, cases in 11 districts are growing at double-digit rates.

Should schools reopen? Balancing COVID-19 and learning loss for young children By Kathy Hirsh-Pasek, Michael Yogman, and Roberta Michnick Golinkoff

Sadly, there is no risk-free decision about school reopening: Decisionmakers must balance the risks of children contracting and/or spreading COVID-19 with counteracting risks of children falling academically behind and being deprived of social relationships from in-school learning. Decisions as to whether students should return to school in person must be tailored to fit each specific community, school district, and even grade within school. The National Academies of Science, Engineering, and Medicine this week released a report focused on younger children. Their advice? Open schools for children in kindergarten through fifth grade with well-funded safety measures in place. On the one hand, there is much scientific data to suggest that even our youngest children have already lost academic and social readiness during the COVID-19 slump. This is even more true for children from underserved communities. Science tells us that social relationships with friends and teachers are essential for social and academic learning during early childhood. Children learn, love, and thrive best when interacting with other adults and children. For example, research shows that strong language skills are born in the context of conversations with other people. Interactions between young children, their peers, and adults—real interactions—literally mold areas of the brain that support social bonding, language, and the seeds of literacy. Put simply, social relationships play a critical role in learning and child development. On the other hand, with respect to public health, there is much that we do not know. Data are still evolving and are sometimes contradictory on 1) the level of health risk children with COVID-19 personally face; 2) whether children are more likely to be asymptomatic shedders; and 3) whether children are likely to spread COVID-19 to teachers and parents. According to a recent report based on international data, countries like Denmark and Germany have had fairly safe results. This is to be contrasted with data out of Israel suggesting that school reopening created a spike in cases. It remains unclear what factors (i.e., timing of reopening with respect to national COVID-19 trajectories and other cultural factors) drive these differences. A new study out of Korea examined 65,000 people and concluded that even younger children do catch and spread the virus. Those under 10 are roughly half as contagious. A true unknown is whether the virus has lasting effects on children as they grow up. Importantly, we have yet to know whether young children can follow the safety mandates. Try to envision a group of 4-year olds really keeping a mask on throughout the day. It is as baffling as imagining a team of 3-year-olds who can truly keep six feet apart? Ask any parent or early childhood educator: Preschoolers are not well known for following rules. So, what is a parent to do? What is a teacher to do? What policies should guide decisions about whether, and if so, how to open school? This is the balancing act. In two pieces, the American Academy of Pediatrics recommended that for young children, returning to school with the right provisions in place would be optimal. In an amendment to their post, they write: “Returning to school is important for the healthy development and well-being of children, but we must pursue reopening in a way that is safe for all students, teachers, and staff.” There is no one-size-fits-all blueprint for reopening, and significant resources will be required. Local conditions are paramount. These include the prevalence of the virus in the community, the health risks for staff (both teachers and custodial staff), whether adequate financial resources are provided for schools to disinfect classrooms, students and employees are screened for symptoms, and academic spaces are reconfigured, such as by setting up tented learning areas for outdoor classes. The risk-benefit calculus is also influenced by individual characteristics associated with student needs. Importantly, children from underserved communities—who are disproportionately racial minorities and immigrants—as well as children with food insecurity and special needs, often receive services that are only provided through schools. The bottom line is that the answer is just not as black and white as many in the media lead us to believe. Decisions about whether and how to reopen schools require a delicate balance of dynamic factors. Surely with such complicated decisions, a scientific response rather than a political one is in order. The scientific data about how children are affected by and spread COVID-19 are accumulating before our eyes. While the health risks are real, they must be balanced with the scientific consensus that children must be around other people. The optimal way for schools to strike this balance is not yet known. But if we empower decisionmakers with the scientific evidence, and update them as it accumulates, we can at least make informed decisions about how to keep our children safe while also feeding them the psychological nutrients to develop in a healthy way.

Coronavirus is preventable, not treatable till vaccine found BY FAKIR BALAJI

With no sign of the pandemic flattening the curve, as evident from the daily surge in positive cases across the country, Bengaluru-based eminent pediatric cardiologist Vijayalakshmi I. Balekundri said Coronavirus is preventable but not treatable till its vaccine is found.
In an exclusive interview to IANS, the Bengaluru Medical College and Research Institute Emeritus Professor said the only way to avoid getting infected is to wear mask, wash hands and maintain physical distance because prevention is better than cure till a vaccine is found to treat the deadly disease. Excerpts:
Q: Why and how different is Covid-19 from other viruses?
A: Corona viruses are not a living organism like bacteria or fungus. They are non-living large, lipid capsule enveloped and positive-stranded RNA viruses. Like other viruses, the novel Coronavirus tries to burrow into a cell and turns it into a virus-replicating factory. If it succeeds, it can produce an infection in throat, respiratory system, heart, brain, blood vessels and in all the 100 trillion cells in a human body.
The type of cells a virus targets and how it enters them depends on how it is built. The genetically engineered Coronavirus is virulent, spreads from human to human without a vector and enters the body through nose, throat and eyes as an airborne infection. It affects vital organs and cells in the body through blood vessels.
The novel Coronavirus gets its family name from a telltale series of spikes — tens or even hundreds of them — that circle its blob-like core as a crown or corona. Studying its cousins which cause SARS and MERS, virologists know that the spikes interact with receptors on cells like keys in locks, enabling the virus to enter body cells.
As the Corona virus that spread from Wuhan in China is mutant, efforts are on the world over to develop a vaccine that can treat its 11 mutations so far.
Covid-19 is a mutant in a clever disguise! Like sugar (carbohydrate molecule) dots outside the spike, it dots outside human cells. The carbohydrate camouflage makes the virus difficult for the human immune system to recognise it initially.
Each spike is made up of three identical proteins twisted and they have to open to gain access into a cell. We need to find a method to prevent these tiny invaders, which are 1,000 times smaller than our body cells they infect.
Q: How the new Coronavirus enters human cells?
A: To infect a human host, the virus gains entry into an individual’s cells, uses their machinery to replicate, spill out of them and spread to other cells. The tiny molecular key on SARS-CoV-2 gives the virus entry into the cell. This key is called a spike protein.
The structure of coronavirus is like a key and receptors on cells are like a lock. Theoretically, they provide an entry point to a thief (virus) into a house (body cells) through a lock (receptors).
Q: How to prevent the virus from spreading further although it has infected lakhs the world over during the last 6 months and threatens to attack more till a vaccine is discovered?
A: First of all, we should understand the Coronavirus structure, method of its spread, mechanism to replicate and organs it damages, whom all it affects the most, how to contain it and myths about it.
The virus can be prevented transmitting from person to person, entering body and replicating in cells by wearing mask, washing hands repeatedly, keeping 4-6 feet distance from others, toilet hygiene and avoid travelling.
As Covid-19 is an air born droplet infection, millions of its viruses are thrown out in small droplet forms at 166km per hour speed when an infected person sneezes. When a person coughs, many larger droplets with billions of the virus are thrown out at 100km per hour from mouth.
Larger droplets fall on a person’s face standing even at three feet or on objects around. Hence, wearing mask is mandatory for everyone.
The three-layer surgical masks doctors and nurses wear are not enough to protect them from Coronavirus. They need N95 or N99 masks with 7 layers to prevent the virus infecting them. Face protection shields are better for all healthcare warriors.
As N95 or N99 masks are costly and meant for medical staff, citizens can wear a home-made cloth mask. They should be changed every 4-6 hours after dipping them in antiseptic solution for 15 minutes, washed and dried in sunlight, as ultraviolet rays sterilise them.
Those who ignored wearing mask and not maintained physical distance were the most infected by the pandemic, as evident from the whopping number of cases in all countries the world over, including the US, Brazil, India, Russia, South Africa, Peru, Mexico, Chile, the UK and Iran.
Social distancing has to be maintained as a person standing even 3 feet of an infected being is sprayed with millions of viruses, as smaller droplets float in the air up to 33 feet.
If an infected person is in an enclosure like an office, mall, community hall or party hall, the virus spreads to everyone present, as it happened in South Korea, where a single infected lady from Wuhan spread it 900 people in a church.
Hence, large gatherings in grounds, religious places, movie halls, malls, schools, colleges, stadiums and markets have been banned to prevent the virus spread.
Repeated hand wash is also compulsory for infected as well as non-infected persons to prevent the virus spread.
The fat covering (lipid capsule) over the Coronavirus gets destroyed in soap water and sugar (carbohydrate) molecule that helps to disguise gets dissolved in water. By rubbing hands, the thorns (spikes) on the surface get damaged making it impossible for the virus to stick or enter body cells as key to the lock.
Toilet hygiene is most important as the virus shred from 22-feet long small intestine can contaminate toilets. Stool and farts contain billions of coronaviruses and can infect anyone using common toilets. While community toilets were sealed in cities like Seattle in the US, open defecation is banned in India.
The reason for avoid travelling is that an estimated 4.5-lakh infected people travelled from China to the US, especially New York, spreading the Coronavirus. Travelling increases transmission of the infection.
Going out of house unnecessarily to market or visiting relatives and friends, especially by a infected person can trigger community transmission, which is the most dangerous phase of the virus, as it will double or treble the cases, making it impossible for any government or healthcare system to contain it.
Senior citizens and elders with comorbid conditions like diabetes, high blood pressure, heart disease, bronchial asthma, cancer, kidney diseases and other chronic debilitating diseases with immune compromised state should stay at home till the virus is found to treat it, as mortality in them is very high.
Q: What are signs and symptoms of Corona infection and how fatal it is?
A: If a person is not able to smell anything or taste sugar or salt and is having fever with a bitter tongue, he or she should immediately take a Covid test, as they are signs or symptoms of Corona infection. If the test shows positive, it indicates that the virus has entered the body through nose, eyes or mouth into cells of mucus membrane and replicated inside the body cells.The patient will have mild fever, body ache, throat irritation and dry cough for 3-4 days without sense of smell and taste. The virus enters lungs or stomach through nose or throat and causes viral pneumonia, abdominal pain and loose motions from 5-7th day.
The virus replicate in lung cells leading to breathlessness, fatigue and drop in saturation from 8-10th day. At this stage, steroid inhalations or nasal spray are useful. An x-ray will show the damaged lungs while pulse oxymeter indicates drop in oxygen saturation.
As the virus spreads from lungs to heart, brain, kidney and all blood vessels by 14th day, it causes multi-organ failure and eventual death.
Q: How quarantine helps in preventing or treating the virus?
A: Those coming from hot spots like Mumbai, Chennai and Delhi to Karnataka have to undergo 14-day quarantine, including a week institutional and a week at home because they may not show the symptoms on arrival but develop after 3-4 days. If they test positive, they are shifted to a designated hospital for treatment. If they are asymptomatic, they get quarantined at home or a Covid care centre to recover. (IANS)

Nature study identifies 21 existing drugs that could treat COVID-19

Multiple drugs improve the activity of remdesivir, a current standard-of-care treatment for COVID-19 A Nature study authored by a global team of scientists and led by Sumit Chanda, Ph.D., professor at Sanford Burnham Prebys Medical Discovery Institute, has identified 21 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19. The scientists analyzed one of the world’s largest collections of known drugs for their ability to block the replication of SARS-CoV-2, and reported 100 molecules with confirmed antiviral activity in laboratory tests. Of these, 21 drugs were determined to be effective at concentrations that could be safely achieved in patients. Notably, four of these compounds were found to work synergistically with remdesivir, a current standard-of-care treatment for COVID-19.  “Remdesivir has proven successful at shortening the recovery time for patients in the hospital, but the drug doesn’t work for everyone who receives it. That’s not good enough,” says Chanda, director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys and senior author of the study. “As infection rates continue to rise in America and around the world, the urgency remains to find affordable, effective, and readily available drugs that can complement the use of remdesivir, as well as drugs that could be given prophylactically or at the first sign of infection on an outpatient basis.” Extensive testing conducted  In the study, the research team performed extensive testing and validation studies, including evaluating the drugs on human lung biopsies that were infected with the virus, evaluating the drugs for synergies with remdesivir, and establishing dose-response relationships between the drugs and antiviral activity. Of the 21 drugs that were effective at blocking viral replication, the scientists found: 13 have previously entered clinical trials for other indications and are effective at concentrations, or doses, that could potentially be safely achieved in COVID-19 patients. Two are already FDA approved: astemizole (allergies), clofazamine (leprosy), and remdesivir has received Emergency Use Authorization from the agency (COVID-19). Four worked synergistically with remdesivir, including the chloroquine derivative hanfangchin A (tetrandrine), an antimalarial drug that has reached Phase 3 clinical trials.  “This study significantly expands the possible therapeutic options for COVID-19 patients, especially since many of the molecules already have clinical safety data in humans,” says Chanda. “This report provides the scientific community with a larger arsenal of potential weapons that may help bring the ongoing global pandemic to heel.”  The researchers are currently testing all 21 compounds in small animal models and “mini lungs,” or lung organoids, that mimic human tissue. U.S. Food and Drug Administration (FDA) to discuss a clinical trial(s) evaluating the drugs as treatments for COVID-19. “Based on our current analysis, clofazimine, hanfangchin A, apilimod and ONO 5334 represent the best near-term options for an effective COVID-19 treatment,” says Chanda. “While some of these drugs are currently in clinical trials for COVID-19, we believe it’s important to pursue additional drug candidates so we have multiple therapeutic options if SARS-CoV-2 becomes drug resistant.” Screening one of the world’s largest drug libraries The drugs were first identified by high-throughput screening of more than 12,000 drugs from the ReFRAME drug repurposing collection—the most comprehensive drug repurposing collection of compounds that have been approved by the FDA for other diseases or that have been tested extensively for human safety. Arnab Chatterjee, Ph.D., vice president of medicinal chemistry at Calibr and co-author on the paper, says ReFRAME was established to tackle areas of urgent unmet medical need, especially neglected tropical diseases. “We realized early in the COVID-19 pandemic that ReFRAME would be an invaluable resource for screening for drugs to repurpose against the novel coronavirus,” says Chatterjee.  The drug screen was completed as rapidly as possible due to Chanda’s partnership with the scientist who discovered the first SARS virus, Kwok-Yung Yuen, M.D., chair of Infectious Diseases at the University of Hong Kong; and Shuofeng Yuan, Ph.D., assistant research professor in the Department of Microbiology at the University of Hong Kong, who had access to the SARS-CoV-2 virus in February 2020.  About the ReFrame library  ReFRAME was created by Calibr, the drug discovery division of Scripps Research, under the leadership of President Peter Shultz, Ph.D., with support from the Bill & Melinda Gates Foundation. It has been distributed broadly to nonprofit collaborators and used to identify repurposing opportunities for a range of disease, including tuberculosis, a parasite called Cryptosporidium and fibrosis.  A global team  The first authors of the study are Laura Riva, Ph.D., a postdoctoral research fellow in the Chanda lab at Sanford Burnham Prebys; and Shuofeng Yuan at the University of Hong Kong, who contributed equally to the study. Additional study authors include Xin Yin, Laura Martin-Sancho, Naoko Matsunaga, Lars Pache, Paul De Jesus, Kristina Herbert, Peter Teriete, Yuan Pu, Courtney Nguyen and Andrey Rubanov of Sanford Burnham Prebys; Jasper Fuk-Woo Chan, Jianli Cao, Vincent Poon, Ko-Yung Sit and Kwok-Yung Yuen of the University of Hong Kong; Sebastian Burgstaller-Muehlbacher, Andrew Su, Mitchell V. Hull, Tu-Trinh Nguyen, Peter G. Schultz and Arnab K. Chatterjee of Scripps Research; Max Chang and Christopher Benner of UC San Diego School of Medicine; Luis Martinez-Sobrido, Wen-Chun Liu, Lisa Miorin, Kris M. White, Jeffrey R. Johnson, Randy Albrecht, Angela Choi, Raveen Rathnasinghe, Michael Schotsaert, Marion Dejosez, Thomas P. Zwaka and Adolfo Garcia-Sastre of the Icahn School of Medicine at Mount Sinai; Ren Sun of UCLA; Kuoyuan Cheng of the National Cancer Institute and the University of Maryland; Eytan Ruppin of the National Cancer Institute; Mackenzie E. Chapman, Emma K. Lendy and Andrew D. Mesecar of Purdue University; and Richard J. Glynne of Inception Therapeutics.

Dr. Babu Prasad, A Retired Anesthesiologist Donates $1M To St. John’s NICU

Dr. Babu Prasad’s recent $1 million donation to the HSHS St. John’s Foundation for the neonatal intensive-care unit (NICU) at St. John’s Children’s Hospital is his love letter to the hospital and community. “I am giving back to a hospital, a community and a country that I dearly love,” Prasad said Thursday at a press conference at the hospital. “Springfield is a beautiful city and a wonderful place to live. I gave this contribution because I want Springfield to continue to grow, to bring new jobs here and to build upon the excellent medical community and medical services that we all enjoy. “Children are our future, so I wanted to direct my gift to the neonatal intensive care unit to give the babies a healthy start to their lives.” Dr. Babu Prasad came to the United States in 1971 after graduating from medical school in India with no money. But Prasad became a successful anesthesiologist, including an 18-year stay at HSHS St. John’s Hospital, where he retired in 2004. Prasad joined St. John’s in 1986. He still works two weeks per month at Interventional Pain Management Specialist in Carterville, Ill. In October, St. John’s began a $19 million renovation and expansion of the NICU to provide single-family patient rooms for premature and critically-ill infants.The project will more than double the size of the NICU, taking it from 15,000 square feet to 36,500. It will open in February. Each year, approximately 2,000 babies are born at St. John’s Children’s Hospital. The NICU cares for about 700 babies annually from a 35-county area. “Dr. Prasad’s gift is a beautiful testament as to who he is as a person,” said Beverly Neisler, chief development officer for the HSHS St. John’s Foundation. “He is a generous and kind man who has built a successful life through his hard work, dedication and determination.“Today, St. John’s and our most vulnerable patients are benefiting from his generosity. It’s a wonderful day for St. John’s Children’s. “He means so much to all of us.” Neisler said Prasad has been “a consistent donor” of the NICU. “He wanted to make a difference for Springfield and he wanted to make a difference for St. John’s,” Neisler added. “He has a real heart for babies and we’re delighted that he does.” “Donors, like Dr. Prasad, make all the difference by giving so generously to provide exceptional care and comfort to our most vulnerable patients,” said E.J. Kuiper, president and chief executive officer of HSHS Illinois. Dr. Beau Batton, director of newborn services at St. John’s Children’s, pointed out that the hospital was one of the first in the state to have a unit dedicated to the exclusive care of premature babies. “The NICU renovation, made possible through generous contributions, like of those of Dr. Prasad, will allow St. John’s to remain in the forefront of innovative, high quality care,” Batton said. Prasad called coming to the U.S. nearly 50 years “a golden opportunity. “It felt like heaven,” he added. “There was no comparison to India in the 1970s.” Prasad passed an exam given by the Educational Commission for Foreign Medical Graduates (ECFMG) that granted him a residency in the U.S. “It was the first time I saw TV,” said Prasad, who was 24 when he came to the U.S. Prasad first worked in Canton, Ohio, before moving to the University of Illinois Chicago, where he completed his anesthesiology residency. He practiced for 10 years in Alabama before coming to Springfield. Prasad has three children, including two daughters who followed him into medicine, and six grandchildren. “I was so pleased this project came up and I was able to do it,” Prasad said. “Those who can afford it have to step in and contribute. “I was amazed. This place looks beautiful. Springfield has the best medical community in the country.”

Coronavirus vaccine: When will we have one?

Coronavirus still poses a significant threat, but there are no vaccines proven to protect the body against the disease it causes – Covid-19. Medical researchers are working hard to change that, and the UK government has ordered 100 million doses of a vaccine that isable to trigger an immune response and appears safe. Why is a coronavirus vaccine important? The virus spreads easily and the majority of the world’s population is still vulnerable to it. A vaccine would provide some protection by training people’s immune systems to fight the virus so they should not become sick. This would allow lockdowns to be lifted more safely, and social distancing to be relaxed. What sort of progress is being made? Research is happening at breakneck speed. About 140 are in early development, and around two dozen are now being tested on people in clinical trials. Trials of the vaccine developed by Oxford University show it can trigger an immune response and a deal has been signed with AstraZeneca to supply 100 million doses in the UK alone. The first human trial data back in May indicated the first eight patients taking part in a US study all produced antibodies that could neutralise the virus. A group in China showed a vaccine was safe and led to protective antibodies being made. It is being made available to the Chinese military. Other completely new approaches to vaccine development are in human trials. However, no-one knows how effective any of these vaccines will be. When will we have a coronavirus vaccine? A vaccine would normally take years, if not decades, to develop. Researchers hope to achieve the same amount of work in only a few months. Most experts think a vaccine is likely to become widely available by mid-2021, about 12-18 months after the new virus, known officially as Sars-CoV-2, first emerged. That would be a huge scientific feat and there are no guarantees it will work. Four coronaviruses already circulate in human beings. They cause common cold symptoms and we don’t have vaccines for any of them. What do I need to know about the coronavirus?A SIMPLE GUIDE: How do I protect myself?AVOIDING CONTACT: The rules on self-isolation and exerciseHOPE AND LOSS: Your coronavirus storiesLOOK-UP TOOL: Check cases in your areaVIDEO: The 20-second hand wash What still needs to be done? Multiple research groups have designed potential vaccines, however, there is much more work to do. Trials need to show the vaccine is safe. It would not be useful if it caused more problems than the disease Clinical trials will also need to show vaccines provoke an immune response, which protect people from getting sick A way of producing the vaccine on a huge scale must be developed for the billions of potential doses Medicines regulators must approve it before it can be given Finally there will be the huge logistical challenge of actually immunising most of the world’s population The success of lockdowns has made the process slower. To know if the vaccine works, you need people to actually be infected. The idea of giving people the vaccine and then deliberately infecting them (known as a challenge study) would give quicker answers, but is currently seen as too dangerous and unethical. How many people need to be vaccinated? It is hard to know without knowing how effective the vaccine is going to be. It is thought that 60-70% of people needed to be immune to the virus in order to stop it spreading easily (known as herd immunity). But that would be billions of people around the world even if the vaccine worked perfectly. How do you create a vaccine? Vaccines harmlessly show viruses or bacteria (or even small parts of them) to the immune system. The body’s defences recognise them as an invader and learn how to fight them. Then if the body is ever exposed for real, it already knows what to do. The main method of vaccination for decades has been to use the original virus. The measles, mumps and rubella (MMR) vaccine is made by using weakened viruses that cannot cause a full-blown infection. The seasonal flu jab takes the main strains of flu doing the rounds and completely disables them. Some scientists, particularly those in China, are using this approach. There is also work on coronavirus vaccines using newer, and less tested, approaches called “plug and play” vaccines. Because we know the genetic code of the new coronavirus, Sars-CoV-2, we have the complete blueprint for building it. The Oxford researchers have put small sections of its genetic code into a harmless virus that infects chimpanzees. They appear to have developed a safe virus that looks enough like the coronavirus to produce an immune response. Other groups are using pieces of raw genetic code (either DNA or RNA depending on the approach) which, once injected into the body, should start producing bits of viral proteins which the immune system can learn to fight. However, this approach is completely new. Would a vaccine protect people of all ages? It will, almost inevitably, be less successful in older people, because aged immune systems do not respond as well to immunisation. We see this with the annual flu jab. It may be possible to overcome this by either giving multiple doses or giving it alongside a chemical (called an adjuvant) that gives the immune system a boost. Who would get a vaccine? If a vaccine is developed, then there will be a limited supply, at least initially, so it will be important to prioritise. Healthcare workers who come into contact with Covid-19 patients would top the list. The disease is most deadly in older people so they would be a priority if the vaccine was effective in this age group. The UK has also said other people considered to be at high risk – potentially included those with some conditions or from certain ethnicities – may be prioritised 

Amitabh Bachchan Shares Message on Religious Harmony from Hospital While Being Treated for Covid

Amitabh Bachchan has shared a message on religious harmony. The veteran actor, who is undergoing Covid treatment in a hospital here, took to his verified Twitter account July 23 to post the message. Big B shared two photographs of himself, one with folded hands and the other where he stretches his palms in prayer. “Mazhab toh yeh do hatheliyaan batati hain, jude to ‘puja’ khule toh ‘dua’ kehlaati hain (The two hands describe religion. Whenever they are folded it is called puja and when they are stretched it is called dua),” he tweeted. Amitabh, his son Abhishek Bachchan, daughter-in-law Aishwarya Rai Bachchan and granddaughter Aaradhya are currently hospitalized with coronavirus infection. Reacting to Bachchan’s tweet, fans shared their prayers and wishes for a speedy recovery. Unconfirmed reports claim that the veteran actor is recovering and might be discharged from hospital soon. Big B, meanwhile, July 23 evening tweeted to refute a news reports claiming he has tested Covid-19 negative. On his verified Twitter account, he shared a video clip of a TV news channel that claims “Amitabh Bachchan tests negative for COVID” as “breaking news.” “.. this news is incorrect, irresponsible, fake and an incorrigible LIE !!” Big B tweeted on his official account, @SrBachchan. The Bollywood icon seems quite disturbed by the fake news surrounding his health. He also retweeted a tweet posted by a fan that reads: “That’s playing with someone’s privacy. Why do media play with people’s emotions? Take Care Sir Ji.” Earlier on July 22, Amitabh Bachchan shared a video on social media that shows students of Wroclaw University, Poland, paying a tribute to his father, poet Harivansh Rai Bachchan. Big B shared the video on Instagram, where students from the university recite a few lines from his father’s renowned poem “Madhushala.” Alongside the clip, Big B wrote: “Last year the Mayor of Wroclaw declared me as the Ambassador of the City of Wroclaw, in Poland… Today they organized a recitation of my Babuji’s Madhushala by the University students on the roof of the University building. “As Wroclaw was awarded the title of a UNESCO City of Literature, they could pass on the message to Babu Ji’s lovers from all around the world – Wroclaw is a City of Dr Harivansh Rai Bachchan. Moved beyond emotion .. thank you Wroclaw .. in this time of my trial it brings so much cheer to me.” Sharing about his life in general from his Covid ward, Bachchan took to his blog July 21 and wrote: “It is the silence and the uncertainty of the next … it is a wonder of the nature of life .. of all that it brings to us each moment, each living breathing day… In the activity driven past days of normalcy, never was there inclination to assess or sit back and think of what thoughts invade us now.””But they do now with a regularity that fills those idle hours, sitting, thinking, looking out into nowhere .. “.. in these conditions thoughts race at greater speed and in a vividity that had eluded us before .. they were always there, but just the presence of them remained silenced by the mind in its other business of existence ..the business is dormant now. The thespian added that “the mind is freer.” “It reflects greatly more than ever .. and I wonder if this is correct, admissible pertinent or not.” He wrote that a wandering mind often leads to “destinations that, because of their complex vagaries, brings on that which at times be not what you may want to hear or see .. but you do .. the eventuality of all that surrounds us blows heavily about us.” “Ignorance of it would not be a considered act .. so you succumb to it .. bear it .. live it .. caress it at times .. play with it at others.. wish it away, hold on to it, embrace it and accept .. but never be able to desist its presence ..” He says the time “today gives liberty to stretch the gravitas of the cerebrum.” “We may never get opportunity to be involved in this act, but given the circumstance, I would like to believe that each one of us .. each individual has the will and the capacity to be what they may have believed, they would never be.” Talking about his health, Bachchan wrote: “In the condition of the solace in the room of cure .. the restlessness keeps in the search for reaction .. for a connect .. for something to respond to .. to do .. to do just more than what the condition dictates..” “At times you find it .. at times you stare at barren walls and with empty thoughts .. and you pray that they be filled with the life of existence .. of reaction and company .. All of you push your prayers and concern each hour I know .. and I have only folded hands ..”

Want to live a healthy life? Have sex once a week

Having sex at least once a week halves the risk of early death, say researchers, adding that regular action between the sheets is linked to lower odds of dying from cancer, heart disease and other illness. According to researchers from Washington University in the US, sex is equivalent to “moderate intensity exercise,” and has similar health benefits for those partaking.

For the findings, the research team picked more than 15,000 adults. They had an average age of 39 and were quizzed on their sex lives for around 11 years, the mirror.co.uk reported.

The researchers found that almost three quarters engaged in sexual activity at least once a month and 36 per cent at least once a week. Over the course of the lengthy study, 228 died, including 62 from cancer and 29 from cardiovascular disease.

The study showed that those who had sex weekly were 49 per cent less likely to die than those who only had sex once a year or less. Their odds of dying from cardiovascular disease were 21 per cent less and from cancer 69 per cent lower.

According to the media reports, The researchers said that sex releases feel-good chemicals, which boost mental health and promote the activity of “natural killer cells”.

Those cells lower the risk of cancer and viral illness, prevent infections of the lungs and improve other conditions, such as asthma, they claimed. (IANS)

‘Hopes Of Developing Vaccine Against Covid Rising

The race to develop the first effective vaccine against COVID-19 involves an awfully crowded field, with 137 candidate vaccines in pre-clinical study worldwide and another 23 actually in development. But a leader seemed to emerge today with research published in the Lancet reporting promising results in a robust study by investigators at Oxford University in England. The study began in April, with a sample group of 1,077 adults aged 18 to 55—an age group young enough to tolerate exposure to SARS-CoV2, the virus that causes COVID-19, with less risk of adverse effects than would be seen in older, more vulnerable adults. The group was divided more or less in half, with 543 participants receiving the experimental COVID-19 vaccine, and the other 534 serving as a control group, receiving an existing vaccine against meningococcal vaccine. (The investigators chose not to use an inert saline solution for the control group because both vaccines can cause side effects such as achiness, fever and fatigue. Saline would cause no such symptoms and would thus reveal which group was the control group and which was not.) The vaccine uses a harmless-to-humans chimpanzee adenovirus as a delivery vector. That virus is modified to carry spike proteins from SARS-CoV-2—the component of the coronavirus that, in theory, should induce the sought-after immune response in humans. What the researchers were looking for were two kinds of immune reaction: humoral immunity, or the system-wide generation of antibodies against the virus; and cellular immunity, or the activation of immune system T-cells that attack human cells infected with the COVID-19 virus. Oxford vaccine triggers immune response, trial findsA Covid-19 vaccine candidate developed by the Oxford University has safely prompted a protective immune response in hundreds of volunteers who got the shot in an early trial, preliminary findings published Monday in the journal Lancet said. The vaccine, ChAdOx1 nCoV-19 (also called AZD1222), designed by Oxford and developed by AstraZeneca, the Anglo-Swedish pharma major, triggered a dual immune response in people aged 18 to 55 that lasted at least two months. The preliminary findings are from the placebo-controlled, phase-I trial held between April 23 and May 21, involving 1,077 participants. 543 were administered the vaccine ChAdOx1 nCoV-19, another 534 a control vaccine (to rule out placebo). Further, ten participants were given a booster shot of the ChAdOx1 nCoV-19 vaccine. All participants who received the vaccine developed spike-specific antibodies by day 28, an immune response similar to those who recover from Covid-19. Spikes are the spike proteins on the surface of the SARS-CoV-2 coronavirus that it uses to attach to human receptor cells. The ten who received a booster shot produced neutralizing antibodies (antibodies in higher titers). The vaccine also triggered T cells, a type of white blood cell that “remembers” and attacks the coronavirus. Side effects including fever, headaches, muscle aches, and injection site reactions were observed in about 60% of patients; but all these were deemed mild or moderate and were resolved during the trial. T-cells and antibodies: That the vaccine has induced antibodies and T cells are significant. T cells can stay in the body for a longer period in a dormant state, and can re-emerge to attack the virus in case of an infection. The science behind the Oxford vaccine

Preliminary data from the phase I/II trial of the Covid-19 vaccine developed by Oxford University showed it was safe and prompted an immune response that lasted at least two months. More on that and India’s role in the eventual rollout of the vaccine in today’s Times Top10. Here, we delve deeper into the science behind the vaccine.

Oxford’s candidate, ChAdOx1 nCoV-19 (also called AZD1222), is a non-replicant viral vector vaccine. The vector (the carrier) is derived from adenovirus (ChAdOx1) taken from chimpanzees. This is a harmless, weakened adenovirus that usually causes the common cold in chimps. It is genetically engineered so that it does not replicate itself in humans. Now, a gene (the load) from the coronavirus, SARS CoV-2, that instructs cells to build spike proteins is loaded into the vector.

Remember, coronaviruses have club-shaped spikes on their outer coats — the ‘corona’. These spike proteins allow the virus to attach to the ACE2 receptors in human cells. When the genetically engineered ChAdOx1 with the spike-responsible gene from coronavirus is administered in a person, the gene is “expressed”, causing the build-up of spike proteins. The body’s immune system recognises this and begins to create the antibodies to defeat the foreign object. Note: the vaccine vector is non-replicant so it doesn’t harm the person, but the spike proteins nevertheless trigger antibodies. The preliminary findings showed participants also produced T cells, a type of white blood cell that “remembers” and attacks the coronavirus infection. Oxford researchers led by Professor Sarah Gilbert were able to quickly develop the vaccine candidate as they had been working on the ChAdOx1 platform against Ebola and MERS viruses.

And other vaccine candidates?

India’s hope: Pune-based Serum Institute of India, under an agreement with AstraZeneca, is to bulk produce the Oxford vaccine. The company’s CEO, Adar Poonawalla, had earlier said it will produce 5 million doses per month for the first 6 months before ramping up the production. The findings are from the phase-I/II trial. The larger, phase-III trials of the vaccine have already begun in Brazil and South Africa. A vaccine being developed by China’s CanSino Biologics and China’s military research also appeared to safely induce both antibodies and T cells, a mid-stage study released Monday said. Both CanSino’s and Oxford’s vaccines are based on a similar science of using a non-replicating viral vector to trigger the immune response. Hyderabad-based Bharat Biotech has announced that the Phase-I clinical trials of India’s first indigenous Covid-19 vaccine Covaxin began across the country on July 15. “This is a randomized, double-blind, placebo-controlled clinical trial on 375 volunteers in India,” the company said in a brief statement. The leading vaccine maker had announced on June 29 that it successfully developed Covaxin in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology.The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine was developed and manufactured in Bharat Biotech’s BSL-3A (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad.

The vaccine developed by China’s CanSino Biologics in partnership with the country’s military research wing also relies on a viral vector, but a weakened human cold virus, adenovirus 5 (Ad5). CanSino, too, published its findings from phase I/II trial on Monday that showed it safely prompted an immune response.

But… the vaccine was inadequate to induce immunity response in people aged 55 or older — a group vulnerable to Covid-19. Researchers contend an additional dose given between the third and sixth month could negate this. The use of Ad5 itself has left some scientists unconvinced. Since most people would have already been infected by Ad5 (cold virus), they fear the immune system induced would focus on the Ad5 parts of the vaccine rather than the SARS-Cov-2 material fused to it.

Two other advance candidates are developed by Massachusetts-based Moderna and Germany’s BioNTech in partnership with Pfizer. These are messenger-RNA based candidates. They rely on synthetic mRNA that delivers the genetic code for spike proteins, thus triggering an immune response. Early findings by Moderna and BioNTech-Pfizer, too, showed they prompted an immune response.

Another reason to be hopeful about the Oxford vaccine: Viral vector-based vaccines need only be cold stored, whereas mRNA vaccines need to be in a frozen state — a challenge for developing countries.

Dr. Sampat Shivangi Elected Delegate For GOP Convention In Florida

Dr. Sampat Shivangi, a physician, an influential Indian-American community leader, a Member of the National Advisory Council, National Mental Health Center, SAMSHA, Washington, DC, Chair of Mississippi State Board of Mental Health, and a veteran leader of the American Association of Physicians of Indian Origin (AAPI) , has been elected as a Republican delegate for the fifth consecutive term to the party’s convention that would formally nominate US President Donald Trump as its candidate for the November presidential elections. The Republican National Convention (RNC) in Jacksonville, Florida is scheduled to be held from August 24 to August 27. “It is a great honor to be a part of this historic convention to re-nominate and re-elect Trump for another four years,” he said. “Under President Trump, the United States has made unprecedented progress. Until, we were hit by coronavirus, the US economy was at an all time best. And to top it all, under President Trump, India and Indian-Americans have the best ever friend in the White House,” Dr Shivangi, the national president of Indian-American Forum for Political Education and a long-time Republican leader, said. A conservative life-long member of the Republican Party, Dr. Shivangi is the founding member of the Republican Indian Council and the Republican Indian National Council, which aim to work to help and assist in promoting President Elect Trump’s agenda and support his advocacy in the coming months. Dr. Shivangi is the National President of Indian American Forum for Political Education, one of the oldest Indian American Associations. Over the past three decades, he has lobbied for several Bills in the US Congress on behalf of India through his enormous contacts with US Senators and Congressmen. Dr. Shivangi is a champion of women’s health and mental health whose work has been recognized nationwide. Dr. Shivangi has worked enthusiastically in promoting India Civil Nuclear Treaty and recently the US India Defense Treaty that was passed in US Congress and signed by President Obama. Dr. Sampat Shivangi, an obstetrician/gynecologist, has been elected by a US state Republican Party as a full delegate to the National Convention. He is one of the top fund-raisers in Mississippi state for the Republican Party. Besides being a politician by choice, the medical practitioner is also the first Indian to be on the American Medical Association. Dr. Shivangi has actively involved in several philanthropic activities, serving with Blind foundation of MS, Diabetic, Cancer and Heart Associations of America. Dr. Shivangi has been carrying on several philanthropic works in India including Primary & Middle Schools, Cultural Center, IMA Centers that he opened and helped to obtain the first ever US Congressional grant to AAPI to study Diabetes Mellitus amongst Indian Americans. The Indian-American physician was first elected as a delegate at the Republican convention in New York City in 2004, to nominate President George W Bush. In 2008, he was elected as a Republican delegate at Minneapolis to nominate John McCain and in 2012 at Tampa, to nominate Mitt Romney. In 2016, Dr. Shivangi attended the RNC convention in Cleveland, Ohio as a delegate to nominate and elect the current president, Donald Trump. “This is my fifth time to be part of the RNC delegation to nominate and help to elect our next president of USA,” Dr. Shivangi said. “This convention and the upcoming presidential election is going to be historic for our nation, possibly for India and to the whole world. I am glad that I can contribute a little, to my beliefs in nation building,” he said in a statement.

Yoga Will Improve Reproductive, Sexual Health

Yoga is an ancient method of relaxation, exercise, and healing that has gained a wide following across the world. It rejuvenates the mind, body and soul. It may come as no surprise, then, that yoga may also serve to enhance sexual function. According to a study published online in The Journal of Sexual Medicine (Nov 12, 2009), regular yoga practice improves several aspects of sexual function in women, including desire, arousal, orgasm, and overall satisfaction, points out Dr Arockia Virgin Fernando, Fertility Specialist, Obstetrician and Gynaecologist at Cloudnine Group of Hospitals. The expert shares some benefits of yoga on sex life and during pregnancy. Benefits of Yoga on your Sex life More and more people are discovering the benefits of practicing yoga, from building strength to relieving stress. 40 percent of women with fertility related issues have anxiety, stress or both. Yoga and mindfulness exercises like deep breathing helps in reducing the cortisol levels in our blood which is a marker for stress. High levels of cortisol damages the fine balance between the hormones which control the brain, heart and reproductive system. Many fertility groups who conduct support group meetings to help the anxious couples trying to conceive- have included yoga in their program. It can improve your sex life. Here’s how: Yoga can target your sexual zones. Many forms of yoga refer to the root lock “Mula Bandha,” which is the root of the spine, the pelvic floor, the perineum. Bringing awareness to these areas in a yoga class will help you be more in touch with them overall and can help you enjoy having sex more. In the challenging physical postures such as downward dog, chatarunga, supta konasana and plow pose, engaging Mula Bandha actually helps lift the pelvic-floor muscles, which increases core strength, which then functions to support and protect the spine. Engaging Mula Bandha can help with balance in postures such as warrior 3 and crow pose. You’ll feel better in your skin: Yoga is a series of physical exercises and postures that are geared toward improving one’s flexibility, strength and balance. A regular practice helps to strengthen, and tone your body, and all of these will make you feel better about yourself. Improved self-thoughts about your appearance will boost your body confidence and self-esteem. All of these will help you boost your personal life. Yoga helps reduce stress and anxiety: By transferring focus and attention to breathing and the body, yoga can help to lower anxiety and release physical tension. Lower stress levels at the end of the day can lead to feeling better about being with your partner. If you are not worried about other things and feel mentally balanced, you are more likely to want and be able to give to your significant other. It will allow you to relax and enjoy sex, which makes it even better. The calming, toning practice can be a wonderful escape from the stressors of daily life, while increasing your flexibility and strength to boot. This will also bring increased relationship satisfaction along with improvements in sex life and intimacy levels. It brings overall satisfaction, better communication and trust among couples along with the overall reduction in stress and anxiety. Yoga can increase the beta endorphin hormone release from the brain which gives a sense of well-being, improve immunity and prevents infections in turn increasing our reproductive health. With better hormone balance, there is increased sexual desire and reproductive function, also an increase in sperm production. Regular yoga practice may improve the interaction between the brain and the reproductive system in both men and women. There are many positive and negative feedback systems in our reproductive endocrinology and even a subtle imbalance disrupts the whole system.With better hormone balance, there is increased sexual desire and reproductive function, also an increase in sperm production. Yoga indirectly improves the reproductive health by improving immunity and thereby decreasing infections which damages the vaginal, tubal and uterine bacterial flora and thus preventing pregnancy. It increases the success rates of Assisted Reproductive Technologies like In vitro Fertilisation and Intra uterine Insemination by reducing the stress levels; thereby improving ovulation and sperm production. Women with high levels of stress biomarkers like cortisol have less chance of conceiving during ovulation and also an increased risk of miscarriage. Therefore Yoga can play a major role in these people. Breathing, meditation, asanas can reduce pain levels in people suffering from painful periods and pain during sexual intercourse, thus in turn increasing the odds of conception. The beginners should focus on breathing and poses which are comfortable. Above all it is safe. The key is to start slow. Benefits of Yoga during pregnancy Yoga helps you in dealing with the symptoms of pregnancy like morning sickness and mood swings, ensuring smoother and easier delivery, and faster recovery after childbirth. So, if you want to make your pregnancy and childbirth a peaceful and easy journey, you must go for a prenatal yoga class during and after your pregnancy. Look for a prenatal yoga programme where you are comfortable with the activities, style, and the yoga class environment. Always remember doing “Lamaze” which is a simple breathing yoga techniques, it always encourages you to be active throughout your pregnancy and increases your sense of wellbeing. All the exercises should be started pre pregnancy so as to have the best result during pregnancy. Do not start exercise for the first time in the first trimester except the breathing exercises under the supervision and consultation of your gynaecologist/ fertility expert. (IANS)

Dr. Sudhakar Jonnalagadda To Lead AAPI To Be Stronger, More Vibrant, And United

“I will work to make AAPI stronger, more vibrant, united, transparent, politically engaged, ensuring active participation of young physicians, increasing membership, and enabling that AAPI’s voice is heard in the corridors of power,” Dr. Sudhakar Jonnalagadda, who will assume charge as the 37th President of American Association of Physicians of Indian Origin (AAPI) said here today.

Dr. Jonnalagadda, who will be administered the oath of office as the President of AAPI at the 1st ever Virtual Oath ceremony on July 11th, 2020, has vowed to take the nearly four decades old organization to the next level and “bring all the AAPI Chapters, Regions, Members of the Executive Committee and Board of Trustees to work cohesively and unitedly for the success of AAPI and the realization of its noble mission.”  He wants to increase AAPI membership by offering more benefits and opportunities for mem­bers.

Dr. Jonnalagadda will lead AAPI as its President in the year 2020-2021, the largest Medical Organization in the United States, representing the interests of the over 100,000 physicians and Fellows of Indian origin in the United States, serving the interests of the Indian American physicians in the US and in many ways contributing to the shaping of the healthcare delivery in the US for the past 39 years. “AAPI must be responsive to its members, supportive of the leadership and a true advocate for our mission,” he said.

As a very compassionate, goal oriented and with strong leadership skills, Dr. Jonnalagadda will be assisted by an executive committee consisting of Dr. Anupama Gotimukula, President-Elect; Dr. Ravi Kolli, Vice President, Dr. Amit Chakrabarty, Secretary of AAPI; Dr. Satish Kathula,  Treasurer of AAPI, and Sajani Shah, Chair of AAPI’s BOT.

“AAPI has given me so much — networking, advocacy, and education — and I am honored to serve this noble organization.  I sincerely appreciate the trust you placed in me as the President of AAPI, and I am deeply committed to continue to work for you,” declared Dr. Sudhakar Jonnalagadda, the new President of American Association of Physicians of Indian Origin (AAPI).

He was born in a family of Physicians. Dr. Jonnalagadda’s dad was a Professor at a Medical College in India and his mother was a Teacher. He and his siblings aspired to be physicians and dedicate their lives for the greater good of humanity. “I am committed to serving the community and help the needy. That gives me the greatest satisfaction in life,” he says with modesty.

Ambitious and wanting to achieve greater things in life, Dr. Jonnalagadda has numerous achievements in life. He currently serves as the President of the Medical Staff at the Hospital. And now, being elected as the President of AAPI is greatest achievement of my life,”

AAPI has been able to serve as a platform in helping young physicians coming from India to seek residencies and help them in settlement and get jobs. Knowing that AAPI’s growth lies with the younger generation, Dr. Jonnalagadda has made it his priority to support and promote YPS and MSRF, the future of AAPI.

As the President of AAPI, the dynamic physician from the state of Andhra Pradesh, wants to “develop a committee to work with children of AAPI members who are interested in medical school, to educate on choosing a school and gaining acceptance; Develop a committee to work with medical residents who are potential AAPI members, to educate on contract negotiation, patient communication, and practice management; Develop a committee to work with AAPI medical students, and to provide proctorship to improve their selection of medical residencies.”

In his address to the Young Physicians Section (YPS) recently, Dr. Jonnalagadda told them, “I am so delighted and proud to be part of this great event and see you, the young physicians of Indian origin today, who are the hope and life, igniting a bright future for AAPI and for the healthcare delivery in the US. As you are aware, Indian Americans continue to come in large numbers and join this noble profession. That gives us hope and strength that the future of the healthcare is in good, safe and effective hands.”

In order for us to help and support the youngsters who want to pursue Medicine and want to succeed in their dreams to be successful healthcare professionals, “I envisage a plan for young aspiring physicians of Indian origin,” he had told them. “I want to launch a program that will, Educate the Residents from India on ways to negotiate contract with insurance companies and Medical Institutions; Identify Centers/Areas across the US for Clinical Observership Program for aspiring young physicians; and, help Youth who want to pursue medicine as their career, guide them with the skills for participating in interviews and ways to succeed in school. This is the first time ever AAPI is embarking on this new initiative and I am excited to be able to take this to the next level”

Dr. Jonnalagadda wants to emphasize the importance of Legislative Agenda both here in the US and overseas, benefitting the physicians and the people AAPI is committed to serve. According to him, “The growing clout of the physicians of Indian origin in the United States is seen everywhere as several physicians of Indian origin hold critical positions in the healthcare, academic, research and administration across the nation.” He is actively involved with the Indian community and member at large of the Asian Indian Alliance, which actively participates in a bipartisan way to support and fund electoral candidates.

His vision for AAPI is to increase the awareness of APPI globally and help its voice heard in the corridors of power.  “I would like to see us lobby the US Congress and create an AAPI PAC and advocate for an increase in the number of available Residency Positions and Green Cards to Indian American Physicians so as to help alleviate the shortage of Doctors in the US.”

As a dedicated member and leader of AAPI for over a decade, Dr. Jonnalagadda rose through the ranks due to his hard work and dedication. He had served as the national Treasurer, Secretary and Vice President of AAPI from 2016 onwards. He was elected and had served as a member of the Board of Trustees, AAPI in 2014-2015, and had served as the Regional Director, AAPI South Region from 2011-2013.

Dr. Jonnalagadda was the Chair, AAPI Awards Committee in 2015, and had served as the Alumni Chair, Atlanta AAPI Convention in 2006. His leadership and commitment were much appreciated when he had served as the Convener of AAPI 2012 Fundraiser, and helped AAPI raise $150,000, and in the 2013 Fundraiser, he had helped AAPI raise $120,000 in Atlanta. In 2016, he had helped in AAPI 2016 Fundraiser through his efforts in Atlanta raise funds for Hurricane Harvey.

A Board-Certified Gastroenterologist/Transplant Hepatologist, working in Douglas, GA, Dr. Jonnalagadda is a former Assistant Professor at the Medical College of Georgia. He was the President of Coffee Regional Medical Staff 2018, and had served as the Director of Medical Association of Georgia Board from 2016 onwards. He had served as the President of Georgia Association of Physicians of Indian Heritage 2007-2008, and was the past Chair of Board of Trustees, GAPI. He was the Chairman of the Medical Association of Georgia, IMG Section, and was a Graduate, Georgia Physicians Leadership Academy (advocacy training).

One of the major objectives of founding AAPI was to offer a platform and opportunities for members to give back to their mother land and the adopted nation. Realizing this, the new President believes AAPI members will be provided with opportunities to support charitable activities in India and in the United States and increase our impact both in Indian and the US.

Endowed with the desire to give back to his motherland and lead AAPI to identify and invest in the delivery of cost effective, efficient and advanced medical care in India, Dr. Jonnalagadda says, “AAPI does a lot of work in India. The Global Healthcare Summit 2021 planned to be held in Visakhapatnam, Andhra Pradesh, will be a great way of achieving our objectives for mother India.”

“AAPI and the Charitable Foundation has several programs in India. Under my leadership with the pioneering efforts of Dr. Surender Purohit, Chairman of AAPI CF, we will be able to initiate several more program benefitting our motherland, India,” Dr. Jonnalagadda said.

According to him, the GHS will serve as a sounding board for many health care leaders to freely exchange ideas, and help resolve challenges that are addressed during the very effective CEO Forums usually chaired by high ranking officials and leading CEOs. This will help in attracting investments, advanced training, and setting up hospitals, medical institutions, etc. AAPI GHS will continue the International Research Competition, EP, Cardiology, Pediatrics, Psychiatry, Gastroenterology, Obesity, Liver Disease Awareness, CPR with the Indian Society of Anesthesiologists, and other workshops that will help in training several India based physicians.  Finally, the women’s forum under the banner of women’s leadership forum will serve as an inspiration for aspiring female leaders to see and hear from their role models.

The COVID-19 pandemic has placed huge challenges before the new executive Team. Dr. Jonnalagadda is confident that he will be able to carry on his agenda for the new year including the Trip to Japan and the Global Healthcare Summit. Utilizing the new technology, he wants to organize monthly online CMEs through Zoom and regular motivational Lectures for physicians.

Financial stability is an important area, where Dr. Jonnalagadda wants to focus on as President, and promises “to make sincere efforts in making AAPI financially stronger by increasing fund raising activities.”

He is grateful to his predecessor, Dr. Suresh Reddy and Dr. Anupama Gotimukula and the current Team for initiating the AAPI Endowment Fund, which he plans to strengthen during his presidency, making AAPI financially viable and stronger in the years to come.

Dr. Jonnalagadda is committed to upholding and further augment the ideals for which AAPI stands. “I am confident that my experience, work ethic and firsthand experience in organizing Conventions and fundraisers are best suited to carry on the responsibilities and lead this noble organization to new heights.”

Dr. Jonnalagadda is married to Dr. Umamaheswari, who comes from a family of physicians. The couple have one child, Veeraeen, who is a Medical School student.

In all of his efforts, Dr. Jonnalagadda wants to work with his executive committee and all branches of AAPI membership in a congenial and non-competitive manner, focusing on the noble mission of this prestigious organization. His experiences in organizing conferences and meetings which help to bring members together and attract new members is vital to the success of the organization.

AAPI represents more than 100,000 physicians and fellows of Indian Origin in the US, and being their voice and providing a forum to its members to collectively work together to meet their diverse needs, is a major challenge.

With the changing trends and statistics in healthcare, both in India and US, we are refocusing our mission and vision, AAPI would like to make a positive meaningful impact on the healthcare delivery system both in the US and in India.

AAPI will continue to be an active player in crafting the delivery of healthcare in the most efficient manner in the United States and India. “We will strive for equity in healthcare delivery globally.” Dr. Jonnalagadda is confident that with the blessings of elders, and the strong support from the total membership of AAPI and his family, he will be able to take AAPI to stability, unity, growth and greater achievements.”

Trump’s Move to Pull U.S. Out of World Health Organization Could Impact Global Health Adversely: Dr. Soumya Swaminathan

The plan by President Trump to “withdraw from the World Health Organization will affect the global healthcare system adversely,” Dr. Soumya Swaminathan, Chief Scientist at World Health Organization said. The Indian origin top scientists at the WHO was addressing The First Ever Virtual Summer Summit by the American Association of Physicians of Indian Origin (AAPI), held from June 16th to 28th, 2020. The Trump administration sent a letter giving the United Nations a one-year notice for the U.S. to quit the World Health Organization, formalizing President Donald Trump’s decision to leave the agency even as the coronavirus rages out of control in the U.S. and in many other countries. The administration sent the letter to UN Secretary-General Antonio Guterres Monday, making the U.S. withdrawal official on July 6, 2021, under a requirement for a one-year notice, according to Stephane Dujarric, the secretary-general’s spokesman. It’s almost certain that Democratic rival Joe Biden would reverse Trump’s decision if he’s elected in November.  US President Donald Trump’s decision, announced on 29 May, to withdraw funding from the World Health Organization (WHO) was never in doubt. Since the beginning of the coronavirus outbreak, the White House has been intensifying its charge that the WHO was slow to respond to the threat, and overly influenced by China. Undoubtedly, the agency has lessons to learn, and, at the World Health Assembly last month, WHO member states endorsed an independent evaluation. It is irresponsible and dangerous for the United States — the WHO’s largest donor — to bypass the agreed process and withhold roughly US$450 million in annual funding in the middle of one of the worst pandemics in recent history. This will undermine the world’s efforts to control the new coronavirus and will endanger more lives as COVID-19 continues on its destructive path. Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, said he learned of President Trump’s intentions of “terminating” the decades-long U.S. relationship with WHO through Trump’s press briefing. “The U.S. government’s and its people’s contribution and generosity toward global health over many decades has been immense, and it has made a great difference in public health all around the world. It is WHO’s wish for this collaboration to continue,” Tedros said.  While stating that the monetary contributions of the US will not be a huge factor if it chose to leave the world body, Dr. Soumya Swaminathan said, due to the close collaboration between US Healthcare Agencies and WHO, the departure of the US will affect the ongoing sharing of scientific data and thus prevent the world from accessing and sharing of knowledge and research which are vital for developing vaccines and effective healthcare delivery system around the world. “Good health is the foundation for good economy,” she said. Neglecting health will affect the economic progress negatively, she added. She referred to the Accelerated Program to study and find the most effective drug/vaccination development that is accessible to all the nations, and creating safe protocol and procedure for all nations as well developing International Health Regulations by WHO. She pointed to the Global Outbreak Network with 10,000 healthcare professionals from around the world, who are deployed in emergencies. WHO Academy has been set up train Healthcare workers to manage and respond to emergencies, she said. Dr. Soumya Swaminathan pointed out the examples of how smaller nations and the state of Kerala in India have been able to contain the virus spread due though long term investment in education and healthcare and via decentralization. She urged the nations for urgent investment in health care mostly on primary healthcare focusing on prevention rather than treatment. Referring to several initiatives under WHO in coordination with countries and private companies to develop safe vaccine and to prevent the spread of the virus, she spoke about the Accelerated Program to study and find the most effective drug/vaccination development that is accessible to all the nations.

Seeing is Believing: Effectiveness of Face Masks – FAU College of Engineering and Computer Science Researchers Use Flow Visualization to Qualitatively Test Facemasks and Social Distancing

Newswise — Currently, there are no specific guidelines on the most effective materials and designs for facemasks to minimize the spread of droplets from coughs or sneezes to mitigate the transmission of COVID-19. While there have been prior studies on how medical-grade masks perform, data on cloth-based coverings used by the vast majority of the general public are sparse.

Research from Florida Atlantic University’s College of Engineering and Computer Science, just published in the journal Physics of Fluids, demonstrates through visualization of emulated coughs and sneezes, a method to assess the effectiveness of facemasks in obstructing droplets. The rationale behind the recommendation for using masks or other face coverings is to reduce the risk of cross-infection via the transmission of respiratory droplets from infected to healthy individuals.

Researchers employed flow visualization in a laboratory setting using a laser light sheet and a mixture of distilled water and glycerin to generate the synthetic fog that made up the content of a cough-jet. They visualized droplets expelled from a mannequin’s mouth while simulating coughing and sneezing. They tested masks that are readily available to the general public, which do not draw away from the supply of medical-grade masks and respirators for healthcare workers. They tested a single-layer bandana-style covering, a homemade mask that was stitched using two-layers of cotton quilting fabric consisting of 70 threads per inch, and a non-sterile cone-style mask that is available in most pharmacies. By placing these various masks on the mannequin, they were able to map out the paths of droplets and demonstrate how differently they perform.

Results showed that loosely folded facemasks and bandana-style coverings stop aerosolized respiratory droplets to some degree. However, well-fitted homemade masks with multiple layers of quilting fabric, and off-the-shelf cone style masks, proved to be the most effective in reducing droplet dispersal. These masks were able to curtail the speed and range of the respiratory jets significantly, albeit with some leakage through the mask material and from small gaps along the edges.

Importantly, uncovered emulated coughs were able to travel noticeably farther than the currently recommended 6-foot distancing guideline. Without a mask, droplets traveled more than 8 feet; with a bandana, they traveled 3 feet, 7 inches; with a folded cotton handkerchief, they traveled 1 foot, 3 inches; with the stitched quilted cotton mask, they traveled 2.5 inches; and with the cone-style mask, droplets traveled about 8 inches.

“In addition to providing an initial indication of the effectiveness of protective equipment, the visuals used in our study can help convey to the general public the rationale behind social-distancing guidelines and recommendations for using facemasks,” said Siddhartha Verma, Ph.D., lead author and an assistant professor who co-authored the paper with Manhar Dhanak, Ph.D., department chair, professor, and director of SeaTech; and John Frakenfeld, technical paraprofessional, all within FAU’s Department of Ocean and Mechanical Engineering. “Promoting widespread awareness of effective preventive measures is crucial at this time as we are observing significant spikes in cases of COVID-19 infections in many states, especially Florida.”

When the mannequin was not fitted with a mask, they projected droplets much farther than the 6-foot distancing guidelines currently recommended by the United States Centers for Disease Control and Prevention. The researchers observed droplets traveling up to 12 feet within approximately 50 seconds. Moreover, the tracer droplets remained suspended midair for up to three minutes in the quiescent environment. These observations, in combination with other recent studies, suggest that current social-distancing guidelines may need to be updated to account for aerosol-based transmission of pathogens.

“We found that although the unobstructed turbulent jets were observed to travel up to 12 feet, a large majority of the ejected droplets fell to the ground by this point,” said Dhanak. “Importantly, both the number and concentration of the droplets will decrease with increasing distance, which is the fundamental rationale behind social-distancing.”

The pathogen responsible for COVID-19 is found primarily in respiratory droplets that are expelled by infected individuals during coughing, sneezing, or even talking and breathing. Apart from COVID-19, respiratory droplets also are the primary means of transmission for various other viral and bacterial illnesses, such as the common cold, influenza, tuberculosis, SARS (Severe Acute Respiratory Syndrome), and MERS (Middle East Respiratory Syndrome), to name a few. These pathogens are enveloped within respiratory droplets, which may land on healthy individuals and result in direct transmission, or on inanimate objects, which can lead to infection when a healthy individual comes in contact with them.

“Our researchers have demonstrated how masks are able to significantly curtail the speed and range of the respiratory droplets and jets. Moreover, they have uncovered how emulated coughs can travel noticeably farther than the currently recommended six-foot distancing guideline,” said Stella Batalama, Ph.D., dean of FAU’s College of Engineering and Computer Science. “Their research outlines the procedure for setting up simple visualization experiments using easily available materials, which may help healthcare professionals, medical researchers, and manufacturers in assessing the effectiveness of face masks and other personal protective equipment qualitatively.”

Pandemic threatens to veer out of control in U.S., public health experts say

By Alvin Powell from the The Harvard GazetteHarvard public health experts said the nation’s COVID-19 epidemic is getting “quite out of hand” and that, with cases rising rapidly in the hardest-hit states and a two-week lag between infection and hospitalization, the situation appears set to worsen quickly.

“I have this awful feeling of déjà vu, like it’s March all over again,” said William Hanage, associate professor of epidemiology at the Harvard T.H. Chan School of Public Health.

Hanage, who spoke with reporters during a conference call Thursday morning, said that hospitals are nearing capacity in Arizona and Houston and are likely to be stressed elsewhere soon. And, in contrast to the nation’s early spike in COVID-19 cases that were concentrated in a few states, the current surge is much more widespread and so has greater potential to take off.

“The increases that we’re seeing right now have the capacity to cause far more disease in the future,” Hanage said.

Barry Bloom, the Joan L. and Julius H. Jacobson Research Professor of Public Health, who also fielded reporters’ questions Thursday, said other countries have shown that the epidemic can be contained by acting swiftly when cases appear. Even Italy, once on the verge of health system collapse, has regained control of its epidemic, Bloom said. Italy on Tuesday reported just 113 new cases and 18 deaths.

“If you only look at what you see today, you’re three weeks behind the curve. … It’s trying to imagine what will be three weeks from now … that should be determining policy.”— Barry Bloom, Harvard Chan School

“When political leaders wait until it gets really bad, that’s where we are now,” Bloom said. “If you only look at what you see today, you’re three weeks behind the curve. … It’s trying to imagine what will be three weeks from now — rather than what you see today — that should be determining policy.”

Hanage said he understands political leaders’ reluctance to reimpose lockdowns, but with few tools to fight the coronavirus and more moderate steps like masking and hand-washing most effective when numbers are also more moderate, a shutdown may turn out to be what’s needed.

“Let me be clear: I do not like shutdowns. But if they’re the only thing to prevent a worse catastrophe, you have to use them,” Hanage said.

A bright spot in the current epidemic is that the age of those contracting COVID-19 appears to be declining. Hanage said that he didn’t view it as a sign of the epidemic evolving, but rather a marker of testing being more widespread and catching more cases than during the March-April spike. Though younger people have better survival rates, that good news is tempered by the fact that we’ve been largely ineffective at keeping the virus away from those most susceptible for severe illness: the elderly and people with pre-existing conditions. But that may nonetheless mean there is a window of opportunity to suppress the epidemic before it takes hold among those more vulnerable populations.

“Let me be clear: I do not like shutdowns. But if they’re the only thing to prevent a worse catastrophe, you have to use them.”— William Hanage, Harvard Chan School

“If there is a window of action, it’s now,” Hanage said.Hanage struck a similar note on lower death rates in the current spike, saying deaths lag behind cases, so we should wait for a few weeks before concluding that anything different is going on.

Bloom said the difference between the U.S. and nations where the pandemic appears to be controlled is that those countries had uniform national policies and didn’t lift lockdowns until case numbers were very low. The fact that some of them have experienced new outbreaks — like the recent spate of cases in Beijing — is to be expected. Once the local epidemic is controlled, easing the lockdown will inevitably lead to new cases. The strategy then is to use testing to quickly identify cases and use contact tracing and isolation to contain outbreaks before they become widespread. In a state like California, with 7,000 new cases reported Tuesday, tracing the contacts of each positive test becomes a monumental task.

Rather than flinging the doors wide, the two said reopening should more closely resemble refining the shutdown, letting some things resume with safeguards in place that can be tightened should cases rise. Leaders should consider risk versus value to society in deciding what to reopen and when. For instance, bars, casinos, and churches, where people are crammed together and which have been shown to be hotspots of infection in some instances, may need to stay closed in order to keep the overall infection rate in the community low enough that we can safely reopen places with broad societal benefit, Bloom and Hanage said.

“We should be wanting to be able to open schools, and schools should have a higher priority, arguably, than other parts of the economy,” Hanage said. “What those [other parts of the economy to reopen] are, ought to be debated. … What we should be thinking about in reopening is not reopening everything in a safe way, but which things we want to reopen and being able to do that without enhancing community transmission.”

Even well-honed strategies will fail if citizens are noncompliant, however, Bloom said. In New York City, contact tracing programs have run into people not answering phones or refusing to isolate after hearing they’ve been exposed to infection. “If people are ignoring the epidemic, it’s going to be very hard to control,” Bloom said, “and leadership should be inspiring people to be more cautions.”

Will India Have A Covid-19 Vaccine By Aug 15?

Indian Council of Medical Research (ICMR) head Dr Balram Bhargava on July 2 wrote to all 12 trial sites for the Covid-19 vaccine candidate, Covaxin, that all clinical trials had to be completed by August 15, in time for a public launch. Bioethics experts, however, have questioned how all three phases of testing for a vaccine candidate yet to even begin human trials can be crunched into a timeframe of a month.

What is Covaxin? It has been developed by the company Bharat Biotech India (BBIL) in collaboration with ICMR’s National Institute of Virology (NIV). It is an “inactivated” vaccine — one made by using particles of the Covid-19 virus that were killed, making them unable to infect or replicate. Injecting particular doses of these particles serves to build immunity by helping the body create antibodies against the dead virus, according to BBIL.

Is ICMR serious? The August 15 deadline given by the Indian Council of Medical Research (ICMR) for the launch of the indigenous Covid-19 vaccine being jointly developed by Bharat Biotech International (BBIL) — called Covaxin — has raised a storm within the scientific and medical community about the unrealistic timeline. That apart, it appears even the company may be unable to meet the target. Here’s why:

What ICMR wants: The ICMR has written a letter to 12 select hospitals across the country, practically warning them that “non-compliance will be viewed very seriously” if they failed to enrol human test subjects by next week Tuesday. The country’s governing body for medical research said that this measure was being taken “in view of the public health emergency due to Covid-19 pandemic” and that BBIL was “working expeditiously to meet the target”.

Really now? However, BBIL CMD Dr Krishna Ella, in an interview to The New Indian Express said on Thursday that he expects the “vaccine to be available early 2021“. In fact, BBIL, in its filing to the Clinical Trial Registry of India (CTRI) has stated that follow-ups for the clinical trial will be conducted on the 14th, 28th, 104th and 194th day — which clearly means a timeline of beyond 6 months. Additionally, the company lists the date of enrolment for the first phase of clinical trials from July 13 — almost a week after the ICMR’s deadline for enrolment.

Scrunch & crunch: Vaccine development is a long drawn process, usually spread over a number of years to determine any side-effects. Human clinical trials are a three phase process — starting from a small batch of healthy humans, usually between 40-50, moving on to a larger pool of over 100 with variations on dosage and frequency before the final phase, wherein randomly selected thousands or perhaps hundreds of thousands of volunteers are administered the vaccine. Under fire: While independent experts have been aghast at the ICMR’s vaccine-by-deadline approach, the governing body’s chairperson of ethics advisory committee Vasantha Muthuswamy conceded (as reported by Scroll) that “a month to decide whether to release a vaccine is a very short time” and that even if the vaccine was fast-tracked, “it will take a minimum of one year“.

Indo American Press Club Awards IAPC EXCELLENCE AWARDS 2020

(New York, NY: July 4, 2020) During the solemn virtual induction ceremony live telecast on social media and viewed by thousands from around the world, Indo American Press Club honored three prominent Indian Americans for their contributions to the larger society and for their great achievements on Sunday, June 28th, 2020. Bob Miglani was presented with the IAPC Literature Excellence Award by Dr. Mathew Joys, IAPC Vice Chairman BOD.  Badal Shah was given the IAPC Business Excellence Award by Biju Chacko, IAPC BOD Member. Ravinder Singh was honored with the IAPC Technology Excellence Award by Ms. Annie Koshy, Executive VP of IAPC. Several world renowned media personnel from around the world felicitated the new officers and IAPC, the largest Indian American Association of Media Personnel begin a new journey under the stewardship of two great leaders well known for their commitment and leadership.   The highlight of the ceremony was Dr. Joseph M. Chalil assuming charge as the Chairman, while Dr. SS Lal became the President of Indo American Press Club. Also, along with the two dynamic leaders, several new members of the Board of Directors, Executive Committee members, and Local Chapter leadership were administered the oath of office. In his acceptance speech, Dr. Chalil said, “Your choice humbles me, and I promise to do my duties with the best of my abilities.” Describing current phase in human history as “unprecedented times for the journalists and the media,” he pointed out that “AT LEAST 146 JOURNALISTS HAVE DIED FROM CORONAVIRUS IN 31 COUNTRIES.”  The new Executive Committee led by Dr. S S Lal, Annie Koshy, C G Daniel, James Kureekattil, Prakash Joseph, Sunil Manjanikara, Biju Chacko, Andrews Jacob, Raj Dingra, Annie Chandran, Neethu Thomas, Innocent Ulahannan, Baiju Pakalomattom, O. K. Thyagarajan, Shiby Roy and  Korasan Varghese were administered the oath of office by Chairman Dr. Joseph M Chalil. In his Presidential Address, Dr. Lal highlighted the importance of journalists and the need to coordinate and bring together journalists under one umbrella. “And it is the commitment and sacrifice of the leaders and members of this organization that has helped us build collaborations between the journalists and writers of the US and India,” Dr. Lal said. Ambassador Pradeep Kapur, in his keynote address stressed the importance of the media, especially in these challenging times as they work hard to bring the truth before the public. Dr. Shashi Tharoor, a Member of Indian Parliament, in his message stressed the importance of media and congratulated IAPC for its contributions to the society. Isaac John Pattaniparambil from Khaleej Times in Dubai, MG Radhakrishnan from Asianet NewsTV, Srikantan Nair from 24News,  Preetu Nair from Times of India were others who addressed the IAPC members and felicitated the organization for its growth and success in a short period of seven years,  BOB MIGLANI: Bestselling Author, Speaker and Founder of Embrace the Chaos – a change & transformation company. His Washington Post Bestselling book titled, Embrace the Chaos:How India Taught Me to Stop Overthinking and Start Living – celebrated the India experience of dealing with uncertainty and learning to embrace change in our daily lives and to always be moving forward. Bob’s other books include Treat Your Customers, about business lessons he learned working at his family’s Dairy Queen store and Make Your Own Luck, which he launched in India in November 2019. Today, Bob speaks, writes and advises companies on change and transformation. He lives in New Jersey, USA. BADAL SHAH: Badal Shah is another recent exemplar of an Indian coming from humble background from India and fulfilling his American dream. A 22 year old pharmacist who came to US in 2012, in search of his dream, rose through the ranks to become the youngest Managing Director of QPharma Inc.- a premium Medical, Commercial and Compliance partner of Pharmaceutical companies and was recently declared as one of the top 100 healthcare leaders in 2020 by IFAH (International Forum on Advancement in Healthcare). He pioneered the unique approach of “How to achieve effective medical communication and optimize field force during drug launch” which helped in successfully launching more than 25 drugs that were paramount in treating various diseases. He created the entire Health analytics services in last three years at QPharma and created unique platforms and solutions, which are being used by more than 2500 pharmaceutical leaders from top 20 pharmaceutical companies all over the world. Ravinder (Ravi) Pal Singh: An award Winning Technologist, Rescue Pilot and Investor with over 50+ global recognition and 17 Patents. Ravi’s body of work, is considered groundbreaking and considered first in the world in making a difference within acute constraints of culture and cash via commodity technology. He has been acknowledged as one of the world’s top 25 CIOs and one of the top 10 Robotics Designers in 2018. Ravi is a global speaker and has delivered over 100+ lectures and papers in Asia, Europe, USA and Africa in 2018-19. Ravi is advisor to board of 9 enterprises where incubation and differentiation is a core necessity and challenge. He sits on the advisory council of 3 global research firms where he contributes in predicting practical future automation use cases and respective technologies.  In the acceptance speeches, the awardees congratulated the new Office Bearers, and felicitated the organization for its collective activities and recognizing exceptional professionals from media, medical and innovations by young entrepreneurs.  Indo American Press Club (IAPC) is the fast growing syndicate of print, visual, online, and electronic media journalists and other media related professionals of Indian origin working in the United States, Canada, and Europe. IAPC is committed to enhance the working conditions of our journalists, exchanging ideas and offering educational and training opportunities to our members, aspiring young journalists and media professionals around the globe; and also by honoring media people for their excellence, and for bringing in positive changes through their dedicated service among the community. Today IAPC envisages its vision through collective efforts and advocacy activities through its 15 Chapters across the US and Canada, in the larger public sphere

Pope Francis Backs UN Call for Ceasefire to Deal with Covid-19 – ‘May this Security Council Resolution Become a Courageous First Step Towards a Peaceful Future’

Pope Francis has offered his support for this week’s call by the United Nations for a general ceasefire to allow humanitarian relief in combat zones hit by the Covid-19 virus. The Holy Father’s statement of support came after he prayed the noonday Angelus on July 5, 2020, with pilgrims gathered in St. Peter’s Square. “This week the United Nations Security Council adopted a Resolution which proposes some measures to deal with the devastating consequences of the Covid-19 virus, particularly for areas in conflict zones,” Pope Francis said. “The request for a global and immediate ceasefire, which would allow that peace and security necessary to provide the needed humanitarian assistance is commendable. I hope that this decision will be implemented effectively and promptly for the good of the many people who are suffering. May this Security Council Resolution become a courageous first step towards a peaceful future.” On July 1, members of the United Nations Security Council unanimously adopted a resolution demanding “a general and immediate cessation of hostilities in all situations on its agenda.” The resolution calls on parties to armed conflicts to immediately in a “durable humanitarian phase” provide aid to countries to help fight the COVID-19 pandemic, according to Vatican News. In the resolution, the Council also voiced support for UN Secretary-General Antonio Guterres, who first proposed a global ceasefire on 23 March. That appeal has been echoed by world leaders, including Pope Francis, who, at the Angelus on 29 March invited everyone “to follow it up by ceasing all forms of hostilities, encouraging the creation of corridors for humanitarian aid, openness to diplomacy, and attention to those who find themselves in situations of vulnerability.”

COVID-19 Fatality Risk Is Double Earlier Estimates: Study New estimates are based on robust New York City data are underline the importance of infection prevention, particularly among older adults whose risk is significantly elevated – By Columbia University, Mailman School of Public Health

Newswise — In one of the most robust studies of COVID-19 mortality risk in the United States, researchers estimate an infection fatality rate more than double estimates from other countries, with the greatest risk to older adults. Columbia University Mailman School of Public Health scientists and New York City Department of Health and Mental Hygiene colleagues published the findings on the pre-print server medRxiv ahead of peer review.
Researchers estimate an overall infection fatality rate (IFR) of 1.45 percent in New York City, from March 1-May 16, 2020—in other words, between 1 and 2 percent of New Yorkers infected with COVID-19 including those with no or mild symptoms died during this period. The new estimate is more than double the IFR previously reported elsewhere (e.g., about 0.7 percent in both China and France where most IFR estimates have come from). So far, IFR in the U.S has been unclear.
Greatest Risk to Older People
The new study finds mortality risk was highest among older adults, with IFR of 4.67 percent for 65-74-year-olds and 13.83 percent for 75+ year-olds. Younger people had far lower chances of dying from the disease: 0.011 percent among those younger than 25 and 0.12 percent among 25-44-year-olds. However, risk to young people should not be taken lightly, especially given cases of post-infection Multi-system Inflammatory Syndrome in Children, the researchers caution.
“These dire estimates highlight the severity of COVID-19 in elderly populations and the importance of infection prevention in congregate settings,” the authors write. “Thus, early detection and adherence to infection control guidance in long-term care and adult care facilities should be a priority for COVID-19 response as the pandemic continues to unfold.”
Robust Data Points to Elevated Risk
New York City has among the most complete and reliable data on COVID-19 deaths—specialists review all death certificates and rapidly record deaths into a unified electronic reporting system. For this reason, the new estimate likely more accurately reflects the true higher burden of death due to COVID-19. Further, given the likely stronger public health infrastructure and healthcare systems in New York City than many other places, the higher IFR estimated in the new study suggests that mortality risk from COVID-19 may be even higher elsewhere in the United States, and likely other countries as well. 
“It is thus crucial that officials account for and closely monitor the infection rate and population health outcomes and enact prompt public health responses accordingly as the pandemic unfolds,” the authors write. “As the pandemic continues to unfold and populations in many places worldwide largely remain susceptible, understanding the severity, in particular, the IFR, is crucial for gauging the full impact of COVID-19 in the coming months or years.”
About the Model and Its Uncertainties
During the pandemic, the Columbia Mailman School of Public Health and the New York City Department of Health and Mental Hygiene have been collaborating in generating real-time model projections in support of the city’s pandemic response. Weekly projections are posted on Github.
In the current study, researchers used a computer model to analyze mortality data, including 191,392 laboratory-confirmed COVID-19 cases and 20,141 confirmed and probable COVID-19 deaths occurred among New York City residents from March 1-May 16, 2020. The model, which was developed to support the City’s pandemic response, estimated IFR based on case and mortality data combined with mobility information from cell phone data used to model changes in COVID-19 transmission rate due to social distancing. The model includes a number of uncertainties on questions such as the number of New Yorkers initially infected and the movement of people between New York City neighborhoods. 
The model’s estimates are in line with serology surveys (e.g., 19.9 percent positive in New York City, as of May 1, 2020, likely from testing of 25-64-year-olds). In addition, spatial variation estimates were in line with other reports (i.e., highest in the Bronx and lowest in Manhattan).
Estimating the IFR is challenging due to the large number of undocumented infections, fluctuating case detection rates, and inconsistent reporting of fatalities. Further, the IFR of COVID-19 could vary by location, given differences in demographics, healthcare systems, and social construct (e.g., intergenerational households are the norm in some societies whereas older adults commonly reside and congregate in long-term care and adult care facilities in others).
Study authors include Wan Yang, Sasikiran Kandula, and Jeffrey Shaman at Columbia Mailman School; and Mary Huynh, Sharon K. Greene, Gretchen Van Wye, Wenhui Li, Hiu Tai Chan, Emily McGibbon, Alice Yeung, Donald Olson, and Anne Fine at the New York City Department of Health and Mental Hygiene. 
This study was supported by the National Institute of Allergy and Infectious Diseases (AI145883), the National Science Foundation Rapid Response Research Program (RAPID; 2027369), and the NYC DOHMH. Jeffrey Shaman and Columbia University disclose partial ownership of SK Analytics, an infectious disease forecasting company. Shaman also discloses consulting for Business Network International.
 

FIA Organizes 6th International Day of Yoga

Yoga enthusiasts of all age groups attend 5 different sessions offered on Zoom, maxing out the capacity of the streaming platform.

The Federation of Indian Associations of NY-NJ-CT (FIA-Tri-state) successfully commemorated the 6th annual International Day of Yoga on June 21, 2020. Since the inception of the International Day of Yoga, the FIA, in partnership with the Consulate General of India in New York, has celebrated the day which highlights the importance of yoga.

Yoga enthusiasts of all age groups a logged on to the virtual celebration on Zoom, which included five simultaneous yoga segments, taught by renowned yoga teachers. The event was very well received by The Indian diaspora, maxing out the capacity of the streaming platform.

Highlighting the importance of yoga, FIA President Anil Bansal said it is the “greatest gift” from Bharat to the world. “Besides so many benefits of yoga, it improving our lung resiliency has become more pronounced during this Covid-19 pandemic,” he said.

Yoga is an ancient physical, mental, and spiritual practice that originated in India. The word ‘yoga’ derives from Sanskrit and means to join or to unite, symbolizing the union of body and consciousness. Today it is practiced in various forms around the world and continues to grow in popularity.

The International Day of Yoga has been celebrated annually on June 21, 2015, following its inception in the United Nations General Assembly in 2014. The International Day of Yoga aims to raise awareness worldwide of the many benefits of practicing yoga.

FIA Organizes 6th International Day of YogaAlok Kumar, FIA Immediate Past President and one of the organizers of the Yoga Day 2020 celebration, said the International Day of Yoga an initiative from the Government of India “has added a positive vibe” to millions across the world. He conveyed his gratitude to Consul General of India in New York, Sandeep Chakravorty, including the CGI-NY Team as well as the Yoga 2020 team, including Himanshu Bhatia, Saurin Parikh, Falguni Pandya, and Andy Bhatia, for successfully implementing all the logistics and coordination needed to make the event a grand success.

Consul General Chakravorty, in his address to the participants, noted that June 21, 2020, had a special significance, because, along with the International Day of Yoga, it was also the summer solstice, Father’s Day, and a day when parts of the world witnessed a solar eclipse. “Today is the coming together of celestial as well as manmade phenomena,” he said. He highlighted the importance of yoga in helping create a physical and mental balance, “particularly in these times when we cannot indulge in outdoor activities.” The Consul General also took this opportunity to bid farewell to the attendees and members of the community as his New York term comes to an end.

Speakers gave an overview of the importance of yoga and talked about how yoga has integrated into our daily life.

Vijay Kumar of the North American Institute of Vihangam Yoga talked about the different forms of yoga and their significance and stressed on the importance of asana and pranayama. “Asana is irreplaceable,” Vijay Kumar said, as it not only stabilizes the outside body but also works on the organs inside the body. He conducted a session on ancient meditation techniques.

Eddie Stern, a New York-based Ashtanga Yoga teacher, author, and lecturer, conducted a session on beginner yoga where he taught attendees some breathing techniques, basic asanas and modified Surya Namaskar or sun salutations.

Aashka Amin, a certified yoga teacher, conducted the kids yoga session. She has been trained to work with kids, especially with disabilities and trauma. She believes that yoga can provide much-needed relief to troubled kids and those with special needs.

Rahul Bhalerao of Subodh Yoga focused on Raj Yoga meditation, a simple form of meditation without rituals or mantras and can be practiced anywhere at any time.

Mitali Das focused on pilates, a physical fitness system developed in the early 20th century by Joseph Pilates, after whom it was named. Pilates primarily focuses on trying to relax muscles which are tense and provide strengthening of the numerous muscles of the body.

The virtual event was deemed very successful. The FIA team, once again, maintained its commitment to bringing authenticity and spirit community in each of their events.

India is 4th worst hit among 213 countries infected by COVID-19

As India continued to be the fourth worst hit among 213 countries infected by COVID-19 with 2,10,120 active cases and 16,475 deaths, Union Health Ministry on Monday said the recovery of infected patients shows “encouraging results”.
“The recovery rate continues to steadily improve. It has reached 58.67 amongst COVID-19 patients today,” said Ministry of Health and Family Welfare (MoHF).
It further said that the difference between recovered and active cases has increased to 1,11,602.
So far, as many as 3,21,722 patients have been cured of COVID-19, the Ministry said, adding there are 2,10,120 active cases in the country and all are under active medical supervision.
During the last 24 hours, the Ministry said, a total of 12,010 COVID-19 patients have been cured.
The Ministry said the improvement is the result of the Centre’s graded, pre-emptive and proactive steps taken along with the states and Union Territories (UTs) for prevention, containment and management of the deadly virus .
The data was shared when India noted a record spike of 19,459 COVID-19 cases in the last 24 hours on Monday pushing the total infected tally to 5,48,318.
According to the Health Ministry data, 380 deaths were recorded in a day taking the COVID-19 death toll to 16,475.
With a spike of 5,493 cases, Maharashtra remained the worst hit state in the country. The state has a total of 1,64,626 cases, including 7,429 deaths.
The national capital is the second worst hit state with a total of 83,077 COVID-19 cases, including 2,623 deaths and 52,607 recoveries. Delhi is followed by Tamil Nadu with 82,275 confirmed cases, of which, 1,079 have died, 45,537 have recovered and 35,659 are active cases.
States with more than 10,000 cases include Gujarat with 31,320 cases and 1,808 deaths, Uttar Pradesh (22,147), Rajasthan (17,271), Madhya Pradesh (13,186), West Bengal (17,283), Haryana (13,829), Karnataka, (13,190), Andhra Pradesh (13,241) and Telangana (14,419) cases.
The Ministry also added that a total of 1,047 diagnostic labs have been functioning dedicatedly to test COVID-19. Of these labs, 760 are run by the government and 287 by private sectors.
In the last 24 hours, the Union Health Ministry has inducted 11 new COVID-19 labs operated by the government sector.
Of the total, 567 are Real-Time RT PCR based labs which include 362 government and 205 private labs. A total of 393 are TrueNat based testing labs– 366 government and 27 private. However, CBNAAT based testing labs are 87 in the country that include 32 government labs and 55 private.
The total number of samples tested is showing an uphill trend, and has touched 83,98,362, it said. “Yesterday, 1,70,560 samples were tested.” (IANS)

Countries with Early Adoption of Face Masks Showed Modest COVID-19 Infection Rates

Regions with an early interest in face masks had milder COVID-19 epidemics, according to a new letter-to-the-editor published in the American Journal of Respiratory and Critical Care Medicine.
In “COVID-19 and Public Interest in Face Mask Use,” researchers from the Chinese University of Hong Kong shared findings from their analysis of how public interest in face masks may have affected the severity of COVID-19 epidemics and potentially contained the outbreak in 42 countries in 6 continents.
The authors noted that “In many Asian countries like China and Japan, the use of face masks in this pandemic is ubiquitous and is considered as a hygiene etiquette, whereas in many western countries, its use in the public is less common.”
There was a clear negative correlation between the awareness or general acceptance of wearing a face mask and its infection rates. “One classic example is seen in Hong Kong,” said Sunny Wong, MD, associate professor, Department of Medicine and Therapeutics, The Chinese University of Hong Kong.
“Despite [Hong Kong’s] proximity to mainland China, its infection rate of COVID-19 is generally modest with only 1,110 cases to-date. This correlates with an almost ubiquitous use of face masks in the city (up to 98.8 percent by respondents in a survey). Similar patterns are seen in other Asian areas, such as Taiwan, Thailand and Malaysia. To date, there are more than two million cases in the U.S. and more than one million cases in Brazil.
While, the authors acknowledge that face masks are seen as important in slowing the rise of COVID-19 infections, it is difficult to assess whether it is more effective than handwashing or social distancing alone.
As cities in the U.S. and elsewhere put re-opening plans into effect, Dr. Wong said the use of face masks should be encouraged: “Face masks can help slow the spread of COVID-19, and have a relatively low cost compared to the health resources and death toll associated with the pandemic.”
He added, “We believe that face mask use, hand washing and social distancing are all important components of the non-pharmaceutical measures against COVID-19.”

Soundarya Sharma Gives Up Her Seat on Repatriation Flight from USA to Accommodate Needy

Actress Soundarya Sharma, who had approached the Indian embassy and Ministry of External Affairs for assistance to return to India amid a coronavirus pandemic, has opted out of travelling by the repatriation flight phase one so that people who are in distress can travel back home first.

Soundarya said, “I am certainly missing my folks back home but the priority is not me. It’s for those who are in a difficult situation here and have to get back. As it’s a must have for them and I always have felt my happiness should not be at anyone cost. My appeal was for the people and I am so thankful to everyone for mission VANDE BHARAT,” she added.

Soundarya had approached the Indian embassy and Ministry of External Affairs for assistance, along with more than 400 Indians including students who are stranded in the USA amid the coronavirus pandemic. The actress was in Los Angeles to attending an acting course at Lee Strasberg Theatre and Film Institute.

The actress, who featured in the film Ranchi Diaries, had earlier said, “I would humbly request the Indian embassy and the MEA for a stimulus package for all those students and fellow Indians who are stuck here to help overcome this situation and hopefully arrange an evacuation flight back to India,” she said.

Actress Soundarya Sharma believes getting stuck in Los Angeles due to COVID-19 pandemic and experiencing the struggle to get access to essentials things has turned out to be a life-altering period for her. She says that she tries not to think about when she will be able to return to India because the wait is “never-ending”.

“Honestly, it’s been a true life-learning experience for me. I had never even imagined myself to be in lockdown in a place like Los Angeles,” Soundarya told IANS.

“I had come here to attend an intensive acting course at Lee Strasberg and New York Film Academy and then we were shooting in Universal Studios the day they announced this pandemic. Since then, things changed completely. The corona happened and now these protests are going on. The situation is quite grim and things are different, so it’s been an experience and I’ve learnt so many things during this time,” she added.

Reflecting upon the challenges that came with the global shutdown, she said: “When they announced this pandemic, I was here in Los Angeles and I used to go out every day at 6 am in the morning, standing in the queues, I could not get grocery for almost one-one and half month and I had to manage with very little whatever I used to get. There was so much paranoia. Then, I did not have masks and sanitisers and gloves, initially. So, that was again a big challenge. I had to make my own mask.

“My flight was cancelled almost 5 times. So that was another challenge for me. Now because of these protests and riots which were happening, my apartment where I used to live was West Hollywood, West Beverly Hills and I had to move out of my apartment because of the situation. Now, I have moved to a much safer place in Central Beverly Hills. I mean challenges were there at different levels, we all do have challenges,” she added.

The actress, who made her debut in the digital world with “Raktanchal”, is coping up with her struggles by keeping a positive attitude.

“I am learning Spanish. I am watching a lot of performances, as in movies and important shows. Because being a medical student, I never watched films and performances so I am doing my homework that way. I do lots of workouts, I go for a walk because it was not a 100% lockdown, so I used to go for my workout. Since, I’m spiritually inclined, I meditate a lot. It really helps me. I realise that we all do take things so much for granted in our life but life has its own plans now, it’s become like we are taking it day-wise. So, this whole period of quarantine and lockdown has been really different and evolving, as in on a personal level,” she said.

She has realised that “life is not about just achievement, it’s about fulfilment”.

“I felt fulfilled by helping and doing my bit for people who were needy, who needed the most and people who were stranded, whatever bit I could do, I cooked for them for Eid. I had to give up my seat on the repatriation flights. So, this whole process, this whole thing has made me very selfless and made me realise the value of things and grateful for even the smaller things we have in a nutshell. This is a quite selfless period for me,” she added.

The actress who has worked in the Bollywood film “Ranchi Diaries” is not spending her time fretting over getting back to India.

“I try not to think too much about when I’ll be flying back home because it’s never-ending. It’s been almost 5 months for me to be here and months that I’ve seen my folks. So stuck in a foreign land alone can be quite emotionally challenging. I’m just taking it day-by-day. I do face-time my family but then being on your own and dealing with things and you know so many things happening, it can be quite emotionally draining and challenging,” she said.

On the work front, she was recently seen in the web series “Raktanchal”. The crime drama is inspired by real events that happened in Purvanchal, Uttar Pradesh, in the eighties, around the time when state development work was distributed through tenders. It streams on MX Player.

Children’s Hope India Raises $52,000 For Covid Relief

Children’s Hope India (CHI), a 501c3 nonprofit organization dedicated to lifting children from poverty to prosperity in India and the United States, released “CHI On-The-Ground COVID-19 Relief,” a new report detailing the organization’s efforts to meet the growing needs of vulnerable children and their families in the face of the global COVID-19 outbreak.
The organization held an online fundraiser, entitled “A Virtual Celebration of Hope” on May 16, 2020 in support of these efforts, raising $52,000.
“CHI On-The-Ground COVID-19 Relief” reveals not only how vulnerable populations are grappling with the new realities created by the COVID-19 outbreak, but also unique solutions both NGOs and grassroots projects are designing to help fill gaps, said the organization, in a press release.
With the COVID-19 outbreak and resulting closures, the organization’s work shifted: schools closed and children and their families found themselves with new, pressing needs such as how to feed a family of seven in the absence of a daily wage.
Children’s Hope India launched a comprehensive hunger prevention program, distributing food and grocery kits to families in and around their project sites that total almost 300,000 meals, in addition to thousands of hygiene products such as soaps, handwashing stations and sanitizers.
“The populations we work with–from day laborers to refugees, from urban dwellers to village residents–lost their meager earnings overnight, so we needed to act fast in distributing rice, lentils and essential food items to feed whole families,” said Dina Pahlajani, the organization’s president and cofounder.
At the same time, the communities impacted by Children’s Hope India have fallen victim to shortages of personal protection equipment (PPE) and black market pricing. The organization’s leadership recognized an opportunity early-on to empower refugee women by teaching them how to manufacture masks.
To date, these enterprising refugees have already distributed 2,000 masks to local hospitals and first responders. They also scaled their learning to other Children’s Hope India project sites where, with materials and machinery donated by the organization, students and their families have manufactured more than 11,000 masks and are pivoting to make scrubs and other PPE–many of which are being distributed nationally, including in Mumbai. In the New York City area, the organization’s youth and young professional volunteers have coordinated critical donations to local families and first responders through partnerships with Island Harvest, Elmhurst Hospital and many other organizations, the release said.
“A Virtual Celebration of Hope” brought together 2,443 people from around the globe for an hour filled with love, laughter and compassion in support of this important cause.
The event, hosted by comedian Zarna Garg, featured celebrities Juhi Chawla and Kiara Advani, and honored Consul General of India in New York Sandeep Chakravorty as its Chief Guest.
Juhi Chawla inspired attendees to support CHI’s work, saying “If all of us helped some people everyday, everyone would receive help, have hope and happiness in our lives.” Kiara Advani added, “I pray that we can uplift people around us and look forward to a better tomorrow.”
The virtual event paid tribute to Michelin star chef Vikas Khanna with the CHI Action Hero Award for his compassionate feeding of millions of needy people during the lockdown in India, who said, “CHI has always inspired me to do more, to add more and to give more.”
Dr. Roopa Kohli-Seth of Mount Sinai Hospital received the CHI Woman of Courage Award for her dedicated work on the frontlines of the COVID-19 pandemic in New York.
The event raised $52,000 in support of hunger prevention, medical support and educational opportunities in the wake of the COVID-19 outbreak.
Anuja Khemka, Children’s Hope India’s Executive Director said, “We know that the impact of the outbreak is only just starting to surface, particularly among vulnerable populations, so we recognize that this is the right time to invest our resources in bringing emergency relief and meaningful learning opportunities to the community. We were humbled on May 16th when an incredible community of dedicated donors came together to underwrite this growth and relief efforts around the world.”
Children’s Hope India was founded in 1992 when a group of professional women in New York gathered to make a difference in the lives of children. Now, as then, the mission of Children’s Hope India is to lift children from poverty to prosperity through education. This is accomplished with a whole child approach that seeks to ensure that each child is healthy, safe, supported, engaged and challenged with comprehensive programming including informal learning and vocational training, critical medical support, and nutrition.
Today, Children’s Hope India supports more than 20 projects and 300,000 children across India and the United States to improve children’s health and education prospects, and the communities they live in.

Dexamethasone, the cheap steroid hailed as ‘big breakthrough’ against Covid

More than 100 potential vaccines against Covid-19 are in development around the world but none has yet been solidly proven to be able to effectively protect people from the virus that has killed more than 400,000 people worldwide.
Amid the race for a vaccine, Dexamethasone, a cheap and widely used steroid, has become the first drug to be able to save the lives of Covid-19 patients. Dexamethasone’s encouraging performance has prompted scientists to hail it as a “major breakthrough”.
The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, experts say.  The drug is part of the world’s biggest trial testing existing treatments to see if they also work for coronavirus.
It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth. Had the drug had been used to treat patients in the UK from the start of the pandemic, up to 5,000 lives could have been saved, researchers say.
Trial results announced by the University of Oxford on Tuesday showed dexamethasone, which is used to reduce inflammation in other diseases such as arthritis, reduced death rates by around a third among Covid-19 patients on ventilators and by a fifth for those on oxygen.
Scientists at Imperial College London will start the first clinical trials of a potential Covid-19 vaccine this week with funding from the British government and philanthropic donors.
The trials involve about 300 healthy volunteers who will receive two doses of the vaccine to test whether it is safe in people and whether it produces an effective immune response.
In Singapore, scientists testing a vaccine from U.S. firm Arcturus Therapeutics plan to start human trials in August after promising initial responses in mice.
AstraZeneca’s potasssssential coronavirus vaccine is likely to provide protection against contracting Covid-19 for about a year, the company’s chief executive said on Tuesday.
The vaccine being evaluated by Singapore’s Duke-NUS Medical School works on the relatively-untested Messenger RNA (mRNA) technology, which instructs human cells to make specific coronavirus proteins that produce an immune response.
In China where the coronavirus originated, China National Biotec Group (CNBG) said on Tuesday its experimental vaccine has triggered antibodies in clinical trials and the company plans late-stage human trials in foreign countries.
The vaccine, developed by a Wuhan-based research institute affiliated to CNBG’s parent company Sinopharm, was found to have induced high-level antibodies in all inoculated people without serious adverse reaction, according to the preliminary data from a clinical trial initiated in April involving 1,120 healthy participants aged between 18 and 59.

Rajiv Shah Is Hopeful Vaccine Being Developed In India Will Help Covid Patients

Rajiv Shah, President of the Rockefeller Foundation, says the vaccine being developed in India is among the most promising in the world. In an interview on Politico’s “Global Translations” program, Shah also said the United States should lead the global response to the global threat as it did successfully when the Ebola crisis happened.
More than 100 initiatives are ongoing around the world to find a vaccine for COVID-19, Shah noted. And more than 10 clinical trials are ongoing. “The Serum Institute of India and Oxford are working together on a particularly promising vaccine candidate,” Shah said.
“We will have a vaccine. It may take 12 to 18 months to have scaled production and distribution,” Shah estimated. “And when we do, it will be critical that that vaccine reaches not just those with access and wealth but those most vulnerable,” Shah said.
The Serum Institute of India Pvt. Ltd., ranked as India’s No. 1 biotechnology company, is now the world’s largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines, the company says on its website. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute.
Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world, the company said.
The Serum Institute was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals.
Dr. Purvi Parikh, an immunologist at New York University Langone Health, who is currently involved with testing another vaccine candidate, indicated the Serum Institute of India’s work was creditable.
” This is a great initiative to provide vaccines to one of the most densely populated regions of the world that need it the most,” said Dr. Parikh. “But this underscores the need for large scale vaccine trials to assess safety and efficacy of vaccines as we get close to mass distribution of the vaccine,” she added.
“We are currently testing one of the Pfizer vaccine’s safety and efficacy on healthy individuals here at NYU Langone’s vaccine center and likely will be testing additional vaccines from other companies before the summer’s end,” Dr. Parikh said.
In the U.S., Shah’s Foundation has been behind the push for nationwide testing through its National Testing Plan, and instrumental in bringing together the public and private sectors, Republicans and Democrats, to work towards that goal. From barely 7,000 tests a day, the U.S. is now doing some 3 million tests a week, Shah said. By the Fall, he expected the number of tests to rise to 30 million a week, making it possible to safely open schools.
The Rockefeller Foundation is behind calling for a $100 billion government investment in the testing initiative, of which Congress has approved $25 billion in the CARES Act, Shah said. He . expects the remaining $75 billion to be forthcoming in the near future. This effort is critical to implementing a science-based and data driven policy which has proved successful in the past, for example during the Ebola crisis.
“I led the response to the Ebola crisis,” and U.S. leadership was able to restrict the infection rate  to around 30,000 and the deaths to around 11,000, Shah recalled. Some 3,000 American troops were also deployed in the effort, he said.
Equity of access is an important point, Shah said. This is a global threat that requires a global response, he noted.
Nevertheless, he pointed out, if the Serum Institute of India vaccine is a success, it would first be available to India since it is an Indian institution spearheading the trials. For starters, something like 4 billion to 5 billion doses of the vaccine would be needed, Shah estimated, adding that the U.S. is most capable of leading a global response on that front. Shah said he saw first-hand when he was heading the USAID, that America has to lead that global effort. “The world still looks to America,” he said.

FIA to Host Virtual Yoga Event to Observe International Day of Yoga

The Federation of Indian Associations of NY-NJ-CT (FIA-Tri-state) is calling yoga enthusiasts as well as novices of all age groups to attend their virtual celebration to commemorate the 6th annual International Day of Yoga on June 21, 2020. The event is held in association with the Consulate General of India in New York.

The virtual yoga event will begin at 9:00 a.m., with an address from FIA President Anil Bansal and Consul General of India in New York Sandeep Chakravorty.

The event will include four simultaneous yoga segments, taught by renowned yoga teachers. The sessions include Kids Yoga, Gentle Yoga, Intermediate Yoga and Pranayama and other styles of yoga. Each segment will have its own zoom id, which will be shared at the time of the event. Each segment will have its own instructor as well.

To register for the event, please email: info@fianynjct.org

Yoga is an ancient physical, mental and spiritual practice that originated in India. The word ‘yoga’ derives from Sanskrit and means to join or to unite, symbolizing the union of body and consciousness. Today it is practiced in various forms around the world and continues to grow in popularity.

The International Day of Yoga has been celebrated annually on June 21, 2015, following its inception in the United Nations General Assembly in 2014. The International Day of Yoga aims to raise awareness worldwide of the many benefits of practicing yoga.

The draft resolution establishing the International Day of Yoga was proposed by India and endorsed by a record 175 member states.The proposal was first introduced by Prime Minister Narendra Modi in his address during the opening of the 69th session of the General Assembly, in which he said: “Yoga is an invaluable gift from our ancient tradition Yoga embodies unity of mind and body, thought and action … a holistic approach [that] is valuable to our health and our well-being. Yoga is not just about exercise; it is a way to discover the sense of oneness with yourself, the world and the nature.”

The resolution notes: “The importance of individuals and populations making healthier choices and following lifestyle patterns that foster good health.” In this regard, the World Health Organization has also urged its member states to help their citizens reduce physical inactivity, which is among the top ten leading causes of death worldwide, and a key risk factor for non-communicable diseases, such as cardiovascular diseases, cancer and diabetes.

Dr. Ankit Bharat performs first known U.S. lung transplant for covid-19 patient

Dr. Ankit Bharat, chief of thoracic surgery and surgical director of Northwestern’s lung transplant program, said organ transplantation may become more frequent for victims of the most severe forms of covid-19. The disease caused by the new coronavirus most commonly attacks the respiratory system but also can inflict damage on kidneys, hearts, blood vessels and the neurological system.

“I certainly expect some of these patients will have such severe lung injury that they will not be able to carry on without transplant,” said Bharat, who performed the operation. “This could serve as a lifesaving intervention.”

A former covid-19 patient has received a double-lung transplant, a surgery believed to be the first of its kind in the United States since the pandemic began, medical officials announced Thursday.

Northwestern Medicine in Chicago said the recipient, a woman in her 20s who would not have survived without the transplant, is in intensive care recovering from the operation and from two previous months on lung and heart assistance devices.

Surgeons in Austria on May 26 performed the world’s first known lung transplant to save the life of a covid-19 survivor, a 45-year-old woman stricken with a severe form of the disease. Bharat said he and others in his field are not aware of another organ transplant of any kind in the United States involving a recipient who had contracted the coronavirus.

The United Network for Organ Sharing, a nonprofit that coordinates transplantation in the United States, has no record of an organ transplant into a covid-19 patient as of May 29, spokeswoman Anne Paschke said. However, hospitals have two months from the date of surgery to report a transplant to the Richmond organization, she said.

The United States has suffered a severe shortage of transplant organs for many years, with more than 100,000 people on waiting lists for kidneys, livers, lungs, hearts and other organs. During the worst weeks of the pandemic in March, the numbers of transplants dipped even more, UNOS statistics show.

But the picture has improved in recent weeks, and because the number of transplants performed in 2020 was ahead of 2019’s pace before the pandemic began, the totals for the two years are comparable, the statistics show.

Bharat’s patient, who has not been publicly identified, was on immunosuppressant medication for a previous condition when she contracted the coronavirus, he said. Perhaps for that reason, the virus devastated her lungs, leaving physicians few options. She developed secondary bacterial infections that could not be controlled by antibiotics because her lungs were so badly damaged, he said.

“They develop these strange holes in the lungs,” Bharat said. “If you were to cut the lung, it kind of resembles a Swiss cheese.”

As the woman’s lungs deteriorated, her heart also began to fail, followed by other organs that were not receiving enough oxygen. She was placed on a mechanical ventilator to help her breathe and later an extracorporeal membrane oxygenation device, which adds oxygen to blood outside the body and helps the heart pump blood through vessels.

Doctors repeatedly tested fluid from her lungs to be certain she was negative for the coronavirus before operating, Bharat said. By that time, she was even sicker, he said. “This is one of the toughest transplants I’ve done,” he said. “This was truly one of the most challenging cases.”

Technological Solutions That Help with Common Sleeping Disorders

For most adults, getting seven to nine hours of sleep is enough to wake up rested and keep us functioning throughout the day. Granted, some people can manage to sleep a lot less, while others don’t want to leave the warmth of their bed. However, the problem occurs when we want to sleep only to find ourselves being restless in bed or continuously waking up unable to get a good night’s sleep.

 

However, there’s no reason to worry. We’ve comprised a list of the most common sleeping disorders and technological solutions for them, which you can make use of and get some shuteye.

Insomnia

According to stats, 30% of the grown-up Americans experience insomnia. It causes people to have difficulty falling asleep or staying awake, which can then result in daytime sleepiness, depressed mood, irritability, and low energy.

 

Insomnia may occur either independently or as a result of another problem, such as chronic pain, heart failure, restless leg syndrome, and stress. The first steps in treating insomnia are lifestyle changes and better sleep hygiene.

 

When it comes to technological solutions, you can use bulbs that stop the blue light, such as the Good Night Biological LED Bulb. Also, you can try blackout shades or devices like Ebb Insomnia Therapy.

Sleep Apnea

Sleep apnea is a sleeping disorder that affects up to 20% of the world’s population, and it causes a person’s breathing to be interrupted during sleep. There are two main types of sleep apnea—obstructive sleep apnea (OSA) and central sleep apnea (CSA). Common reasons that cause sleep apnea are enlarged tonsils or adenoids, smoking, frequent alcohol use, and weight.

 

Between the two, OSA is the more common one, and it occurs when the soft tissue in our throat collapses while we’re asleep. Its symptoms are daytime sleepiness, restlessness, gasping for air while sleeping, snoring, and fatigue.

 

When it comes to CSA, the issue starts in our central nervous system. Our breathing isn’t interrupted, but our brain fails to relay the information to our body to breathe.

 

Many inventions can help with sleep apnea, such as slumberBUMP that nudges you into sleeping on your side. As a result, it prevents the blocking of your airways. Another solution is EPAP by Theravent that regulates your airflow and creates a gentle pressure in your airway, keeping it open and reducing vibration.

Snoring

If you snore, you’re not alone. Approximately 40% of men and 20% of women snore, which is more than two billion people. It may be caused by sleep deprivation, sleep position, nasal problems, alcohol consumption, or simply due to our mouth’s anatomy.

 

For example, when muscles surrounding our throat relax during sleep, they cause the airway to get narrower, which then causes the tissue in our throat to vibrate as air passes through.

 

Luckily, since it’s one of the most common sleeping disorders around the globe, there are many technological solutions that can help with snoring, such as Hupnos’ Snoring MaskURGONight EEG Headband, as well as many different sleeping solutions by Philips.

The Humanitarian Cost of COVID-19

The coronavirus has wreaked havoc throughout the world. Industrialized economies with world-renowned health systems have struggled with hundreds of thousands of cases of COVID-19, tens of thousands of deaths, and significant economic disruption. But what has been, and what could be, the experience of extremely vulnerable populations who are already in precarious situations — those in fragile states throughout the world, in war zones such as Syria and Yemen, and in refugee camps such as the Rohingya in Bangladesh? How can unprepared and under-resourced health systems respond? How can the international community coordinate a humanitarian response to help attend to the health crisis, as well as the ensuing impacts on already frail communities facing challenging political, economic, and security situations?
In order to assess these questions, Asia Society Policy Institute President Kevin Rudd spoke last week with two experts — former U.K. Foreign Secretary and current International Rescue Committee President and CEO David Miliband and former U.N. Under Secretary-General for Humanitarian Affairs and Emergency Relief Coordinator and now the University of London’s SOAS Director Valerie Amos.
One issue that both Miliband and Amos highlighted was declining American leadership in global institutions. They noted that the Trump administration’s announcement on Friday that the U.S. would withdraw from the World Health Organization has hampered these institutions’ ability to respond on the ground to crises like COVID-19.
 “When you have a pandemic like this that is affecting countries in a very deep way, countries aren’t necessarily going to raise their hands and take on the leadership that is required,” said Amos. “There’s a vacuum there that’s very hard to fill.”

Study says, Young women more affected by alcohol use than men

Female college students are more likely to depend on alcohol to improve mental well-being, say researchers, adding that the young women appear to be more affected by high alcohol use than men, which may lead to less interest in academics.

“Cognitive aptitudes of young women appear to be more affected than for men with high alcohol use,” said study lead author Lina Begdache, Assistant Professor at Binghamton University in the US.

“These behaviours are regulated by the limbic system of the brain. However, the cognitive functions for high alcohol use among the young men and women were different,” Begdache added.

For the findings, published in the journal Trends in Neuroscience and Education, researchers sought to compare neurobehaviours and academic effort among college students with low alcohol use with those of high alcohol consumption and build conceptual models that represent the integration of the different variables.

They sent an anonymous survey to assess college students’ alcohol use and frequency along with questions on sleep, academic performance and attitude toward learning. They compared gender responses and found that both young men and women exhibit common behavioural responses to high alcohol use such as abuse of other substances and risk-taking.

The findings showed that young women reported generally less interest in the academic work and performance than young men. The latter reported more risky behaviours, such as being arrested, from excessive drinking.

The study also found that young women are more likely to depend on alcohol to improve mental well-being, which is also concerning, as they may self-medicate through drinking. In both genders, the researchers reported an increase in impulsive behaviours, which are under the control of the limbic system (the oldest part of the brain, evolutionary speaking).

Another reason for the difference seen is the differential metabolism of alcohol. Women metabolise alcohol at a slower rate, therefore, they are more likely to feel the effect of alcohol. Consequently, their brain is more likely to accumulate a toxic metabolite, acetaldehyde, which may be altering brain chemistry further to add to the differential behaviours identified in this study.

“Academic performance and risky behaviours among college students may be linked to their drinking habits, so more education and awareness should be shared with college students,” said Begdache.

“These findings are also explained by the fact that women tend to have higher connectivity between cortices, while men have a large cortical volume in the areas on the limbic system that support impulsivity,” Begdache added. (IANS)

Q&A With David BarunKumar Thomas: Helping Indian Women During COVID-19

Since 2005, India Nirman Sangh has worked toward women’s development in the villages and hills in and around the Kodaikanal and Palani towns of Tamil Nadu. India Nirman Sangh has distributed basic grocery packs to 2000 women and their families while running a tailoring centre producing free masks. INS is also providing basic income support to those in utmost need. The organization is led by David BarunKumar Thomas, who serves the non-profit as a volunteer.

 

Answers have been edited for length and clarity.

 

Q: How did you get into this line of work?

Thomas: I was working for IBM. When I was 45, I decided to leave that job and go back to a place close to where I was born and do something that I found more interesting, which was working with people. In 2004 I started an organization that worked among the poor, particularly women, and helped them organize into groups to start small businesses, send children to school, and improve their standards of living. Part of our strategy includes distributing microloans, but we also go beyond that with organizing and education.We now have 4,000 women who are a part of the group, and the members of the organization work among them. For the last two years we have also started to work among farmers. Farming in the area is becoming unprofitable, so we are working to bring new technology and methods to improve farming’s profitability, all while remaining organic and environmentally sustainable.

Q: How has your organization assisted with the COVID response effort?

Thomas: We have distributed groceries to more than 2000 poor women in the Kodaikanal and Palani Blocks of Dindigul District in Tamil Nadu. In addition, we have given monetary assistance to 42 of the poorest families in this area. We have also produced more than 2000 reusable masks at our tailoring centre in Kodaikanal and distributed them free to the poor.

We have located poor migrants from Nepal in Kodaikanal and have given them food, groceries and monetary assistance. We have also helped a group of 15 LGBT community members with groceries in Palani.

Q:  How does diversity of faith and caste impact your organization’s work?

Thomas: The organization is secular, but about 80 percent of the women we work with are Hindus, 10 percent are Muslims, and 10 percent are Christians. We respect the beliefs of all with whom we work.  The people in this area belong to a variety of castes, mainly the lower castes, so roughly about 40 percent of the people we work with belong to the most depressed castes. We make it a point not to bring caste into the equation. Society is still divided along caste lines, but we make everybody sit together, eat together, and keep telling them in various ways that caste should not be important.

Q: Is there also government relief aid, and is it reaching the neediest?

Thomas: The government here is giving free rations to people, and that covers roughly about 95 percent of the people in this area. They get rice, lentils, and sugar. It’s not really enough for a family to live on, but it does prevent complete starvation. In the North it’s not as good, but here they are giving rations to almost everybody. As a supplement, our group has distributed lentils, sugar, tea, and rice to 2,000 people, and this week we are in the process of distributing wheat flour and a form of pasta and spices. For that, we have used all the funds that we had … which came from those regularly supporting our organization. We like to concentrate on the 2,000 who are very, very poor and who have no family members earning income. We would also like to expand to help others who are not quite so badly off, but who are still very poor. We could very much use additional funding.

Q:  What gives you hope?

Thomas: How much poor people help each other. They share a lot more than people who are [financially] better off. They have a very informed support system among the very poor. They share the little they have. You see this happening all the time. That’s what really keeps people from starvation; the poor helping the poor. That is something Gandhi used to admire a lot and which we see at times like this.

IIT Alumnus Dipanjan Pan’s Rapid Naked Eye Test Uses Innovative Nanoparticle Technique To Detect Coronovirus In 10 Minutes

A team of US scientists led by an Indian American researcher has developed an experimental diagnostic test for covid-19 that can visually detect the presence of the virus in 10 minutes.

The test developed by scientists from the University of Maryland School of Medicine (UMSOM) does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis.

It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present, according to an UMSOM release.

“Based on our preliminary results, we believe this promising new test may detect RNA material from the virus as early as the first day of infection,” said study leader Dipanjan Pan, PhD, Professor of Diagnostic Radiology and Nuclear Medicine and Pediatrics at the UMSOM.

“Additional studies are needed, however, to confirm whether this is indeed the case,” added Dr. Pan who has a doctorate in chemistry from the Indian Institute of Technology (IIT).

Once a nasal swab or saliva sample is obtained from a patient, the RNA is extracted from the sample via a simple process that takes about 10 minutes.

The test uses a highly specific molecule attached to the gold nanoparticles to detect a particular protein.

his protein is part of the genetic sequence that is unique to the novel coronavirus.

When the biosensor binds to the virus’s gene sequence, the gold nanoparticles respond by turning the liquid reagent from purple to blue.

“The accuracy of any COVID-19 test is based on being able to reliably detect any virus. This means it does not give a false negative result if the virus actually is present, nor a false positive result if the virus is not present,” informed Dr Pan.

Many of the diagnostic tests currently on the market cannot detect the virus until several days after infection. For this reason, they have a significant rate of false negative results.

Dr Pan now plans to have a pre-submission meeting with the US Food and Drug Administration (FDA) within the next month to discuss requirements for getting an emergency use authorisation for the test.

“This RNA-based test appears to be very promising in terms of detecting the virus,” said study co-author Matthew Frieman.

Others in Dr. Pan’s team were research scientist Parikshit Moitra, research fellow Maha Alafeef, along with research fellow Ketan Dighe from the University of Maryland, Baltimore County.

The authors published their work in the American Chemical Society’s nanotechnology journal ACS Nano.

Prof. Dipanjan Pan, MS, PhD, is an expert in nanomedicine, molecular imaging and drug delivery.  He is presently a tenured Associate Professor in Bioengineering and Materials Science and Engineering and Institute of Sustainability in Energy and Environment in University of Illinois, Urbana-Champaign. He also holds a full faculty position with Beckman Institute for Advanced Science and Technology, University of Illinois Cancer Center and recently joined newly started Carle-Illinois College of Medicine.

He Administratively directs the Professional Masters in Engineering Program in Bioengineering within the College of Engineering. He is also an Associate course director for the newly founded engineering inspired Carle-Illinois school of medicine. Prior to coming to Illinois, he was a faculty in Washington University School of Medicine, St Louis. Prof Pan’s lab uniquely merges fundamental chemistry, biology and engineering to bring solution to today’s healthcare problems.

His research is highly collaborative and interdisciplinary centering on the development of novel materials for biomedical applications, immune-nanomedicine and targeted therapies for stem-like cancer cell with phenotypically screened nanomedicine platforms.

Over the years, this research has resulted in more than 100 high impact peer reviewed publications in scientific journals, numerous conference abstracts and has been supported by external funding from NIH, NSF, DoD, American Heart Association and other private/foundational funding sources.

Prof. Pan edited and co-written two books published from Taylor and Francois (Nanomedicine: A Soft Matter Perspective, ISBN-13: 978-1466572829) and Springer (Personalized Medicine with a Nanochemistry Twist: Nanomedicine (Topics in Medicinal Chemistry, ISBN-13: 978-3319335445). He holds multiple patents (8 granted US patents), several ongoing clinical trials and is the founder of three University based early start-ups. He is the CEO/President for a biotechnology start-up Vitruvian Biotech dedicated to develop novel image guided therapies.

He also co-founded InnSight Technologies dedicated to nanotechnology based application for ocular diseases. His other company Kalocyte, which he cofounded with his clinical collaborators, develops artificial oxygen career. His technology has been licensed for commercial development multiple times. He serves as study section review board member for NIH, CDMRP (DoD), NSF and multiple review committee member for American Heart Association.

In 2016 he received Nanomaterials Letter (NML) Researcher award, in 2017 an Young Innovator Award from Biomedical Engineering Society (BMES) and most recently Dean’s Award for Research Excellence in 2018. He is an elected fellow of Royal Society of Chemistry, a Fellow of American Heart Association and an elected fellow of American College of Cardiology.

India Opens Up Even As Coronavirus Case Spreads

Nearly two months after the unplanned and abrupt lockdown of the country by Modi government, putting millions of immigrant workers and the poor stranded on the streets without food and shelter, India is cautiously opening up its economy and the lifting the lockdown in phases.

More states opened up and crowds of commuters trickled onto the roads in many of India’s cities on Monday as a three-phase plan to lift the nationwide coronavirus lockdown began despite an upward trend in new infections.

Businesses and shops reopened in many states and the railways announced 200 more special passenger trains. Some states also opened their borders, allowing vehicular traffic.

India reported more than 8,000 new cases of the coronavirus in a single day, another record high that topped the deadliest week in the country.

Confirmed infections have risen to 182,143, with 5,164 fatalities, including 193 in the last 24 hours, the Health Ministry said Sunday.

Overall, more than 60% of the virus fatalities have been reported from only two states — Maharashtra, the financial hub, and Gujarat, the home state of Prime Minister Narendra Modi. The new cases are largely concentrated in six Indian states, including the capital New Delhi.

India implemented the lockdown — one of the world’s strictest — on March 25, ordering everyone to stay inside, except for emergencies and essential services, leading to a sudden halt to the economy. The lockdown was brutally devastating for daily laborers and migrant workers, who fled cities on foot for their family homes in the countryside. The country’s unemployment rate rose to 23.48% in May, according to official data released this week.

Public health experts have criticized the Modi government’s handling of the outbreak. A joint statement by the Indian Public Health Association, Indian Association of Preventive and Social Medicine and Indian Association of Epidemiologists, which was sent to Modi’s office on May 25, said it was “unrealistic” to eliminate the virus at a time when “community transmission is already well-established.”

The coastal state of Maharashtra, home to the financial hub of Mumbai and Bollywood, allowed the resumption of film production with some restrictions in place. In New Delhi, the capital, authorities announced the reopening of all industries and salons, while keeping the borders sealed until June 8 to try to prevent a spike in new virus cases.

Although social distancing and the wearing of masks in public are still mandatory across India, some people were seen forgoing both in many places. Others violated lockdown rules. In Prayagraj, a city in northern India’s Uttar Pradesh state, hundreds of Hindu devotees took a dip in the sacred Ganges river even though congregations at religious venues remain barred.

But as India eases more restrictions, it continues to report a rise in infections. India on Monday climbed to the seventh spot in countries worst hit by the virus, passing Germany and France, as its confirmed cases rose to more than 190,000, including over 5,400 deaths.

The first phase of the easing of the lockdown, called Unlock 1, will restrict curbs to containment zones — areas that have been isolated due to coronavirus outbreaks. It gives states more power to decide and strategize lockdown implementations locally.

More than 60% of the country’s virus fatalities have been reported in only two states — Maharashtra and neighboring Gujarat. The new cases are largely concentrated in six states, including New Delhi.

Critics fear that the lockdown, which started over two months ago, is being eased too soon. There are concerns that the virus may be spreading through India’s villages as millions of jobless migrant workers return home from big cities.

The real number of coronavirus patients in the country is likely much higher than the official numbers show, as India is among the countries testing the lowest proportion of its population: With just over 1.1 million tests conducted in a country of 1.3 billion, that’s only about 800 tests per million inhabitants, according to data website worldmeters.info.

The U.S., by comparison, has tested about 21,000 per million residents, and America is nowhere near the leader in that regard.Experts warn that the pandemic has yet to peak in India, and many states have begun to identify more high-risk zones where coronavirus lockdowns will continue until June 30. But restaurants, malls and religious venues are permitted to reopen elsewhere on June 8.

In a radio address to the nation on Sunday, Prime Minister Narendra Modi cautioned citizens and asked them to remain vigilant.

“Becoming careless or lackadaisical cannot be an option,” he said. Modi’s government has stressed that restrictions are being eased to focus on promoting economic activity, which has been severely hit by the lockdown.

Young People are Key to a Nicotine-free Future: Five Steps to Stop them Smoking

By Sam Filby – IPS
Tobacco use kills more than 8 million people each year. Most adult smokers start smoking before the age of 20. This implies that if one can get through adolescence without smoking, the likelihood of being a smoker in adulthood is greatly reduced.
Preventing young people from becoming addicted to tobacco and related products is therefore key to a smoke-free future.
With the advent of novel tobacco products and the tobacco industry falsely marketing them as less harmful than their combustible counterparts, the adage “prevention is better than cure” has never been more important for governments to heed if we are to achieve a smoke-free future.
Here are five things that governments need to do to ensure that a smoke-free future is realised.
1. Raise taxes on tobacco products
Tobacco taxation is one of the most effective population-based strategies for decreasing tobacco consumption. On average, a 10% increase in the price of cigarettes reduces demand for cigarettes by between 4% and 6% for the general adult population.
Because they lack disposable income and have a limited smoking history, young people are more responsive to price increases than their adult counterparts. Young people’s price responsiveness is also explained by the fact that they are also more likely to smoke if their peers smoke. This suggests that an increase in tobacco taxes also indirectly reduces youth smoking by decreasing smoking among their peers.
2. Introduce 100% smoke-free environments
Smoke-free policies reduce opportunities to smoke and erode societal acceptance of smoking. Most countries have some form of smoke-free policy in place. But there are still many public spaces where smoking happens. Many of these places are frequented by young people – or example, smoking sections in nightclubs and bars – contributing to the idea that smoking is acceptable and “normal”.
Research from the United States shows that creating smoke-free spaces reduces youth smoking uptake and the likelihood of youth progressing from experimental to established smokers. In the United Kingdom, smoke-free places have been linked to a reduction in regular smoking among teenagers, and research from Australia finds that smoke-free policies were directly related to a drop in youth smoking prevalence between 1990 and 2015. By adopting 100% smoke-free policies governments can denormalise smoking and turn youth away from tobacco and related products.
3. Adopt plain packaging and graphic health warnings
The tobacco industry uses sleek and attractive designs to market its dangerous products to young people. All tobacco products should therefore be subject to plain packaging and graphic health warnings so that their attractive packaging designs do not lead youth to underestimate the harm of using these products. Currently 125 countries require graphic images on the packaging of tobacco products. Countries like South Africa that rely on a text warning message are far behind the curve. Plain packaging on tobacco products has been adopted in 13 countries to date and, in January 2020, Israel became the first country to apply plain packaging to e-cigarettes.
4. Outlaw tobacco advertising, promotion and sponsorship
Traditional advertising and promotion of tobacco products has been banned in most parts of the world. But the tobacco industry has developed novel ways of keeping its products in the public eye.
Some common strategies used by the industry to target youth include hiring “influencers” to promote tobacco and nicotine products on social media, sponsoring events, and launching new flavours that are appealing to youth, such as bubble gum and cotton candy, which encourages young people to underestimate the potential harm of using them. Evidence also shows how the tobacco industry uses point-of-sale marketing to target children by encouraging vendors to position tobacco and related products near sweets, snacks and cooldrinks, especially in outlets close to schools.
Governments need to outlaw these tactics and impose hefty fines on tobacco companies that make any attempt to circumvent the law.
5. Educate young people
Given that tobacco kills half of its long-term users, the tobacco industry needs to get young people addicted to its products to ensure its survival. Young people need to be made aware of this. Governments should launch counter-advertising campaigns that educate young people on the tactics employed by the industry to target them so that they do not fall prey to them.The Conversation
Sam Filby, Research Officer, Research on the Economics of Excisable Products,, University of Cape Town and Corné van Walbeek, Professor at the School of Economics and Principal Investigator of the Economics of Tobacco Control Project, University of Cape Town
This article is republished from The Conversation under a Creative Commons license. Read the original article.

Technological Solutions That Help with Common Sleeping Disorders

For most adults, getting seven to nine hours of sleep is enough to wake up rested and keep us functioning throughout the day. Granted, some people can manage to sleep a lot less, while others don’t want to leave the warmth of their bed. However, the problem occurs when we want to sleep only to find ourselves being restless in bed or continuously waking up unable to get a good night’s sleep.

However, there’s no reason to worry. We’ve comprised a list of the <a href=”https://dealsoncannabis.net/blog/sleep-deprivation-statistics/“>most common sleeping disorders</a> and technological solutions for them, which you can make use of and get some shuteye.

Insomnia

According to stats, 30% of the grown-up Americans experience insomnia. It causes people to have difficulty falling asleep or staying awake, which can then result in daytime sleepiness, depressed mood, irritability, and low energy.

Insomnia may occur either independently or as a result of another problem, such as chronic pain, heart failure, restless leg syndrome, and stress. The first steps in treating insomnia are lifestyle changes and better sleep hygiene.

When it comes to technological solutions, you can use bulbs that stop the blue light, such as the Good Night Biological LED Bulb. Also, you can try blackout shades or devices like Ebb Insomnia Therapy.

Sleep Apnea

Sleep apnea is a sleeping disorder that affects up to 20% of the world’s population, and it causes a person’s breathing to be interrupted during sleep. There are two main types of sleep apnea—obstructive sleep apnea (OSA) and central sleep apnea (CSA). Common reasons that cause sleep apnea are enlarged tonsils or adenoids, smoking, frequent alcohol use, and weight.

Between the two, OSA is the more common one, and it occurs when the soft tissue in our throat collapses while we’re asleep. Its symptoms are daytime sleepiness, restlessness, gasping for air while sleeping, snoring, and fatigue.

When it comes to CSA, the issue starts in our central nervous system. Our breathing isn’t interrupted, but our brain fails to relay the information to our body to breathe.

Many inventions can help with sleep apnea, such as slumberBUMP that nudges you into sleeping on your side. As a result, it prevents the blocking of your airways. Another solution is EPAP by Theravent that regulates your airflow and creates a gentle pressure in your airway, keeping it open and reducing vibration.

Snoring

If you snore, you’re not alone. Approximately 40% of men and 20% of women snore, which is more than two billion people. It may be caused by sleep deprivation, sleep position, nasal problems, alcohol consumption, or simply due to our mouth’s anatomy.

For example, when muscles surrounding our throat relax during sleep, they cause the airway to get narrower, which then causes the tissue in our throat to vibrate as air passes through.

Luckily, since it’s one of the most common sleeping disorders around the globe, there are many technological solutions that can help with snoring, such as Hupnos’ Snoring MaskURGONight EEG Headband, as well as many different sleeping solutions by Philips.

Author’s Bio

Maja Talevska is a content curator and contributor for several different publications, including DealsOnCannabis.  As one of her biggest passions, writing is more than just a profession, which is why she always delivers top-notch content. When she is not immersed in her work, she spends her time planning her next destination or walking her adorable dog Leo.

Harvard professor says this odd activity is a game changer for dealing with stress

Right now is stressful. We’re trying to stay healthy, reevaluating values and questioning what we’ll define as normal going forward. We all need breaks to heal our minds and bodies from time-to-time and to renew motivation. But sometimes our house or streets are too full of distractions to help. Although needed, many of us can’t take the time or money out for therapy.

Try forest therapy, meditative practice of walking through the woods using all your senses.

“Unlike a hike or guided nature walk aimed at identifying trees or birds, forest therapy relies on trained guides, who set a deliberately slow pace and invite people to experience the pleasures of nature through all of their senses. It encourages people to be present in the body, enjoying the sensation of being alive and deriving profound benefits from the relationship between ourselves and the rest of the natural world,” said Dr. Susan Abookire MPH, an assistant professor at Harvard Medical School.

The practice of forest therapy is shockingly healthy for your body. Sounds silly? It was touted in Japan in the 1980s to help people relax from a culture of stress and overwork. It might help you. There are many benefits to getting into some greenery.

Getting in nature relieves stress. One of the first effects is that forest bathing or forest therapy relieves cortisol, a stress hormone. A research review showed, “In all but two included studies, cortisol levels were significantly lower after intervention in forest groups if compared with control/comparison groups.”

Forest bathing may also boost immunity. The essential oils trees put off, called phytoncides,  have antimicrobial properties. Dr. Abookire said, “One Japanese study showed a rise in number and activity of immune cells called natural killer cells, which fight viruses and cancer, among people who spent three days and two nights in a forest versus people who took an urban trip. This benefit lasted for more than a month after the forest trip!”

 Just a short trek in the woods can boost health. Studies suggest spending just about two hours can help people report better health. Another study shows that depression, anxiety and high blood pressure can all be relieved by forest therapy. By walking in the woods, taking in the wind rustling the leaves, we absorb many of the helpful effects tree oils produce. It can also make you feel and look less inflamed. So getting outdoors makes you look and feel better.

Looking at nature shortens the time it takes to heal. Looking out a window can boost healing. In one study from decades ago, patients that had a window to look out of, and patients with gallbladder surgery left the hospital quicker.

Green spaces or even pictures help focus. If you’re stuck inside, just looking at photographs of nature or touching tree bark can get you back in tune with senses. And doing so improves focus.

How to recreate it in your situation

Sitting: Get into the greenest space you can, take a deep breath supporting the spine and close your eyes. Take in the sounds. If you’re stuck in a city, put up posters of natures and put on earbuds. Bilateral sound, in both ears, helps you feel and connect sound to your mind.

Walking: Go very slow for ten minutes or so, touching, feeling and seeing all you can. “Be present in nature, and discover what nature has to present you,” said Jane Burress, a forest therapy guide.

If you do live near nature, check out the Association of Nature and Forest Therapy to find a guide to walk you through the practice. Take some time to breathe this week, and notice the green leaves of the trees, even the stray weed or two. You’ll feel chiller for it.

WEBMEDQUEST: Over 12,000 Medical Students & Professionals Participate At India’s First and Largest Online Medical Conference

The deadly pandemic, COVID-19 that has been instrumental in the lockdown of almost all major programs and activities around the world, could not lockdown the creative minds of young Medical Professionals in India. The lockdown due to COVID-19 has led to the cancellation of all the conferences that were planned this year, disheartening the medical students who work all year long to get a chance to present their work and learn from their colleagues.  Taking the lockdown and the social isolation as a challenge, the organizing committee of WEB MEDQUEST has come up with this idea of conducting a full-fledged conference online.
An all-inclusive conference virtually, including keynote speeches, workshops, Medical MUN Case/Paper presentations, Literary and cultural events, and whatnot was organized from May 15t to 18th, 2020 and was attended by over 12,000 live participants from India, the United States and from around the world.
Shubham Anand, Snigdha Sharma, Shubhika Jain and Samarth Goyal have set an example that hardwork and dedication can do wonders like organizing a full-fledged conference from scratch in a little over a month.
WEBMEDQUEST: Over 12,000 Medical Students & Professionals Participate At India's First and Largest Online Medical ConferenceA brainchild of the four medical undergraduates students proved many things, including the fact that a simple spark can be fanned into flames when it’s a question of teamwork. In their quest of doing something out of the box, the conference also introduced an online Model UN session. The exceptional leadership and coordination has made webmedquest 2020, India’s first conference with different associations on one platform.
 “Web Medquest is India’s first and biggest online medical conference conducted in India with over 12,000 registrations including undergraduates, interns and postgraduates,” said Shubham Anand, Organizing Chairman, WEB MEDQUEST.  A plethora of events like cultural, literary, academic and games to name some were conducted efficiently over the 4 days span.
Describing the origins of the first ever such conference, Anand says, “It all began like a simple “jumanji board” lying in one corner and became a full scale adventure of sorts. It took birth about a month and a half ago in  a rather informal conversation between acquaintances, in the throes of the ongoing pandemic, it seemed a rather solid thought to conduct one virtually.”
Realizing that “Learning happens everywhere, not just in the classrooms,” Anand and his colleagues set out on a dream project.  The idea of bedside teaching was introduced in the spring of ’90s which was then called “scientific medicine” and later modified to be termed as “evidence-based medicine.
Since the advent of evidence-based medicine, sharing ideas all over the world has become more important than ever. Undergraduate Medical conferences are one such means to inculcate this idea of sharing knowledge in young budding medicos.
WEBMEDQUEST: Over 12,000 Medical Students & Professionals Participate At India's First and Largest Online Medical ConferenceIndia itself witnesses many such conferences all year round. But the lockdown due to COVID-19 has led to the cancellation of all the conferences that were planned this year, disheartening the students who work all year long to get a chance to present their work and learn from their colleagues.
Consisting of eminent and reputed speakers from across the world who had shared their knowledge and enlightened the delegates with new advances in their field of practice.  Scientific events such as Poster Presentations, Case Presentations and Research Presentations brought out the best from the medical students from hundreds of Medical Schools from across India.  The webinars consisted of UNESCO Bioethics seminar, USMLE/PLAB orientation  and an enlightening Seminar on “Mental health and productivity during quarantine.”
Workshops on Research methodology, Communication skills, Artificial intelligence in healthcare, and Diabetes care were very informative and provided new perspectives to the thousands of participants from around the world.   Medical quiz, including Pre-clinical quiz, Para-clinical quiz and Clinical quiz were a challenge to the best of the minds.
India’s first ever Model United Nations conducted for medical students had everts such as, Literary events, Creative Writing – “Catharsis,” Debate – “Depolarize,” and  E- Poster- “Art-pIECe. The cultural extravaganza with brilliant Dance – “Dance Battle,” Singing – “Dhwani,”  Instrumental solo – “Thunder beat,” and Paintography were a treat to the souls and hearts of all participants, showcasing the creative talents of the medical students.

Dr. Suresh Reddy, President of American Association of Physicians of Indian Origin (AAPI), which is a collaborating partner in organizing the event,  in his keynote address, spoke about “Atychiphobia and Serendipity.” Quoting from world renowned leaders, he spoke about the “Fear of Failure Phobia.” He said, “Normal amount of doubt regarding success in certain project, relationships or examinations is usually present in most people. However, when the fear of failure takes on an extreme form then it is termed as Atychiphobia,” he said.
WEBMEDQUEST: Over 12,000 Medical Students & Professionals Participate At India's First and Largest Online Medical ConferenceDr. Ravi Kolli, Secretary of AAPI and a Board Certified Psychiatrist, in his address, highlighted the challenges the medical students are facing at the very crucial stage of their psycho social and  brain development  and  how it can negatively affect them. He explained the scientific rationale and the benefits of various coping mechanisms including, mindfulness cultivating optimism, emotional intelligence, yoga, exercise proper nutrition, sleep hygiene as well as value of  social connections and  gratitude and spirituality in combating the harmful effects of chronic stress and challenges.
“I am proud to have the younger generation as mentor,” said Dr. Lokesh Edara, a keynote speaker and Chair of AAPI’s Education Committee. “Shubham Anand is a mentor to us on how to conduct a webmedquest.” Lauding the creativity and the organizing skills of Medical Students from India, he said, “Students in India are brilliant and they are lucky to excellent faculty. We need some changes in medical education. These debates will results in change in medical education so every doctor nurse paramedics in India graduate equal to the ones in the US and other developed countries. I like our students to present their issues on nationwide panel discussions in digital platforms  and thus help change the medical system in India. I wish them success in delivering high quality of health to all citizens of India or wherever they choose to settle,” Dr. Edara added.

On “Overcoming the Fear of Failure” Dr. Reddy suggested that “Some simple things you can do that will make you become more comfortable with risk-taking.  To make a breakthrough you have to be willing to make mistakes,” he told them. “Make as many mistakes as you need to learn. Failure is a strengthening process. Success is going from ‘Failure to Failure’ with great enthusiasm. Make Failure Respectable. There is no sure thing as ‘failure.’ It is only an event on the learning curve –  UNLESS you do not learn from the event,” Dr. Reddy told the 12,000 delegates at the highly successful 1st ever webmedquest.

First Human Trial Of Possible COVID-19 Vaccine Triggers Rapid Immune Response, Few Side-Effects

As the worldwide number of COVID-19 cases reaches five million, the search for a vaccine has taken an important step forward. Researchers say the first human trial of a possible vaccine has been found to be safe and may effectively fight the virus.

Scientists in China say 108 healthy adults were given a dose of adenovirus type 5 vectored COVID-19 (Ad5-nCoV) during the trial. The drug uses a weakened strain of the common cold (adenovirus) to deliver genetic material which codes itself to find the protein in SARS-CoV-2 — the virus that causes COVID-19. These coded cells then head to the lymph nodes where the immune system creates antibodies that can recognize the virus and attack it.

“These results represent an important milestone. The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days,” Professor Wei Chen of the Beijing Institute of Biotechnology said in a statement.

Although Ad5 was found to create a rapid immune response in the body, scientists warn there’s no guarantee the drug will effectively fight the coronavirus.

“These results should be interpreted cautiously… The ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from COVID-19. This result shows a promising vision for the development of COVID-19 vaccines, but we are still a long way from this vaccine being available to all,” Chen explained.

The test group of 18-60 year-olds was split into three groups of 36 and given either a small, medium, or large dose of Ad5. Researchers found that none of the patients suffered from serious reactions to the vaccine after four weeks. The most common side-effects included mild pain in the injection area, fever, and fatigue. The symptoms typically lasted for less than two days.

Rapid Response

The study, published in The Lancet, found that nearly every patient had more binding antibodies after 28 days. The antibodies, which learned to attach to the coronavirus, had increased by four times in 97 percent of the test group. Among the patients given the large dose of Ad5, 75 percent were found to have antibodies that can neutralize SARS-CoV-2 in their systems.

Patients also saw their T cell response increase rapidly, with nearly 93 percent seeing a rise in the body’s ability to fight off infections.

Vaccine Roadblocks

Researchers cautioned that Ad5 still has some issues. The biggest problem is that humans could be immune to adenovirus type 5. About half of the trial patients were found to have a pre-existing immunity to the cold virus which may have slowed the progress of the vaccine.

“Our study found that pre-existing Ad5 immunity could slow down the rapid immune responses to SARS-CoV-2 and also lower the peaking level of the responses,” said Professor Feng-Cai Zhu from Jiangsu Provincial Center for Disease Control and Prevention.

The final results of the Ad5 injections will be evaluated after six months. Researchers are hoping the patients will show a continued resistance to the coronavirus.

A second trial involving 500 healthy adults is already underway in Wuhan, the alleged starting point of the worldwide pandemic. This trial will also see how the drug affects patients over the age of 60.

An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced May 18.

Study volunteers given either a low or medium dose of the vaccine by Cambridge, Massachusetts-based Moderna Inc. had antibodies similar to those seen in people who have recovered from COVID-19.

In the next phase of the study, led by the U.S. National Institutes of Health, researchers will try to determine which dose is best for a definitive experiment that they aim to start in July.

In all, 45 people have received one or two shots of the vaccine, which was being tested at three different doses. The kind of detailed antibody results needed to assess responses are only available on eight volunteers so far.

The vaccine seems safe, the company said, but much more extensive testing is needed to see if it remains so. A high dose version is being dropped after spurring some short-term side effects.

The results have not been published and are only from the first of three stages of testing that vaccines and drugs normally undergo. U.S. government officials have launched a project called “Operation Warp Speed” to develop a vaccine and hopefully have 300 million doses by January.

Worldwide, about a dozen vaccine candidates are in the first stages of testing or nearing it. Health officials have said that if all goes well, studies of a potential vaccine might wrap up by very late this year or early next year.

More than 4.7 million infections and 315,000 deaths from the coronavirus have been confirmed worldwide since it emerged in China late last year. There are no specific approved treatments, although several are being used on an emergency basis after showing some promise in preliminary testing.

Sen. Kamala Harris Introduces Bill to Provide Monthly $2,000 Payments During COVID-19 Crisis

U.S. Senator Kamala D. Harris (D-CA), Bernie Sanders (I-VT), and Ed Markey (D-MA) May 8 had introduced the Monthly Economic Crisis Support Act, legislation that provides a monthly $2,000 check to those struggling to make ends meet during the COVID-19 pandemic. As rent comes due and bills continue to pile up, Americans desperately need assistance to financially survive this crisis, said a press release.

“The coronavirus pandemic has caused millions to struggle to pay the bills or feed their families,” said Harris. “The CARES Act gave Americans an important one-time payment, but it’s clear that wasn’t nearly enough to meet the needs of this historic crisis. Bills will continue to come in every single month during the pandemic and so should help from government. The Monthly Economic Crisis Support Act will ensure families have the resources they need to make ends meet. I am eager to continue working with Senators Sanders and Markey as we push to pass this bill immediately,” the Indian American senator said in the release.

“As a result of this horrific pandemic, tens of millions of Americans are living in economic desperation not knowing where their next meal or paycheck will come from,” said Sanders. “The one-time $1,200 check that many Americans recently received is not nearly enough to pay the rent, put food on the table and make ends meet. During this unprecedented crisis, Congress has a responsibility to make sure that every working-class household in America receives a $2,000 emergency payment a month for each family member. I am proud to be introducing legislation with Senators Harris and Markey to do exactly that. If we can bail out large corporations, we can make sure that everyone in this country has enough income to pay for the basic necessities of life.”

The Monthly Economic Crisis Support Act is endorsed by Economic Security Project Action, Humanity Forward, Community Change Action, High Ground Institute, LatinxVoice, Shriver Center on Poverty Law, Income Movement, People’s Action, NETWORK Lobby for Catholic Social Justice, Golden State Opportunity, MyPath, National Domestic Workers Alliance, Heartland Alliance, One Fair Wage, Caring Across Generations, End Child Poverty CA/The GRACE Institute, Coalition on Human Needs, Black to the Future Action Fund, ParentsTogether Action, RESULTS, and Forum for Youth Investment.

The Monthly Economic Crisis Support Act:

  • Provides up to $2,000 a month to every individual with an income below $120,000 throughout and for three months following the coronavirus pandemic.
    • Married couples who file jointly would receive $4,000.
    • $2,000 per child up to three children
    • Retroactive to March
    • Begins to phase out after $100,000
  • Ensures that every U.S. resident receives a payment, regardless of whether or not they have filed a recent tax return or have a social security number.
    • Uses the data from the Supplemental Nutrition Assistance Program (SNAP), Supplemental Security Income, (SSI), Medicare and housing assistance programs
  • Forbids debt collectors from seizing the rebate payments.
  • Ensures the homeless and foster youth receive payments.

Research Shows Electroceutical Fabric Eradicates Coronavirus Infectivity On Contact

By Allison Gasparini (Courtesy: FORBES)

In the fight against Covid-19, protective personal equipment has played a central and critical role for the safety of healthcare workers. However, the virus can attach to the surface of PPE where it may continue to be infectious for an extended period of time. There’s a risk that a person removing their face mask could touch viral particles latched onto the outside and further spread the virus.
A preprint paper published recently by scientists from Indiana University suggests a fabric which eradicates the infectivity of coronaviruses on contact by generating an electric field could be the answer to the problem.
Last month, a team of researchers determined a hybrid combination of one layer of cotton and two layers of chiffon is the most effective fabric for a face mask. They noted the high-efficiency of the combination is likely due to the combined effect of mechanical and electrostatic filtration of infective particles.
The new study from IU further explores the potential of electrostatic forces to act against Covid-19.
The research is a part of a still-growing field of medical devices known as “electroceuticals” — a fusion of the words “electrostatic” and “pharmaceuticals.” Electroceuticals use weak electric fields not harmful to humans to treat a variety of conditions. Pacemakers, which are used to treat arrhythmias, are one common example.
Chandan Sen, the paper’s lead author and director of the Indiana Center for Regenerative Medicine and Engineering, previously worked on developing the current-generating fabric for antimicrobial applications. Bioelectric technology company Vomaris Inc currently commercializes the electroceutical fabric for use as a pathogen-killing wound dressing.
The fabric is polyester printed with little metal dots made of zinc and silver. The geometric, alternating pattern of zinc and silver make microcell batteries which generate an electric field upon exposure to moisture. When used in wound care, the electric field prevents biofilms from forming and reduces the risk of bacterial infection during the healing process.
Knowing viruses rely on electrostatic forces to assemble and attach to cells, the researchers suspected the electroceutical fabric could be used to destabilize the coronavirus as well.
As a control for their test, the team used a polyester fabric without the microcell batteries on the surface. They then exposed both fabrics to an aqueous solution containing cells with a respiratory coronavirus at room temperature and allowed it to absorb.
Their subsequent analysis revealed that just one minute of contact to the electroceutical fabric led to significant reduction in the electrokinetic property of the viral particles. Additionally, researchers monitored the infected cells recovered from the electroceutical fabrics and noticed an absence of the cytopathic effects expected in the presence of viral invasions.
The team reported the cells from the electroceutical fabric were as healthy as non-infected cells, indicating the virus had lost its infectivity, while cells from the control fabric didn’t receive the same protection.
Though further studies are needed to characterize the structural change of coronaviruses in exposure to electroceutical fabric, the researchers hope their findings are the first step toward receiving FDA Emergency Use Authorization which will allow the technology to be distributed widely for use as face masks.

Indian American students connect patients with the medicines they need

Aarogya, a social-enterprise nonprofit created by three President’s Engagement Prize winners and graduating seniors, will bring affordable medicines to low-income people living in India.

Each year, 500 million patients in India living with chronic conditions like diabetes—to name just one—go without medicines they need because they can’t afford them. After witnessing this first-hand as a volunteer two years ago in a private charitable hospital in Bangalore, observing a child with chronic juvenile diabetes walk away without medication, Shivansh Inamdar also saw an opportunity to make an impact.
The idea: leverage pharmacies’ unsold medicines—ones that have not yet reached expiry but have passed their sell-by date—and get them, free of charge, in the hands of people who need them with the help of secure and transparent technology.
Proposing the mission first to Aditya Siroya, a senior in the Wharton School, and later Artemis Panagopoulou, a senior in the School of Engineering and Applied Science and the College of Arts and Sciences, they combined skills and perspectives to tackle the problem in the best way they could, and submitted an application for the President’s Engagement Prize.
Founded by Penn President Amy Gutmann in 2015, the 2020 President’s Engagement Prize is intended to empower students to design and undertake post-graduation projects that make a positive, lasting difference in the world. Each prize-winning project receives $100,000, as well as a $50,000 per-student living stipend.
“This seems like such a natural solution to this problem,” muses Inamdar, a senior in the School of Engineering and Applied Science, discussing their winning project. “But the status quo has really not allowed the pharmaceutical companies to be looking for a second distribution channel for these medicines.”
Three to five percent of medicines are returned to pharmaceutical companies’ warehouses each year in India and later incinerated upon their expiry, all at a cost of millions of dollars to store and eventually destroy. Which, too, comes at a global price of 1.5-2.6 tons of carbon dioxide emissions per year.
Aarogya, which is interpreted to mean “freedom from disease” in Sanskrit, will solve the problem of medicine wastage by using a tailor-made digital redistribution platform, with a decentralized blockchain system set up for traceability, to bridge the divide between pharmaceutical companies and charitable hospitals.
“Of course, this is an inefficiency in a sense that you have these unused medicines lying idle when they should be used for what they were made for, which is to treat people,” Inamdar says. “We thought this was a relatively easy inefficiency for us to come in and solve. Which, on an individual company level, is quite small, but across the [Indian] health care system is quite significant.”
Siroya adds that it’s a financial problem that seems minor across each company, but adds up to a much larger problem when considered together—with no one able to individually “devote bandwidth to the problem,” he says.
Through a four-month pilot in a small village in Karnataka, they’ve already gotten $6,300 worth of medicines to 900 low-income people and proven Aarogya’s concept. They also established partnerships, toured warehouses, and spoke with doctors, administrators, and, really, anyone who would allow them to learn more about the problem. They will now take what they’ve learned from the pilot and flesh out their platform—which, they emphasize, is more timely than ever in the COVID-19 pandemic, and can be completed without interpersonal interactions.
The platform itself, they further explain, is designed to accommodate systems already in place in the health care system to ensure there are no added barriers or burdens for hospital administrators, doctors, or pharmaceutical companies. Hospitals list medicines they need, the pharmaceutical companies list information about what medications they have, and an algorithm built into the platform matches the two. A strip with a QR code is used to track the shipments at checkpoints and notify involved parties.
“What we’re asking them to do is just have a small additional step of entering their stock in our platform,” says Panagopoulou. “And then at the same time, on the other side, the charitable hospitals can again list what they need, and then we can use some optimization algorithms given some aspects like distance, quantity, and other [variables] that are a typical supply chain optimization problem, to deliver the medicines through the best possible way and get it where it’s needed most.
“It’s essentially matching supply and demand.”
Mark Pauly, the Bendheim Professor of Health Care Management and Business Economics and Public Policy at the Wharton School, has been advising the team on their project, pointing out potential concerns from pharmaceutical companies as they’ve continued negotiations, and has largely been delighted by their enthusiasm and research.
“Their knowledge on the ground is of great value, and they came back [from their pilot] even more thoughtful,” says Pauly. “And I like that this team is multinational as well as multi-school. The University’s idea of making [ideas] actually happen in a real-world setting is on display here and I’m excited about it.”
Aarogya will partner with pharmaceutical companies, a charitable institution, and a charitable hospital to provide access to $1.19 million worth of unused medicines and approximately 12,500 low-income patients per day.
“Now more than ever, it is imperative that we find new ways to get life-sustaining and life-saving medicines into the hands of those who need them most,” says Gutmann. “Aditya, Artemis, and Shivansh are harnessing the power of purpose-driven technology to efficiently and ethically ensure that the right medicines reach the right hands in the right place and at the right time.”

‘Human development on course to decline after 30 yrs’

Global human development, which can be measured as a combination of the world’s education, health and living standards, could decline this year for the first time since the concept was introduced in 1990, the UN Development Programme (UNDP) warned.

“The world has seen many crises over the past 30 years, including the Global Financial Crisis of 2007-09. Each has hit human development hard but, overall, development gains accrued globally year-on-year,” UNDP Administrator Achim Steiner was quoted as saying by Xinhua news agency on Wednesday.

“COVID-19, with its triple hit to health, education, and income, may change this trend.”

Declines in fundamental areas of human development are being felt across most countries, rich and poor, in every region, according to a UNDP statement.

The worldwide COVID-19 death toll has increased to 328,095, while the global per capita income this year is expected to fall by 4 per cent, it said.

With school closures, UNDP estimates of the “effective out-of-school rate”, the percentage of primary school-age children, adjusted to reflect those without internet access, indicate that 60 per cent of children are not getting an education, leading to global levels not seen since the 1980s.

The combined impact of these shocks could signify the largest reversal in human development on record, the statement said.

The negative impacts on women and girls span economic — earning and saving less and greater job insecurity — reproductive health, unpaid care work and gender-based violence.

The drop in human development is expected to be much higher in developing countries that are less able to cope with the pandemic’s social and economic fallout than richer nations.

“This crisis shows that if we fail to bring equity into the policy toolkit, many will fall further behind. This is particularly important for the ‘new necessities’ of the 21st century, such as access to the internet, which is helping us to benefit from tele-education, tele-medicine, and to work from home,” said Pedro Conceicao, director of the Human Development Report Office at the UNDP.

The UNDP is the leading UN organization fighting to end the injustice of poverty, inequality, and climate change.

Working with its broad network of experts and partners in 170 countries, the UNDP helps nations to build integrated, lasting solutions for people and planet. (IANS)

The price of good health is eternal vigilance

By Michael Sainsbury (Courtesy: UCANews)

Second waves of the Covid-19 pandemic are beginning to emerge across the Asia-Pacific region, even though other nations have barely felt (at least officially) the impact of the disease’s first surge.

With predictions of a vaccine not being available until 2021 at the earliest, these new surges will not be the last.

A corollary of this is that the disease, like all viruses, is also random in the way that it spreads, but contagion is usually denser in urban areas where close human contact is nearly unavoidable.

This means that outbreaks have been patchy. In India, for instance, Mumbai is in all sorts of trouble while Kerala seems largely safe, at least for now.

Similarly, in Indonesia, Jakarta is the epicenter of the virus but far-flung islands like Flores and Bali have been relatively unscathed so far.

Of course, a lack of testing accounts for some of this, but not all. Yet it is a major mistake to think that any particular town, city or region will escape the coronavirus. Its contagion is such that one infected person can infect many.

In Singapore, authorities were forced to ramp up lockdowns after infections surged in the dormitories of migrant workers, the city’s largely “out of sight, out of mind” underclass.

In South Korea, bars and nightclubs were shuttered almost as quickly as they were reopened — a matter of days — when nightspots turned out to be the center of fresh clusters on infections.

And let’s not forget China where a growing number of towns and cities are being locked down as infections spike, especially in the northeast near Russia and North Korea. Chinese experts have openly spoken about future waves of the coronavirus.

“The majority of Chinese at the moment are still susceptible to Covid-19 infection because of a lack of immunity,” Dr. Zhong Nanshan, a senior medic involved in China’s top-level response, was reported as saying. “We are facing a big challenge; it’s not better than other countries, I think, at the moment.”

He also tacitly admitted that China’s infection numbers may be under-reported, a widespread problem in the region according to experts.

The message from these countries, all of whom have been held up as having responded best to the virus in terms of containment, is that this disease requires constant vigilance in the absence of any vaccine or cure.

Second waves of outbreaks are also emphasizing the discrimination through Covid-19 shaming that has emerged during the still-early stages of this pandemic and which is fast become a toxic byproduct of the virus.

In Singapore, foreign workers are being blamed for spreading the virus — a reaction that is unfortunately commonplace in the region.

In Malaysia, migrant workers from Indonesia and Myanmar have been blamed for carrying and spreading it when in fact the first recorded hotspot was at a middle-class Muslim summit.

In South Korea, many LGBTQ people are in hiding because a gay nightclub was named as a recent hotspot.

Chinese people were racially targeted initially in the region and around the globe. Then in Asia, it was the turn of Europeans who were accused of bringing the disease back to Asia after outbreaks in southern Europe.

Over time, there will be second, third and fourth waves of the virus simply because this slippery disease is so highly contagious. It is therefore imperative that we find sustainable new ways to interact, to work, to socialize and to worship.

As we do this, we must keep in mind that this disease knows no borders and does not respect race, class or ideology. Fighting and protecting ourselves against this virus should be something that brings us together, not something which tears us further apart.

Healthcare Workforce Resilience Act S.3599/HR6788 will address shortage of Doctors in USA: AAPI

“AAPI supports the Healthcare Workforce Resilience Act S.3599/ HR6788, introduced by Senators Durbin, Perdue, Young, Coons addressing Shortage of doctors, nurses, and urges the Congress to approve the bill and allow the thousands of immigrant Indian American doctors on green card backlog to bolster the American health care system and extend their patient care whole-heartedly without disruption,” said Dr. Suresh Reddy, President of AAPI.

Dr. Reddy was responding to the Bill. the Healthcare Workforce Resilience Act, introduced by U.S. Senate Democrats Dick Durbin (D-IL), Ranking Member of the Senate Judiciary Immigration Subcommittee, along with Senators David Perdue (R-GA), Todd Young (R-IN), and Chris Coons (D-DE), which recaptures 15,000 green cards to provide a temporary stopgap to quickly address our nation’s shortage of doctors. This legislation will help underserved communities with physician shortage to recruit more physicians and thus effectively extend health care coverage.

The Health care Resilience Act S.3599/ HR6788 would recapture 25,000 unused immigrant visas for nurses and 15,000 unused immigrant visas for Physicians. This would help the American health care force to mobilize the medical professionals to the areas of health care needs.

Healthcare continues to be at the center of the national debate, especially in the context of the global Corona Virus pandemic affecting millions of people in the United States. This deadly virus has claimed lives of many healthcare professionals who are in the frontline caring for the hundreds of thousands of patients affected by this disease.

An estimated 800,000 legal immigrants who are working in the United States are waiting for green card. This unprecedented backlog in employment-based immigration has fueled a bitter policy debate but has been largely ignored by the Congress. Most of those waiting for employment-based green cards which would allow them to stay in the United States are of Indian origin. The backlog among this group is so acute that an Indian national who applies for a green card now can expect to wait up to 50 years to obtain it. The wait is largely due to the annual per-country quota immigration law, which has been unchanged since 1990.

This heightened demand for physicians will only continue to grow, and will soon outpace supply leading to a projected shortfall of nearly 122,000 physicians by 2032. Thus, recapturing the unused visas/Green cards that are available for International Medical Graduates is critical to addressing this mounting shortage of physicians.

Healthcare Workforce Resilience Act S.3599/HR6788 will address shortage of Doctors in USA: AAPIIn a detailed report on Green Card delays affecting Indian American physicians, the Green Card Backlog Task Force by AAPI had pointed out that there are over 10,000 Physicians waiting for Green Card for decades. AAPI members would like to see the Green Card backlog addressed, which it says has adversely impacted the Indian American community. During their annual Legislative Day on Capitol Hill, they have stressed the need for bipartisan efforts in passing the Health care Resilience Act, which will recapture and provide Green Cards for physicians serving in America’s under-served and rural communities.

“Consider this: one-sixth of our health care workforce is foreign-born. Immigrant nurses and doctors play a vital role in our health care system, and their contributions are now more crucial than ever. Where would we be in this pandemic without them? It is unacceptable that thousands of doctors currently working in the U.S. on temporary visas are stuck in the green card backlog, putting their futures in jeopardy and limiting their ability to contribute to the fight against COVID-19,” said Sen. Durbin.

“This bipartisan, targeted, and timely legislation will strengthen our health care workforce and improve health care access for Americans in the midst of the COVID-19 pandemic. I encourage my colleagues on both sides of the aisle to support these vital health care workers,” the Senator from Illinois pointed out.

“The growing shortage of doctors and nurses over the past decade has been exacerbated by the COVID-19 crisis,” said Sen. Perdue.  “Fortunately, there are thousands of trained health professionals who want to practice in the United States.  This proposal would simply reallocate a limited number of unused visas from prior years for doctors and nurses who are qualified to help in our fight against COVID-19.  This shortage is critical and needs immediate attention so that our healthcare facilities are not overwhelmed in this crisis.”

Specifically, the Senators’ proposal:

  • Recaptures unused visas/green cards from previous fiscal years for doctors, nurses, and their families
  • Exempts these visas/green cards from country caps
  • Requires employers to attest that immigrants from overseas who receive these visas will not displace an American worker
  • Requires the Department of Homeland Security and State Department to expedite the processing of recaptured visas
  • Limits the filing period for recaptured visas to 90 days following the termination of the President’s COVID-19 emergency declaration

“AAPI joins other similar organizations including American Medical Association, Illinois Health and Hospital Association, American Hospital Association, American Organization for Nursing Leadership, Physicians for American Healthcare Access, American Immigration Lawyers Association, and National Immigration Forum, that have come in support of The Healthcare Workforce Resilience Act,” said Dr. Sampat Shivangi, Chair of AAPI’s Legislative Committee.

Dr. Seema Arora, Chair of the Board of Trustees of AAPI, urged the members of Congress to include physicians graduating from U.S. residency programs for Green Cards in the comprehensive immigration reform bill. “Physicians graduating from accredited U.S. residency programs should also receive similar treatment. Such a proposal would enable more physicians to be eligible for Green Cards and address the ongoing physician shortage,” she said.

Dr. Sudhakar Jonnalgadda, President-Elect of AAPI, said, “AAPI has once again succeeded in bringing to the forefront many important health care issues facing the physician community and raising our voice unitedly before the US Congress members.”

Healthcare Workforce Resilience Act S.3599/HR6788 will address shortage of Doctors in USA: AAPI“AAPI welcomes this bipartisan legislation introduced by Senators Perdue, Durbin, Young and Coons; the bill would help address the critical healthcare shortage in the United States, a weakness that has been evident during the COVID-19 national emergency,” said Dr. Anupama Gotimukula, Vice President of AAPI.

“The Healthcare Workforce Resilience Act recognizes the importance and the need of immigrant doctors, nurses and their families. At this critical time, addressing shortages in the health care workforce is imperative.  By ensuring unused visas do not go waste, the bill will help doctors, nurses and their families, who have been waiting in line, immigrate sooner,” said Dr. Raghuveer Kurra, Chair of AAPI Committee on Green Card Backlog.

“Thousands of Indian-American Physicians have been affected by the backlog for Green Card. This negatively impacted their ability to work and provide the much-needed health care services for the people affected by the COVID-19 pandemic across the nation,” said Dr. Ram Sanjeev Alur, Co-Chair, AAPI Committee on Green Card Backlog. “These Indian physicians constitute less than one percent of the country’s population, but account for nine percent of the American physicians. One out of every seven doctors serving in the US health care system is of Indian heritage. These Indian origin Physicians provide medical care to over 40 million American population living in rural and underserved areas,” added Dr. Pavan Panchavati, Co-Chair, AAPI Committee on Green Card Backlog.

Dr. Ravi Kolli, Secretary of AAPI, said, “Prior to the COVID-19 pandemic, the U.S. was already facing a serious shortage of physicians largely due to growth, aging of the population and the impending retirements of many physicians.” Raj Bhayani, Treasurer of AAPI, pointed out, “This shortage was dramatically highlighted by the lack of physicians in certain key areas during the COVID-19 pandemic which forced states to recall retired physicians, expand physicians’ scope of practice, and amend out of state licensing laws.”

AAPI has recently heard calls from New York , New Jersey and California for physicians from out of state to help them care for patients, and there will be more areas of need in these states and also nationally who certainly will need additional physician force for staffing  their hospitals, fever clinics, COVID care centers and Emergency rooms in near future.

 According to Dr. Suresh Reddy, “AAPI has been consistent in bringing many important health care issues faced by the physician community and raising our voice unitedly before the US Congress members. we have been able to discover our own potential and have been playing an important role in shaping the health of each patient with a focus on health maintenance rather than disease intervention. AAPI is also instrumental in crafting the health care delivery in the most efficient manner and has been striving for equality in health care globally.”

For more details on AAPI and its legislative agenda, please visit: www.aapiusa.org

Coronavirus: Trump’s ‘inconsistent and incoherent’ response’ slammed by The Lancet

Editorial calls for the president to be voted out
(Courtesy: The Independent)

One of the world’s oldest and best-known medical journals slammed Donald Trump’s “inconsistent and incoherent national response” to the novel coronavirus pandemic and accused the administration of relegating the Centers for Disease Control and Prevention (CDC) to a “nominal” role.

The unsigned editorial from The Lancet concluded that Mr Trump should be replaced. “Americans must put a president in the White House come January, 2021, who will understand that public health should not be guided by partisan politics,” said the journal, which was founded in Britain in 1823.

The strongly worded critique highlights mounting frustration with the administration’s response among some of the world’s top medical researchers. Medical journals sometimes run signed editorials that take political stances, but rarely do publications with The Lancet’s influence use the full weight of their editorial boards to call for a president to be voted out of office.

“It’s not common for a journal to do that – but the scientific community is getting increasingly concerned with the dangerous politicization of science during this pandemic crisis,” said Benjamin Corb, public affairs director for the nonprofit American Society for Biochemistry and Molecular Biology. “We watch as political leaders tout unproven medics advice, and public health and science experts are vilified as partisans – all while people continue to get sick and die.”

The Lancet published the editorial as the death toll in the United States surpassed 85,000 and many states moved to reopen businesses and ease coronavirus restrictions that experts say are necessary to contain the virus.

The journal said that while infection and death rates have declined in hard-hit states such as New York and New Jersey after two months of virus restrictions, new outbreaks in Minnesota and Iowa have raised questions about the efficacy of the Trump administration’s response.

The authors accused the administration of undermining some of the CDC’s top officials, saying the agency “has seen its role minimized and become an ineffective and nominal adviser”. They said the agency, which is supposed to be the primary contact for health authorities during crises, had been hamstrung by years of budget cuts that have made it harder to combat infectious diseases. The editorial also alleged the administration left an “intelligence vacuum” in China when it pulled the last CDC officer from the country in July.

The Lancet took the CDC to task too, criticizing its botched rollout of diagnostic testing in the critical early weeks when the virus began to spread in the United States. The country remains ill-equipped to provide basic surveillance or laboratory testing to combat the disease, the journal said.

“There is no doubt that the CDC has made mistakes, especially on testing in the early stages of the pandemic,” the editorial said. “But punishing the agency by marginalizing and hobbling it is not the solution.”

“The Administration is obsessed with magic bullets – vaccines, new medicines, or a hope that the virus will simply disappear,” it continued. “But only a steadfast reliance on basic public health principles, like test, trace, and isolate, will see the emergency brought to an end, and this requires an effective national public health agency.” A White House spokesperson did not immediately respond to a request for comment on Friday morning.

The Lancet editorial board has criticized the actions of government officials before, although rarely, if ever, has it waded into electoral politics. During the Obama administration, a 2015 editorial from the publication demanded an independent investigation into a US military airstrike on a Doctors Without Borders hospital in northern Afghanistan that killed 42 people. The Lancet called the attack a violation of the Geneva Conventions and dismissed then-president Barack Obama’s apology for the bombing.

Editor of The Lancet Richard Horton has decried the British government’s response to the pandemic in editorials and public statements published under his name. In a tweet earlier this week, he said Boris Johnson had “dropped the ball” in containing the virus.

Dr. Sudheer S Chauhan, Another Indian American Physician Succumbs to Deadly Corona Virus

Dr. Sudheer S Chauhan, a kind hearted physician of Indian Origin, who had dedicated his life at the service of his thousands of patients in the New York region, succumbed to the deadly corona virus on May 19th.
Dr. Chuhan, an Internal Medicine specialist in South Richmond Hill, New York, who was diagnosed with COVID-19 and battling for his life for the past few weeks, died of complications from the illness.
“Our Father, Dr. Sudheer Singh Chauhan, Internal Medicine Physician and Associate Program Director IM Residency Program at Jamaica Hospital, New York passed away on May 19 after battling with COVID  for two months. We will miss this unique, kind, gentle and caring spirit. May his soul rest in peace,” wrote his daughter, Sneh Chuhan on COVID-19 Physicians Memorial.
Dr. Chauhan, who had attended and graduated from medical school in 1972, has had nearly half a century  of diverse experience, especially in Internal Medicine. Dr. Chauhan received his graduate medical education from GSUM Medical College, University of Kanpur, India in 1972. He was chief resident in Internal Medicine at Jamaica Hospital and graduated in 1997. He is Board Certified in Internal Medicine. He also received MRCP and FRCP from Royal College of Physicians and FACP from American College of Physicians.
Dr. Sudheer S Chauhan, Another Indian American Physician Succumbs to Deadly Corona VirusDr. Chauhan joined the Department of Medicine at Jamaica Hospital upon graduation in 1997 and is currently working as a faculty supervisor and attending physician. He is also the Associate Program Director in Internal Medicine Residency Program for the hospital.
Dr. Priya Khanna, 43, another Indian American nephrologist died in a New Jersey Hospital last month. The deadly virus also took the life of her father Satyendra Khanna (78), a general surgeon, after being in a critical condition in the intensive care unit in the same hospital for several days.

“We have a proud moment, it is (also) a scary moment; it is a mixed feeling, but this virus is a deadly virus” Dr. Suresh Reddy, President of the American Association of Physicians of Indian Origin (AAPI), describing the situation under which the physicians of Indian Origin serving people infected with the virus. “They tend to work disproportionately in areas that are medically underserved like rural and inner city areas taking on a heavier workload with patients who are more ill. We are definitely in the frontline fighting this deadly battle,” against the coronavirus, Reddy said.
Dr. Seema Arora, Chairwoman of AAPI’s Board of Trustees pointed to the fact that “The deadly Corona Covid-19 virus has has placed the entire healthcare sector, and in particular the Indian American medical fraternity at the frontlines of the fight against the pandemic.”
“Dr. Chauhan is one of the most loved and admired physicians at the Jamaica Medical Center,” Dr. Raj Bhayani, who has known Dr. Chuhan personally, informed this writer. “He was a very kind hearted person and had served his patients with passion and devotion and taught Medical Residents for several decades.  The Indian American community and the fraternity of doctors, particularly in  the New York region will miss him for ever,” said Dr. Bhayani, President of AAPI-QLI.
During a recent candle light vigil and inter-faith prayer organized by AAPI, with one minute of silence with folded hands and heads bowed, the AAPI members and spiritual leaders prayed for the speedy recovery of Drs. Ajay Lodha, Anjana Samaddar, Dr. Sunil Mehra and thousands of other healthcare professionals who are in the front line and are admitted to hospital and receiving treatment.
 “Even in the midst of scare and fear, healthcare workers including physicians report to work with or without adequate protective equipment to save the lives of others knowing that they could be the next victim,” Dr. Narendra R. Kumar, Past President of AAPI & AKMG, from Michigan, pointed out. “Hundreds of healthcare workers are under quarantine or under active treatment at home and in hospitals. Many of them are on ventilators including few of our senior AAPI leaders struggling for their lives. One thing is clear, this is a deadly disease and doesn’t discriminate anyone, anywhere.”

Dr. Sudheer S Chauhan, Another Indian American Physician Succumbs to Deadly Corona Virus “While it’s more common among elderly and with multiple comorbidities, COVID 19 infection is also common in health care workers as they get exposed during their line of duty. We have reports of several thousands of health care workers who have got COVID 19 infection and many of them are critically ill in intensive care unit. Several Indian American Healthcare professionals  have been admitted in hospitals and we have already lost one young physician to this pandemic. We want to make sure that all health care workers have proper PPE while taking care of these patients,” said Dr. Jayesh Shah, President, South Texas Wound Associates, PA and President, American College of Hyperbaric Medicine.
Dr. Sudhakar Jonnalagadda, President-Elect of AAPI, said,  “The American Association of Physicians of Indian Origin (APPI) the largest ethnic medical organization in the country has taken several proactive steps in educating their members and the general public about the disease, the preventive steps that needs to be taken at this time and most importantly, they are using all their contacts and resources at the hospital administrative and government level to facilitate treatment protocols to be in place at the various hospitals around the country.”
Describing Indian American physicians as “the real heroes” Dr. Anupama Gotimukula, Vice President of AAPI said, “Several immigrant physicians work in the New York and New Jersey regions, the epic center of the pandemic. They are struggling with Green Card Backlog and on temporary Visa plans. Due to their vulnerability, they are forced to work and often they have no choice. Not having adequate PPEs while caring for the Covid patients, many have become positive in the process, some have died, some are in ICU now and some are recuperating at home. These are the true saviors and unsung heroes saving the lives of so many Americans. We are proud of the services of Indian American physicians in this country.”
Ravi Kolli, Secretary of AAPI and a Psychiatrist by profession, said, “AAPI members as a group are over represented in all the hot spot areas as well as caring for underserved populations. They are bravely leading the enormous challenge of fighting COVID 19 pandemic at their own personal risk without a second thought which speaks volumes for their compassion, commitment and sense of duty.
“Our Indian American Physicians are down in the trenches in the frontline bravely taking care of the sick,” Dr. Amit Chakrabarty, Regional Director of AAPI pointed out.  “Unfortunately, we have had multiple heart-bearing incidents about our physicians that have contracted the disease while performing their duties, several who are on ventilator and in critical condition and some who have succumbed to the disease.   However, undaunted, they continue to perform their duties in this time of national crisis.”
“Indian American Physicians are bearing the brunt of this pandemic in the US,” said Dr. Joseph M. Chalil, a cardiologist and professor at several Universities in the United States. “Not a day goes by without hearing about many of them getting infected with Coronavirus, and several of them fighting for their life, because of their disproportionate share of the population in the Healthcare field. This pandemic is hitting close to home for me and my colleagues,” Dr. Chalil said.
Expressing his anguish that “There is no standardized treatment protocols available at this time but multiple trial therapies are being conducted at several institutions around the world,” Dr. Narendra Kumar is “very optimistic that Convalescent plasma therapy, anti-viral drug Remdesivir and other medications will be made available with significant promising results in the coming days and weeks. We are also working on a national level to make new treatment protocols easily available to the needy patients by eliminating the unnecessary policy and procedural delays which is costing many valuable lives.”
There have been proud moments for the Indian American Doctors. Last week,  Dr. Uma Madhusudana, who graduated from Mysore Medical College, and currently working in a New York Hospital treating Covid19 patients, saving several lives was honored. More than 200 cars with recovered patients, relatives and police passed through in front of her house to express their gratitude for her services. It was indeed a great experience.
Known around the world for their compassion, expertise, brilliance and intellect, Indian American physicians are reputed for the quality healthcare they provide to millions of their patients in the United States. In patient care, administration, leadership or academics, they have excelled in their respective fields, holding important positions across the United States and the world.
Indian-Americans constitute less than one percent of the country’s population, but they account for nine percent of the American doctors and physicians. One out of every seven doctors serving in the US is of Indian heritage, providing medical care to over 40 million of US population.
There are about 80,000 practicing Indian American physicians who are at the forefront of fighting COVID-19 pandemic in the United States. In addition, there are around 40,000 medical students, residents, and fellows of Indian origin in this country who are supporting many of the hospitals affected by the pandemic.
Expressing hope, Dr. Amit Chakrabarty says, “AAPI members continue to donate money for AAPI to provide essential personal protective equipment to areas that are in short supply. Finally, AAPI has provided through various channels, spiritual and motivational guidance to our members and their families.  We are in this together and we will emerge victorious.  That is our belief and are working hard towards it.”

Beyond Trump — US, UN & Global Health Governance

Lawrence Surendra, an environmental economist, is former staff member of UN-ESCAP and has worked with UNU and UNESCO. He advises on the UN SDGs and currently a Council Member of TSP Asia (www.tspasia.org) and lives in South India.

(IPS) – US President Donald Trump’s battle with the World Health Organization (WHO) hides two important issues. One, the long running love-hate relationship between the US and the UN, and two, a better understanding of how global public health is governed and in the overall context of global governance.

We must first recognize, that notwithstanding Trump’s disdain for multilateralism and international institutions especially the UN, his behavior is basically consistent with history of the US threatening UN institutions periodically by withholding financial contributions.

One should not therefore let the impression gain, especially among younger generations not familiar with global and international politics, that the US as a power is innocent and Trump is but a bull in the China shop of international governance and global public policy.

As for the love-hate relationship of the US with the UN, just rewind back to the days of President Reagan in the 1980s and which saw the peak of such hostility to the UN. Advised by the conservative Heritage Foundation, the US pulled out of the UN Educational, Scientific and Cultural Organization (UNESCO).

The latter decision though, was only a shadow play; behind the scenes the US severely undermined the work of important UN agencies like the International Labour Organization (ILO) and the UN Conference on Trade and Development (UNCTAD). The UN Centre on Transnational Corporations (UNCTC) seen as opposed to US multinationals was dismantled. The resignation letter of Peter Hansen, the Danish Director of UNCTC then made him a cause celebre.

UN agencies such as UNCTC, working on a Code of Conduct for TNCs and WHO with its Drugs for All policy were viewed with suspicion by US corporate interests especially US pharmaceutical and agribusiness companies. The Food and Agriculture Organization (FAO) was not spared either.

The US made sure that the FAO was under the influence of US multinational companies especially US agribusiness and in critical areas such as the International Board for Plant Genetic Resources of the FAO and in the Codex Alimentarius to weaken and undermine regulation of US TNCs.

One cannot forget, the ignominious manner in which Dr. Gamani Corea the eminent Sri Lankan economist was asked to quit as Secretary General of UNCTAD by the US. Countries like India were singled out and the role they played at the UN monitored.

India’s independent international public policy then while seen as valuable for the international community was viewed as a threat to US domination of international institutions and attacked. India’s role at the UN was relevant to not only India’s national interests and the developing world but also to Europe and Scandinavian Countries.

India made significant contributions, for example, in the creation of the South Centre, an institution, that was relevant in contributing to the international public policy of developing countries; its relevance continues even more so in the context of issues such as global taxation regimes and how India, as well as developing countries are being deprived of taxes from TNCs.

The Reagan and Thatcher domination of the international arena in the 1980s saw the North-South dialogue being scuttled. Mrs. Gandhi, a trusted leader of developing countries and the global South, played a major role on their behalf, in trying to bring the North-South Dialogue back on track. She did this, even while India was facing the brunt of US pressure including in strategic and national security terms.

A meeting of world leaders in Cancun, Mexico, in 1981, was possibly the last of the North-South Dialogue meeting, where Mrs Gandhi met with Reagan to work out a compromise. However, what resulted was the South being thrust with the Uruguay Round of GATT negotiations instead of the North-South Dialogue.

The Uruguay Round, after a decade or more of tortuous negotiations led by the US, and for US dominance in world trade though projected as promoting free trade, produced an elephant in the form of the WTO. The latter seems to have now metamorphosed to a mouse.

As for Trump and WHO, let us not make the mistake that withdrawal of US funding means any less influence of the US or its corporate interests in the WHO. More so in influencing global public health policies.

A must read and very relevant in this regard is the book by Chelsea Clinton (yes President Clinton’s only daughter) and Devi Sridhar, Professor at the University of Edinburgh’s Medical School, who holds the Chair in Global Public Health.

The book was published in 2017, as if anticipating the unique global public health crisis of today. Appropriately titled, ‘Governing Global Health’ with an even more piercing sub title, “Who Runs the World and Why?’, the book tells us as a lot about what is happening regarding how Public Health is governed globally.

In the Preface, they present a clear case as to why such a book now, and point out, that we live in the best of times as well as the worst of times and give reasons for saying so. The book deserves an in-depth review, but for now in the present conjecture of COVID 19 it is important to first bring the book to public notice.

The Covid Pandemic, has also kept social media abuzz with conspiracy theories especially around Bill Gates his Foundation and the profits to be made in the vaccines to be developed. This given the Gates Foundation’s large financial contributions to the GAVI (Global Alliance for Vaccines and Immunization) and the Global Fund.

While there may be grains of truth as in all conspiracy theories, unfortunately their wild allegations also damage serious important initiatives such as the UN SDGs (especially SDG 3) and the 2030 Road Map by making them part of these conspiracies.

Another reason to read this book, and be informed not only who the actors in global public health governance are, but more importantly how global public health governance has shifted from UN institutions governed by Member States to Global Public Health International NGOs and private companies.

This is especially so with the rise of this nebulous and ubiquitous practice (recognised by the authors) of Public Private Partnerships (PPP) and its increasing dominance in international cooperation and governance including ironically the UN.

It might be nice to repeat the oft repeated statements of present and past UN bureaucrats about UN institutions being governed by Member States but they all miss a major reality of today’s world. A reality succinctly captured by Kofi Annan in 1999 and quoted in the book.

He has noted that, “our post War institutions were built for an international world, but we now live in a global world”. Negotiating this “global world” is not easy for nation states and more so for international and UN institutions. In this world crisis we need the UN more than ever before.

At this moment of deep crisis for global public health and global governance, we are fortunate that like the late Kofi Annan and Ban Ki-Moon of the past, we now have a Secretary General, in the person of Antonio Guterres who commands both respect and legitimacy. Even before the pandemic, he was faced with the unenviable task of steering the UN through massive financial constraints that it was already in”

The challenge for the UN and its agencies including the WHO is far greater now including establishing their legitimacy. The implementation of the UN Sustainable Development Goals which is in its fifth year of its launch will be seriously affected.

The role of the UN as a global public goods organization can be reclaimed by using the SDGs and thus also gain greater legitimacy for the work of the UN. This is the route to be taken for the UN’s own survival, not the narrow public-private partnerships that excludes wider partnership with other actors and will make a big difference.

UN staff, in an age of ‘ultra-nationalism’ should keeping with their allegiance to the UN and its Charter, vaccinate themselves from such toxic nationalism, and remind themselves that they are International Civil Servants serving the needs of global public goods.

They should reassure themselves that the shrinking budget of the UN for a global institution needed in a crisis, is no more than that of a small European City Municipality and the budget of the WHO is perhaps as much as a medium sized New York hospital and rededicate themselves with a new sense of ethics and purpose and work on synergy, coherence and partnership as the core thrust of their work.

-+=